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ABSTRACT 
 
 
DEVELOPMENT OF SPINAL NEURONAL HYPEREXCITABILITY AND 
STRUCTURAL PLASTICITY AFTER CERVICAL FACET INJURY: 
IMPLICATIONS FOR MODULATING PERSISTENT PAIN 
 
 
Nathan D. Crosby 
 
 
Beth A. Winkelstein 
 
 Chronic neck pain is a prevalent and costly condition that commonly develops 
after whiplash injuries. The cervical facet joint and its capsular ligament are frequently 
identified as a source of pain in patients, particularly those with whiplash-associated 
disorders. Spinal neuronal hyperexcitability is a common feature of persistent pain that 
can be induced by enhanced excitatory signaling in the dorsal horn. Spinal dorsal horn 
neurons develop hyperexcitability after painful facet joint injury, but the 
neurophysiological mechanisms that lead to spinal hyperexcitability and persistent pain 
after facet joint loading remain unclear. This thesis uses a rat model of painful facet joint 
injury to define the peripheral and spinal signals that promote dorsal horn neuronal 
hyperexcitability. In particular, the development of spinal hyperexcitability is evaluated 
by characterizing neuronal activity at multiple times within the first day after painful 
facet joint injury. To evaluate the role of injury-induced joint afferent activity in the 
potentiation of excitatory signaling and spinal neuronal excitability, afferent activity is 
blocked at various times after painful facet joint injury. Excitatory synaptogenesis and the 
mechanisms inducing synaptogenesis are evaluated to determine whether structural 
plasticity in the spinal cord contributes to facet-mediated pain. Spinal cord stimulation 
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(SCS) is an effective clinical therapy that attenuates chronic pain by modulating spinal 
hyperexcitability, but the mechanisms and effectiveness of SCS for persistent neuropathic 
or joint-mediated pain remain unclear. This thesis evaluates the use of a novel mode of 
SCS, burst SCS, in rat models of cervical radiculopathy and painful facet joint injury. 
The role of GABA signaling in the inhibitory effects of burst SCS on dorsal horn neurons 
is assessed by applying GABA receptor antagonists to the spinal cord during the 
application of burst SCS. Studies in this thesis demonstrate that afferent discharge 
induced by injurious loading of the facet joint initiates excitatory synaptic and structural 
changes in the spinal cord that promote neuronal hyperexcitability, but SCS can attenuate 
persistent pain by reducing spinal hyperexcitability. This thesis provides a foundation for 
future investigations into the mechanisms underlying the transduction of mechanical joint 
injury to centrally-mediated pain and the development of effective therapies for chronic 
pain. 
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CHAPTER 1 
 
Introduction and Background 
   
 
1.1. Introduction 
Chronic pain affects at least one in three adults in the United States, and has an 
estimated annual cost of over $635 billion (Roehr, 2011). Costs associated with painful 
spine conditions alone increased by 65% to $85.9 billion between 1997 and 2005, 
reaching expenditures similar to the costs associated with diabetes and cancer (Martin et 
al., 2008). The prevalence of spine pain has been reported at 26-66% in the general 
population, with a 30-50% annual incidence of neck or cervical spine pain (Hogg-
Johnson et al., 2008; Linton et al., 1998; Martin et al., 2008). Whiplash injuries are a 
primary cause of cervical spine pain, and account for up to 53% of the injuries from 
motor vehicle accidents (Freeman et al., 1999). The annual incidence of whiplash-
associated pain has been reported to be at least 300 per 100,000 people in the United 
States (Holm et al., 2008). Furthermore, up to 50% of the patients with whiplash injuries 
develop chronic pain that is resistant to conservative interventions, like exercise and 
physical therapy (Sterling et al., 2012). Recent increases in clinical interventions for 
chronic neck pain (Manchikanti et al., 2013), and the fact that motor vehicle collisions 
continue to be a leading cause of emergency room visits (Quinlan et al., 2004), suggest a 
continued growth in the prevalence of whiplash injuries. 
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Many different tissues in the cervical spine have the capacity to generate pain 
from injurious mechanical loading owing to their innervation by nerve fibers that detect 
and transmit painful signals (Antonacci et al., 1998; Inami et al., 2001; McLain, 1994; 
Rhalmi et al., 1993). Among those tissues with the potential to generate pain, the cervical 
facet joints are most commonly implicated as the source of chronic pain after whiplash 
(Barnsley et al., 1995; Lord et al., 1996; Manchikanti et al., 2004). The facet joints are 
bilateral articulations between each pair of vertebrae that guide the motions of the 
vertebrae. Each joint is enclosed by a facet capsular ligament, or facet capsule, that is 
highly innervated with primary afferent nerve fibers that detect both low-threshold 
mechanical stimulation and noxious, painful stimulation (Cavanaugh et al., 1989; 
McLain, 1994; Yamashita et al., 1990). Those primary afferent fibers converge in the 
dorsal horn of the spinal cord, where they transmit sensory information to second-order 
neurons that integrate and project signals supraspinally (Steeds, 2009). 
The cervical facet joints are at risk for excessive loading during abnormal motions 
of the cervical spine. Biomechanical studies of human volunteers and cadaveric subjects 
have determined that the facet joint can undergo injurious motions during simulated low-
velocity rear-impact collisions (Bogduk and Yoganandan, 2001; Deng et al., 2000; 
Kaneoka et al., 1999; Panjabi et al., 1998c; Winkelstein et al., 2000). These abnormal 
motions of the facet joint can cause tensile and shear loading of the facet capsular 
ligament, resulting in strains exceeding the physiologic limit of the capsule (Panjabi et 
al., 1998b; Pearson et al., 2004; Siegmund et al., 2001). In a goat model of tensile loading 
of the facet joint, facet capsule stretch has also been shown to activate the nerve fibers 
that innervate the joint (Chen et al., 2006; Lu et al., 2005a), suggesting that joint loading 
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has the potential to induce painful signals that are transmitted from the joint to the spinal 
cord. Despite evidence of the transduction of mechanical loading to potentially painful 
neural signals, the relationship between facet joint loading and the development of 
persistent joint-mediated pain is still unclear. 
Nociceptive pain is the normal sensory response to stimulation that exceeds the 
activation threshold of nociceptors, which are the nerve fibers that specifically respond to 
noxious stimuli (Loeser and Treede, 2008). Nociception typically persists only in the 
presence of continued suprathreshold stimulation, but pathological pain can develop after 
tissue damage and persist even in the absence of noxious stimulation (Coderre et al., 
1993; Steeds, 2009). Chronic pain can be maintained by central sensitization, a state in 
which the second-order neurons that integrate sensory information in the spinal dorsal 
horn become hyperexcitable (Latremoliere and Woolf, 2009; Loeser and Treede, 2008). 
Both nociceptive and nonpainful signals that converge in the spinal cord can be amplified 
by increased excitability and decreased activation thresholds of the dorsal horn neurons. 
Central sensitization is initiated by a period of sustained afferent discharge (Seltzer et al., 
1991a; Wall et al., 1974), which can occur after excessive loading of the joint that leads 
to increased firing of the primary afferents that innervate the facet capsule (Lu et al., 
2005a); despite this notion, no study has defined the role of afferent firing from the facet 
joint in the onset of central sensitization. 
Central sensitization is associated with widespread changes in the spinal cord that 
enhance neuronal excitability and promote persistent pain after tissue injury. For 
example, potentiation of excitatory glutamatergic signaling can amplify nociception by 
increasing the firing of neurons in the spinal regions that integrate and transmit painful 
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signals (Basbaum et al., 2009; Latremoliere and Woolf, 2009). Structural plasticity, like 
the growth of new excitatory synapses, can also promote aberrant nociception in the 
spinal cord by increasing the number of excitatory inputs to the dorsal horn neurons 
(Jaken et al., 2010; Peng et al., 2010). Noxious loading of the rat facet joint has been 
shown to induce dorsal horn neuronal hyperexcitability and spinal modifications that 
contribute to the potentiation of glutamatergic signaling (Dong and Winkelstein, 2010; 
Lee et al., 2004a; Lee et al., 2008; Quinn et al., 2010b). However, the neurophysiological 
mechanisms that underlie the development and maintenance of spinal hyperexcitability 
after excessive loading of the facet joint are unknown. 
Central sensitization leads to the development of hyperalgesia, defined as a 
general increase in pain sensitivity, and allodynia, defined as a painful response to a 
typically non-noxious stimulus (Loeser and Treede, 2008). Hyperalgesia can develop 
both at the site of injury (primary hyperalgesia) or at remote locations in which there is 
no tissue injury (secondary hyperalgesia) because of the amplification of nociceptive 
signals as they converge in the spinal cord from widespread anatomical regions (Coderre 
et al., 1993). Many of the symptoms exhibited by patients with whiplash-associated pain 
are indicative of central sensitization, including decreased pain thresholds in the neck and 
back, and at distant sites with no tissue damage, like the head, arms, and legs (Banic et 
al., 2004; Curatolo et al., 2001; Curatolo et al., 2004; Herren-Gerber et al., 2004; Jansen 
et al., 2008; Lord et al., 1996). In order to prevent the development of persistent pain or 
treat the symptoms of pain after facet joint injury, the timeline and factors affecting the 
onset of facet joint pain must be elucidated. However, despite the development of 
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primary and secondary hyperalgesia after whiplash, the relationship between facet joint 
injury and the development of centrally-mediated pain has not been defined.  
Current treatment strategies for facet joint-mediated pain focus on reducing pain 
by eliminating nociceptive input from symptomatic facet joints using peripheral nerve 
blocks or neurotomy; however, the effects of those treatments invariably are only 
temporary and patients require periodic re-intervention (Barnsley et al., 1995; Lord et al., 
1996; Manchikanti et al., 2008). The inability of peripheral interventions to permanently 
reverse central sensitization after its onset is common across many different models of 
neuropathic and inflammatory pain (Araujo et al., 2003; Shankarrapa et al., 2012; Xie et 
al., 2005). For patients with facet joint-mediated pain after whiplash, conventional 
treatment strategies, including physical therapy, pharmacological interventions, or 
blocking nerve conduction from the facet joint, fail to target the hyperexcitability of the 
neurons in the spinal dorsal horn that contribute to persistent pain (Lord et al., 1996; 
Manchikanti et al., 2008; Peeters et al., 2001). Direct modulation of spinal 
hyperexcitability, as occurs with spinal cord stimulation, may be more effective for 
treating persistent pain after the development of central sensitization (Cameron, 2004; 
Compton et al., 2012; Simpson, 1997). Yet, the effectiveness and mechanisms of spinal 
cord stimulation for the reduction of spinal hyperexcitability require further investigation. 
The next sections of this chapter provide relevant background information about 
the cervical spine and facet joint anatomy, neuroanatomy, facet joint injury and whiplash 
kinematics, central sensitization, in vivo animal models for the study of facet joint pain, 
and spinal cord stimulation. Additional background information related to the specific 
studies is also provided at the beginning of each chapter as relevant. 
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1.2. Background 
1.2.1. Cervical Spine and Facet Joint Anatomy 
The cervical spine is comprised of seven articulating vertebrae that are supported 
by soft tissues, including ligaments, musculature, and cartilage. Each pair of bony 
vertebrae is connected by the collagenous intervertebral discs ventrally, and by the 
bilateral articulating facet (or zygapophyseal) joints posterolaterally (Fig. 1.1a). The facet 
joints are formed by contact of the superior and inferior articular facets of two adjacent 
vertebrae (Fig. 1.1a). The articulating surfaces of the facet joints are covered by articular 
cartilage and lubricated by synovial fluid to allow the vertebral bodies to rotate with 
respect to each other during normal head and neck motion (Fig. 1.1b). The joints guide 
and limit motions of the head and neck, while protecting the spinal cord from mechanical 
loading (Lang, 1993; Watson et al., 2009). The joint space and synovial fluid are 
 
 
Fig. 1.1. Lateral view of the human cervical spinal column. (a) The facet joints are 
formed by the superior and inferior articulating processes of each pair of vertebrae 
(adapted from Benzel, 2012). (b) The articulating surfaces of the facet joints are 
covered with cartilage (blue), and the facet capsule (red) encloses the joint space. 
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enclosed by the facet capsular ligament, or facet capsule (Fig. 1.1b) (Jaumard et al., 
2014), which is a heterogeneous, fibrous structure composed of dense bundles of collagen 
and elastic fibers (Yamashita et al., 1996). 
The cervical facet joints are innervated by the medial branches of the dorsal 
primary rami immediately superior and inferior to the joint, although the joint can be 
innervated to a lesser degree by the dorsal rami of more distant spinal levels (Bogduk and 
Marsland, 1988; Kras et al., 2013a; Ohtori et al., 2001). The facet capsule, in particular, 
is innervated by mechanosensitive nerve fibers that are activated by capsule stretch 
(Cavanaugh et al., 1989; McLain, 1994; Yamashita et al., 1990). Many mechanosensitive 
fibers in the capsule exhibit proprioceptive properties, suggesting that the capsule 
communicates information about head and neck position and movement (McLain and 
Pickar, 1998). The capsule also contains free nerve endings that are typically associated 
with nociceptors, the nerve fibers that specifically respond to painful stimuli (Cavanaugh 
et al., 1989; McLain, 1994). A subset of the nerve fibers in the capsule express substance 
P (SP) and calcitonin gene-related peptide (CGRP), two neuropeptides with demonstrated 
roles in nociception, further suggesting that the facet joint is likely capable of signaling 
pain under excessive mechanical loading conditions (Beaman et al., 1993; Inami et al., 
2001; Kallakuri et al., 2004; Ohtori et al., 2000; Yamashita et al., 1993). 
 
1.2.2. Neuroanatomy and Neurophysiology of Nociception 
Sensory signals are transmitted from the periphery to the spinal cord through 
primary afferent nerve fibers. Primary afferents project axons distally from the dorsal 
root ganglia (DRG) to innervate peripheral targets and centrally to the spinal cord (Grant 
 8 
and Robertson, 2004). Primary afferents are classified into several groups (Aα/β, Aδ, C) 
based on their structure and function. Aα and Aβ fibers (also called group I and II fibers) 
have large, myelinated axons and rapid conduction velocities (Guyton and Hall, 1996). 
They generally respond to innocuous mechanical stimuli or movement, and are classified 
as low-threshold mechanoreceptors or proprioceptors. The other two types of fibers, Aδ 
(group III) and C fibers (group IV), are classified as nociceptors and contribute to the 
sensation of pain (Steeds, 2009). Aδ fibers are thinly myelinated, with smaller diameters 
and slower conduction velocities than Aβ fibers, and are thought to evoke sharp, pricking 
pain and “fast” pain (Basbaum et al., 2009; Guyton and Hall, 1996; Meyer et al., 2006). C 
fibers have small-diameter, unmyelinated axons with relatively slow conduction 
velocities, and transmit “slow” pain and diffuse pain from heat and pressure (Basbaum et 
al., 2009; Meyer et al., 2006). C fibers are further classified as peptidergic fibers, if they 
express SP and CGRP, or non-peptidergic fibers, based on the expression of the 
purinergic ATP receptor, P2X3, or binding of isolectin B4 (Braz et al., 2005; Snider and 
McMahon, 1998). 
Nociceptive pain is established in response to stimuli (mechanical, chemical, 
thermal, etc.) that exceed the activation thresholds of nociceptive afferent fibers. 
Nociception is a protective response designed to warn of impending tissue damage, so it 
typically continues only in the presence of noxious stimuli (Costigan et al., 2009). 
However, repetitive stimulation of afferent fibers can temporarily sensitize them by 
inducing wind-up, which is a progressive increase in dorsal horn neuronal firing in 
response to repetitive stimulation of nociceptive afferents (Woolf and Salter, 2000), or 
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afterdischarge, which is a continuation of afferent firing after the termination of the 
initiating stimulus (Li et al., 1999). 
Afferents synapse in the spinal cord with three main classes of second-order 
neurons (Fig. 1.2). Nociceptive-specific neurons (NS), or high-threshold (HT) neurons, 
receive input only from nociceptive afferents, therefore they are only activated by 
noxious stimuli (Dostrovsky and Craig, 2006; Steeds, 2009). Wide dynamic range 
(WDR) neurons receive input from non-nociceptive and nociceptive afferents, and 
exhibit a graded response to innocuous and noxious stimuli (Baron, 2006; Basbaum et al., 
2009; Dostrovsky and Craig, 2006; Steeds, 2009). Low-threshold mechanoreceptors 
(LTM) only process light touch sensation from innocuous stimuli. 
 
 
 
Fig. 1.2. Primary afferent connections in the spinal dorsal horn. The superficial 
laminae (I-II) contain nociceptive-specific (NS) neurons that receive input from C and 
Aδ fibers. The deep laminae (III-VI) contain wide dynamic range (WDR) and low-
threshold mechanoreceptive (LTM) neurons that receive input from Aδ and Aβ fibers 
(adapted from Basbaum et al., 2009). Also shown are the dorsal columns, where some 
Aβ fibers collateralize without first synapsing in the dorsal horn. 
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Primary afferents synapse with second-order neurons in the dorsal horn region of 
the spinal cord. The dorsal horn is organized into laminae, or layers, that contain 
specialized populations of second-order neurons, and receive input from specific groups 
of afferent fibers (Fig. 1.2) (Grant and Koerber, 2004; Molander et al., 1989; Rexed, 
1952; Todd and Koerber, 2006; Watson et al., 2009). For example, the most dorsal, 
superficial laminae (laminae I and II) almost exclusively contain NS neurons and the 
central terminals of nociceptive Aδ and C fibers (Fig. 1.2) (Basbaum et al., 2009; Todd 
and Koerber, 2006). In contrast, Aβ mechanoreceptors and some additional Aδ fibers 
terminate largely at WDR and LTM neurons in the deeper laminae (laminae III-VI) (Fig. 
1.2) (Basbaum et al., 2009; Grant and Robertson, 2004; Todd and Koerber, 2006).  
Secondary neurons project supraspinally from the dorsal horn, carrying sensory 
information to the brain. Most nociceptive signals are conveyed to the brainstem and 
thalamus through the spinothalamic and spinoreticular tracts (Fig. 1.3) (Basbaum et al., 
2009; Watson et al., 2009). For projection of low-threshold mechanical signals, some Aβ 
fibers collateralize into the dorsal horn and send mechanosensory information through the 
spinothalamic and spinoreticular pathways (Fig. 1.3) (Yaksh and Luo, 2001; Steeds, 
2009). However, a large number of Aβ fibers also project directly through the dorsal 
columns, carrying proprioceptive and light touch signals to the brainstem without first 
synapsing in the dorsal horn (Figs. 1.2 and 1.3) (Steeds, 2009; Watson et al., 2009). 
 
1.2.3. Whiplash Kinematics and Facet Joint Injury 
The facet joint and its capsular ligament are among the cervical spinal tissues with 
the potential to generate pain during its excessive mechanical loading. Distension of 
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the cervical facet joints in normal subjects by intra-articular injection of fluoroscopic 
contrast medium produces neck pain in distributions similar to those observed after 
whiplash (Dwyer et al., 1990). Additionally, the cervical facet joints have been 
implicated as the source of pain in 54-60% of whiplash patients using diagnostic blocks 
of symptomatic joints with intra-articular injection of local anesthetics (Barnsley et al., 
1995; Lord et al., 1996; Manchikanti et al., 2004). The lower cervical levels (C5-C7) are 
the most common source of neck and shoulder pain (Barnsley et al., 1995; Bogduk and 
Marsland, 1988). Local anesthetic block or radiofrequency ablation of the medial 
branches of the dorsal rami that innervate the symptomatic facet joints attenuates pain 
(Aprill, 1990; Lord et al., 1996; Manchikanti et al., 2004), further supporting the role of 
the facet joints as a primary source of pain following whiplash. 
 
Fig. 1.3. Ascending pathways from the spinal dorsal horn. Input from primary afferent 
fibers converges in the spinal dorsal horn, and then continues through spinothalamic 
tract projections that convey sensory information to the brain. Aβ fibers can also 
project supraspinally through the dorsal columns (adapted from Baron, 2006). 
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Facet joint injury has been hypothesized to result from excessive loading of the 
facet capsular ligament beyond its physiologic limit. Biomechanical studies using human 
volunteers and post-mortem human subjects have defined the kinematics of the head and 
cervical spine during simulated low-velocity rear-impact collisions (Deng et al., 2000; 
Ono et al., 1997; Panjabi et al., 1998a; Pearson et al., 2004; Sundararajan et al., 2004; 
Winkelstein et al., 2000; Yoganandan et al., 2001). Based on high-speed X-ray imaging 
of the cervical spine during rear impact, the spine forms an S-shaped curvature within the 
first 100-120ms after impact, with the upper cervical spine undergoing flexion and the 
lower cervical spine being extended (Fig. 1.4) (Bogduk and Yoganandan, 2001; Kaneoka 
et al., 1999; Panjabi et al., 1998c). Extension and vertebral retraction at the lower cervical 
spinal levels produces tensile and shear loading across the facet joints and capsular 
ligaments (Fig. 1.4) (Luan et al., 2000; Panjabi et al., 1998b; Panjabi et al., 1998c; 
Siegmund et al., 2001; Winkelstein et al., 2000).  
 
 
 
Fig. 1.4. Deformation of the cervical spine during rear-impact. Abnormal motions of 
the cervical spine, including excessive extension in the lower cervical levels, can 
induce excessive strains in the facet capsule that exceed the physiologic levels (adapted 
from Croft, 2000). 
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Facet capsule strains from joint loading during low-speed rear impacts can be as 
high as five times the peak strains that are observed for the same cervical levels during 
normal neck bending (Panjabi et al., 1998b; Pearson et al., 2004). Capsule strains during 
simulated rear-impact collisions are the greatest at the lower cervical facet joints, peaking 
at 38.5±24.6% strain at the C5/C6 joint and 39.9±26.3% strain at the C6/C7 joint during 
8g accelerations (Pearson et al., 2004), potentially explaining the prevalence of 
symptomatic C5-C7 facet joints reported after whiplash (Barnsley et al., 1995; Bogduk 
and Marsland, 1988). Capsular strains can be further increased by more complicated out-
of-plane head postures, such as a turned head (Sundararajan et al., 2004; Winkelstein et 
al., 2000). 
Up to 77% of the nerve fibers that innervate the cervical facet capsule are 
activated by physiologic or noxious stretching of the capsule in a goat model of tensile 
facet joint loading, and the discharge of nerve fibers is directly related to the magnitude 
of facet capsule stretch (Chen et al., 2006; Lu et al., 2005a; Lu et al., 2005b). Although 
mechanosensitive fibers are activated by strains as low as 10%, a subpopulation of high-
threshold nociceptors are only activated by noxious strains of 47.2±9.6% (Lu et al., 
2005a). Many activated fibers also exhibit afterdischarge, which is a continuation of 
afferent firing after the termination of the initiating stimulus, for up to 30 minutes after 
the facet joint is returned to the unloaded configuration (Cavanaugh et al., 1989; Lu et al., 
2005a). Those studies collectively establish the role of nerve fibers in transducing the 
magnitude of facet joint loading into proprioceptive and nociceptive signals. However, no 
study has investigated the role of discharge and afterdischarge of capsule-innervating 
fibers in the development of persistent facet-mediated pain. 
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1.2.4. Central Sensitization 
Sensory signals are processed in the spinal dorsal horn by the convergence of 
excitatory input from afferent fibers, local excitation and inhibition from interneurons, 
and descending supraspinal inhibition (Fig. 1.3). Nociception can, therefore, be 
augmented or suppressed by changes in those convergent inputs that alter dorsal horn 
neuronal excitability. Central sensitization is a state in which nociceptive signaling is 
amplified by spinal neuronal hyperexcitability, resulting in persistent pain that outlasts 
the inciting injury or tissue damage (Latremoliere and Woolf, 2009). Central sensitization 
is characterized by altered neuronal function in the spinal cord that includes increased 
spontaneous activity, reduced thresholds for activation, heightened responses to both non-
noxious and noxious stimuli, and expansion of receptive fields (Coderre et al., 1993; 
Latremoliere and Woolf, 2009; Woolf, 1983; Woolf and Salter, 2000). Those functional 
changes in the central nervous system (CNS) result in spontaneous pain, painful 
responses to typically non-noxious stimuli like light touch (allodynia), and 
hypersensitivity to noxious stimuli at the site of injury (primary hyperalgesia) and at 
regions distant from the site of injury (secondary hyperalgesia) (Coderre et al., 1993; 
Lamotte et al., 1991). 
Central sensitization is initiated by sustained afferent firing that occurs during 
noxious stimulation or tissue injury (Seltzer et al., 1991a; Wall et al., 1974). Blocking the 
increased afferent discharge that accompanies nerve injury effectively reduces the 
subsequent development of central sensitization in models of neuropathic pain 
(Dougherty et al., 1992; Gonzales-Darder et al., 1986; Seltzer et al., 1991a). Blocking 
injury-induced afferent discharge is also a foundational concept for the use of preemptive 
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analgesia in order to reduce postoperative pain (Coderre et al., 1993; Woolf and Chong, 
1983; Woolf and Wall, 1986). Once spinal neuronal hyperexcitability develops, neurons 
can return to a baseline state in the absence of continuing afferent discharge, but 
hyperexcitability can be maintained by low levels of firing, such as the ectopic discharge 
that develops in damaged neural tissue (Devor, 2009; Devor et al., 1992; Djouhri et al., 
2006; Koltzenburg et al., 1992; Xie et al., 2005). Although excessive stretch of the facet 
capsule has been shown to induce increased firing of the afferents that innervate the joint 
(Chen et al., 2006; Lu et al., 2005a), no study has evaluated the role of injury-induced 
afferent discharge from the joint in the development and maintenance of persistent facet-
mediated pain. 
 Many of the changes in the spinal dorsal horn that are associated with central 
sensitization involve altered glutamatergic signaling. Glutamate is the primary excitatory 
neurotransmitter in the CNS (Sheng and Lin, 2001; Yaksh, 2006). Glutamate activates 
several different ionotropic and metabotropic receptors on the post-synaptic membrane 
(Fig. 1.5a). Ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors 
(AMPAR) are permeable to Na
+
 and K
+
 currents and mediate rapid excitatory 
neurotransmission (Yaksh, 2006). N-methyl-D-aspartate receptors (NMDARs) are a 
second class of ionotropic receptor that are activated by glutamate in a voltage-dependent 
manner and, once activated, allow calcium influx into the postsynaptic terminal (Fig. 
1.5b) (Petrenko et al., 2003; Sheng and Lin, 2002; Yaksh 2006). Metabotropic glutamate 
receptors (mGluRs) are a family of G protein-coupled receptors that mediate slower 
synaptic responses. Glutamate binding to group 1 metabotropic receptors, namely 
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mGluR1 and mGluR5, can also contribute to calcium influx by releasing calcium from 
intracellular stores (Fig. 1.5b) (Sheng and Lin, 2002; Yaksh, 2006).  
 
Central sensitization is induced by increases in intracellular calcium from 
NMDAR and group 1 mGluR activation during sustained afferent discharge in the dorsal 
horn (Fig. 1.5) (Petrenko et al., 2003; Soliman et al., 2002; Woolf and Thompson, 1991; 
Young et al., 1997). Calcium influx activates calcium-dependent kinases, including PKC, 
PKA, CamKII, and ERK, that act on numerous targets to directly influence excitatory 
signaling (Fig. 1.5c) (Kawasaki et al., 2004; Latremoliere and Woolf, 2009). For 
example, phosphorylation of AMPARs and NMDARs at multiple sites increases their 
activation kinetics and trafficking to the membrane, enhancing membrane excitability 
 
 
Fig. 1.5. The initiation of central sensitization in the dorsal horn. (a) Glutamatergic 
signaling activates ionotropic (AMPAR, NMDAR) and metabotropic (mGluR5) 
receptors. (b) NMDAR and mGluR5 activation cause calcium influx from external 
and intracellular sources like the endoplasmic reticulum (ER). (c) Calcium influx 
activates kinases (PKC, ERK, and CamKII) and voltage-dependent calcium channels 
(VDCC) to increase membrane excitability and the strength of excitatory synapses, 
leading to neuronal hyperexcitability (adapted from Latremoliere and Woolf, 2009). 
 
 
mGluR5 NMDAR AMPAR
VDCC
mGluR5 NMDAR AMPAR
VDCC
mGluR5 NMDAR AMPAR
VDCC
PKC ERK CaMKII
Ca2+ glutamate
a)
b)
c)
ER
ER
ER
 17 
(Daulhac et al., 2011; Liu and Salter, 2010; Petrenko et al., 2003; Ultenius et al., 2006). 
Activation of calcium-dependent kinases also leads to transcriptional changes that alter 
expression of proteins in primary afferent and dorsal horn neurons to further enhance 
spinal excitability (Kawasaki et al., 2004; Latremoliere and Woolf, 2009). 
Temporal and spatial management of glutamate concentrations in synapses is 
important for preventing aberrant signaling and excitotoxicity. Glutamate signaling is, 
therefore, regulated by astrocytic and neuronal transporters that remove glutamate from 
the synapse (Danbolt, 2001; Liaw et al., 2005). The excitatory amino acid transporters 
(EAAT1-5) are one family of glutamate transporters that are crucial for the regulation of 
extracellular glutamate concentrations in the spinal dorsal horn (Queen et al., 2007). 
EAAT1 and EAAT2 are homologous to two glutamate transporters in the rat, glutamate 
aspartate transporter (GLAST) and glial glutamate transporter 1 (GLT1), and are 
expressed primarily on astrocytes. A third member of the transporter family, EAAT3, is 
neuronally expressed and is homologous to the rat glutamate transporter EAAC1 (Queen 
et al., 2007). In rodent models of neuropathic pain, downregulation of GLAST and GLT1 
contributes to persistent behavioral sensitivity (Hu et al., 2009; Sung et al., 2003; Xin et 
al., 2009), but dorsal horn expression of those astrocytic transporters has not been 
evaluated in the context of facet joint-mediated pain. 
 Astrocytes can also contribute to central sensitization and pathological pain after 
tissue injury. Astrocytes can be activated by excitatory signaling molecules, including 
substance P, glutamate, and ATP, that are released by primary afferent nociceptors in 
response to tissue damage or noxious stimulation (Milligan and Watkins, 2009). Once 
activated, astrocytes increase their expression of glial fibrillary acidic protein (GFAP), 
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vimentin, and nestin, which are intermediate filament proteins that form part of the 
intracellular cytoskeletal network, resulting in hypertrophy of cellular processes 
(Benveniste, 1992; Pekny and Nilsson, 2005). Activated astrocytes in the dorsal horn also 
release substances that can both enhance neuronal excitability (i.e., excitatory 
neurotransmitters, growth factors, and prostaglandins) and promote spinal inflammation 
(i.e., pro-inflammatory cytokines) (Benveniste, 1992; Watkins et al., 2001). Astrocytes 
may play a particularly important role in facet joint-mediated pain, because spinal GFAP 
is upregulated in conjunction with the development of persistent behavioral sensitivity 
after injurious facet joint loading (Lee et al., 2004a; Lee et al., 2008). Separately, anti-
inflammatory treatments and spinal treatments that attenuate neuronal excitability reduce 
GFAP expression in parallel with attenuation of behavioral sensitivity, further supporting 
the contribution of astrocyte activation to facet-mediated pain (Dong et al., 2013a; Dong 
et al., 2013b). 
 
1.2.5. Spinal Structural Plasticity 
Spinal structural plasticity, which is broadly defined as changes in the number, 
distribution, and connectivity of neurons in the spinal cord, has the potential to modify 
CNS processing of sensory signals by introducing aberrant synaptic connections between 
neurons that do not normally synapse. For example, after peripheral nerve injury, low-
threshold Aβ afferents may sprout from the deep laminae of the dorsal horn into the 
superficial laminae and synapse with nociceptive dorsal horn neurons, producing painful 
sensation from normally innocuous stimuli (Woolf et al., 1992). Electron microscopy and 
immunolabeling show increases in synapses and synaptic proteins in the superficial 
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dorsal horn in conjunction with the onset of behavioral sensitivity after nerve injury, 
supporting the potential role of dorsal horn synaptogenesis in neuropathic pain (Chou et 
al., 2002; Chung et al., 1989; Jaken et al., 2010; Lin et al., 2011; Peng et al., 2010). 
Although synaptogenesis may contribute to spinal hyperexcitability by altering the 
connectivity of nociceptive and non-nociceptive afferents and second-order neurons, the 
mechanisms promoting synaptogenesis after injury are unknown. 
Astrocytes are important regulators of synapse assembly in the CNS. In the 
absence of astrocytes, neurons develop only small numbers of immature synapses in vitro 
(Ullian et al., 2001; Christopherson et al., 2005); astrocytes or astrocyte-conditioned cell 
culture media significantly increase the number of functional, mature synapses on 
cultured CNS neurons (Christopherson et al., 2005). Blocking astrocyte activation after 
peripheral nerve injury in the neonatal CNS prevents injury-induced synaptogenesis (Lo 
et al., 2011), suggesting that astrocytes mediate synaptogenesis in pathological settings as 
well. Studies have identified several astrocyte-derived extracellular matrix proteins with 
synaptogenic properties, including hevin, secreted protein acidic and rich in cysteine 
(SPARC), and the thrombospondins (TSP1-5) (Christopherson et al., 2005; Kucukdereli 
et al., 2011). The thrombospondins in particular have been characterized as astrocyte-
secreted factors necessary for CNS synaptogenesis during development (Christopherson 
et al., 2005; Ehlers, 2005; Eroglu et al., 2009; Risher and Eroglu, 2012). One member of 
the thrombospondin family, TSP4, is localized to synapses in the CNS and 
neuromuscular junctions (Arber and Caroni, 1995). Gene array analysis and subsequent 
studies of TSP4 protein expression found upregulation of spinal TSP4 in multiple models 
of neuropathic pain, implicating TSP4 in the development of behavioral sensitivity and 
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dorsal horn neuronal hyperexcitability (Kim et al., 2009; Kim et al., 2012; Li et al., 
2014a; Zeng et al., 2013). However, despite the synaptogenic properties of TSPs, the 
mechanisms by which TSP4 contributes to behavioral sensitivity and neuronal 
hyperexcitability remain unclear. 
 
1.2.6. In Vivo Animal Models of Facet-Mediated Pain from Joint Trauma 
Whiplash injuries can produce a variety of symptoms that are collectively termed 
“whiplash-associated disorders” (Jansen et al., 2008; Spitzer et al., 1995). The symptoms 
of whiplash-associated disorders may include neck and back pain, dizziness, tinnitus, 
headache, paresthesias, temporomandibular joint pain, and disturbances in concentration, 
vision, or memory (Barnsley et al., 1995; Jansen et al., 2008; Lord et al., 1996). Patients 
with whiplash-associated disorders demonstrate painful responses to stimuli that are 
normally non-noxious (allodynia), increased sensitivity to noxious stimuli (hyperalgesia), 
and local and widespread decreases in the activation thresholds of spinal reflexes (Banic 
et al., 2004; Curatolo et al., 2001; Moog et al., 2002; Sheather-Reid and Cohen, 1998; 
Van Oosterwijck et al., 2013). The body is divided into dermatomes that correspond to 
the regions that are innervated by each spinal level (Fig. 1.6). Whiplash-associated pain 
symptoms often develop in a dermatome-specific fashion, depending on the spinal level 
of the symptomatic facet joints (Dwyer et al., 1990). For example, the C6 and C7 levels 
of the spinal cord receive primary afferent innervation from the arms, shoulders, and 
back, including the C6/C7 facet joints (Fig. 1.6). Those anatomical regions, collectively 
called the C6 and C7 dermatomes, commonly develop decreased pain thresholds after 
noxious stimulation of C6/C7 facet joint (Aprill, 1990; Dwyer et al., 1990). 
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 The cervical spine anatomy, neurophysiology, and dermatomal distribution of the 
rat are similar to those of the human (Fig. 1.6), enabling the use of rat models to 
investigate the biomechanical and neurophysiological mechanisms underlying persistent 
pain. A rat model of facet joint loading has been developed to evaluate the development 
of persistent facet-mediated pain. Facet joint loading is induced in rats by distracting the 
facet joint to induce capsule stretch and simulate the injurious tensile strains that occur in 
the capsule during whiplash (Dong et al., 2012; Lee et al., 2004a; Lee et al., 2008; 
Pearson et al., 2004; Siegmund et al., 2001). Behavioral sensitivity develops one day after 
injurious C6/C7 facet joint loading and persists for up to six weeks (Rothman et al., 
2008). Pain develops in the shoulders, neck, and forepaws in a dermatome-specific 
pattern similar to the symptoms that develop following noxious stimulation of the human 
cervical facet capsule (Fig. 1.6) (Crosby et al., 2014a; Curatolo et al., 2001; Dong et al., 
 
Fig. 1.6. Patterns of sensory innervation in the cervical region of the human and rat. 
Pain commonly develops in the C6 and C7 dermatomes after noxious stimulation or 
loading of the C6/C7 facet joints. (a) The C6/C7 dermatomes are highlighted on a 
human dermatomal map. (b) Corresponding innervation patterns and locations of 
behavioral hypersensitivity after painful C6/C7 facet joint injury are shown for the rat 
(adapted from Takahashi and Nakajima, 1996). 
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2012; Dwyer et al., 1990; Lee et al., 2008; Van Oosterwijck et al., 2013). However, 
physiologic strains in the facet capsule do not induce behavioral sensitivity in the rat, and 
capsule transection that alleviates mechanical loading of the capsule prevents the 
development sensitivity (Dong et al., 2012; Lee and Winkelstein, 2009; Winkelstein and 
Santos, 2008). Together, these findings suggest that capsule strain magnitude plays a key 
role in the initiation of persistent facet joint pain. 
Injurious C6/C7 facet joint loading that produces pain in rats induces spinal 
modifications that are associated with central sensitization. Neurons in the dorsal horn of 
the spinal cord develop hyperexcitability by day 7 after painful facet joint injury (Dong et 
al., 2013a; Quinn et al., 2010b), including increased responses of WDR neurons to both 
non-noxious and noxious mechanical stimulation of the forepaw (Quinn et al., 2010b). 
Intrathecal treatment with gabapentin, a neuropathic pain drug that reduces neuronal 
excitability, attenuates spinal hyperexcitability and behavioral sensitivity (Dong et al., 
2013a), further supporting that neuronal sensitization contributes to persistent facet-
mediated pain. 
Spinal hyperexcitability may be facilitated by increases in excitatory 
glutamatergic signaling in the dorsal horn after painful facet joint injury. Metabotropic 
glutamate receptor mGluR5 is upregulated in the dorsal horn seven days after painful 
facet injury, while neuronal glutamate transporter EAAC1 expression is decreased at that 
time point (Dong and Winkelstein, 2010). Increases in mGluR5 and decreases in EAAC1 
correlate to the magnitude of capsule strain, suggesting that mechanotransduction of facet 
capsule loading alters spinal glutamatergic signaling (Dong and Winkelstein, 2010). 
Painful facet joint injury also increases spinal expression of PKCε (Dong et al., 2012), a 
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member of one kinase family that contributes to neuronal hyperexcitability in central 
sensitization (Chen and Huang, 1992; Kawasaki et al., 2004). Although some 
components of glutamate signaling have been characterized after painful facet joint 
injury, many glutamate signaling proteins that play important roles in central sensitization 
have not been studied after facet joint injury, including the activation of NMDA receptors 
and the expression of astrocytic glutamate transporters GLAST and GLT1.  
Spinal glial activation also develops after painful facet joint injury in the rat, as 
measured by an increase in GFAP expression in spinal astrocytes at day 7 after injury 
(Lee et al., 2004a; Weisshaar et al., 2010). Astrocyte activation has been reported to be 
modulated by the magnitude of facet capsule stretch, because GFAP expression exhibits a 
graded response to sham procedures, physiologic or injurious levels of facet capsule 
stretch, and joint distraction that causes rupture of the capsule (Lee et al., 2004a; Lee et 
al., 2008). Intrathecal gabapentin treatment that reduces spinal hyperexcitability also 
attenuates the injury-induced increase in GFAP in the dorsal horn (Dong et al., 2013a), 
suggesting that GFAP expression is modulated by spinal neuronal activity. However, the 
relationship between mechanical facet joint injury and the spinal neuronal and glial 
activation that may contribute to persistent pain has not been fully defined. 
 
1.2.7. Spinal Cord Stimulation 
Spinal cord stimulation (SCS) is used to treat a wide range of chronic neuropathic 
pain conditions by directly modulating neuronal activity in the spinal dorsal horn 
(Cameron, 2004; Compton et al., 2012; Simpson, 1997). Common clinical indications 
include failed back surgery syndrome, complex regional pain syndrome, ischemic pain, 
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peripheral neuropathy, and cervical and lumbar radiculopathy (Alo et al., 2002; Cameron, 
2004; Compton et al., 2012; Stojanovic and Abdi, 2002). SCS has also been used to treat 
whiplash-associated pain in a small number of patients (Kirvela and Kotilainen, 1999; 
Van Buyten et al., 2001). Conventional tonic SCS administers continuous electrical 
pulses to the dorsal columns of the spinal cord using various pulse frequencies (40-60Hz) 
and pulse widths (0.2-0.5ms) (De Ridder et al., 2010; Guan, 2012; Tang et al., 2014). 
Activation of Aβ fibers is believed to induce orthodromic (forward-propagating) signals 
from Aβ fibers to the brain are believed to be the cause of the tingling paresthesias in the 
stimulated dermatome(s) that frequently accompany tonic SCS (De Ridder et al., 2010; 
Tang et al., 2014). Aβ fibers can collateralize in the dorsal horn and synapse with 
inhibitory interneurons (Yaksh and Luo, 2001), so Aβ activation in the dorsal columns 
can also cause antidromic (backward-propagating) signals that activate those inhibitory 
interneurons to attenuate nociception (Melzack and Wall, 1965; Mendell, 2014). Many 
studies report decreased dorsal horn neuronal excitability during and after SCS, 
supporting the assertion that activation of Aβ afferents in the dorsal columns suppresses 
persistent painful signals at the dorsal horn level (Guan, 2012; Guan et al., 2010; 
Yakhnitsa et al., 1999). 
Based on studies in animal models, the attenuation of neuronal firing by γ-
aminobutyric acid (GABA) has been proposed as a key mechanism of action for tonic 
SCS. GABA is the primary inhibitory neurotransmitter in the spinal cord, and acts 
through GABAA (ligand-gated) and GABAB (G-protein-coupled) receptors that are 
localized to inhibitory synapses (Malcangio and Bowery, 1996; Yaksh, 2006). After 
peripheral nerve injury, rats with behavioral sensitivity have less extracellular GABA in 
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the dorsal horn compared to uninjured rats, suggesting that a disinhibition of dorsal horn 
neuronal activity leads to persistent pain (Drew et al., 2004; Stiller et al., 1996). 
However, dorsal horn GABA levels are increased during tonic SCS (Linderoth et al., 
1994; Stiller et al., 1996), suggesting that SCS acts by enhancing spinal inhibitory GABA 
signaling. The GABA receptor agonist, baclofen, enhances pain-suppression during SCS 
(Cui et al., 1997), but GABA receptor antagonists abolish the analgesic effects of dorsal 
column stimulation (Cui et al., 1996), further supporting the role of inhibitory GABA 
signaling in the effects of tonic SCS. 
Despite extensive reports that SCS is effective for treating chronic pain, the mean 
success rate of SCS in clinical studies is only 58%, and that rate has improved little in the 
last several decades (Cameron, 2004; Zhang et al., 2014). Recently, new modes of SCS 
have been developed with the aim of improving pain relief. Burst stimulation is one novel 
mode of SCS that delivers short bursts of pulses rather than continuous pulses of 
stimulation (De Ridder et al., 2010). Burst SCS reduces pain in patients with chronic 
neuropathic pain better than tonic stimulation without inducing the paresthesia that is 
typically associated with tonic SCS (De Ridder et al., 2013; De Vos et al., 2014). 
However, the mechanisms underlying the analgesic effects of burst SCS are unknown, 
and a better understanding of the neurophysiology and mechanisms of burst SCS may be 
required to more effectively design and administer novel SCS therapies. 
 
1.3. Overview 
The overall aim of this thesis is to define the development of spinal neuronal 
hyperexcitability and structural plasticity after painful facet joint injury, and to evaluate 
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the modulation of spinal hyperexcitability for the treatment of persistent pain. Using a rat 
model of painful cervical facet joint injury, the temporal development of spinal neuronal 
hyperexcitability is evaluated by quantifying spontaneous and evoked neuronal activity at 
times between facet joint injury and the onset of behavioral sensitivity. To establish the 
role of facet joint injury-induced afferent firing in the induction of neuronal 
hyperexcitability, afferent activity is transiently blocked at times during the development 
of spinal hyperexcitability. Structural plasticity is assessed by quantifying excitatory 
synapse density in the spinal dorsal horn and characterizing the role of thrombospondin-4 
in persistent facet-mediated pain. Lastly, the effectiveness and mechanisms of burst SCS 
are evaluated for the attenuation of spinal neuronal hyperexcitability in models of painful 
facet joint injury and cervical radiculopathy. 
The studies in this thesis are organized into chapters that summarize the relevant 
experiments. Chapter 2 details the hypotheses and specific aims of this thesis. Chapter 3 
presents the studies that establish the temporal development of spinal neuronal 
hyperexcitability after painful facet joint injury (Aim 1a). Chapter 4 presents the studies 
related to Aims 1b-1d that evaluate the role of injury-induced afferent discharge in spinal 
neuronal hyperexcitability and the potentiation of glutamatergic signaling. Chapter 5 
presents studies defining the role of dorsal horn excitatory synaptogenesis in promoting 
persistent pain (Aim 2). In Chapter 6, the studies related to Aim 3a are presented, 
including the optimization of burst spinal cord stimulation for the attenuation of spinal 
hyperexcitability. Chapter 7 extends the findings from Chapter 6, comparing burst SCS to 
conventional tonic SCS for the treatment of neuropathic pain and persistent joint-
mediated pain (Aims 3b and 3c). Additional studies in Chapter 7 also evaluate 
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GABAergic signaling as a potential mechanism for the action of burst SCS (Aim 3b). 
Finally, in Chapter 8 all of the studies are synthesized in the broader context of facet-
mediated pain, along with limitations and implications of this work for future research. 
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CHAPTER 2 
 
Rationale, Context and Hypotheses 
   
 
2.1. Rationale and Context 
Chronic neck pain affects a substantial portion of the general population annually 
(Hogg-Johnson et al., 2008; Martin et al., 2008). Cervical facet joint-mediated pain is 
prevalent after neck trauma, during which the cervical facet joints are susceptible to 
injurious loading (Bogduk and Yoganandan, 2001; Pearson et al., 2004; Winkelstein et 
al., 2000). The cervical facet joint is implicated as a source of pain in 54-60% of 
whiplash pain cases (Barnsley et al., 1995; Freeman et al., 1999; Lord et al., 1995; 
Manchikanti et al., 2004). Patients with facet joint-mediated pain experience decreased 
pain thresholds both in the neck and at distant sites in which there is no tissue damage, 
like the upper and lower limbs (Banic et al., 2004; Curatolo et al., 2001; Curatolo et al., 
2004; Koelbaek et al., 1999). Those widespread symptoms are characteristic of central 
sensitization, a state in which hyperexcitability of spinal neurons amplifies the 
nociceptive signals that converge in the dorsal horn from diverse anatomical regions, 
leading to extensive pain hypersensitivity (Curatolo et al., 2004; Moog et al., 2002). 
Studies of cervical spine kinematics during simulated low-velocity rear impacts 
suggest that excessive loading of the facet capsular ligament is a primary injury 
mechanism for persistent pain (Panjabi et al., 1998b; Pearson et al., 2004; Winkelstein et 
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al., 2000). Strains in the facet capsule can exceed physiologic levels by nearly five-fold 
during low-speed rear impacts (Pearson et al., 2004), and approach the strain thresholds 
for activation of nociceptive fibers in the facet joint (Lu et al., 2005a). In animal models 
of painful facet joint injury, excessive facet capsule stretch induces behavioral 
hypersensitivity to mechanical stimuli and spinal neuronal hyperexcitability (Dong et al., 
2013a; Lee et al., 2004b; Lee and Winkelstein, 2009; Quinn et al., 2010b). However, 
despite evidence implicating facet capsule stretch in the initiation of persistent facet joint-
mediated pain, the temporal relationship between mechanical loading of the facet joint 
sufficient to induce pain and the development of spinal hyperexcitability is still unclear. 
Spinal neuronal hyperexcitability after painful facet joint injury may be 
maintained by excitatory synaptic plasticity, which includes changes in synapse strength 
or structure that enhance neurotransmission. Plasticity in the dorsal horn can promote 
aberrant firing in nociceptive neurons by potentiating excitatory signaling at 
glutamatergic synapses and/or inducing excitatory synaptogenesis (Dong and Winkelstein 
et al., 2010; Kawasaki et al., 2004; Latremoliere and Woolf, 2009; Peng et al., 2010; 
Ultenius et al., 2006; Woolf et al., 2000). However, it remains unknown if plasticity in 
the spinal cord that promotes neuronal hyperexcitability is induced by painful facet joint 
injury. Therefore, the central aim of this thesis is to define the development, 
maintenance, and modulation of spinal hyperexcitability after painful facet joint injury 
using an established rat model of painful C6/C7 facet joint distraction. The overall 
hypothesis is that injury-induced afferent activity from the facet joint initiates the 
development of spinal neuronal hyperexcitability by potentiating excitatory signaling and 
inducing excitatory synaptogenesis in the spinal dorsal horn. 
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The first aim of this thesis determines the time after painful facet joint injury at 
which behavioral sensitivity and dorsal horn neuronal hyperexcitability develop by 
measuring mechanical hyperalgesia and neuronal excitability in the spinal dorsal horn 
within the first day following painful injury (Aim 1a). In order to evaluate the role of 
afferent discharge following joint injury in the initiation of spinal modifications that 
promote neuronal hyperexcitability, intra-articular bupivacaine injections were used to 
block afferent activity at a range of times from immediately after injury (within minutes) 
to day 4 after injury, and behavioral sensitivity and spinal neuronal excitability were 
measured at day 7 (Aims 1b-1d). Collectively, those studies define the temporal 
development of spinal hyperexcitability after painful facet joint injury and evaluate the 
relevance of the timing of joint interventions for the attenuation of persistent pain. 
Persistent facet-mediated pain may be maintained by structural modifications in 
the spinal cord, like the development of new excitatory synapses that enhance dorsal horn 
neuronal excitability (Jaken et al., 2010; Peng et al., 2010; Woolf et al., 1995). The 
synaptogenic protein thrombospondin-4 (TSP4) has recently been implicated in the 
development of neuropathic pain after peripheral nerve injury (Kim et al., 2012; Risher 
and Eroglu, 2012). Injury-induced TSP4 is largely expressed by activated astrocytes in 
the spinal dorsal horn (Kim et al., 2012). Although astrocytic TSP4 can induce 
synaptogenesis (Christopherson et al., 2005; Eroglu et al., 2009), it is unclear whether 
TSP4 contributes to persistent pain by inducing excitatory synaptogenesis in the spinal 
cord. Spinal astrocytic activation is evident after painful facet joint injury (Lee et al., 
2004a; Weisshaar et al., 2010), so astrocyte-derived thrombospondin proteins may play a 
key role in mediating persistent pain after facet joint injury. Studies in Aim 2 quantify 
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changes in the number of excitatory synapses in the dorsal horn (Aim 2a) and define the 
temporal expression of TSP4 in the dorsal root ganglia (DRG) and spinal cord after 
painful facet joint injury (Aim 2b). Lastly, the role of spinal TSP4 in persistent facet-
mediated pain is evaluated by blocking TSP4 expression (Aim 2c) and augmenting levels 
of spinal TSP4 prior to facet joint loading (Aim 2d-e), in separate studies. 
Analgesics often fail to provide sustained treatment of persistent pain after the 
development of spinal hyperexcitability has already occurred (Lin et al., 2011; Lord et 
al., 1996; Xie et al., 2005). However, spinal cord stimulation (SCS) offers effective 
analgesia for otherwise intractable chronic pain by directly modulating neuronal activity 
in the spinal dorsal horn (Cameron, 2004; Guan, 2012; Simpson, 1997). Conventional 
tonic SCS inhibits nociceptive signals in the dorsal horn by applying continuous electrical 
stimulation to the dorsal columns of the spinal cord. However, novel modes of 
stimulation have been developed recently to improve the effectiveness of SCS for 
reducing pain. Burst SCS is one such mode of SCS that delivers periodic bursts of 
electrical stimulation rather than continuous tonic pulses (De Ridder et al., 2010). Despite 
studies showing the clinical effectiveness of burst SCS for treating chronic pain, the 
mechanisms underlying its attenuation of pain remain only speculative (De Ridder et al., 
2013; De Vos et al., 2013). Studies in the first two aims of this thesis focus on the 
development of spinal hyperexcitability as a key feature of central sensitization, so 
studies in Aim 3 evaluate the effectiveness of spinal cord stimulation for modulating 
spinal hyperexcitability and attenuating persistent pain, after painful facet joint injury and 
in a more traditional model of neuropathic pain. 
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In Aims 3a and 3b, studies evaluate burst SCS for the treatment of neuropathic 
pain using an established model of painful cervical nerve root compression (Hubbard and 
Winkelstein, 2005; Hubbard et al., 2008; Zhang et al., 2013). The burst stimulation 
parameters are optimized for neuropathic pain in Aim 3a. Burst SCS is then compared 
directly to conventional tonic SCS for the attenuation of dorsal horn neuronal activity 
(Aim 3b). Inhibitory γ-aminobutyric acid (GABA) signaling has been shown to play a 
key role in the decrease of dorsal horn activity during tonic SCS (Cui et al., 1996; Stiller 
et al., 1996), but the potential role of GABA signaling in burst SCS is not known. 
Therefore, Aim 3b also evaluates the role of GABA signaling in burst SCS to determine 
if that mechanism contributes to its attenuation of dorsal horn neuronal activity. Lastly, 
SCS has not been tested for reduction of the spinal hyperexcitability that is associated 
with persistent pain from other etiologies. As such, in Aim 3c, both burst and tonic SCS 
are evaluated for the attenuation of dorsal horn neuronal activity after painful facet joint 
injury. 
 
2.2. Overall Hypothesis and Specific Aims 
The overall goal of this dissertation is to elucidate when and how facet capsule 
stretch leads to spinal hyperexcitability that promotes persistent pain, and to define the 
role of synaptic plasticity and synaptogenesis in that process. The overall hypothesis of 
this thesis is that the increased primary afferent activity from the facet joint that is 
initiated by painful facet joint injury potentiates excitatory neuronal signaling and 
induces excitatory synaptogenesis in the spinal dorsal horn. These changes lead to 
hyperexcitability of dorsal horn neurons that amplifies nociceptive signals as they are 
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transmitted to the spinal cord. Blocking the injury-induced signals that initiate excitatory 
changes in the spinal cord can prevent the development of persistent neuronal 
hyperexcitability and behavioral sensitivity. In addition, it is hypothesized that 
hyperexcitability of dorsal horn neurons after a painful injury may be attenuated by direct 
stimulation of the spinal dorsal columns using both tonic and burst modes of SCS. These 
overarching hypotheses have three sub-hypotheses that are tested in the following 
associated aims and sub-aims. 
 
Hypothesis 1. Painful facet joint injury induces an increase in neuronal excitability in the 
dorsal horn of the spinal cord that parallels the temporal development of sustained 
mechanical hyperalgesia. Neuronal hyperexcitability is initiated by increased discharge of 
afferents from the facet joint that is induced during painful capsule stretch. Attenuation of 
afferent activity from the facet joint immediately following stretch of its capsule prevents 
the subsequent development of spinal neuronal hyperexcitability. However, blocking 
afferent activity after hyperalgesia has already developed does not reduce behavioral 
sensitivity or dorsal horn neuronal hyperexcitability at later time points. 
 
Aim 1. Define the relationship of a painful mechanical facet joint capsule injury to the 
development of spinal neuronal hyperexcitability, using an in vivo rat model of painful 
facet joint injury. Evaluate the role of afferent activity from the injured joint in the 
induction and maintenance of dorsal horn neuronal hyperexcitability by blocking joint 
afferent activity with intra-articular injections of bupivacaine, a fast-acting local 
anesthetic that transiently blocks axonal conduction. After bupivacaine injection, measure 
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the subsequent behavioral sensitivity, dorsal horn neuronal excitability, and potentiation 
of glutamatergic signaling in the spinal cord. 
1a. Determine the time after painful facet joint injury at which dorsal horn neurons 
develop hyperexcitability by quantifying the evoked firing response of spinal 
neurons to non-noxious and noxious mechanical stimuli at 6 hours or day 1 after 
painful facet injury. 
1b. Determine if the initial painful facet capsule stretch or ongoing joint afferent firing 
is responsible for hyperalgesia and spinal hyperexcitability by eliminating primary 
afferent activity from the joint using intra-articular injections of bupivacaine, either 
immediately or at day 4 after the capsule stretch, in separate studies. 
1c. Define the spinal expression of a panel of excitatory neuronal and glial signaling 
proteins (mGluR5, NR1/pNR1, ERK/pERK, GLAST, GLT1, GFAP) by Western 
blot at day 7 after injury, following bupivacaine treatment at the times specified in 
Aim 1b. 
1d. Identify the time period after painful facet joint injury during which afferent input 
from the facet joint induces sustained spinal neuronal hyperexcitability. Administer 
single intra-articular doses of bupivacaine to the bilateral facet joints at different 
times throughout the period when hyperexcitability develops (immediately, 4 hours, 
8 hours, day 1, or day 4), and measure behavioral sensitivity and spinal neuronal 
excitability at day 7 after injury. 
 
Hypothesis 2. Excitatory synaptogenesis in the dorsal horn contributes to facet joint-
mediated pain and spinal hyperexcitability following capsule stretch. The release of the 
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synaptogenic protein thrombospondin-4 (TSP4) from activated astrocytes induces 
excitatory synaptogenesis that contributes to behavioral sensitivity and hyperexcitability 
of dorsal horn neurons after painful facet joint injury. 
 
Aim 2. Determine if painful facet joint injury induces excitatory synaptogenesis in the 
spinal dorsal horn. Define the temporal expression of TSP4 in the DRG and spinal cord 
after painful facet joint injury. Evaluate the role of TSP4 in dorsal horn synaptogenesis 
and the development of behavioral sensitivity by blocking spinal TSP4 expression or 
augmenting spinal TSP4 levels prior to physiologic or painful levels of joint loading. 
2a. Quantify excitatory synapse density in the superficial and deep laminae of the 
spinal dorsal horn at day 7 after painful facet joint injury by counting synapsin-
labeled puncta (pre-synaptic marker) colocalized with homer (post-synaptic 
marker). In order to evaluate the effects of analgesic gabapentin treatment on 
excitatory synaptogenesis, quantify excitatory synapse density in the dorsal horn at 
day 7 in rats receiving intrathecal gabapentin treatments that have been previously 
shown to reduce spinal hyperexcitability after painful facet joint injury. 
2b. Evaluate TSP4 expression in the DRG and spinal cord at days 1 and 7 after a 
painful facet joint injury to determine if upregulation of TSP4 is induced and over 
what time course. 
2c. Administer intrathecal antisense oligonucleotides designed against a segment of 
TSP4 mRNA to block TSP4 protein expression before, and continuously following, 
painful facet joint injury. Measure behavioral sensitivity and quantify TSP4 
expression and synapse densities at day 7 after painful injury to determine whether 
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increased spinal TSP4 is necessary for the development of hyperalgesia and 
excitatory synaptogenesis in the dorsal horn. 
2d. Administer TSP4 intrathecally in naïve rats to evaluate the role of spinal TSP4 in 
the development of behavioral sensitivity. Define the threshold dose of TSP4 for 
inducing behavioral sensitivity, and identify separate TSP4 doses that: (1) induce 
behavioral sensitivity and (2) do not induce behavioral sensitivity. 
2e. Administer TSP4 prior to facet joint loading to determine whether pre-injury levels 
of TSP4 mediate behavioral sensitivity and/or dorsal horn neuronal excitability. 
Apply sham surgical procedures, nonpainful but physiologic joint loading, or 
painful facet joint loading after TSP4 treatments defined in Aim 2d to determine if 
spinal TSP4 levels modulate the hyperalgesia and/or spinal hyperexcitability that 
develop after painful facet loading. 
 
Hypothesis 3. Dorsal horn neuronal hyperexcitability can be reduced by spinal cord 
stimulation of the dorsal columns. Burst SCS is more effective than conventional tonic 
SCS for attenuating spinal hyperexcitability. Since tonic SCS utilizes GABAergic 
signaling to inhibit aberrant dorsal horn neuronal activity, and because burst and tonic 
SCS both reduce pain symptoms, burst SCS also reduces neuronal firing through a 
GABAergic mechanism. 
 
Aim 3. Separately evaluate the effectiveness of burst SCS to attenuate symptoms of 
persistent pain following painful nerve root compression and painful facet joint injury. 
Optimize the stimulation conditions and parameters needed to maximize the effectiveness 
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of burst SCS for the reduction of dorsal horn neuronal firing during noxious mechanical 
stimulation of the forepaw. Evaluate the role of GABA signaling as a potential 
mechanism of action for burst SCS. 
3a. Optimize the burst stimulation parameters for attenuating dorsal horn neuronal 
hyperexcitability after painful nerve root compression. Determine how the 
parameters of the burst waveform (pulse number, pulse frequency, pulse width, 
burst frequency, and amplitude) alter the effectiveness of burst SCS by measuring 
dorsal horn neuronal firing in response to noxious mechanical stimulation, and the 
percentage of dorsal horn neurons responding to stimulation. Identify the set of 
burst parameters that is most effective in reducing dorsal horn neuronal firing 
following burst SCS. 
3b. Assess the effectiveness of burst SCS compared to tonic SCS for attenuating 
neuronal firing in the spinal dorsal horn after painful nerve root compression. In 
separate groups, apply the GABAA antagonist, bicuculline, or the GABAB 
antagonist, CGP35348 to the dorsal spinal cord continuously on day 7 after painful 
nerve root compression to determine whether burst SCS reduces firing in dorsal 
horn neurons through modulation of GABA signaling. 
3c. Evaluate the effectiveness of burst SCS compared to tonic SCS for attenuating 
spinal neuronal hyperexcitability on day 7 after painful facet joint injury by 
quantifying dorsal horn neuronal firing after burst and tonic SCS. 
 
The aims in this thesis are organized into chapters summarizing the relevant 
experimental studies. Aim 1a is presented in Chapter 3 to establish a timeline for the 
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development of spinal neuronal hyperexcitability after painful facet joint injury. Studies 
investigating Aims 1b-1d are presented in Chapter 4 evaluating the role of afferent 
discharge from the facet joint in the development of persistent pain. Chapter 5 reports 
studies addressing Aim 2 to evaluate the role of excitatory synaptogenesis in behavioral 
and neuronal hypersensitivity. Aim 3a is presented in Chapter 6 to optimize the 
parameters of burst spinal cord stimulation for the attenuation of spinal hyperexcitability, 
and Chapter 7 compares burst to conventional tonic SCS for treatment of neuropathic 
pain and persistent joint-mediated pain, and evaluates GABAergic signaling as a potential 
mechanism for the effects of burst SCS (Aims 3b and 3c). Lastly, Chapter 8 summarizes 
the main findings of this thesis in the broader context of cervical spine injury and 
persistent pain, including limitations and implications of this work for future research. 
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CHAPTER 3 
 
Spinal Neuronal Plasticity is Evident within One 
Day after a Painful Cervical Facet Joint Injury 
   
 
This chapter was adapted from: 
Crosby ND, Weisshaar CL, Winkelstein BA. Spinal neuronal plasticity is evident within 
1 day after a painful cervical facet joint injury. Neuroscience Letters 2013; 542:102-106. 
 
3.1. Overview 
Chronic facet joint-mediated pain is prevalent in the both the lumbar and cervical 
regions of the spine (Manchikanti et al., 2004; Schwarzer et al., 1995). Spinal syndromes 
are responsible for an estimated annual cost of over $85 billion in the United States 
(Martin et al., 2008). The facet joints in the cervical spine have been reported as the 
source of pain in 54-60% of individuals who experience chronic pain from whiplash 
(Barnsley et al., 1995; Lord et al., 1996, Manchikanti et al., 2004). Many cadaveric 
studies report abnormal motions of the cervical facet joints and excessive facet capsular 
ligament stretch during neck injury that may lead to chronic neck pain (Bogduk and 
Yoganandan, 2001; Panjabi et al., 1998b; Pearson et al., 2004; Winkelstein et al., 2000). 
Clinically, chronic cervical spine pain symptoms include decreased pain thresholds, 
secondary hyperalgesia that extends into the extremities, enlarged receptive fields, and 
insensitivity of pain to peripheral administration of local anesthetics (Banic et al., 2004; 
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Curatolo et al., 2001; Curatolo et al., 2004; Herren-Gerber et al., 2004; Munglani, 2000). 
Those symptoms are characteristic of central sensitization, a state in which spinal 
neuronal hyperexcitability potentiates nociceptive responses to the non-noxious and 
noxious stimuli that converge in the spinal dorsal horn from widespread anatomical 
regions (Latremoliere and Woolf, 2009). However, despite the development of persistent 
pain after mechanical injury to the cervical facet joint, it is not known how early the 
spinal changes occur after injurious loading of the joint, and the physiologic sequelae 
leading to chronic pain from that injury remain unclear. 
In a rat model of painful facet joint injury, hyperalgesia develops as early as day 1 
and persists through day 7 after injury (Dong et al., 2012; Lee et al., 2008; Lee and 
Winkelstein, 2009). Spinal neuronal hyperexcitability is also evident at day 7 after 
painful facet injury (Quinn et al., 2010b), but dorsal horn neuronal activity has not been 
measured at earlier time points. This chapter addresses the objectives outlined in Aim 1a 
in order to characterize the temporal development of spinal hyperexcitability after painful 
facet joint injury. Behavioral sensitivity was measured at 6 hours or 1 day after sham or 
painful facet joint injury, in separate groups.  Spontaneous activity and neuronal firing 
evoked by non-noxious and noxious mechanical stimuli applied at the forepaw were also 
quantified at 6 hours or 1 day after sham or painful facet joint injury. The work in this 
chapter defines the onset of behavioral sensitivity and spinal hyperexcitability to provide 
context for the studies in Aims 1b-1d, which evaluate the role of afferent activity from 
the injured facet joint in inducing spinal neuronal hyperexcitability. 
 
 41 
3.2. Background 
The facet capsular ligament is innervated by both proprioceptive and nociceptive 
mechanoreceptors that project to the spinal cord at largely the same spinal level as the 
facet joint from which they originate (Chen et al., 2006; McLain, 1993; Ohtori et al., 
2001; Yamashita et al., 1990). During facet capsule stretch, afferents that innervate the 
capsule have been shown to increase their firing rates with increases in applied capsular 
strain (Lu et al., 2005a). Increased peripheral neuronal input to the spinal cord can be 
sufficient to produce long-lasting central sensitization via increased excitability of dorsal 
horn neurons, leading to hyperalgesia and allodynia as early as minutes or hours after the 
initial discharge of afferent firing (Cook et al., 1987; Koltzenburg et al., 1992; Ren and 
Dubner, 1998; Wall and Woolf, 1986; Woolf, 1983). Central sensitization has been 
studied in several models of chronic joint-mediated pain, including knee inflammation 
and temporomandibular joint disorders (Hathaway et al., 1995; Lam et al., 2008; 
Martindale et al., 2007), but such models do not investigate mechanical injury to the 
joint. Transient mechanical facet joint trauma induces sustained behavioral sensitivity 
and neuronal hyperexcitability by day 7 after injury (Lee and Winkelstein, 2009; Quinn et 
al., 2010b). Yet, it is not known how early such putative spinal changes develop after 
painful facet injury and how the timing of the onset of spinal involvement relates to pain. 
Central sensitization often involves plasticity among wide dynamic range (WDR) 
neurons in the spinal cord, a subpopulation of second-order cells found largely in the 
deep laminae (III-VI) of the dorsal horn (Christensen and Hulsebosch, 1997; Hains et al., 
2003c; Hao et al., 1992; Zhang et al., 2005). WDR neurons receive input from both non-
nociceptive and nociceptive neurons, so they are involved in the integration and 
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supraspinal projection of both innocuous and painful sensation (Baron, 2006; D’Mello 
and Dickenson, 2008). WDR neurons develop hyperexcitability to both mechanical and 
thermal stimuli in a variety of pain models in addition to expansion of their receptive 
fields, and are believed to mediate the hyperalgesia and allodynia that manifest during 
central sensitization (Cata et al., 2006; Coghill et al., 1993; Hains et al., 2003c; Hao et al., 
1991; Martindale et al., 2007; Zhang et al., 2005). Painful facet joint injury induces WDR 
neuronal hyperexcitability at day 7 after injury, along with a shift among second-order 
dorsal horn neurons to the multi-receptive WDR phenotype (Quinn et al., 2010b). 
However, plasticity in dorsal horn neurons remains undefined at earlier time points after 
painful facet joint injury. 
This study investigates the development of hyperalgesia and dorsal horn neuronal 
hyperexcitability in the spinal cord during the first day after painful facet joint injury, and 
tests the hypothesis that spinal neuronal hyperexcitability develops concurrently with 
hyperalgesia within one day after injury. Painful cervical facet joint injury was imposed 
and behavioral sensitivity measured in the forepaw at either 6 hours or 1 day. 
Extracellular potentials were recorded from neurons in the deep laminae of the dorsal 
horn at those times in order to assess spontaneous firing and evoked responses to 
peripheral non-noxious and noxious mechanical stimuli. 
 
3.3. Methods 
3.3.1. Study Design and Facet Joint Injury 
All experimental procedures were approved by the University of Pennsylvania 
Institutional Animal Care and Use Committee and carried out under the guidelines of the 
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Committee for Research and Ethical Issues of the International Association for the Study 
of Pain (Zimmerman, 1983). Male Holtzman rats (350-464g) were divided into two 
groups designated to undergo behavioral and electrophysiological testing at either 6 hours 
(n=4 injury, n=4 sham) or 1 day (n=6 injury, n=6 sham). Normal rats (n=6) were also 
included for both assays as an additional control group. All statistical analyses were 
performed using JMP9 (SAS; Cary, NC) with α=0.05. 
Rats were anesthetized with isoflurane (4% for induction, 2-3% for maintenance). 
Injurious distraction of the C6/C7 facet joints was administered using a custom loading 
device as previously described (Lee and Winkelstein, 2009). Rats were placed in a prone 
position and the paraspinal musculature was separated to bilaterally expose the laminae 
and facet capsules of the cervical vertebrae from C5-T1. The C6 and C7 vertebrae were 
attached to a custom loading device using microforceps. The C6 vertebra was then 
distracted 0.7mm rostrally to stretch the facet capsule across the joint. Polystyrene beads 
were placed on the C6 and C7 vertebrae and a grid of beads was placed on the right 
C6/C7 facet capsule to track motions during the imposed capsule stretch (Fig. 3.1). A 
Phantom v4.3 CCD camera (Vision Research; Wayne, IN) recorded the bead marker 
positions at a rate of 500fps. The bead marker positions before joint distraction and also 
at the peak of imposed capsule stretch were used to calculate the vertebral and capsular 
distraction magnitudes and the maximum principal strains on the facet capsule during 
each joint distraction (Fig. 3.1). Although there is a negative slope of the facet capsule 
running from the rostral insertion to the caudal insertion site, that angle of incline is small 
enough that the strains can be calculated using a single camera (Lee et al., 2004a). A 
sham group was included in which the facet capsule was kept intact without any joint 
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distraction imposed in order to control for the effects of surgical procedures. Following 
surgery, incisions were closed using 3-0 polyester suture and surgical staples, and rats 
were monitored during recovery in room air. Vertebral and capsule distractions and 
capsule strains were compared between the 6 hour and 1 day injury groups using 
Student’s t-tests. 
 
3.3.2. Assessment of Mechanical Hyperalgesia 
Mechanical hyperalgesia in the left and right forepaws was assessed 
preoperatively and at either 6 hours or 1 day after injury to evaluate behavioral 
hypersensitivity. Hyperalgesia was measured by quantifying the paw withdrawal 
threshold in response to application of a series of von Frey filaments (1.4, 2, 4, 6, 8, 10, 
15, and 26g) to the plantar surface of the forepaws (Chaplan et al., 1994; Hubbard and 
Winkelstein, 2005; Lee et al., 2008). Beginning with the 1.4g filament, each filament was 
applied to the forepaw five times, in order of increasing buckling weight. A response was 
considered as positive if the rat reacted to the filament by withdrawing, licking, or 
 
Fig. 3.1. The right facet joint of the rat with vertebral and capsule bead markers. 
Vertebral markers were placed on the laminae of the C6 and C7 vertebrae to measure 
joint distraction magnitudes. A grid of bead markers on the facet capsule was used to 
quantify capsule distraction and capsule strain. 
C6 vertebral 
marker
C7 vertebral 
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C7 vertebra
C6 vertebra
facet capsule 
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medial
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shaking the stimulated forepaw. The first filament magnitude to elicit a positive response 
was recorded as the paw withdrawal threshold if the next larger filament strength also 
evoked a positive response. If the next filament failed to elicit a positive response, testing 
was continued until two consecutive filaments both elicited a positive response (Lee and 
Winkelstein, 2009). A rat failing to respond to any of the filaments was assigned the 
maximum threshold, 26g, for that round. The paw withdrawal threshold for each rat was 
averaged from three rounds of repeated testing separated by at least ten minutes to 
provide an adequate rest period (Dong et al., 2012; Kras et al., 2013b). A repeated-
measures ANOVA compared paw withdrawal thresholds between the sham and injury 
groups at each time point.  
 
3.3.3. Spinal Cord Electrophysiological Recordings 
Immediately after testing for hyperalgesia at the designated time point (6 hours or 
1 day) following surgery, extracellular electrophysiological recordings were acquired in 
order to assess neuronal excitability in the dorsal horn of the spinal cord. Rats were 
anesthetized with sodium pentobarbital (45mg/kg, i.p.) and given supplementary doses 
(5-10mg/kg, i.p.) as needed based on toe pinch, corneal, and palpebral reflexes (Field et 
al., 1993). The C6 and C7 vertebrae were exposed by separating the paraspinal 
musculature that was dissected during the original facet joint distraction surgery. A 
bilateral laminectomy and dural resection at C6 and C7 exposed the spinal cord. A 
tracheotomy was performed and rats were connected to a ventilator and CO2 monitor to 
control respiration during the recording session (CWE; Ardmore, PA). A lateral 
thoracotomy was also performed to alleviate intrathoracic pressure and to isolate the 
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spinal cord from any movement of the thoracic wall that is induced by respiration. Rats 
were then immobilized on a stereotaxic frame (David Kopf Instruments; Tujunga, CA) 
using ear bars and a vertebral clamp at T2 to stabilize the cervical spine (Fig. 3.2). The 
forepaws were inverted and secured to the stereotaxic frame, exposing the plantar surface 
of the paw for mechanical stimulation. Core temperature was maintained at 35-37ºC 
using a temperature controller with a rectal probe (Physitemp; Clifton, NJ). The spinal 
cord was bathed in 37ºC mineral oil for the duration of recording to prevent drying. 
 
 
 
Fig. 3.2. Schematic of the instrumentation for extracellular electrophysiological 
recordings. Rats were mounted on a stereotaxic frame with ear bars and a clamp at T2. 
Body temperature and respiration were monitored and controlled for the duration of 
recording. A carbon fiber electrode was lowered into the dorsal horn of the spinal cord 
to record neuronal firing during mechanical stimulation of the forepaw. Mechanical 
stimuli were coupled to a load cell to synchronize the application of stimuli with 
electrophysiological recordings.  
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Extracellular potentials were recorded continuously using a carbon fiber electrode 
(Carbostar-1; Kation; Minneapolis, MN). Signals were amplified with a gain of 10
3
 and 
conditioned using a bandpass filter between 0.3kHz and 3kHz (World Precision 
Instruments; Sarasota, FL). The signal was processed with a 60Hz HumBug adaptive 
filter (Quest Scientific; North Vancouver, BC), digitally sampled at 25kHz (Micro1401, 
CED; Cambridge, UK), and monitored with a speaker for audio feedback (A-M Systems; 
Carlsborg, WA) (Fig. 3.3). Mechanical stimuli were attached to a load cell whose signal 
was also sampled and recorded at 25kHz in order to synchronize stimulus application 
with the electrophysiological data (Fig. 3.3). 
 
Neuronal activity within the dorsal horn was recorded by lowering the electrode 
through the pial surface of the C6 or C7 spinal cord with a micropositioner (Narishige; 
Tokyo, Japan). Mechanically-sensitive neurons were identified by brushing of the plantar 
surface of the forepaw on the side ipsilateral to the electrode. A neuron was selected for 
 
 
Fig. 3.3. General scheme for data collection and processing of electrophysiological 
recordings. Extracellular potentials and stimulus loads were conditioned and recorded 
using Spike2. Voltage potentials were also used for audio feedback during recording.  
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recording if the brushing evoked activity with an estimated signal-to-noise ratio of at 
least two, and if the evoked activity did not increase in amplitude when the electrode was 
lowered further into the dorsal horn. Once selected, the neuron was mechanically 
stimulated at the forepaw with a series of non-noxious and noxious stimuli (Fig. 3.4), 
including a two-second baseline period before each stimulus, ten seconds of light 
brushing, five consecutive one-second stimulations at one-second intervals with a series 
of von Frey filaments (1.4g, 4g, 10g, 26g), followed by ten seconds of noxious pinch with 
a 60g vascular clip (Hains et al., 2003a; Quinn et al., 2010b). At least 30 seconds were 
allowed between stimuli in order to prevent wind-up of mechanically-sensitive neurons 
(Fig. 3.4). The von Frey filaments were chosen to be logarithmically spaced and span the 
range of filaments used for measuring hyperalgesia. The specifics of the spike recording 
protocol are described in detail in Appendix A. 
 
 
 
 
Fig. 3.4. Protocol for mechanical stimulation of the forepaw during recording of 
dorsal horn neuronal firing. Baseline firing (BL) was recorded for two seconds before 
each stimulus. Light brush was applied for ten seconds, followed by five applications 
of 1.4g, 4g, 10g, and 26g von Frey (vF) filaments each over a ten-second period. 
Noxious pinch was applied for ten seconds with a 60g vascular clip. 
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3.3.4. Electrophysiological Data Analysis 
Voltage recordings from each neuron were spike-sorted using Spike2 software 
(CED; Cambridge, UK) to ensure that spikes from only one neuron were considered at a 
time. Baseline firing was established before each stimulus by totaling the number of 
spikes in the two-second baseline period prior to stimulation (Fig. 3.4). To evaluate 
spontaneously active neurons, the number of neurons with no spikes and the number of 
neurons with more than one spike in the baseline period before application of the brush 
stimulus was counted for each time point in each of the injury and sham groups. Evoked 
responses were quantified for the brush and pinch stimuli by summing the spikes over the 
ten seconds that each stimulus was administered. For the von Frey filament stimuli, 
spikes were considered to be evoked by a single von Frey stimulus if they occurred 
during the one-second application or the one-second rest period immediately following 
stimulus application; each filament had a total of five spike counts since each filament 
was applied to the forepaw five times (Fig. 3.4). Baseline firing was subtracted from the 
spike counts for each stimulus to quantify the evoked response. Spike counts for each 
stimulus were log-transformed due to a positive skew in the distributions of the spike 
totals. Residuals were plotted after transformation to confirm a normal distribution. The 
spike sorting protocol is described in detail in Appendix A. 
Pearson’s Chi-square test was used to evaluate differences in the number of 
spontaneously firing cells in each group. Evoked responses to the brush and pinch stimuli 
were tested between groups using a mixed-effect ANOVA with neurons nested within 
rats and rats nested within groups; post-hoc Tukey’s HSD tested for differences between 
the individual groups. For the von Frey stimuli, a mixed-effect ANOVA with the same 
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nesting structure and post-hoc analysis was used to test the differences between groups, 
von Frey stimulus magnitudes, stimulus order, and their interactions. Neurons having 
evoked responses with Studentized residuals greater than two were excluded from 
statistical analysis as outliers. 
 
3.4. Results 
The vertebral distractions for the injury groups tested at 6 hours (0.53±0.31mm) 
and 1 day (0.63±0.16mm) are not significantly different from each other. The capsule 
distractions (0.31±12mm for the 6 hour injury group; 0.29±0.12mm for the 1 day injury 
group) and the maximum principal strains in the capsule (28±14% for 6 hour group; 
21±14% for 1 day group) also are not significantly different between the 6 hour and 1 day 
injury groups. The detailed mechanical data for each facet joint distraction are 
summarized in Appendix B. Paw withdrawal threshold (PWT) at 6 hours is not changed 
from baseline (BL) for the injury group (9.0±4.3g BL; 10.2±3.4g at 6 hours) or the sham 
group (11.7±3.2g BL; 12.9±6.2g at 6 hours) (Fig. 3.5). At 1 day, the PWT of the sham 
group (13.4±7.9g) also is not changed from BL responses (12.8±10.4g); however, the 
PWT is significantly reduced (p=0.012) at 1 day after painful facet joint injury 
(12.0±6.6g BL; 6.5±3.3g at day 1) (Fig. 3.5). The baseline PWT for each group is not 
different from the PWT (10.2±4.4g) measured in normal rats (Fig. 3.5). Paw withdrawal 
thresholds for each rat on each day can be found in Appendix C. 
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A total of 229 neurons (46±13 neurons/group) was recorded at an average depth 
of 636±170μm in the dorsal horn (Table 3.1), which is a depth included in laminae III-VI 
in the rat spinal cord (Watson et al., 2009). Of the 229 neurons, 31 neurons were removed 
from analysis as outliers because their evoked responses had Studentized residuals 
greater than two (6±4 neurons/group). Appendix D lists the spike counts for each 
individual neuron from each rat. 
 
Table 3.1. Total number of neurons recorded for each spinal cord level. 
  C6 C7 C6/C7 Total Avg. Depth ± SD 
Injury, 6h 22 19 41 633±167μm 
Sham, 6h 25 11 36 656±175μm 
Injury, 1d 29 12 41 652±152μm 
Sham, 1d 27 15 42 607±170μm 
Normal 33 36 69 646±174μm 
Totals 136 93 229 636±170μm 
6h = 6 hours; 1d = 1 day; Avg. = average; SD = standard deviation 
 
 
 
Fig. 3.5. Mechanical hyperalgesia at 6 hours or 1 day after painful facet joint injury. 
Paw withdrawal threshold (PWT) at baseline (BL) for the 6 hour and 1 day groups is 
not different from normal. At 6 hours (6h), PWT is not different from baseline in the 
sham or injury groups. PWT is significantly reduced (*p=0.012) from baseline at 1 
day (1d) after injury but is unchanged at that time point in the sham group. 
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Spontaneous firing is increased at both 6 hours and 1 day after injury, although 
firing at 1 day after sham procedures is not different from normal (Fig. 3.6). Two groups 
of neurons were classified based on spontaneous activity during the baseline period prior 
to stimulation: neurons with no baseline firing (Fig. 3.6a) and those with baseline firing 
rates greater than one spike/sec (Fig. 3.6b). Eighty percent of neurons in the normal 
group have no spontaneous firing and 5% have firing greater than one spike/sec. At 6 
hours after injury or sham procedures, the percentages of neurons with no spontaneous 
firing (68% after injury, 64% after sham) and spontaneous firing greater than one 
 
Fig. 3.6. Spontaneous firing in the spinal dorsal horn. Example recorded voltage 
potentials from neurons with (a) no baseline firing and (b) baseline firing greater than 
one spike/sec. (c) The number of quiescent neurons (presented as the percentage of 
total recorded neurons in each group) is unchanged at 6 hours relative to sham at that 
time point, but at 1 day is significantly lower after injury compared to sham 
(*p=0.038). (d) The number of active neurons exhibits a similar trend with a 
significantly greater number of neurons (*p=0.006) at 1 day after injury. Percentages 
of cells in the normal group are shown (dotted line) for (c) and (d). 
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spike/sec  (24% after injury, 31% after sham) are not different (Fig. 3.6). However, 1 day 
after injury the percentages of neurons with no spontaneous firing (61% after injury, 81% 
after sham, p=0.038) and spontaneous firing greater than one spike/sec (27% after injury, 
5% after sham, p=0.006) are significantly different (Fig. 3.6). 
Overall, evoked firing is elevated at 6 hours and 1 day after injury, but firing 
returns to normal levels in the sham group at 1 day (Figs. 3.7 and 3.8). The evoked 
responses for light brushing and noxious pinch are not different between the 6 hour sham 
(107±15 spikes for brush, 78±15 spikes for pinch), 6 hour injury (91±12 spikes for brush, 
79±11 spikes for pinch), or 1 day injury groups (89±8 spikes for brush, 77±15 spikes for 
pinch) (Fig. 3.8a); each is also elevated over normal (48±4 spikes for brush, 29±5 spikes 
for pinch) for both brush (p<0.004) and pinch (p<0.0001). The evoked responses for the 
injury group at 1 day also are significantly higher than the sham responses at that time 
point (59±7 spikes for brush, 32±5 spikes for pinch) for light brush (p=0.003) and 
noxious pinch (p=0.014) (Fig. 3.8a). Likewise, evoked responses for the 4g, 10g, and 26g 
von Frey filaments are not different between any of the groups at 6 hours or the injury 
group at day 1. However, for the 4g, 10g, and 26g filaments, each of the 6 hour sham, 6 
hour injury, and 1 day injury groups exhibit significantly elevated firing over both sham 
at day 1 (p<0.004) and normal (p<0.017) (Fig. 3.8b). For the 1.4g filament, only the 6 
hour sham and 1 day injury groups demonstrate evoked firing that is significantly greater 
than at 1 day after sham (p<0.03) and normal responses (p<0.007) (Fig. 3.8b). There is no 
difference from normal evoked responses for any stimulus applied at 1 day after a sham 
procedure. 
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3.5. Discussion 
This study demonstrates that neuronal hyperexcitability in the dorsal horn 
develops within the first day after transient mechanical facet joint injury, corresponding 
to the development of hyperalgesia (Figs. 3.5-3.8). Although neuronal hyperexcitability is 
evident at 1 day after painful facet joint injury, neither behavioral nor neuronal responses 
are different from sham at 6 hours after the injury (Figs. 3.5-3.8). The hyperexcitability in 
dorsal horn neurons at day 1 is measured as an increase over sham in both spontaneous 
 
 
Fig. 3.7. Representative firing for sham and injured rats at 6 hours or 1 day. Voltage 
recordings are presented prior to spike sorting to demonstrate the relative differences 
in neuronal activity in response to light brush, von Frey filament (1.4-26g) and 
noxious pinch stimuli. Sham and injured rats have similar firing at 6 hours, but at 1 
day after the injury there is demonstrably more neuronal firing relative to sham. 
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firing and responses evoked by non-noxious and noxious mechanical stimuli (Figs. 3.6-
3.8). These results suggest that spinal neuronal hyperexcitability indicative of central 
sensitization develops early after facet joint injury and plays a role in the development of 
the behavioral sensitivity that is known to persist at later time points in this model (Lee 
and Winkelstein, 2009; Quinn et al., 2010b). 
 
 
Fig. 3.8. Evoked firing in the spinal dorsal horn. (a) Normal rats and those at 1 day 
after sham exhibit significantly lower evoked responses to light brush and noxious 
pinch than those at 1 day after painful injury (*p≤0.014). Only normal rats are 
significantly lower than those at 6 hours after sham (#p<0.0008) and 6 hours after 
injury (^p<0.004). (b) In response to von Frey filament stimuli, normal rats and those 
at 1 day after sham exhibit significantly less evoked firing than those at 1 day after 
injury (*p<0.03), 6 hours after sham (#p<0.0006), and 6 hours after injury (^p<0.017). 
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The mechanical parameters defining the extent of facet joint injury, including 
vertebral distractions, capsule distractions, and maximum principal capsule strains, are 
not different between the two groups studied at 6 hours and 1 day after injury, indicating 
that those two groups received the same injury. The vertebral distractions for both painful 
injury groups (0.53±0.31mm for 6 hour; 0.63±0.16mm for 1 day) are not different from 
those previously reported to induce microstructural damage in the capsular ligament 
(Quinn et al., 2010a), and to produce persistent pain (Lee et al., 2004a; Lee and 
Winkelstein, 2009). Furthermore, the capsular strains measured in this study (28±14% 
and 21±14% for the 6 hour and 1 day groups, respectively) are similar to those strains 
induced in the C5-C7 facet capsules during whiplash injury (Pearson et al., 2004). Strains 
greater than 10% have been shown to be sufficient to activate the nociceptive fibers that 
innervate the facet joint in a caprine model (Lu et al., 2005b). Increases in afferent 
discharge after nerve injury have been shown to induce neuropathic pain, and blocking 
afferent activity after injury can suppress the development of behavioral sensitivity 
(Seltzer et al., 1991a). Therefore, the levels of facet joint distraction in this study that 
produce persistent pain may induce neuronal hyperexcitability by increasing afferent 
discharge from the injured joint. Studies in Chapter 4 further evaluate the role of primary 
afferent discharge from the cervical facet joint in the initiation of spinal hyperexcitability. 
There are no behavioral or electrophysiological differences between the injury 
and sham groups at 6 hours, and behavioral sensitivity at 6 hours after injury is not 
different from baseline, indicating that the potentiation of nociception in the dorsal horn 
has not yet occurred at that time. However, at 6 hours, 31% of neurons in sham rats and 
24% in injured rats exhibit spontaneous firing greater than one spike/sec, similar to those 
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percentages found at day 1 after injury (27%) (Fig. 3.6). Both spontaneous and evoked 
firing are elevated over normal for injury and sham at 6 hours, suggesting that afferent 
activity may be acutely potentiated by the initial surgical procedure itself without causing 
secondary behavioral sensitivity. However, the neuronal activity largely returns to that of 
normal levels over the following hours in sham controls, while aberrant spontaneous 
activity and spinal hyperexcitability persist after injury (Figs. 3.6-3.8). It is possible that 
the increased firing that is observed at 6 hours after the sham and injury procedures 
relative to normal responses (Fig. 3.8) may be due, in part, to interactions between the 
isoflurane used for the initial surgery and the pentobarbital used for the electrophysiology 
procedures. However, the sham group received the same anesthesia as the painful injury 
group, so the direct comparison of behavioral sensitivity and neuronal activity between 
those two groups at 6 hours is not affected by any potential anesthesia interactions. 
Mechanical hyperalgesia in this study is measured in the forepaw, a site remote 
from the injury, which is consistent with clinical reports of secondary hyperalgesia and 
centrally-mediated pain following whiplash (Curatolo et al., 2004; Herren-Gerber et al., 
2004). The development of mechanical hyperalgesia parallels the onset of persistent 
spinal neuronal hyperexcitability within the first day after facet joint injury (Figs. 3.5 and 
3.8). The significant decrease in PWT at that same time point (Fig. 3.5) is consistent with 
other studies of behavioral sensitivity after painful facet joint injury, in which sensitivity 
was induced at day 1 after injury (Lee et al., 2008; Weisshaar et al., 2010). In fact, in the 
current study, facet capsule stretch reduces PWTs to below the baseline 10-15g threshold 
in normal rats, suggesting the recruitment of typically non-nociceptive Aβ afferents for 
nociception. Aβ afferents may acquire nociceptive functionality through de novo 
 58 
expression of neuromodulators, like substance P, that are typically associated with 
nociceptive fibers (Latremoliere and Woolf, 2009). Low-threshold afferents may also 
sprout processes into the superficial dorsal horn and structurally integrate into 
nociceptive pathways by synapsing with nociceptive-specific dorsal horn neurons (Woolf 
et al., 1992). Regardless of the mechanism, the activation of nociceptive neurons in the 
dorsal horn by typically non-nociceptive low-threshold mechanosensitive fibers can 
directly cause aberrant pain in response to innocuous stimuli, and supports the assertion 
that facet joint loading that produces pain also initiates modifications in the spinal 
processing of sensory information that leads to behavioral hypersensitivity. 
Spontaneous activity in primary afferents is a potential mechanism for the 
initiation and long-term maintenance of central sensitization (Devor, 2009; Latremoliere 
and Woolf, 2009). In this study, a greater percentage of dorsal horn neurons (27%) 
exhibit spontaneous firing at day 1 after painful injury compared to each of sham exposed 
(5%) and normal rats (5%) (Fig. 3.6). This finding is supported by reports that up to one-
third of primary sensory neurons develop spontaneous activity after peripheral nerve 
axotomy (Devor, 2005; Devor, 2009). The development of spontaneous activity also 
corresponds to the onset of tactile allodynia after peripheral nerve injury (Devor, 2009; 
Sun et al., 2005). Indeed, ectopic activity in nociceptive Aδ and C fibers may contribute 
to central sensitization and neuropathic pain after injury (Cook et al., 1987; Djouhri et al., 
2006; Wall and Woolf, 1986). However, other work examining the role of afferent firing 
in the development of neuropathic pain has shown that allodynia can be induced by Aβ 
fibers in the absence of C fiber activation (Devor, 2009; Liu et al., 2000). Although 
spontaneous Aδ and C fiber activity and low-threshold Aβ fibers each have been 
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proposed as contributors to central sensitization after injury (Devor, 2009; Djouhri et al., 
2006; Liu et al., 2000), WDR neurons receive input from both non-nociceptive and 
nociceptive afferents (Baron, 2006). As such, the presence of WDR spontaneous activity 
alone in this study does not determine whether low-threshold afferents or nociceptors 
mediate the development of central sensitization after painful facet joint injury. However, 
ectopic firing in C fibers develops weeks after injury while the majority of spontaneous 
firing in the immediate hours or days after injury occurs in the low-threshold touch-
sensitive Aβ fibers (Devor, 2009). Based on Devor’s study (2009), the development of 
aberrant spontaneous activity between 6 hours and 1 day after painful facet joint injury 
(Fig. 3.6) suggests that Aβ fibers are likely to be the source of that ectopic activity. 
Ultimately, better classification of the primary afferents is necessary during spinal 
electrophysiological recordings to determine which afferent populations are involved in 
the ectopic firing that is observed here. 
The temporal responses after this painful joint injury mimic the timing of changes 
after peripheral nerve injury, in which up to 27% of A fibers, but not C fibers, begin 
spontaneously firing between 6 and 30 hours after the injury (Michaelis et al., 1995). 
Given the similarity to neuropathic pain models in both the timing and scope of ectopic 
firing observed in this study, it should be noted that this painful facet joint model is a 
ligamentous injury and not an explicit nerve injury. However, axonal swelling indicative 
of secondary axotomy has been reported in a similar caprine model of facet capsule 
stretch (Kallakuri et al., 2008). Nonetheless, taken together with the literature, the 
increased spontaneous activity in the spinal cord evident at day 1 after painful facet joint 
injury suggests that the etiology of pain and central sensitization following mechanical 
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joint injury may be similar to peripheral neuropathic injuries. As such, studies of the 
initiation and development of neuropathic pain in nerve injury models may provide 
valuable insight for continued elucidation of the biomechanical and neurophysiological 
mechanisms underlying persistent facet joint-mediated pain. 
Evoked activity is elevated over sham in neurons recorded at day 1 after painful 
facet joint injury (Fig. 3.7 and 3.8). There is a significantly greater evoked response to 
light brush and the 4g von Frey filament at day 1 after injury (Fig. 3.8), both of which are 
non-noxious stimuli that do not elicit a behavioral response in uninjured rats and do not 
typically activate high-threshold nociceptors (Kitagawa et al., 2005). These results 
suggest that the Aβ fibers that transduce non-noxious mechanosensation may have a role 
in the early development of spinal hyperexcitability following painful facet joint injury. 
The evoked responses to noxious stimuli, including the 10g and 26g von Frey filaments 
and 60g pinch, are also significantly greater at day 1 after injury (Fig. 3.8). WDR neurons 
receive input from non-nociceptive and nociceptive afferent populations (Baron et al., 
2006), so the consistent increase in excitability across both non-noxious and noxious 
stimuli supports the involvement of WDR neurons in the development of central 
sensitization after painful facet joint injury. 
The increases in evoked activity following both non-noxious and noxious stimuli 
are consistent with the hyperexcitability that has been reported at day 7 after this facet 
joint injury (Quinn et al., 2010b). These similarities in spinal hyperexcitability at two 
different time points suggest that the mechanisms of neuronal plasticity associated with 
the development of sustained spinal hyperexcitability begin between 6 hours and 1 day 
after a facet capsule stretch. One potential mechanism may involve protein kinase C 
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epsilon (PKCε), an important downstream regulator of excitatory glutamate signaling and 
N-methyl-D-aspartate (NMDA) glutamate receptor activation (Xu et al., 2007). NMDA 
receptor activation is a key step in the induction and maintenance of sensitization since it 
is an important glutamatergic receptor in the dorsal horn (Latremoliere and Woolf, 2009). 
PKCε is upregulated in the DRG at day 7 and in the spinal dorsal horn at day 1 after 
painful facet joint injury (Dong et al., 2012; Weisshaar et al., 2010). The increased PKCε 
in the DRG and spinal cord may potentiate the excitability of primary afferents and dorsal 
horn neurons, respectively, by increasing the depolarizing inward currents through 
activated NMDA receptors and voltage-dependent ion channels (Deriemer et al., 1985; 
Weisshaar et al., 2010). Potentiation of the glutamatergic system is believed to play a key 
role in the amplification of nociception that causes pain hypersensitivity after nerve 
injury; consequently, many pharmacological interventions for neuropathic pain are 
designed to modulate glutamatergic signaling (Kawasaki et al., 2004; Ultenius et al., 
2006; Yaksh, 1999). Expression of some glutamatergic signaling proteins has been 
characterized after painful facet joint injury (Dong et al., 2012; Dong and Winkelstein, 
2010; Weisshaar et al., 2010). However, future studies should more fully evaluate the 
potentiation of spinal glutamatergic signaling after facet joint injury, including the 
activation of NMDA glutamate receptors and the secondary signaling molecule, ERK. 
Activation of each of those glutamatergic signaling proteins has been reported to promote 
central sensitization by increasing spinal neuronal excitability (Kawasaki et al., 2004; 
Ultenius et al., 2006). Understanding their role in the overall potentiation of 
glutamatergic signaling and the onset of persistent joint-mediated pain may provide a 
foundation for the development of effective analgesic treatments after joint injury. 
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3.6. Conclusions and Integration 
Dorsal horn neuronal hyperexcitability develops between 6 hours and 1 day after 
painful facet joint injury, and parallels the onset of behavioral hypersensitivity (Crosby et 
al., 2013). Those results support the hypothesis that electrophysiological and behavioral 
hypersensitivity develop concurrently early after painful facet joint injury. The findings 
from this study suggest that spinal modifications play a key role in promoting mechanical 
hyperalgesia by potentiating firing in the WDR neurons that integrate and transmit non-
nociceptive and nociceptive mechanosensation (Baron, 2006; Christensen and 
Hulsebosch, 1997; Hains et al., 2003a; Zhang et al., 2005). Additionally, the increase in 
aberrant spontaneous activity at day 1 suggests that ectopic firing develops in parallel 
with spinal neuronal hyperexcitability and mechanical hyperalgesia. Ectopic activity in 
afferent fibers may directly contribute to the increase in spinal neuronal excitability by 
maintaining low levels of excitatory input to the dorsal horn. 
Overall, data in this chapter provide evidence that spinal neuronal 
hyperexcitability contributes to the development of persistent facet-mediated pain within 
the first day after painful facet joint injury. However, spinal hyperexcitability and 
behavioral sensitivity do not develop until at least 6 hours after painful joint injury 
(Crosby et al., 2013), so there is a critical, and likely short, time between injury and the 
development of persistent elevated spinal responses. That potential temporal window 
before the onset of spinal hyperexcitability may provide an opportunity to attenuate the 
subsequent development of persistent pain, and could have importance in the design of 
more effective acute treatments for traumatic joint injuries. However, the role of afferent 
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activity in the initiation of persistent pain and the importance of the timing of that 
afferent activity from the injured joint has not been established. 
Studies in Chapter 4 evaluate the role of afferent firing from the facet joint in the 
induction of spinal hyperexcitability by blocking afferent activity at different times in the 
hours following painful joint injury. Furthermore, the neuronal hyperexcitability that 
develops after painful facet joint injury likely directly contributes to persistent pain, but 
the spinal modifications that result in hyperexcitability have not been fully elucidated. 
Subsequent chapters of this thesis evaluate if spinal plasticity is induced by painful facet 
joint injury and the mechanisms that may contribute to neuronal hyperexcitability, 
including potentiation of excitatory glutamate signaling (Chapter 4) and excitatory 
synaptogenesis (Chapter 5). 
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CHAPTER 4 
 
Early Afferent Activity from the Injured Facet 
Joint Potentiates Spinal Sensitization 
   
 
This chapter was adapted from: 
Crosby ND, Gilliland TM, Winkelstein BA. Early afferent activity from the facet joint 
after painful trauma to its capsule potentiates neuronal excitability and glutamate 
signaling in the spinal cord. Pain 2014; 155(9):1878-1887. 
 
4.1. Overview 
Painful facet joint injury induces dorsal horn neuronal hyperexcitability and spinal 
modulation of excitatory glutamatergic signaling, both of which are indicative of central 
sensitization, as early as one day after injury (Crosby et al., 2013; Dong et al., 2010; 
Dong et al., 2012; Quinn et al., 2010b; Weisshaar et al., 2010; Winkelstein, 2004). Direct 
injury to peripheral nerve fibers can induce significant discharge from the damaged 
afferents that is believed to be a primary contributor to central sensitization (Blenk et al., 
1996; Chi et al., 1993; Seltzer et al., 1991a; Seltzer et al., 1991b; Wall et al., 1974). 
Painful facet joint injury may lead to central sensitization in a similar fashion via an 
increase in firing of the afferents that innervate the joint, during and after noxious facet 
capsule stretch (Chen et al., 2006; Lu et al., 2005a). Treatments that block the initial 
afferent discharge after nerve injury are more effective for attenuating neuropathic pain 
than treatments that are given after pain has already developed (Araujo et al., 2003; Lin et 
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al., 2011; Seltzer et al., 1991a). Those studies indicate that effective intervention for 
chronic pain relies, in part, on understanding the timing of the afferent firing that initiates 
sensitization. Despite this, the temporal relationship between afferent discharge and the 
development of persistent facet joint pain after mechanical joint injury is not defined. 
The studies of the temporal development of spinal hyperexcitability after painful 
facet joint injury in Chapter 3 suggest that the onset of hyperalgesia and aberrant spinal 
neuronal hyperexcitability does not occur for at least 6 hours after facet joint injury 
(Crosby et al., 2013). During that time before the onset of hyperalgesia, noxious stretch 
of the cervical facet capsule increases discharge and afterdischarge from the afferent 
fibers that innervate the capsule. However, the role of that increased afferent firing in the 
induction and maintenance of spinal hyperexcitability is unknown. This chapter 
summarizes the experiments under Aims 1b-1d, which determine the role of facet injury-
induced afferent discharge in the initiation of behavioral sensitivity, spinal 
hyperexcitability, and the potentiation of glutamatergic signaling in the spinal cord.  
Intra-articular bupivacaine was administered immediately, or at day 4, after 
painful injury to the bilateral C6/C7 facet joints to block the afferent firing from the joint. 
Mechanical hyperalgesia was assessed through day 7 to measure behavioral sensitivity. 
Dorsal horn neuronal activity, and the spinal expression of glial fibrillary acidic protein 
(GFAP) and glutamate signaling proteins, including the secondary signaling molecule, 
ERK1/2, the NR1 subunit of NMDA glutamate receptors, the metabotropic glutamate 
receptor mGluR5, and astrocytic glutamate transporters GLAST and GLT-1, were each 
quantified at day 7 to evaluate the development of, and mechanisms that may promote, 
spinal hyperexcitability. Studies also evaluated the importance of the timing of peripheral 
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intervention after painful facet joint injury by transiently blocking joint afferent firing at 
times throughout the development of spinal hyperexcitability, and subsequently 
measuring behavioral sensitivity and spinal hyperexcitability at day 7. 
 
4.2. Background 
The cervical facet joints are at risk for injury during abnormal neck motions and 
have been implicated as a source of pain in up to 60% of chronic neck pain cases 
(Barnsley et al., 1995; Lord et al., 1996; Manchikanti et al., 2004). Current treatments for 
facet joint-mediated pain include intra-articular injection of analgesics or corticosteroids, 
and nerve block or radiofrequency neurotomy of the medial branches of the dorsal ramus 
that innervates the joint (Barnsley and Bogduk, 1993; Lander, 2007; Lord et al., 1996b; 
Manchikanti et al., 2008). Although these treatments can provide relief in some patients, 
that relief is often only temporary. It is unclear whether the effectiveness of local 
interventions for spinal joint pain depends on the timing of the treatment relative to the 
traumatic event and/or the onset of pain, or the development of spinal modifications that 
enhance neuronal excitability and amplify nociception. 
Interrupting the neuronal signals that initiate central sensitization has been a focus 
of therapeutic approaches to preemptively reduce postoperative pain (Chen et al., 2014; 
Wei et al., 2013; Woolf and Chong, 1993), and to alleviate neuropathic pain following 
nerve injury (Seltzer et al., 1991a; Xie et al., 2005). For nerve injury, early intervention 
blocking discharge from the injured fibers is more effective for reducing or preventing 
neuropathic pain than treatments initiated after central sensitization has already 
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developed (Araujo et al., 2003; Gonzales-Darder et al., 1986; Seltzer et al., 1991a; Seltzer 
et al., 1991b; Shankarrapa et al., 2012; Xie et al., 2005). Although injury to the cervical 
facet joint and its capsule is primarily a ligamentous injury, the facet capsule is 
innervated with primary afferent fibers that exhibit signs of secondary damage after 
excessive loading of the facet joint (Chen et al., 2006; Kallakuri et al., 2008; Kras et al., 
2013a; McLain, 1994; Yamashita et al., 1990). Evidence of axonal damage in the facet 
capsule suggests that the pain after facet joint injury is due, at least in part, to neuropathic 
mechanisms. In fact, capsule stretch in a caprine model of facet joint distraction induces 
transient increases in the firing of afferents that innervate the facet capsule, similar to the 
increases in afferent firing that accompany nerve injury (Chen et al., 2006; Kallakuri et 
al., 2008; Lu et al., 2005a). Painful facet joint injury also leads to the development of 
ectopic firing and hyperexcitability in dorsal horn neurons (Crosby et al., 2013; Quinn et 
al., 2010b). Despite evidence of enhanced facet capsule afferent activity and spinal 
neuronal hyperexcitability after joint injury, the temporal relationship between capsule 
afferent activity, spinal hyperexcitability, and pain after mechanical facet joint injury has 
not been defined and could help to inform timing of effective treatments. 
Potentiation of excitatory glutamatergic signaling in the dorsal horn can 
contribute to the spinal hyperexcitability that is associated with central sensitization 
(Latremoliere and Woolf, 2009). Glutamate signaling from primary afferents activates 
both ionotropic (i.e., AMPA, NMDA) and metabotropic (i.e., mGluR1-5) receptors at 
excitatory synapses in the dorsal horn (Yaksh, 2006). Increases in afferent input to the 
dorsal horn can overstimulate glutamate receptors, especially NMDA receptors and 
mGluR5, whose activation causes increases in intracellular calcium concentrations 
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(Latremoliere and Woolf, 2009; Petrenko et al., 2003). Activation of calcium-dependent 
secondary signaling molecules like PKC and ERK1/2 can then lead to further potentiation 
of NMDA receptor activity, including phosphorylation of the NR1 subunit (pNR1), and 
changes in the expression of proteins like mGluR5 that can enhance dorsal horn neuronal 
excitability (Kawasaki et al., 2004; Ultenius et al., 2006). Glutamatergic signaling is 
normally regulated by astrocytic and neuronal transporters that remove glutamate from 
the synapse and prevent overstimulation of glutamate receptors (Danbolt, 2001; Liaw et 
al., 2005). However, downregulation of the astrocytic glutamate transporters, GLAST 
and GLT1, in the dorsal horn can prevent clearance of synaptic glutamate, and 
contributes to the persistent behavioral sensitivity that is evident after nerve injury (Sung 
et al., 2003; Xin et al., 2009). Some modifications in glutamatergic signaling have been 
measured in the dorsal horn after painful facet joint injury, including upregulation of 
mGluR5 and PKC (Dong et al., 2012; Dong and Winkelstein, 2010; Weisshaar et al., 
2010). However, the roles of many glutamatergic signaling proteins that play important 
roles in central sensitization have not been studied in the context of facet joint injury, 
including activation of the secondary signaling molecule ERK1/2, phosphorylation of 
NMDA-NR1, and the expression of the astrocytic glutamate transporters GLAST and 
GLT1. Furthermore, the role of afferent discharge from the facet joint in the potentiation 
of spinal glutamatergic signaling after painful joint injury has not been evaluated. 
These studies investigate the role of afferent activity from the facet joint in 
inducing behavioral sensitivity and spinal modifications indicative of central sensitization 
in a rat model of facet capsule trauma. It was hypothesized that the afferent activity from 
the facet joint capsule that occurs early after joint injury is critical for initiating spinal 
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hyperexcitability, and that quieting peripheral inputs from the joints after 
hyperexcitability is established is ineffective at attenuating central sensitization. To test 
these hypotheses, painful facet capsule stretch was imposed followed by intra-articular 
injection of bupivacaine at two times after injury, in separate groups – immediately after 
capsule stretch and at day 4, after spinal hyperexcitability is established (see Chapter 3) 
(Crosby et al., 2013). Behavioral sensitivity was measured through day 7 and then evoked 
activity was recorded from dorsal horn neurons to assess neuronal excitability. Spinal 
expression of ERK, pERK1/2, NR1, pNR1, mGluR5, GLAST, and GLT1 were quantified 
to determine the role of afferent activity in potentiating glutamatergic signaling and in 
enhancing neuronal excitability in the dorsal horn. Glial activation can also contribute to 
spinal hyperexcitability, so spinal GFAP expression was quantified as an indicator of 
astrocytic activation (Watkins et al., 2001). Expanding that work in a second study, 
bupivacaine was administered to quiet joint afferent activity at 4 hours, 8 hours, or 1 day 
after injury, times throughout the period when spinal hyperexcitability develops (Crosby 
et al., 2013). Mechanical hyperalgesia was measured through day 7, and dorsal horn 
neuronal excitability was assessed at day 7 in order to determine the extent to which the 
timing of afferent inputs modulates the transition to sustained pain. 
 
4.3. Methods 
All experimental procedures were approved by the University of Pennsylvania 
Institutional Animal Care and Use Committee and carried out under the guidelines of the 
Committee for Research and Ethical Issues of the International Association for the Study 
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of Pain (Zimmerman, 1983). Male Holtzman rats (395±30g) were housed under USDA- 
and AAALAC-compliant conditions with free access to food and water. 
 
4.3.1. Facet Joint Injury with Immediate or Delayed Intra-articular Bupivacaine 
Separate groups of rats received a bilateral intra-articular injection of bupivacaine 
either immediately after injury (inj-BP0h, n=12) or delayed until day 4 after injury (inj-
BPd4, n=12). Similarly, separate groups of rats received control injections of the saline 
vehicle immediately following either the injury (inj-VEH0h, n=13) or a sham surgery 
(sham-VEH0h, n=12); as with the delayed bupivacaine treatment, groups also received 
saline vehicle at day 4 after injury (inj-VEHd4, n=11) or sham surgery (sham-VEHd4, 
n=12). Mechanical hyperalgesia was assessed prior to and at days 1, 3, 5, and 7 after 
surgery, and compared to baseline and between groups using repeated-measures ANOVA 
with post-hoc Tukey’s HSD tests. On day 7, extracellular electrophysiological recordings 
were acquired from a subset of rats that received intra-articular injections of bupivacaine 
(inj-BP0h, inj-BPd4, n=6 per group) or saline (inj-VEH0h, n=7; sham-VEH0h, inj-
VEHd4, sham-VEHd4, n=6 per group). Spinal cord tissue was collected after 
electrophysiology for Western blot analysis of ERK, pERK1/2, NR1, pNR1, mGluR5, 
GLAST, GLT1, and GFAP expression. Spinal cord samples were also collected from the 
remaining rats (n=5-6 per group) to assess region-specific expression of mGluR5, pNR1, 
and GFAP by immunohistochemical analysis. Evoked neuronal firing and protein 
expression were compared between groups for each injection time by ANOVA with a 
post-hoc Tukey’s HSD test. 
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4.3.2. Painful Facet Joint Capsule Injury 
The surgical methods used to impose painful facet joint injury are detailed in 
Section 3.3.1 of Chapter 3, and have been previously described (Dong and Winkelstein, 
2010; Lee et al., 2004a). Rats were anesthetized with isoflurane (4% induction, 2-3% 
maintenance) and placed in a prone position. An incision was made along the midline of 
the back of the neck to expose and separate the paraspinal musculature. The bilateral 
vertebral laminae and facet joints from C5 to T1 were exposed, the soft tissue was 
resected, and the interspinous ligaments cut to enable attachment of the C6 and C7 
vertebrae to a custom loading device (Dong and Winkelstein, 2010; Lee et al., 2004a). 
The C6 vertebra was distracted 0.7mm rostrally while the C7 vertebra was held fixed to 
stretch the facet capsules across the bilateral C6/C7 joints (Dong and Winkelstein, 2010). 
Beads were placed on the C6 and C7 vertebrae and in a grid on the right C6/C7 facet 
capsule to track motions during the imposed capsule stretch. A Phantom v4.3 CCD 
camera (Vision Research; Wayne, IN) monitored the bead marker positions, which were 
used to calculate vertebral and facet capsule displacements, and maximum principal 
strains on the facet capsule surface during each joint distraction. Separate rats underwent 
surgical procedures for a sham injury with attachment to the loading device but with no 
joint distraction applied. Following surgery, incisions were closed using 3-0 polyester 
suture and surgical staples, and rats were monitored during recovery in room air. 
 
4.3.3. Intra-articular Bupivacaine Injections 
Intra-articular injections of 0.5% bupivacaine or 0.9% saline solution were given 
in a volume of 10µL injected into the left and right facet joints using a 10μL 
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microsyringe with a 33G beveled needle (Hamilton; Reno, NV). The microsyringe was 
held in the joint for at least 30 seconds after injection before it was slowly removed in 
order to prevent fluid leakage from the joint space. For those treatments given 
immediately after injury, intra-articular injections were administered following the injury 
or sham facet joint loading, prior to closing the surgical incisions. For the intra-articular 
injections made on day 4, rats were anesthetized with isoflurane (4% induction, 2-3% 
maintenance), the paraspinal musculature was separated to re-expose the C6/C7 facet 
joints and injections were performed as described above. All incisions were closed using 
3-0 polyester suture and surgical staples, and rats were monitored during recovery in 
room air. 
 
4.3.4. Assessment of Mechanical Hyperalgesia 
Mechanical hyperalgesia was evaluated in all rats prior to and after injury and/or 
treatment, using methods described in Section 3.3.2 of Chapter 3 and detailed previously 
(Dong et al., 2012; Kras et al., 2013b). A series of weighted von Frey filaments was 
applied to the left and right forepaws in increasing weight (1.4, 2, 4, 6, 8, 10, 15, and 
26g). Each filament was applied five times. If a rat responded to two consecutive filament 
weights by withdrawing, licking, or shaking the forepaw, the lower of those filament 
weights was recorded as the paw withdrawal threshold, with a maximum threshold of 
26g. Testing was repeated in three rounds and the average of all rounds was calculated 
for each rat, by averaging the left and right paw withdrawal thresholds (mean±SD) (Dong 
et al., 2012; Kras et al., 2013b). 
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4.3.5. Spinal Cord Electrophysiology and Analysis of Neuronal Excitability 
Electrophysiological recordings were acquired on day 7 after painful facet joint 
injury, using methods described in Section 3.3.3 of Chapter 3. Briefly, rats were 
anesthetized with sodium pentobarbital (45mg/kg, i.p.) and given supplementary doses 
(5-10mg/kg, i.p.) as needed based on toe pinch reflexes. The C6/C7 spinal cord was 
exposed by performing a bilateral laminectomy and dural resection, and the rat was 
immobilized on a stereotaxic frame (David Kopf Instruments; Tujunga, CA). 
Extracellular potentials were recorded using carbon fiber electrodes (Carbostar-1; Kation 
Scientific; Minneapolis, MN). Potentials were amplified with a gain of 10
3
 and 
conditioned using a bandpass filter between 0.3kHz and 3kHz (World Precision 
Instruments; Sarasota, FL) and a 60Hz HumBug adaptive filter (Quest Scientific; North 
Vancouver, BC). Signals were then digitally sampled at 25kHz (Micro1401, CED; 
Cambridge, UK), and monitored with a speaker for audio feedback (A-M Systems; 
Carlsborg, WA). 
The electrode was lowered by a micropositioner (Narishige; Tokyo, Japan) into 
the spinal dorsal horn by entering the pial surface of the C6 or C7 spinal cord. Neurons 
were selected for recording if they were responsive to mechanical stimulation of the 
forepaw by brushing with a cotton swab (Christensen and Hulsebosch, 1997; Crosby et 
al., 2013; Quinn et al., 2010b). Once selected, a neuron was mechanically stimulated at 
the forepaw with a series of non-noxious and noxious stimuli, including a two-second 
baseline period before each stimulus, ten seconds of light brushing, five consecutive one-
second stimulations at one-second intervals with a series of von Frey filaments (1.4, 4, 
10, and 26g), and concluding with ten seconds of noxious pinch with a 60g vascular clip 
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(Crosby et al., 2013; Hains et al., 2003a; Quinn et al., 2010b). Each stimulus was 
separated by at least 30 seconds to prevent wind-up of mechanically sensitive neurons, 
which is a progressive increase in dorsal horn neuronal firing in response to repetitive 
stimulation of nociceptive afferents (Woolf and Salter, 2000). The von Frey filaments 
were chosen to represent the range of stimuli used to evaluate mechanical hyperalgesia 
and their application was synchronized with the electrophysiological recordings. The 
spike recording protocol is presented in detail in Appendix A.  
Voltage potentials were sorted with Spike2 (CED; Cambridge, UK) to ensure that 
spikes from only one neuron were considered for each recording site. Evoked firing was 
counted for a given stimulus (light brush, each von Frey filament, or pinch) by totaling 
the number of spikes during mechanical stimulation and subtracting spontaneous firing as 
determined by the firing counted during the preceding two-second baseline period (Hains 
et al., 2003b). The spike sorting and counting protocol is detailed in Appendix A. The 
distribution of evoked spike counts was positively skewed, so spike counts for each 
stimulus were transformed by calculating the log10 of each spike count. Residuals were 
plotted after transformation to confirm a normal distribution, and subsequent statistical 
analyses were performed on the log-transformed spike counts. Evoked neuronal firing 
was compared between the inj-BP, inj-VEH, and sham-VEH groups at each treatment 
time (immediately or at day 4) by ANOVA with a post-hoc Tukey’s HSD test. 
 
4.3.6. Western Blot Analysis of Spinal Cord Tissue 
Rats were transcardially perfused with 300mL of chilled phosphate-buffered 
saline (PBS). The C6/C7 spinal cord tissue was collected and homogenized in lysis buffer 
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(50mM Tris-HCl, 1% Triton X-100, 150mM NaCl, 1mM EDTA, pH 8.0) with protease 
and phosphatase inhibitors (Sigma-Aldrich Corp; St. Louis, MO). SDS-PAGE was 
performed by loading spinal cord protein (50μg per well) onto a polyacrylamide gel 
(Invitrogen; Carlsbad, CA) and running for 75 minutes at 150V. Protein was transferred 
to a polyvinylidene difluoride (PVDF) membrane using an iBlot (Invitrogen). Gels were 
cut into strips for high molecular weight (75-250kDa) or low molecular weight proteins 
(25-75kDa). Multiple high molecular weight or low molecular weight strips were 
transferred onto single PVDF membranes to allow synchronous detection of numerous 
proteins from the same protein samples and comparative analysis across multiple gels 
that were run simultaneously (Kiyatkin and Aksamitiene, 2009). Membranes were 
blocked for one hour in 5% dry-milk blocking reagent in Tris-buffered saline (TBS). 
The membranes incubated overnight at 4ºC with primary antibodies for the 
secondary signaling molecule, ERK1/2, as an indicator of neuronal activation (mouse, 
1:2000; Cell Signaling; Boston, MA), phosphorylated ERK1/2 (pERK1/2; rabbit, 1:1000; 
Cell Signaling; Boston, MA), the ionotropic glutamate receptor NMDA subunit, NR1 
(rabbit, 1:1000; Millipore; Billerica, MA) and its phosphorylated form (pNR1; rabbit, 
1:667; Millipore; Billerica, MA), the metabotropic glutamate receptor mGluR5 (rabbit, 
1:1250; Millipore; Billerica, MA), the astrocytic glutamate transporters GLAST (rabbit, 
1:2000; Abcam; Cambridge, MA) and GLT1 (rabbit, 1:500, Abcam; Cambridge, MA), 
glial fibrillary acidic protein for activated astrocytes (GFAP; rabbit, 1:1000; Dako; 
Carpinteria, CA), or β-tubulin as a protein loading control (mouse, 1:2000; Covance; 
Princeton, NJ). The PVDF membrane was washed in TBS with 0.1% Tween, followed by 
two hour incubation at room temperature with IRDye goat anti-mouse 680 and goat anti-
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rabbit 800 secondary antibodies (1:10,000; Li-Cor Biosciences; Lincoln, NE). Each 
membrane was imaged using an Odyssey Imaging System (Li-Cor Biosciences; Lincoln, 
NE). The fluorescence intensity of each target protein band was analyzed using the 
Odyssey 2.1 software and normalized to the corresponding β-tubulin fluorescence to 
control for the amount of protein loaded. 
 
4.3.7. Fluorescent Immunohistochemistry of Spinal Cord Tissue 
Rats were transcardially perfused first with 250mL of chilled PBS, then 300mL of 
4% paraformaldehyde (PFA). The C6/C7 spinal cord was dissected and removed, post-
fixed overnight in 4% PFA, and then submerged in 30% sucrose solution for 5-7 days for 
cryoprotection. Spinal cords were embedded in OCT medium and frozen, and then 14μm 
cryosections were mounted on Fisher Superfrost slides. Sections were blocked for two 
hours at room temperature with 10% normal goat serum with 0.3% Triton-X, and then 
labeled overnight at 4ºC with primary antibodies for pNR1 (rabbit, 1:500; Abcam; 
Cambridge, MA), mGluR5 (rabbit, 1:1000; Millipore; Billerica, MA), or GFAP (mouse, 
1:500; Millipore; Billerica, MA). Slides were rinsed with PBS and labeled with goat anti-
mouse Alexa 488 and goat anti-rabbit Alexa 568 secondary antibodies, then coverslips 
were mounted with Fluorogel medium (Electron Microscopy Sciences; Hatfield, PA). 
The spinal dorsal horns were imaged at 200x using an Olympus BX51 microscope, and 
analyzed using densitometry techniques in a customized MATLAB code (see Appendix 
E) to quantify the percentage of pNR1-, mGluR5-, or GFAP-positive pixels in each 
image (Dong et al., 2012; Kras et al., 2014a). The percentage of positive pixels in the 
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injury groups with vehicle or bupivacaine treatment were normalized to sham values and 
compared by one-way ANOVA with post-hoc Tukey’s HSD test. 
 
4.3.8. Painful Facet Joint Injury with Intra-articular Bupivacaine during the 
Development of Spinal Hyperexcitability 
A separate study was performed to determine if blocking afferent activity at times 
during the development of spinal sensitization affects the onset of hyperalgesia and spinal 
neuronal hyperexcitability. Intra-articular bupivacaine injections were used to 
temporarily quiet facet joint afferent firing in separate groups with injections at additional 
times early after the injury (4 hours, 8 hours, or day 1). Hyperalgesia and spinal 
hyperexcitability are first observed 6-24 hours after painful facet joint injury (Crosby et 
al., 2013), so those bupivacaine treatment times are during the development of sensitivity. 
Rats underwent painful facet joint capsule injury as described in Section 4.3.3 and 
received bilateral intra-articular injections of bupivacaine at 4 hours (inj-BP4h, n=5), 8 
hours (inj-BP8h, n=6), or day 1 (inj-BPd1, n=6) after injury. Mechanical hyperalgesia 
was assessed prior to injury and at days 1 and 7 after injury; behavioral responses were 
compared to pre-injury baseline responses by repeated-measures ANOVA with a post-
hoc Tukey’s HSD test. On day 7, electrophysiological recordings were made to quantify 
dorsal horn neuronal activity as described in Section 4.3.6. Evoked neuronal firing was 
compared between bupivacaine-treated groups by ANOVA with a post-hoc Tukey’s HSD 
test. Behavioral and electrophysiological data from the groups that received intra-
articular bupivacaine immediately or at day 4 after injury (see Section 4.3.2) were 
included in these statistical comparisons to compare the effects of immediate or delayed 
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bupivacaine to those treatments that occurred at different times throughout the 
development of spinal hyperexcitability. 
 
4.4. Results 
4.4.1. Immediate, but not Delayed, Intra-articular Bupivacaine Attenuates 
Mechanical Hyperalgesia after Painful Facet Joint Injury 
The vertebral distraction, the average distraction across the facet capsule, and the 
average maximum principal strain in the capsule are not different for any group that 
received painful facet joint injury (Table 4.1). A detailed report of the mechanical data 
from the painful joint distraction for each rat can be found in Appendix B. Facet capsule 
stretch with immediate saline vehicle treatment (inj-VEH0h) induces a significant 
decrease from the baseline paw withdrawal threshold (PWT) (p<0.027) on all testing 
days after injury (Fig. 4.1a). The PWT is not different from baseline on any day after the 
sham injury with vehicle treatment (sham-VEH0h) (Fig. 4.1a). Rats receiving intra-
articular bupivacaine immediately after injury (inj-BP0h) do not develop sensitivity, with 
a PWT not different from baseline on any day (Fig. 4.1a). The overall effect of treatment 
Table 4.1. Facet joint distraction and capsule mechanical measurements. 
 
Vertebral Distraction 
± SD (mm) 
Avg. Capsule 
Distraction ± SD (mm) 
Avg. MPS ± SD (%) 
inj-VEH0h 0.75±0.19 0.35±0.08 23.88±9.58 
inj-VEHd4 0.70±0.07 0.36±0.07 31.16±8.79 
inj-BP0h 0.79±0.19 0.30±0.06 27.50±8.00 
inj-BP4h 0.71±0.17 0.35±0.23 31.47±20.10 
inj-BP8h 0.70±0.17 0.38±0.12 25.88±6.81 
inj-BPd1 0.64±0.17 0.29±0.14 25.72±14.31 
inj-BPd4 0.63±0.16 0.31±0.12 24.41±15.14 
Avg. = average; MPS = maximum principal strain; SD = standard deviation 
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is also significant, with PWTs for the inj-VEH0h group being lower than those for the 
sham-VEH0h (p<0.0001) and inj-BP0h groups (p<0.0001) (Fig. 4.1a). The behavioral 
response after either injury or sham with vehicle injection at day 4 is the same as when a 
vehicle injection is given immediately after injury or sham, respectively. Specifically, the 
inj-VEHd4 group exhibits significant decreases in PWT from baseline (p<0.003) on all 
days after injury and PWT remains at baseline levels in the sham-VEHd4 group (Fig. 
4.1b). Unlike the bupivacaine treatment given immediately (Fig. 4.1a), bupivacaine given 
 
 
Fig. 4.1. Behavioral sensitivity after intra-articular bupivacaine (BP) given either at 
injury or 4 days later. (a) Paw withdrawal threshold (PWT) decreases from baseline on 
all days (*p<0.027) after injury with immediate intra-articular saline (inj-VEH0h), but 
PWT after bupivacaine treatment at the time of injury (inj-BP0h) is not different from 
baseline on all days, as is observed with sham (sham-VEH0h). (b) In contrast, intra-
articular bupivacaine given at 4 days after injury (inj-BPd4) has no effect on PWT, 
with decreased PWT compared to baseline on all days (*p<0.003), similar to the 
injury with a saline vehicle injection (inj-VEHd4) (^p<0.0001).  
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at day 4 after injury (inj-BPd4) does not attenuate sensitivity, exhibiting decreases from 
the baseline PWT on all testing days (p<0.0001) (Fig. 4.1b). Furthermore, the PWTs are 
significantly lower overall for both of the groups receiving treatment on day 4 (inj-
VEHd4, inj-BPd4) relative to sham-VEHd4 (p<0.0001). A summary of the individual 
paw withdrawal thresholds for each rat on each day is provided in Appendix C. 
 
4.4.2. Dorsal Horn Neuronal Hyperexcitability is Prevented by Immediate 
Bupivacaine Injection 
Neuronal activity in the dorsal horn was recorded from a total of 370 neurons 
(62±4 neurons per group) at an average depth of 638±177μm below the pial surface. Rats 
receiving saline vehicle immediately after injury (inj-VEH0h) exhibit increases in evoked 
firing of dorsal horn neurons during light brushing and 4g, 10g, and 26g von Frey 
filament stimulation, relative to sham (p<0.026) (Fig. 4.2). However, immediate 
bupivacaine treatment (inj-BP0h) significantly reduces the number of spikes evoked by 
light brushing (p<0.0001), noxious pinch (p=0.004), and all of the different strength von 
Frey filaments (p<0.0001), compared to the inj-VEH0h group (Fig. 4.2). Immediate 
bupivacaine reduces neuronal firing levels below those of the sham group during brush, 
pinch, and 1.4g von Frey filament stimulation (p<0.0007) (Fig. 4.2). Firing is also 
increased after injury with a day 4 vehicle treatment (inj-VEHd4) during all stimuli 
(p<0.045). In contrast to immediate bupivacaine treatment, bupivacaine given 4 days 
after injury (inj-BPd4) does not alter neuronal firing on day 7 from those responses of the 
matched vehicle group (inj-VEHd4) (Fig. 4.2). In fact, evoked firing is increased in the 
inj-BPd4 group over sham for all mechanical stimuli (p<0.035) (Fig. 4.2). Raw spike 
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counts for baseline firing, light brush, von Frey filament stimulation, and noxious pinch 
are detailed in Appendix D for each neuron from each rat. 
 
 
 
Fig. 4.2. Extracellular spike activity in the spinal dorsal horn 7 days after facet joint 
injury. (a) Traces indicate the filament application, raw extracellular voltage 
recording, and neuron identification and spike counts. Neuronal firing was sorted and 
spikes were counted during a baseline period and mechanical stimulation of the 
forepaw; a representative response to five applications of a 26g von Frey filament 7 
days after facet joint injury is shown. (b) Firing increases after injury (inj-VEH0h) 
over sham (sham-VEH0h) during light brush, 4g, 10g, and 26g von Frey filament 
stimulation (*p<0.026). Immediate bupivacaine attenuates firing in response to all 
stimuli after injury (#p≤0.004). Bupivacaine treatment (inj-BP0h) also reduces 
activity below that of sham for brush, pinch, and the 1.4g von Frey filament 
(^p<0.0007). (c) During all stimuli, for injections at day 4, neuronal firing is 
increased over sham (sham-VEHd4) after injury with either vehicle injection (inj-
VEHd4) (*p<0.045) and after bupivacaine injection (inj-BPd4) (^p<0.035). 
 
 
a)
b)
c)
0
20
40
60
80
100
120
140
160
brush, 0h txt pinch, 0h txt
s
p
i
k
e
s
 
+
/
-
 
S
E
M
inj-VEH
sham-VEH
inj-BP
0
40
80
120
160
b ush p nch
s
p
ik
e
s 
 
S
E
M
0
20
40
60
80
100
120
140
160
brush, d4 txt pinch, d4 txt
s
p
i
k
e
s
 
+
/
-
 
S
E
M
0
40
80
120
160
b sh p ch
s
p
ik
e
s 
 
S
E
M
0
5
10
15
20
25
30
35
40
45
1.4g, d4 txt 4g, d4 txt 10g, d4 txt 26g, d4 txt
s
p
ik
e
s
 +
/-
 S
E
M
1
1
2
2
3
3
4
4
1.4g 4g 10g 26g
s
p
ik
e
s 
 
S
E
M
S
ti
m
u
la
ti
o
n
 a
n
d
 R
e
c
o
rd
in
g
Templates from rat25_neuron4.smr channel 4
Code 01: 48 spikes
template
baseline
E
v
o
k
e
d
 S
p
ik
e
 A
n
a
ly
s
is
45 spikes 35 spikes 34 spikes 34 spikes 30 spikes0 spikes  
-0.1
0
0.1
0.2
1 sec
26g
1 2 3 4 5
V
o
lt
s
 (
V
)
S
p
ik
es
-0.1
-0.05
0
0.05
0.1
0.15
0.2
1 msec
0
5
10
15
20
25
30
35
40
1.4g, 0h txt 4g, 0h txt 10g, 0h txt 26g, 0h txt
s
p
ik
e
s
 +
/-
 S
E
M
0
5
10
15
20
25
30
35
40
1.4g 4g 10g 26g
s
p
ik
e
s 
 
S
E
M
inj-VEH0h
inj-BP0h
sham-VEH0h
inj-VEHd4
inj-BPd4
sham-VEHd4
^
^^
*
*
*
*
* *
*
*
*
*
^
^
^
^
^
^
# #
#
#
#
#
 82 
4.4.3. Excitatory Signaling is Modified by Immediate Bupivacaine Injection 
Several glutamatergic signaling proteins are increased in the spinal cord at day 7 
after painful facet joint injury and are attenuated with immediate bupivacaine 
administration in the joint (Fig. 4.3). Phosphorylated ERK1/2 (p<0.012), pNR1 
(p<0.029), mGluR5 (p<0.026), and GLAST expression (p<0.023) all increase after 
injury, regardless of whether vehicle treatment is given at the time of injury or at day 4 
(Fig. 4.3). However, immediate bupivacaine treatment prevents those increases in the 
expression of pERK1/2, pNR1, mGluR5, and GLAST (Figs. 4.3a and 4.3b), with 
expression in the inj-BP0h group being significantly different for each protein compared 
to that of the inj-VEH0h group (p<0.029), and not different from sham levels (Figs. 4.3a 
and 4.3b). GLT1 expression significantly decreases after injury with vehicle injection 
either immediately (p=0.032) or at day 4 (p=0.0001). Immediate bupivacaine treatment 
also prevents the decrease in GLT1, with expression significantly higher than the inj-
VEH0h group (p=0.049) and not different from sham. Bupivacaine administered at day 4 
after injury does not prevent the increases in pERK1/2 (p=0.048), pNR1 (p=0.034), 
mGluR5 (p=0.0003), and GLAST (p=0.0006), or the decrease in GLT1 (p=0.0001), that 
are typically evident over sham (Figs. 4.3c and 4.3d). Total ERK1/2 and NR1 protein 
levels are not different from sham in any injury or treatment group. Spinal cord protein 
levels quantified by Western blot are detailed for each rat in Appendix F.  
GFAP expression, unlike the other proteins quantified in this study that are 
involved in excitatory signaling, is not attenuated by immediate bupivacaine treatment 
(Fig. 4.3). In fact, GFAP significantly increases over sham after injury with immediate 
vehicle injection (p=0.002), and is similarly increased even after immediate bupivacaine 
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treatment (p=0.006) (Fig. 4.3a). For vehicle treatment given at day 4, GFAP expression is 
increased over sham (p=0.046), but is not different from sham levels with bupivacaine 
treatment given at day 4 (Fig. 4.3c).  
 
Increases in pNR1 and mGluR5 occur in the superficial dorsal horn after painful 
facet joint injury with vehicle treatment immediately after injury (p≤0.046) (Fig. 4.4). 
 
 
Fig. 4.3. Western blot of spinal cord at day 7. (a,b) Facet joint injury (inj-VEH0h) 
increases pERK1/2, pNR1, mGluR5, GLAST and GFAP, and decreases expression of 
GLT1 (*p≤0.032). Immediate bupivacaine treatment (inj-BP0h) prevents such 
increases, with significantly lower expression (#p<0.029) of pERK1/2, pNR1, 
mGluR5, and GLAST than inj-VEH0h and no differences from sham (sham-VEH0h). 
Immediate bupivacaine also prevents the decrease in GLT1 expression that is evident 
after injury (##p=0.049). However, GFAP expression remains significantly elevated 
over sham (*) and is not different from the inj-VEH0h group. (c,d) Injury with vehicle 
treatment at day 4 (inj-VEHd4) induces the same changes relative to sham as does 
injury with vehicle treatment at the time of injury (inj-VEH0h) (*p≤0.046). However, 
pERK1/2, pNR1, mGluR5, GLT1, and GLAST remain at injury levels with 
bupivacaine treatment at day 4 (inj-BPd4), and are significantly elevated over sham 
(^p≤0.048). Total ERK1/2 and NR1 expression is unchanged in all groups. 
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Likewise, increases in pNR1, mGluR5, and GFAP are localized to the superficial dorsal 
horn after painful injury with vehicle treatment at day 4 (p≤0.003) (Fig. 4.4). Immediate 
bupivacaine treatment decreases dorsal horn expression of pNR1 and mGluR5 to sham 
levels (p<0.0001), but treatment at day 4 does not alter the injury-induced increases in 
pNR1 and mGluR5 (p≤0.0009) (Fig. 4.4). GFAP labeling remains elevated over sham 
when injury is followed by immediate (p<0.0001) or day 4 (p=0.024) bupivacaine 
treatment (Fig. 4.4). Densitometry quantifications of immunolabeling in the spinal cord 
for each rat are detailed in Appendix G.  
 
 
 
Fig. 4.4. Immunolabeling of phosphorylated NR1 (pNR1), mGluR5, and GFAP in the 
spinal dorsal horn. Representative images of (a-d) pNR1 (red) and (e-h) mGluR5 (red) 
and GFAP (green) after injury, sham, and injury with immediate or day 4 bupivacaine 
treatment. (i) The percentage of pNR1- and mGluR5-positive pixels increases in the 
dorsal horn after injury with immediate vehicle treatment (inj-VEH0h) (*p≤0.046). 
Immediate bupivacaine treatment (inj-BP0h) prevents increases in pNR1 and mGluR5 
(#p<0.0001), but GFAP remains increased (^p<0.0001). (j) The percentages of pNR1-, 
mGluR5-, and GFAP-positive pixels increase after injury with day 4 vehicle treatment, 
relative to sham levels (*p≤0.003). However, delayed bupivacaine (inj-BPd4) does not 
prevent the increases in pNR1, mGluR5, and GFAP (^p≤0.024). Scale bar=100µm. 
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4.4.4. Intra-articular Bupivacaine within 8 Hours after Injury Attenuates 
Hyperalgesia and Spinal Hyperexcitability 
Bupivacaine treatment administered 4 hours after painful facet joint injury 
prevents the development of mechanical hyperalgesia. Paw withdrawal thresholds at day 
1 and day 7 are not different from baseline when rats receive intra-articular bupivacaine 
up to 4 hours after injury (Fig. 4.5); this is consistent with the PWT responses of the 
group receiving bupivacaine treatment immediately after injury in the first study (Figs. 
4.1a and 4.5). However, paw withdrawal thresholds decrease from baseline values on 
both day 1 (p<0.006) and day 7 (p<0.0002) if intra-articular bupivacaine is given at either 
8 hours or 1 day after painful facet joint injury (Fig. 4.5). That finding is similar to the 
PWT pattern for the group with bupivacaine treatment at day 4 after injury (inj-BPd4) 
(Figs. 4.1b and 4.5). 
 
 
 
Fig. 4.5. Hyperalgesia after bupivacaine administered during spinal sensitization 
onset. Bupivacaine administered immediately (0h) or 4 hours (4h) after facet joint 
injury prevents any change from baseline paw withdrawal threshold (PWT) at day 1 
and day 7 after injury. However, when bupivacaine treatment is given at 8 hours (8h), 
day 1 (d1), or day 4 (d4) after the injury, PWTs are significantly decreased from 
baseline levels on day 1 (*p<0.006) and day 7 (#p<0.0002).   
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Evoked firing in dorsal horn neurons on day 7 exhibits the same general pattern as 
the behavioral responses (Figs. 4.5 and 4.6), with attenuation of firing by intra-articular 
bupivacaine injections that are given before 8 hours. Firing evoked by light brushing is 
significantly lower in the inj-BP0h (p<0.0001) and inj-BP4h (p<0.0001) groups than in 
the groups receiving bupivacaine at later time points (inj-BP8h, inj-BPd1, inj-BPd4) (Fig. 
4.6). The evoked neuronal response to noxious pinch is lower in the groups receiving 
bupivacaine immediately (p<0.0001), 4 hours (p<0.002), or 4 days after injury (p<0.018) 
than in either of the groups receiving intra-articular injections at either 8 hours or 1 day. 
Neuronal firing evoked by any of the von Frey filaments is also significantly lower after 
bupivacaine treatments given immediately after injury (p<0.0001) or 4 hours later 
(p<0.045) compared to the firing evoked in the groups receiving bupivacaine injection at 
later times: 8 hours, day 1, or day 4 post-injury (Fig. 4.6). Immediate bupivacaine 
administration does attenuate firing significantly more than the 4 hour treatment at each 
von Frey filament strength (p<0.0001). In addition, firing is significantly greater in the 
group receiving bupivacaine at 8 hours after injury compared to those groups with 
treatment at day 1 and day 4 after injury, for stimulation with isolated filament strengths 
(Fig. 4.6b). 
 
4.5. Discussion 
Behavioral sensitivity and dorsal horn neuronal excitability are induced within 
hours after painful facet joint injury by afferent activity from the injured joint (Figs. 4.1 
and 4.2) (Crosby et al., 2013). The fast-acting anesthetic, bupivacaine, given in the facet 
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Fig. 4.6. Evoked spike activity in the dorsal horn after painful facet joint injury varies 
with timing of intra-articular bupivacaine. (a) Neuronal firing evoked by light brush is 
significantly higher when bupivacaine is administered at times later than 4 hours after 
injury than when it is given immediately (inj-BP0h) (*p<0.0001) or at 4 hours (inj-
BP4h) (#p<0.0001). Firing during a noxious pinch is increased in the inj-BP8h and inj-
BPd1 groups compared to the inj-BP0h (*p<0.0001), inj-BP4h (#p<0.002), and inj-
BPd4 (^p<0.018) groups. (b) Similarly, firing evoked by stimulation by all of the 
magnitudes of von Frey filaments is significantly greater when bupivacaine is 
administered 8 hours (inj-BP8h), 1 day (inj-BPd1), or 4 days after injury (inj-BPd4) 
than when it is given immediately (inj-BP0h) (*p<0.0001) or at 4 hours (inj-BP4h) 
(#p<0.045). Firing is also greater after treatment given at 4 hours (inj-BP4h) than it is 
when given at the time of injury (inj-BP0h) for all von Frey filament stimuli 
(*p<0.0001). There is also significantly more evoked firing in the inj-BP8h group than 
the inj-BPd1 group for stimulation by the 1.4g and 26g filaments (†p<0.0003) and the 
inj-BPd4 group for the 4g, 10g, and 26 filaments (^p<0.0001). 
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joint immediately after painful facet joint injury prevents the development of behavioral 
sensitivity (Fig. 4.1). Immediate bupivacaine treatment also reduces neuronal 
hyperexcitability and potentiation of excitatory glutamate signaling in the dorsal horn at 
day 7 (Figs. 4.2-4.4). The same attenuation of behavioral sensitivity and evoked dorsal 
horn neuronal firing is measured after intra-articular bupivacaine given at 4 hours after 
injury, but is not observed with later treatment times (Figs. 4.5 and 4.6). Systemic 
infusion of corticosteroids given at up to 8 hours after a motor vehicle collision reduces 
patient disability and chronic pain from whiplash-associated disorders (Pettersson et al., 
1998), but this report is the first to our knowledge that utilizes peripheral joint injections 
in a controlled study in which the time after injury is known. Understanding the timing of 
the sequelae leading from facet joint injury to spinal hyperexcitability is important for the 
development of more effective treatments for facet joint pain. Indeed, the findings in this 
study support the notion that joint afferent fiber blocks must be given within a tightly 
regulated temporal window with respect to the development of spinal hyperexcitability in 
order to prevent the transition to persistent pain. 
Intra-articular bupivacaine given at the time of facet joint injury that is known to 
cause pain prevents both the onset of mechanical hyperalgesia and dorsal horn neuronal 
hyperexcitability on day 7 (Figs. 4.1 and 4.2), suggesting that afferent inputs from the 
injured joint immediately after capsule loading are critical to induce sustained central 
sensitization. The painful joint injury used in this model induces joint capsular strains 
with the same magnitude as those strains that increase firing and afterdischarge for up to 
30 minutes in unmyelinated C fibers that innervate the capsule (Chen et al., 2006; Lee et 
al., 2004a; Lu et al., 2005a). Stimulation of primary afferent C fibers is sufficient to 
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induce hyperexcitability of second-order dorsal horn neurons that long-outlasts their 
initial stimulation (Cook et al., 1987; Wall and Woolf, 1986). Furthermore, both capsule 
transection before injury that removes any local loading in the capsule (Winkelstein and 
Santos, 2008), and selective chemical ablation of spinal C fiber populations prior to 
painful facet joint injury (Weisshaar and Winkelstein, 2014), each prevent the 
development of behavioral sensitivity. So, C fiber afferents in the facet joint and its 
capsule likely play an important role in transducing mechanical loading of that joint’s 
capsule into nociceptive signals that regulate spinal sensitization. However, in addition to 
C fibers, Aβ and Aδ fibers have also been shown to innervate the facet joint (Kallakuri et 
al., 2004; Kras et al., 2013a; McLain, 1994; Yamashita et al., 1990). Bupivacaine does 
not selectively act on C fibers (Gissen et al., 1982; Tabatabai and Booth, 1990), so the 
effects of intra-articular bupivacaine on the development of spinal hyperexcitability in 
this study cannot be attributed solely to the block of firing in any specific subpopulation 
of primary afferents. A fibers and C fibers are believed to have distinct contributions to 
the temporal development of central sensitization after nerve injury (Devor, 2009), so 
understanding the specific roles of Aβ, Aδ, and C fibers in the mechanotransduction of 
noxious facet joint loading and the induction of persistent facet-mediated pain will be 
critical for effective timing and targeting of analgesic treatments. 
Early afferent activity from an injured facet joint potentiates excitatory signaling 
that contributes to dorsal horn neuronal hyperexcitability (Figs. 4.2-4.4). Although this 
study did not classify the phenotypes of the neurons from which recordings were made, 
the increased responses to both innocuous and noxious mechanical stimuli (Figs. 4.2 and 
4.6) suggests that there is enhanced excitatory signaling at the synapses between the 
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primary afferents and the wide dynamic range (WDR) neurons that integrate both non-
nociceptive and nociceptive signals (Christensen and Hulsebosch, 1997). Peripheral 
afferent firing due to facet capsule loading may depolarize WDR neurons sufficiently to 
remove the heavily voltage-dependent magnesium block on ionotropic NMDA glutamate 
receptors (Dingledine et al., 1999; Mayer et al., 1984). Once NMDA receptors are 
activated, they allow rapid calcium influx that induces numerous downstream effects 
leading to neuronal hyperexcitability (Kawasaki et al., 2004; Latremoliere and Woolf, 
2009). For example, calcium-dependent activation of the secondary signaling molecule, 
PKC, can increase NR1 phosphorylation in the dorsal horn after facet injury (Dong et al., 
2012; Kawasaki et al., 2004). Activation of NR1, together with the increases in pERK1/2 
and mGluR5 that are evident after injury (Figs. 4.3 and 4.4), can further enhance 
glutamate signaling and neuronal excitability (Brenner et al., 2004; Chen and Huang, 
1992; Kawasaki et al., 2004; Latremoliere and Woolf, 2009). Additionally, decreases in 
spinal GLT1 (Fig. 4.3), the primary transporter responsible for synaptic glutamate uptake, 
may impair the clearance of glutamate from synapses in the dorsal horn, increasing 
aberrant excitatory neurotransmission (Danbolt, 2001; Ramos et al., 2010).  
Since bupivacaine was used at a 0.5% concentration in the current study, it is 
expected to have a duration of action lasting for several hours (Dyhre et al., 1997; Klein 
et al., 1998). Unfortunately, the specific time between 4 hours and 8 hours after injury 
when joint intervention becomes ineffective is not determined explicitly here since each 
bupivacaine administration likely blocks afferent activity for several hours. Nonetheless, 
silencing afferent firing for a period of several hours before the development of spinal 
plasticity likely returns dorsal horn neurons to their resting membrane potential and 
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allows NMDA receptors to recover their magnesium block, slowing the influx of calcium 
and the resulting potentiation of excitatory signaling (Dingledine et al., 1999). In the 
absence of enhanced glutamatergic signaling, behavioral sensitivity and dorsal horn 
neuronal hyperexcitability are not evident after facet joint loading that typically induces 
persistent pain (Figs. 4.1 and 4.2). Therefore, the results in this study support that the 
potentiation of glutamatergic signaling that is induced by afferent firing after painful 
facet joint injury plays a key role in the development and maintenance of spinal 
hyperexcitability. 
In contrast to the robust effects of immediate bupivacaine injection, blocking 
afferent firing with intra-articular bupivacaine at 8 hours or later after painful facet joint 
loading does not prevent mechanical hyperalgesia or spinal hyperexcitability (Figs. 4.1-
4.6). This suggests that once spinal hyperexcitability has developed after facet joint 
loading, that hyperexcitability remains even without continued peripheral input from the 
joint. After central sensitization is induced, lower levels of activity, like ectopic firing in 
injured nerve fibers, are sufficient to maintain sensitization (Devor, 2009; Koltzenburg et 
al., 1992). In the absence of continuing input to the spinal cord, allodynia and 
spontaneous pain can diminish, but those behavioral hallmarks of central sensitization 
return with the re-establishment of ectopic activity (Gracely et al., 1992; Xie et al., 2005). 
Despite being ineffective for reducing behavioral sensitivity (Fig. 4.1), bupivacaine given 
at day 4 does reduce spinal neuronal firing compared to both the 8 hour and/or 1 day 
treatment times, especially in response to noxious mechanical stimuli (Fig. 4.6). It is 
possible that the partial attenuation of spinal hyperexcitability after bupivacaine treatment 
at day 4 is due to the effect of transiently eliminating ectopic activity from injured 
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primary afferents just three days before the electrophysiological recordings were made. 
Groups receiving bupivacaine treatment at 8 hours or 1 day may experience the same 
transient reduction of spinal hyperexcitability, but hyperexcitability likely redevelops 
fully in the 6-7 days prior to electrophysiological recordings. Studies measuring 
hyperalgesia and dorsal horn neuronal activity for extended post-treatment periods would 
better assess the persistence of hyperexcitability after delayed bupivacaine treatment. 
Mechanical hyperalgesia (Fig. 4.1b), dorsal horn neuronal firing (Fig. 4.2c), and 
spinal expression of excitatory signaling proteins (Fig. 4.3b) after bupivacaine treatment 
at day 4 all remain elevated over sham responses at day 7. Those increases over sham 
suggest that, despite lower neuronal firing after bupivacaine treatment at day 4 relative to 
bupivacaine treatment at 8 hours or day 1 (Fig. 4.6), none of those delayed treatments 
fully attenuate central sensitization. The timing of peripheral intervention is an important 
consideration for the treatment of neuropathic pain and the preemptive treatment of 
postoperative pain (Seltzer et al., 1991a; Shankarappa et al., 2012; Woolf and Chong, 
1993). This study shows that, as with neuropathic injury, early intervention is also critical 
for preventing the transition to persistent centrally-mediated pain for other types of 
traumatic injury, including mechanical joint loading, for which the timing of treatment 
after injury has rarely been considered. 
The differential effects of early (immediate or 4 hour) and delayed (8 hour, 1 day, 
or 4 days) silencing of afferent activity after facet injury (Figs. 4.5 and 4.6) suggest that 
there is a critical period lasting several hours after injury during which inputs from the 
joint are necessary to initiate central sensitization. That timing identified in the rodent 
should not necessarily be taken as directly translating to that in the human due to lifespan 
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differences between species. In adulthood, each day for a rat corresponds to roughly 30 
days for a human, leading to difficulties in defining conditions in the rat as being 
“chronic” and in translating rodent models of persistent pain to analogous chronic human 
conditions (Sengupta, 2013). Nevertheless, studies in humans have reported that systemic 
infusion of corticosteroids up to 8 hours after neck trauma significantly reduces chronic 
pain and the incidence of disability 6 months after injury (Pettersson et al., 1998). The 
reduction of pain by early intervention in humans supports the relevance of the current 
findings in a rat model showing that that analgesic joint intervention occurring up to 8 
hours after painful facet joint injury prevents the development of persistent pain. 
Central hypersensitivity is maintained, in part, by nociceptive input to the spinal 
cord (Herren-Gerber et al., 2004), but many studies also suggest that aberrant 
spontaneous activity from injured afferent fibers is important for the maintenance of 
central sensitization (Crosby et al., 2013; Devor, 2009; Djouhri et al., 2006). 
Pharmacological treatments to suppress aberrant spontaneous activity can transiently 
reduce behavioral sensitivity, but ectopic discharge from injured afferents resumes and 
restores sensitivity as the effects of the treatment diminish (Liu et al., 2000; Xie et al., 
2005). The critical period for facet joint intervention in this study corresponds to the time 
before ectopic afferent activity develops, which occurs between 6 and 24 hours after 
painful facet injury in the rat (Crosby et al., 2013). As such, the onset of spontaneous 
firing from injured primary afferent fibers likely represents a temporal threshold after 
which sensitization persists despite blockade of joint afferent activity with nerve blocks 
or neurotomy (Lord et al., 1996; Manchikanti et al., 2008). 
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The results of this study are consistent with previous reports of pain attenuation 
by anesthetic treatment administered early after nerve injury, before the onset of ectopic 
activity (Araujo et al., 2003; Lin et al., 2011; Shankarappa et al., 2012; Xie et al., 2005; 
Zhang et al., 2005). Xie et al. (2005) found that a local nerve block reduces mechanical 
hypersensitivity in rats when applied immediately after nerve injury and continued for 3-
5 days, but not when administered ten days after injury. Although the current findings 
(Figs. 4.5 and 4.6) support a transition to centrally-mediated responses, after which 
peripheral nerve block is ineffective, this study used a local, short-duration anesthetic 
block. It remains unclear whether other clinically-relevant joint interventions or nerve 
blocks with longer durations of action could be effective at permanently reversing pain 
hypersensitivity and spinal hyperexcitability after they have already developed. However, 
clinical studies and data from other models of persistent pain do suggest that delayed 
treatment is not likely to permanently reverse pain regardless of the treatment mode or its 
duration of action (Araujo et al., 2003; Manchikanti et al., 2008; Roy et al., 1988; 
Shankarappa et al., 2012; Xie et al., 2005). 
Despite early intra-articular bupivacaine reducing behavioral and spinal neuronal 
hypersensitivity, spinal GFAP expression at day 7 after painful facet joint injury and 
immediate bupivacaine treatment remains increased at levels comparable to those after 
injury and vehicle treatment (Figs. 4.3 and 4.4). Further, the increase in GFAP after 
painful facet joint injury with immediate bupivacaine treatment is similar to previously 
reported increases in GFAP in dorsal horn astrocytes after painful facet joint injury alone 
(Lee et al., 2004a; Weisshaar et al., 2010). These results suggest that spinal glial 
activation may not be sufficient to induce pain after mechanical joint injury, despite 
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previous reports that activated astrocytes are a substantial contributor to pathological pain 
(Watkins et al., 2001). It is possible that the quantification of GFAP in this study is not 
sufficient to characterize the effects of intra-articular bupivacaine treatment on the 
activation of astrocytes after painful facet injury. For example, astrocyte activation often 
involves upregulation of a collection of intermediate filaments (IF), including GFAP, 
vimentin, and nestin, that form an intracellular cytoskeletal network (Pekny and Nilsson, 
2005). Early bupivacaine treatment may attenuate the upregulation of vimentin and/or 
nestin, preventing the expansion of the IF network that is critical for astrocytic activation 
even without reducing GFAP expression. Future studies could evaluate different 
hallmarks of astrocyte activation, like vimentin or nestin expression, or the hypertrophy 
of cellular processes that results from IF upregulation (Pekny and Nilsson, 2005; Watkins 
et al., 2001), to better characterize the role of astrocytic activation in persistent pain after 
facet joint injury.  
Facet joint loading induces spinal inflammation as early as day 1 after injury 
(Kras et al., 2014a; Lee et al., 2008), so it is also possible that the astrocytic activation 
observed even after attenuation of spinal hyperexcitability by early bupivacaine treatment 
may result from inflammatory signals that are independent of spinal sensitization 
(Benveniste, 1992). Pro-inflammatory cytokines IL-1 and TNFα promote astrocyte 
activation (Milligan and Watkins, 2001). Blocking IL-1 or TNFα receptors after painful 
facet joint injury prevents the upregulation of GFAP, but does not attenuate hyperalgesia 
(Dong, 2013), further supporting the existence of distinct inflammatory and neuropathic 
mechanisms after painful facet joint injury. This has significant implications for the 
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effective treatment of facet joint-mediated pain, since multi-faceted therapies may be 
necessary to simultaneously address both spinal inflammation and neuropathic pain. 
 
4.6. Conclusions and Integration 
The studies in this chapter suggest that silencing afferent activity from the facet 
joint early after its injury is critical to block the development of spinal sensitization. 
Local intervention at the facet joint to block afferent activity can prevent spinal 
hyperexcitability, but only when initiated before the development of spontaneous firing in 
injured capsule-innervating afferent fibers. Conventional treatments for chronic facet 
joint pain, including intra-articular anesthetic injections and medial branch nerve 
ablation, often fail to offer lasting relief from pain symptoms (Lord et al., 1996b; 
Manchikanti et al., 2008). The findings of the current study suggest reasoning for why it 
is that such joint interventions have limited success clinically, and indicate that early joint 
interventions are most effective for the long-term prevention of persistent pain. One 
clinical study evaluating treatment protocols for whiplash-associated disorders found no 
difference between treatment at 96 hours (considered to be “early intervention”) and 
treatment at 2 weeks post-injury (Rosenfeld et al., 2000). In another study, despite the 
onset of symptoms within 24 hours after a motor vehicle accident, patients were 
considered to be in the acute phase of whiplash-associated pain for up to one month post-
injury (Chien et al., 2010). Rather than treating whiplash-associated disorders in a 
reactionary manner, clinical treatment paradigms may need to evolve as the mechanisms 
of facet joint injury and joint-mediated pain are better understood. Based on the studies in 
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this thesis, early intervention should be considered in the first hours following traumatic 
joint injury in order to more effectively manage, or prevent, chronic joint-mediated pain. 
Together, the studies in Chapter 3 and Chapter 4 support the hypothesis in Aim 1 
that discharge from afferents innervating the facet joint plays a key role in the 
development of persistent pain after joint loading. Dorsal horn neuronal hyperexcitability 
is sustained by dysregulation of excitatory glutamate signaling that potentiates neuronal 
firing. In addition to the enhancement of excitatory signaling at existing synapses, the 
development of new synapses in the dorsal horn may further contribute to aberrant 
nociception by increasing the frequency and/or intensity of excitatory input to 
nociceptive dorsal horn neurons. It is also possible that increases in synaptic proteins like 
mGluR5 may be due to an overall increase in synapse number instead of, or in addition 
to, upregulation at existing synapses. Studies in Chapter 5 evaluate excitatory 
synaptogenesis as an additional potential mechanism of plasticity in the spinal cord that 
could promote the hyperexcitability that is observed in this model (Crosby et al., 2013; 
Crosby et al., 2014a; Quinn et al., 2010b). Given the development of dorsal horn 
neuronal hyperexcitability after painful facet joint injury, treatments that directly 
attenuate spinal neuronal activity or modulate the mechanisms that promote dorsal horn 
neuronal hyperexcitability may attenuate joint pain. 
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CHAPTER 5 
 
Thrombospondin-4 Induces Excitatory 
Synaptogenesis and Primes the Spinal Cord for 
the Development of Sensitization Leading to Pain 
after Facet Joint Loading 
 
   
 
Parts of this chapter were adapted from: 
Crosby ND, Zaucke F, Kras JV, Dong L, Luo ZD, Winkelstein BA. Thrombospondin-4 
and excitatory synaptogenesis promote spinal sensitization after painful mechanical joint 
injury. Submitted. 
 
5.1. Overview 
Painful facet joint injury induces spinal hyperexcitability that develops within the 
first day after injury and persists at least through day 7 (Crosby et al., 2013; Quinn et al., 
2010b). The changes in dorsal horn neuronal activity that are observed after painful facet 
joint injury are characteristic of central sensitization, including the development of 
ectopic activity and increases in evoked firing in response to both non-noxious and 
noxious mechanical stimuli (Chapters 3 and 4) (Crosby et al., 2013; Crosby et al., 2014a). 
Spinal hyperexcitability can be maintained by synaptic changes that increase the activity 
of dorsal horn neurons, including the potentiation of excitatory glutamatergic signaling 
(Crosby et al., 2014a; Dong and Winkelstein, 2010; Weisshaar et al., 2010). As 
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demonstrated in Chapter 4, those changes can include increases in the expression and 
activation of glutamate receptors and decreases in glial glutamate transporter 1 (GLT), 
the primary transporter responsible for clearing glutamate from synapses to prevent 
aberrant neurotransmission (Crosby et al., 2014a). 
Once spinal hyperexcitability develops, it can be maintained by low levels of 
afferent activity, causing decreased pain thresholds (i.e., increased sensitivity) that outlast 
the initial injury (Koltzenburg et al., 1992). The persistence of spinal hyperexcitability 
may be due, in part, to long-term structural modifications in the spinal cord, including 
excitatory synaptogenesis, which alter the dorsal horn processing of sensory signals 
(Jaken et al., 2010; Woolf et al., 1992; Woolf et al., 1995). Synapse densities increase in 
the dorsal horn after nerve injury in conjunction with the development of allodynia, 
suggesting that synaptogenesis contributes to neuropathic pain (Chung et al., 1989; Jaken 
et al., 2010; Peng et al., 2010). However, the spinal signals initiating synaptogenesis 
remain unclear. Thrombospondin-4 (TSP4) is one member of a family of extracellular 
matrix proteins that induces synaptogenesis (Christopherson et al., 2005). TSP4 
expressed by activated astrocytes has been implicated in the development of neuropathic 
pain after peripheral nerve injury (Christopherson et al., 2005; Kim et al., 2012; Risher 
and Eroglu, 2012). Since spinal astrocytic activation has been reported after painful facet 
joint injury in our model (Lee et al., 2004a; Weisshaar et al., 2010), astrocyte-derived 
TSP4 may contribute to persistent pain after facet joint injury. However, the roles of 
TSP4 in synaptogenesis and the development of facet-mediated pain remain unknown. 
Blocking facet joint afferent firing immediately after joint distraction reduces the 
potentiation of glutamatergic signaling, spinal hyperexcitability, and behavioral 
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sensitivity (Chapter 4) (Crosby et al., 2014a), indicating that many of the spinal 
modifications that contribute to hyperexcitability are induced by the discharge of nerve 
fibers that innervate the facet joint. Astrocytic release of TSP-family proteins can be 
stimulated by ATP (Tran and Neary, 2006), a molecule that acts as a neurotransmitter and 
contributes to nociception (Burnstock, 2000). It is possible that primary afferent 
discharge after painful facet joint injury induces TSP4 expression in spinal astrocytes, but 
the potential role of joint afferent activity in the induction of spinal TSP4 release and 
TSP4-mediated excitatory synaptogenesis is unknown. In addition to inducing 
synaptogenesis, TSP4 has also been shown to enhance excitatory neurotransmitter release 
from presynaptic terminals (Kim et al., 2012). Increased levels of TSP4 in the spinal cord 
may potentiate the activation of dorsal horn neurons by primary afferent firing, 
augmenting the effects of noxious peripheral stimuli, like excessive stretch of the facet 
capsule. However, the effects of increasing the pre-injury levels of a spinal molecule like 
TSP4 that enhances neuronal excitability have not been investigated for facet joint 
loading. Together, the studies in this chapter address the objectives outlined in Aim 2 to 
determine whether painful loading of the facet joint induces excitatory synaptogenesis in 
the spinal dorsal horn, and to evaluate the role of TSP4 in synaptogenesis and the 
development of persistent pain. 
 
5.2. Background 
The cervical facet joints are a common source of chronic pain, and are susceptible 
to injury during neck trauma and degeneration (Hogg-Johnson et al., 2008). Abnormal 
motions of the cervical facets can load the joint tissues that are innervated by 
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mechanoreceptive and nociceptive fibers, including the facet capsular ligament (Pearson 
et al., 2004; Siegmund et al., 2009). Facet joint loading that produces pain initiates a host 
of changes in the spinal cord that are characteristic of central sensitization, including 
hyperexcitability and increased spontaneous activity in dorsal horn neurons (Crosby et 
al., 2013; Quinn et al., 2010b). Even with this evidence of centrally-mediated pain, local 
joint injections and radiofrequency neurotomy are used clinically to manage chronic facet 
joint pain, despite the effectiveness of such local therapies being limited (Boswell et al., 
2005). Effective clinical treatment requires a better understanding of the spinal 
mechanisms contributing to central sensitization from joint pain. 
Structural plasticity, including neurite outgrowth and synaptogenesis, is one 
mechanism by which pain can be maintained through the potentiation of both nociceptive 
and non-nociceptive pathways (Jaken et al., 2010; Latremoliere and Woolf, 2009; Woolf 
et al., 1992). Although overall increases in synapse number are observed in the dorsal 
horn in neuropathic pain states (Jaken et al., 2010; Lin et al., 2011; Peng et al., 2010), the 
spinal signals initiating synaptogenesis remain unclear. The TSP family of extracellular 
matrix proteins promotes synaptogenesis (Christopherson et al., 2005; Eroglu et al., 2009; 
Lo et al., 2011). The thrombospondins are glycoproteins that are produced by numerous 
cell types and have widely varying roles in cell signaling (Adams, 2001; Adams and 
Lawler, 2004). For example, platelets, fibroblasts, skeletal muscle, endothelial cells, and 
astrocytes and neurons in the CNS each express one or more TSP isoform (Adams, 2001; 
Arber and Caroni, 2004; Christopherson et al., 2005; Stenina et al., 2003). Astrocytic 
expression of each of the five TSP isoforms has been shown to promote synaptogenesis; 
retinal ganglion cells treated with TSP1-5 or with astrocyte-conditioned media containing 
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TSPs develop more synapses than controls using matching isolated cell cultures 
(Christopherson et al., 2005). Expression of TSPs can be radically altered in 
pathophysiological conditions (Adams and Lawler, 2004; Chen et al., 2000). In 
particular, thrombospondin-4 (TSP4) is upregulated in spinal astrocytes following 
peripheral nerve ligation and enhances excitatory synaptic transmission in the dorsal 
horn, although TSP1 and TSP2 are unchanged after that injury (Kim et al., 2012). Despite 
its potential involvement in spinal hyperexcitability that develops with pain from neural 
trauma, the role of TSP4 in joint-mediated pain and synaptogenesis is unknown. 
Given the involvement of TSP4 in neuropathic pain and its potential to induce 
structural modifications in neurons (Christopherson et al., 2005; Kim et al., 2012), it is 
hypothesized that TSP4 plays a role in joint-mediated pain by promoting dorsal horn 
excitatory synaptogenesis following painful facet joint loading. As such, studies in this 
chapter investigate the role of TSP4 in synaptogenesis and the development and 
maintenance of persistent pain. Synapses can be quantified in the spinal cord by 
immunolabeling pre- and post-synaptic markers and identifying their colocalized puncta 
(Ippolito and Eroglu, 2010). Synapsin is a pre-synaptic protein that regulates 
neurotransmitter release in synapses throughout the peripheral and central nervous 
systems (De Camilli et al., 1983), and homer is a structural protein that binds 
metabotropic glutamate receptors in excitatory post-synaptic terminals (Brakeman et al., 
1997); so, the colocalization of synapsin and homer was used to quantify excitatory 
synapses in the spinal cord at day 7 after painful facet joint loading. To determine 
whether TSP4 dysregulation may contribute to facet joint-mediated pain, TSP4 protein 
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levels were quantified by Western blot and immunolabeling in the DRG and spinal cord 
on day 7 after painful facet joint loading. 
In a separate study, antisense oligonucleotides designed against the TSP4 mRNA 
were delivered intrathecally prior to, and for seven days, after painful facet joint loading 
in order to block the spinal expression of TSP4 (Fig. 5.1). Behavioral sensitivity was 
assessed through day 7 and excitatory synapses were quantified in the dorsal horn at day 
7 after painful facet joint loading in order to determine whether TSP4 expression is 
required to induce synaptogenesis and persistent pain. Although TSP4 can induce 
synaptogenesis, gabapentin blocks the synaptogenic activity of TSP4 by preventing it 
from binding to its neuronal receptor (Eroglu et al., 2009). As such, in separate rats, 
intrathecal gabapentin was administered immediately after painful facet joint loading in 
order to antagonize the synaptogenic activity of TSP4 (Fig. 5.1). Hyperalgesia and 
excitatory synapses in the dorsal horn were quantified at day 7 in those studies to further 
evaluate the role of TSP4 in synaptogenesis and persistent pain. Because primary afferent 
activity after painful facet joint loading has been shown to contribute to spinal 
hyperexcitability by initiating the potentiation of excitatory signaling in the dorsal horn 
(Crosby et al., 2014a), a study was performed to determine whether afferent firing from 
the facet joint also induces TSP4 expression and excitatory synaptogenesis. Joint afferent 
firing was blocked either immediately, or four days, after painful joint loading using 
intra-articular injections of bupivacaine (Fig. 5.1), and TSP4 expression and excitatory 
synapses were quantified in the dorsal spinal cord at day 7. Lastly, to determine whether 
spinal TSP4 levels facilitate the development of joint-mediated pain, intrathecal TSP4 
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was administered prior to different severities of facet joint distraction that separately 
simulate either physiologic or injurious loading of tissues in the joint (Fig. 5.1). 
 
5.3. Methods 
5.3.1. Facet Joint Distraction 
All surgical procedures were performed using adult male Holtzman rats (362-
464g) under inhalation isoflurane anesthesia (4% induction, 2-3% maintenance). Facet 
joint loading was performed by distracting the bilateral C6/C7 facet joints, which has 
been described previously to produce physiologic or injurious tissue loading under 
different magnitudes of distraction (Dong and Winkelstein, 2010; Lee et al., 2004a; Lee 
and Winkelstein, 2009). Facet joint distraction was applied using the methods described 
in detail in Section 3.3.1 of Chapter 3 (Crosby et al., 2013; Crosby et al., 2014a). Briefly, 
 
Fig. 5.1. Schematic showing the peripheral and spinal treatments used to evaluate the 
potential relationships between facet joint loading, spinal TSP4 expression, spinal 
neuronal sensitization and pain. Studies used treatments to block (red) or augment 
(green) TSP4 protein levels and activity in the spinal cord. Bupivacaine was 
administered in the facet joints to block joint afferent firing after facet joint loading. 
Intrathecal TSP4 antisense oligonucleotides (ASO) and intrathecal TSP4 protein were 
used to decrease or increase spinal TSP4 levels, respectively. Gabapentin was used 
intrathecally to block the synaptogenic activity of TSP4. 
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the C6 and C7 vertebrae were attached to a custom loading device using microforceps 
and the C6 vertebra was distracted rostrally to stretch the bilateral facet capsules across 
the C6/C7 joints. In separate rats, distraction of 0.2mm was applied for physiologic 
loading and 0.7mm distraction was imposed for injurious loading (Dong et al., 2012; Lee 
and Winkelstein, 2009). Bead markers were placed on the C6 and C7 vertebrae and the 
right C6/C7 facet capsule to quantify the vertebral and capsule displacements, and the 
maximum principal strain (MPS) on the facet capsule surface during each applied 
distraction. Vertebral and capsule distractions and capsule MPS during physiologic and 
injurious loading were compared using Student’s t-tests. Sham surgeries included all of 
the same procedures with no joint distraction applied in order to control for the effect of 
the surgical procedures. 
 
5.3.2. Assessment of Mechanical Hyperalgesia 
Mechanical hyperalgesia was assessed pre-operatively and on days 1, 3, 5, and 7 
after facet joint distraction. Hyperalgesia was measured by quantifying the paw 
withdrawal threshold (PWT) in the forepaws of each rat during application of a series of 
von Frey filaments (1.4, 2, 4, 6, 8, 10, 15, and 26g) to the plantar surface of the forepaws 
(Hubbard and Winkelstein, 2005; Lee and Winkelstein, 2009). Detailed methods for 
behavioral assessment of mechanical hyperalgesia are presented earlier in Section 3.3.2 
of Chapter 3. PWT was compared over time and between groups by repeated-measures 
ANOVA with a post-hoc Tukey’s HSD test. 
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5.3.3. Western Blot Analysis of DRG and Spinal Cord Tissue 
To measure the temporal expression of TSP4 in the DRG and spinal cord, TSP4 
was quantified by Western blot on day 1 after sham (n=6) or painful facet joint loading 
(n=8), or on day 7 after sham (n=8) or painful loading (n=8). Rats were anesthetized with 
sodium pentobarbital (65mg/kg, i.p.) and transcardially perfused with 300mL of PBS. 
The C6 DRG and C6/C7 spinal cord were removed and homogenized in lysis buffer 
containing 50mM Tris HCl (pH 8.0), 1% Triton X-100, 150mM NaCl, 1mM EDTA, and 
protease and phosphatase inhibitors (Sigma-Aldrich Corp; St. Louis, MO). Protein 
samples (25μg for DRG, 50μg for spinal cord) were loaded on a polyacrylamide gel for 
SDS-PAGE (Invitrogen; Carlsbad, CA) and run for 75 minutes at 150V. Protein was 
transferred to a polyvinylidene difluoride (PVDF) membrane using an iBlot gel transfer 
device (Invitrogen; Carlsbad, CA). Membranes were blocked for one hour with 5% dry 
milk blocking reagent in 0.1% Tween-20 Tris-buffered saline (TBS-T) and incubated 
overnight at 4ºC with rabbit anti-TSP4 (1:1000; Santa Cruz; Dallas, TX) and mouse anti-
β-tubulin (1:2000; Covance; Princeton, NJ). The PVDF membranes were washed in TBS-
T three times for ten minutes each time, followed by a two-hour incubation at room 
temperature with goat anti-rabbit 800 and goat anti-mouse 680 IRDye fluorescent 
secondary antibodies (1:10,000; Li-Cor Biosciences; Lincoln, NE). Membranes were 
imaged using an Odyssey Imaging System (Li-Cor Biosciences; Lincoln, NE). The 
fluorescence of each TSP4 band was analyzed using the Odyssey 2.1 software to quantify 
the intensity of the pixels within the bands and normalized to the corresponding β-tubulin 
fluorescence as a protein loading control for each sample. TSP4 levels were compared 
between groups and over time by two-way ANOVA with post-hoc Tukey’s HSD test. 
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5.3.4. Immunolabeling of Spinal Cord Tissue 
To quantify the region-specific expression of TSP4, spinal cord sections were 
immunolabeled for TSP4 on day 7 after sham (n=4) or painful facet joint loading (n=6). 
Sections were colabeled for GFAP in order to specifically quantify astrocytic TSP4 
expression, because spinal TSP4 expression after nerve injury has been shown to be 
mainly in astrocytes (Kim et al., 2012). Rats were anesthetized with sodium pentobarbital 
(65mg/kg, i.p.) and transcardially perfused with 250mL of PBS followed by 250mL of 
4% paraformaldehyde (PFA). The C6 and C7 spinal cord segments were removed and 
post-fixed in 4% PFA overnight, then cryopreserved in 30% sucrose in PBS for seven 
days at 4ºC. Samples were freeze-mounted in OCT medium (Fisher Scientific; Waltham, 
MA) and axial cryosections (14μm each, 5-6 sections per rat) were mounted on 
Superfrost Plus slides (Fisher Scientific; Waltham, MA). 
Sections were blocked in 10% goat serum in PBS for one hour at room 
temperature. Sections were then incubated overnight at 4°C with chicken anti-TSP4 
(1:1000; from F. Zaucke; Cologne, Germany) and rabbit anti-GFAP (1:500; Dako, 
Denmark) in 10% goat serum with 0.3% Triton-X PBS. The specificity of the chicken 
anti-TSP4 antibody was characterized for immunolabeling of rat TSP4 (Fig. 5.2) (Dunkle 
et al., 2007). Sections were incubated for two hours at room temperature with goat anti-
chicken Alexa 488 and goat anti-rabbit Alexa 568 fluorescent secondary antibodies 
(1:1000, Invitrogen; Carlsbad, CA), and then incubated with DAPI (1:10,000, Invitrogen; 
Carlsbad, CA) for ten minutes. After rinsing in PBS and deionized water, slides were air-
dried and cover slips were applied with Fluorogel mounting medium  (EMS; Hatfield, 
PA). Each tissue section was imaged with using a Zeiss LSM510 confocal microscope. 
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Separate images of subregions of the spinal cord (superficial dorsal horn, deep dorsal 
horn, and dorsal columns) were analyzed by densitometry using a MATLAB code (see 
Appendix E) to quantify the percent of TSP4- or GFAP-positive or colocalized pixels in 
each dorsal horn region (Dong et al., 2013b; Hubbard et al., 2008). 
 
5.3.5. Synapse Quantification in the Dorsal Horn 
Spinal cord sections were immunolabeled as described in Section 5.3.4 with 
mouse anti-synapsin (1:100; Synaptic Systems; Goettingen, Germany) and rabbit anti-
homer (1:200; Synaptic Systems; Goettingen, Germany) to quantify synapse densities in 
the dorsal horn at day 7 after sham (n=4) or painful (n=6) facet joint loading. Because 
synapsin is a general synaptic marker and homer is a glutamatergic synaptic marker 
(Brakeman et al., 1997; De Camilli et al., 1983), excitatory synapses were quantified by 
counting the colocalization of synapsin- and homer-positive puncta. Synapses were 
quantified using previously published methods (Ippolito and Eroglu, 2010). The detailed 
protocol for identifying and quantifying synapses is presented in Appendix H. Image 
 
 
Fig. 5.2. TSP4 antibody specificity. A mouse anti-StrepII antibody (red) was used to 
label transfected 293/EBNA cells in which all TSP4 protein is tagged with a StrepII 
peptide. The StrepII antibody detected the StrepII tag on all recombinant TSP4 protein. 
The cells were colabeled with a chicken anti-rat TSP4 antibody (green) and DAPI. The 
TSP4 labeling was highly colocalized with the StrepII labeling, indicating that the 
TSP4 antibody specifically detected recombinant TSP4 in the 293/EBNA cells. 
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stacks were acquired from the superficial or deep dorsal horn at 0.33μm increments up to 
3μm of depth using a Zeiss LSM510 confocal microscope. The maximum intensity 
projection of each set of three sequential images was used to generate a single image 
(0.02mm
2
 tissue area) corresponding to 1μm of tissue depth. The custom MATLAB code 
used to generate maximum intensity projections is included in Appendix E. Because 
irregular surface topology of the spinal cord sections and lack of antibody penetration led 
to large variations in labeling efficiency in the outermost and innermost maximum 
intensity projections, only the middle projection from each spinal cord section was 
analyzed, corresponding to tissue at 1-2μm from the surface of each section.  
The Puncta Analyzer plugin for ImageJ (National Institutes of Health; Bethesda, 
MD) was used to identify puncta exhibiting colocalization of synapsin and homer in each 
maximum intensity projection. The area of the tissue parenchyma, excluding any holes 
and/or gaps in the tissue sections, was quantified using a custom MATLAB code, which 
can be found in Appendix E. The number of colocalized puncta in the superficial or deep 
dorsal horn was normalized to the corresponding tissue area for the image of that dorsal 
horn region. The synapse number per area was then averaged across all rats in each group 
and compared between groups using Student’s t-test. 
 
5.3.6. Intrathecal Injections 
Rats were anesthetized with isoflurane (4% for induction, 2-3% for maintenance) 
and placed in a prone position. The skin over the dorsal aspect of the lumbar spine was 
shaved and cleaned with Betadyne solution. A 30-gauge needle attached to a 
microinjector (Hamilton; Reno, NV) was inserted perpendicular to the spine in the 
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dorsal-ventral direction, along the midline between the L5 and L6 spinous processes. The 
needle was angled approximately 30° to the right or left and lowered into the spinal canal 
between the laminae of the L5 and L6 vertebrae, with placement in the cauda equina 
confirmed by the presence of a reflexive tail flick or hindpaw flinch. Antisense or 
mismatch oligonucleotides, gabapentin, saline, recombinant TSP4, or StrepII-tag peptide 
were administered in single bolus injections (Fig. 5.1). The needle was held in place for 
30-60 seconds before removing it in order to prevent leakage of the injected solutions 
from the lumbar spine. Rats were then monitored during recovery in room air. 
 
5.3.7. Intrathecal Oligonucleotide Treatment 
Antisense oligonucleotides were used to block spinal TSP4 expression, as 
reported previously (Kim et al., 2012). Antisense oligonucleotides were designed against 
a segment of the TSP4 mRNA using the sequence, CCATCATTGTTGCTATCTTCC, 
with stabilizing modifications as described previously (Kim et al., 2012). An equal length 
random sequence of nucleotides, ACCATCGTTGTTACTTTCTCC, was used as a 
mismatch control for the oligonucleotide treatment. Antisense (75µg/rat/day, n=11) and 
mismatch (75µg/rat/day, n=12) oligonucleotides were delivered by bolus 25µL 
intrathecal injections. Injections were administered daily beginning three days before 
injurious facet joint distraction and continuing for seven days after joint distraction 
because the effectiveness of previous TSP4 antisense treatments peaked on the third day 
of repeated injections (Kim et al., 2012). TSP4 expression was quantified by Western blot 
as described in Section 5.3.3 using fresh spinal cord tissue collected on day 7 after 
painful facet joint loading (n=5 antisense, n=6 mismatch). Excitatory synapses were 
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quantified in the dorsal horn as described in Section 5.3.5 using separate spinal cord 
tissue samples that were also collected as described above on day 7 after joint loading 
(n=6 antisense, n=6 mismatch). 
 
5.3.8. Intrathecal Gabapentin Treatment 
Gabapentin was administered to block TSP4 binding to its neuronal receptor, the 
α2δ-1 subunit of voltage-gated calcium channels (Eroglu et al., 2009; Luo et al., 2002; 
Rose and Kam, 2002) to determine if TSP4 induces synaptogenesis after painful facet 
joint loading by interacting with α2δ-1. Rats received intrathecal injections of gabapentin 
(Inj-GBP, n=6) or a saline vehicle treatment (Inj-VEH, n=6) after painful facet joint 
loading. Gabapentin (4.2μg in 30μL saline) was administered 90 minutes prior to 
injurious facet joint distraction. A second dose was administered one day after injurious 
joint distraction, immediately following behavioral assessment on that day. Saline vehicle 
injections (30μL) were administered under the same paradigm to control for the effects of 
the intrathecal injections. The gabapentin concentration and treatment times were 
optimized previously for the attenuation of behavioral sensitivity in dose-response studies 
(Dong et al., 2013a). Excitatory synapses were quantified as described in Section 5.3.5 
using spinal cord tissue samples that were collected on day 7 after painful joint loading. 
 
5.3.9. Intra-articular Bupivacaine Treatment 
To evaluate the role of injury-induced joint afferent activity in the induction of 
spinal TSP4 expression and synaptogenesis, rats received bilateral intra-articular 
injections of bupivacaine immediately after painful facet joint loading (Inj-BP0h, n=6) or 
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delayed until day 4 after painful joint loading (Inj-BPd4, n=6) (Crosby et al., 2014a). 
Separate groups of rats received control injections of the saline vehicle immediately 
following a sham surgery (Sham-VEH0h, n=6) or a painful joint loading (Inj-VEH0h, 
n=6). As with the delayed bupivacaine treatment, rats also received saline vehicle at day 
4 after sham surgery (Sham-VEHd4, n=6) or painful joint loading (Inj-VEHd4, n=5). 
Intra-articular injections of 0.5% bupivacaine or 0.9% saline solution were injected into 
the left and right facet joints in a volume of 10µL using a microsyringe with a 33-gauge 
beveled needle (Hamilton; Reno, NV). Detailed methods for the immediate or delayed 
intra-articular injections of bupivacaine or saline are presented in Section 4.3.3 of 
Chapter 4 (Crosby et al., 2014a). On day 7 after sham or painful joint loading, spinal cord 
samples were collected to quantify immunolabeling of spinal astrocytic TSP4 and dorsal 
horn excitatory synapses as described in Sections 5.3.4 and 5.3.5. 
 
5.3.10. Recombinant TSP4 Purification and Intrathecal TSP4 Injections 
Full length TSP4 protein was recombinantly expressed in 293/Ebstein-Barr 
nuclear antigen (EBNA) cells using methods described previously by Hansen et al. 
(2011) for COMP, another TSP family member. Briefly, 293/EBNA cells were stably 
transfected with cDNA for rat TSP4 (GenBank accession no. X89963) with a StrepII tag. 
Cell culture media were collected every other day and stored at -20°C with 1.2mM N-
ethylmaleimide (NEM) and 1.2mM phenylmethylsulfonyl fluoride (PMSF) to inhibit 
protease activity. Secreted TSP4-StrepII protein in the cell media was purified with a 
Streptactin affinity chromatography column (1.5mL; IBA; Goettingen, Germany), then 
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concentrated from the elution fractions using Amicon Ultra centrifugal filters with a 
50kDa threshold (Millipore; Billerica, MA) and stored at -80°C.  
To assess the dose-response of spinal TSP4 and behavioral sensitivity, purified 
recombinant TSP4 (20, 30, 45, or 60μg/rat) was administered intrathecally in 25μL bolus 
injections. Based on a previous study showing that hindpaw sensitivity returns to baseline 
levels by ten days after intrathecal TSP4 treatment (Kim et al., 2012), hyperalgesia in the 
forepaw was assessed for ten days after TSP4 injection (n=6 rats per group). Intrathecal 
injection of 60μg StrepII peptide was used to control for the presence of the StrepII tag 
on recombinant TSP4 protein (n=6). Paw withdrawal thresholds for each group were 
compared to baseline on each day after TSP4 injection using a repeated-measures 
ANOVA with a post-hoc Tukey’s HSD test. 
In separate rats, the effect of increased spinal TSP4 on the development of 
hyperalgesia after joint loading was tested by intrathecally injecting 20μg or 60μg TSP4 
three days before sham, physiologic (Phys), or injurious (Inj) facet joint loading (20µg 
TSP4+Sham, 20µg TSP4+Phys, 60µg TSP4+Sham, 60µg TSP4+Phys, 60µg TSP4+Inj, 
n=6-7 per group). Separate rats received 60µg intrathecal injections of StrepII peptide 
prior to sham or physiologic loading of the facet joint (60µg StrepII+Sham, 60µg 
StrepII+Phys, n=6 per group) to control for the presence of the StrepII tag on the TSP4 
protein. Hyperalgesia was assessed in all rats through day 7 after joint loading, and paw 
withdrawal thresholds for each group were compared to baseline on each day using a 
repeated-measures ANOVA with a post-hoc Tukey’s HSD test. 
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5.3.11. Electrophysiological Recording of Spinal Dorsal Horn Neurons 
To evaluate the effect of increased spinal TSP4 on the development of neuronal 
hyperexcitability after facet joint loading, dorsal horn neuronal activity was recorded on 
day 7 from a subset of rats that received intrathecal TSP4 or StrepII injections prior to 
joint loading (60µg StrepII+Sham, 20µg TSP4+Phys, 60µg TSP4+Phys, 60µg TSP4+Inj, 
n=6 rats per group). Briefly, using methods detailed in Section 3.3.3 of Chapter 3 
(Crosby et al., 2013; Crosby et al., 2014a), rats were anesthetized with sodium 
pentobarbital (45mg/kg, i.p.) and given supplemental doses (5-10mg/kg, i.p.) as needed 
based on toe pinch reflexes. A bilateral laminectomy and dural resection were performed 
to expose the C6/C7 spinal cord. Rats were then immobilized on a stereotaxic frame to 
stabilize the cervical spine (David Kopf Instruments; Tujunga, CA). Core temperature 
was maintained at 35-37ºC using a temperature controller with a rectal probe (Physitemp; 
Clifton, NJ). The exposed spinal cord was bathed in 37ºC mineral oil to prevent drying of 
the spinal cord. 
A carbon fiber electrode (Kation; Minneapolis, MN) was used to record neuronal 
activity in the C6/C7 spinal dorsal horn. Neurons were mechanically stimulated at the 
forepaw with ten seconds of light brushing, five consecutive one-second stimulations at 
one-second intervals with a series of von Frey filaments (1.4g, 4g, 10g, 26g), and ten 
seconds of noxious pinch applied by a 60g vascular clip (Crosby et al., 2013; Crosby et 
al., 2014a; Hains et al., 2003a; Quinn et al., 2010b). Voltage recordings from each neuron 
were sorted using Spike2 (CED; Cambridge, UK). For the brush and pinch stimuli, spikes 
were summed over the ten seconds that the stimulus was administered. For the von Frey 
filament stimuli, spikes were summed for each separate application of the filament 
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(Quinn et al., 2010b). Therefore, each filament strength had a total of five spike counts 
since each filament was applied to the forepaw five times. Baseline spike counts recorded 
prior to mechanical stimulation were subtracted from the spike counts for each stimulus 
to isolate the evoked response, and spike counts for each stimulus were log-transformed 
due to a positive skew in the distributions of the spike totals. Detailed protocols for 
recording and counting evoked firing are provided in Appendix A. 
 
5.4. Results 
5.4.1. Facet Joint Distraction Inducing Mechanical Hyperalgesia Also Increases 
Excitatory Synapses in the Spinal Dorsal Horn 
Rats develop mechanical hyperalgesia at day 1 that persists through day 7 after 
injurious loading of the bilateral C6/C7 facet joints. Paw withdrawal threshold decreases 
significantly on all days after painful joint loading relative to baseline (p<0.0001) (Fig. 
5.3). PWT is significantly lower than the sham group after painful joint loading overall 
 
Fig. 5.3. Mechanical hyperalgesia after painful facet joint loading. Paw withdrawal 
threshold (PWT) decreases on all testing days after painful facet joint loading, relative 
to baseline (*p<0.0001). PWT also decreases compared to the sham group on days 1 
and 5 after painful joint loading (#p≤0.024). 
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 (p<0.0001), as well as on days 1 and 5 (p≤0.024) (Fig. 5.3). A summary of the individual 
paw withdrawal thresholds for each rat on each day for this study is provided in 
Appendix C. 
To determine whether the number of dorsal horn synapses is altered in rats with 
sustained hyperalgesia, synapses were quantified in the C6/C7 dorsal horn at day 7 after 
painful joint distraction (Fig. 5.4) (Ippolito and Eroglu, 2010; Ullian et al., 2001). The 
 
 
Fig. 5.4. Quantification of excitatory synapses in the superficial and deep laminae of the 
dorsal horn. (a) The number of excitatory synapses increases in the superficial dorsal 
horn (DH) after painful facet joint injury (*p=0.032), but synapse number does not 
change in the deep DH. (b,c) Representative immunolabeling of synapsin (red) and 
homer (green) in the superficial dorsal horn after sham (b) or painful facet joint injury 
(c). Colocalization (merged, yellow) represents synaptic puncta (arrows). 
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number of excitatory synapses increases in the superficial dorsal horn after painful facet 
joint loading (p=0.032) (Fig. 5.4), suggesting that injury-induced synaptogenesis in the 
dorsal horn is evident with the presence of sustained hyperalgesia after facet joint 
distraction. Synapse number is not altered in the deep laminae of the dorsal horn (Fig. 
5.4). Synapse counts in the dorsal horn for each rat are presented in Appendix I. 
 
5.4.2. Altered Expression of TSP4 Parallels the Development of Sustained 
Mechanical Hyperalgesia 
TSP4 decreases in the DRG (p=0.012) and increases in the spinal cord (p=0.002) 
at day 7 after painful joint loading (Fig. 5.5). TSP4 expression also increases in the C6 
DRG and decreases in the C6/C7 spinal cord at day 1, but not significantly. The 
quantification of DRG and spinal TSP4 by Western blot is presented in Appendix F. 
 
 
Fig. 5.5. Western blot quantification of DRG and spinal TSP4. (a) Expression of 
TSP4 decreases in the C6 dorsal root ganglion (DRG) at day 7 after painful facet joint 
injury, relative to sham (*p=0.012). (b) Spinal TSP4 expression increases relative to 
sham at day 7 after painful joint injury (*p=0.002). TSP4 bands are normalized to β-
tubulin as a loading control. 
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Because significant changes in TSP4 expression are evident at day 7, a time when 
hyperalgesia is also sustained (Fig. 5.3), TSP4 expression and synapse density in the 
spinal cord are evaluated at day 7 in the remaining studies in this chapter. 
Immunolabeling was used to quantify region-specific expression of TSP4 at day 7 
after painful facet joint loading in the superficial dorsal horn, deep dorsal horn, and dorsal 
columns of the C6/C7 spinal cord (Fig. 5.6). Total TSP4 labeling significantly increases 
after painful joint loading only in the dorsal columns (p=0.0082) (Fig. 5.6). The amount 
of colocalized GFAP and TSP4, indicating astrocytic TSP4, increases in both the 
superficial dorsal horn (p=0.036) and the dorsal columns (p=0.024) (Fig. 5.6). 
 
 
Fig. 5.6. Immunolabeling of TSP4 and GFAP in the spinal cord. TSP4 (green), GFAP 
(red) and DAPI (blue) are labeled in the superficial dorsal horn (Sup DH) (a,d), deep 
dorsal horn (Deep DH) (b,e), and dorsal columns (DC) (c,f), after sham or painful 
facet joint injury. (g) TSP4 increases in the dorsal columns (p=0.0082), but (j) GFAP 
is unchanged in any dorsal horn region. (k) The colocalization of TSP4 and GFAP 
(yellow) increases in the superficial DH and dorsal columns (*p≤0.036). 
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Densitometric quantifications of TSP4 and GFAP for each rat are included in Appendix 
G. These results support that spinal TSP4 expression is altered following injurious facet 
joint distraction; in particular, astrocytic expression of TSP4 increases in the dorsal 
regions of the spinal cord where it may potentiate signaling of the nociceptive primary 
afferent fibers terminating in the superficial dorsal horn.  
 
5.4.3. Blocking Spinal TSP4 Expression Prevents Behavioral Sensitivity and 
Synaptogenesis after Painful Facet Joint Loading 
To determine whether the increase in spinal TSP4 at day 7 contributes to 
hyperalgesia, TSP4 expression was blocked prior to painful facet joint loading using 
intrathecal antisense oligonucleotides. Rats receiving daily intrathecal injection of 
mismatch oligonucleotides display decreases in PWT on all days following painful facet 
joint loading (p<0.0001), similar to rats receiving painful joint distraction with no 
treatment (Fig. 5.7a). However, TSP4 antisense oligonucleotides block the development 
of hyperalgesia after painful facet joint loading (p<0.0001) (Fig. 5.7a). Western blot 
analysis of TSP4 on day 7 confirms that antisense oligonucleotide treatment reduces 
TSP4 in the C6/C7 spinal cord relative to TSP4 levels after mismatch oligonucleotide 
treatment (p=0.049) (Fig. 5.7b). Paw withdrawal thresholds for rats receiving antisense or 
mismatch oligonucleotide treatment are detailed in Appendix C, and the quantification of 
spinal TSP4 by Western blot for each rat is presented in Appendix F.  
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Given the synaptogenic properties of TSP4 and its upregulation in the same dorsal 
horn regions where excitatory synapses also increase in this model (Figs. 5.4 and 5.6), 
TSP4 may contribute to persistent hyperalgesia by inducing excitatory synaptogenesis. 
To test this hypothesis, synapses were quantified in the superficial dorsal horn after 
injurious joint distraction in rats that received antisense or mismatch oligonucleotide 
treatment. Fewer excitatory synaptic puncta are observed in the superficial dorsal horn at 
day 7 after painful facet joint loading in rats undergoing daily antisense oligonucleotide 
treatment, relative to rats that receive mismatch oligonucleotides (p=0.001) (Fig. 5.7). 
 
Fig. 5.7. TSP4 antisense oligonucleotides prevent hyperalgesia and spinal excitatory 
synaptogenesis. (a) Paw withdrawal threshold (PWT) decreases relative to baseline 
after painful facet joint loading in rats receiving mismatch oligonucleotides (MM) 
(*p<0.0001). Antisense oligonucleotides (AS) prevent hyperalgesia (#p<0.0001 vs. 
MM) (b) AS treatment reduces spinal TSP4 expression on day 7 compared to MM-
treated rats (*p=0.049) (c) Representative labeling of synapsin (red) and homer 
(green); colocalization (yellow) represents synaptic puncta (arrows). (d) AS treatment 
reduces the number of excitatory synapses relative to MM treatment (*p=0.001). 
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These data suggest that spinal TSP4 plays a role in the development of hyperalgesia after 
injurious joint loading, likely through the initiation of excitatory dorsal horn 
synaptogenesis. Synapse counts in the dorsal horn for each rat after antisense or 
mismatch oligonucleotides are included in Appendix I. 
 
5.4.4. Intrathecal Gabapentin Reduces Injury-Induced Hyperalgesia and Dorsal 
Horn Excitatory Synaptogenesis 
PWT is unchanged from baseline at day 7 after painful facet joint loading in rats 
that receive gabapentin treatment (Fig. 5.8a). However, PWT decreases in vehicle-treated 
rats on day 7 after injurious joint distraction, relative to baseline (p=0.0001) and to the 
gabapentin-treated group (p=0.01). Gabapentin also prevents the injury-induced increase 
in excitatory synapses that is typically observed in the superficial dorsal horn (p=0.0002) 
 
 
Fig. 5.8. Gabapentin attenuates mechanical hyperalgesia and excitatory 
synaptogenesis after painful facet joint loading. (a) Paw withdrawal threshold (PWT) 
decreases on day 7 after painful joint loading in rats receiving saline vehicle (Inj-
VEH) (*p=0.0001 vs. baseline, #p=0.01 vs. gabapentin (Inj-GBP)). (b) Representative 
immunofluorescent labeling of synapsin (red) and homer (green) in the superficial 
dorsal horn. Colocalization (yellow) indicates synaptic puncta (arrows). (c) 
Gabapentin prevents the injury-induced increase in excitatory synapses. (*p=0.0002). 
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 (Fig. 5.8). These results further support the role of TSP4-mediated synaptogenesis in 
persistent pain after facet joint loading. Paw withdrawal thresholds for each rat after 
intrathecal gabapentin or vehicle treatment are presented in Appendix C, and the 
corresponding synapse counts in the dorsal horn are detailed in Appendix I. 
 
5.4.5. Immediate Intra-articular Bupivacaine Prevents Hyperalgesia and Excitatory 
Synaptogenesis 
Blocking injury-induced afferent firing early after painful facet injury prevents the 
development of hyperalgesia and spinal hyperexcitability (Crosby et al., 2014a). As such, 
afferent activity from the joint was blocked to determine if that activity after painful joint 
loading also induces the dysregulation of TSP4 and excitatory synaptogenesis. Astrocytic 
TSP4 increases in the superficial dorsal horn and dorsal columns at day 7 after painful 
joint loading with immediate saline vehicle treatment (Inj-VEH0h) over the 
corresponding sham levels (Sham-VEH0h) (p<0.0001) (Fig. 5.9). However, immediate 
bupivacaine treatment (Inj-BP0h) attenuates those increases in astrocytic TSP4 in the 
superficial dorsal horn and dorsal columns (p<0.0001) (Fig. 5.9). In contrast, although 
astrocytic TSP4 increases in the dorsal horn and the dorsal columns after painful joint 
loading with vehicle treatment given at day 4 (Inj-VEHd4) (p≤0.0061), bupivacaine 
administered at day 4 (Inj-BPd4) does not attenuate spinal TSP4 expression (p≤0.048) 
(Fig. 5.9). Immediate bupivacaine treatment also prevents the injury-induced increase in 
excitatory synapses in the superficial dorsal horn at day 7 after painful joint loading  
(p<0.0001), but synapse numbers increase despite the administration of bupivacaine at 
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day 4 (p≤0.043) (Fig. 5.10). Appendix G summarizes the quantification of astrocytic 
TSP4 for each rat in this study, and the dorsal horn synapse counts for each rat are 
itemized in Appendix I. These results support that afferent activity initiated early after 
painful facet joint loading induces the upregulation of spinal TSP4 and excitatory 
synaptogenesis. 
 
 
Fig. 5.9. Immediate intra-articular bupivacaine prevents TSP4 upregulation after 
painful facet joint loading. (a) TSP4 (green) and GFAP (red) in the superficial dorsal 
horn of rats receiving sham or painful facet joint injury followed by immediate (Inj-
VEH0h, Sham-VEH0h) or day 4 intra-articular vehicle injections (Inj-VEHd4, Sham-
VEHd4) or bupivacaine injections (Inj-BP0h, Inj-BPd4). (b,c) Densitometric 
quantification of colocalized TSP4 and GFAP (yellow) in the superficial dorsal horn 
(Sup DH), deep dorsal horn (Deep DH), and dorsal columns (DC). (b) Increases in 
astrocytic TSP4 after painful joint loading (*p<0.0001 vs. Sham-VEH0h) are 
prevented by immediate bupivacaine (#p<0.0001 vs. Inj-VEH0h). (c) However, 
increases in astrocytic TSP4 after painful joint loading (*p≤0.048 vs. Sham-VEHd4) 
are not blocked by bupivacaine at day 4.  
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5.4.6. Spinal TSP4 Potentiates Hyperalgesia and Neuronal Hyperexcitability 
Induced by Facet Joint Loading 
In addition to synaptogenesis, TSP4 may contribute to spinal hyperexcitability by 
enhancing excitatory input from primary afferent fibers to the dorsal horn (Kim et al., 
2012). Since facet joint loading increases firing of the afferents that innervate the facet 
capsule (Lu et al., 2005a), increased spinal TSP4 levels may potentiate hyperalgesia and 
neuronal excitability after nonpainful or painful loading of the facet joint. To identify the 
dose-response of spinal TSP4 and behavioral sensitivity, mechanical hyperalgesia was 
assessed in the forepaw after intrathecal administration of full-length recombinant TSP4 
protein with a StrepII tag for affinity purification (Fig. 5.11). 
 
 
Fig. 5.10. Immediate intra-articular bupivacaine prevents excitatory synaptogenesis. 
(a) Representative immunolabeling of synapsin (red) and homer (green) to identify 
synaptic puncta (yellow, arrows). Synapses were counted in the superficial dorsal horn 
of rats receiving sham or painful facet joint injury followed by immediate (Inj-VEH0h, 
Sham-VEH0h) or day 4 vehicle injections (Inj-VEHd4, Sham-VEHd4), or bupivacaine 
injections (Inj-BP0h, Inj-BPd4). (b) Increases in excitatory synapses after painful joint 
loading (*p<0.0001 vs. Sham-VEH0h) are prevented by immediate bupivacaine 
(#p<0.0001 vs. Inj-VEH0h), but not by bupivacaine at day 4 (*p≤0.043 vs. Sham-
VEHd4). 
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Mechanical hyperalgesia develops after an intrathecal bolus injection of 30µg 
(p≤0.043), 45µg (p≤0.014), or 60µg (p≤0.011) of TSP4 (see Appendix B for paw 
withdrawal thresholds for each rat) (Fig. 5.12). Hyperalgesia peaks 3-4 days after 
injection and behavioral sensitivity is most prolonged, lasting for 2-6 days, following the 
60µg dose (Fig. 5.12). Injection of either 20µg TSP4 or of 60µg StrepII peptide, as a 
control, does not induce any sensitivity (Fig. 5.12). These results suggest that intrathecal 
TSP4 is sufficient to induce mechanical hyperalgesia in the forepaw, but that 
 
Fig. 5.12. Dose-response of intrathecal TSP4 and mechanical hyperalgesia in the 
forepaw. Injections of 30µg (*p≤0.043), 45µg (#p≤0.014), or 60µg (^p≤0.011) of 
TSP4 induce decreases in paw withdrawal threshold (PWT) in the forepaw that peak 
3-4 days after injection. Injection of either the 60µg StrepII peptide (Strep), to control 
for the StrepII tag on the TSP4 protein, or the 20µg TSP4 do not induce sensitivity. 
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subthreshold doses can be administered that do not independently produce sensitivity. As 
such, two doses of TSP4 were used for further studies: a non-sensitizing dose (20µg) and 
a sensitizing dose (60µg).  
To determine whether spinal TSP4 potentiates the development of hyperalgesia 
and spinal hyperexcitability after facet joint loading, non-sensitizing or sensitizing doses 
of recombinant TSP4 were administered three days before sham, physiologic, or injurious 
loading the facet joint. Physiologic loading of the C6/C7 facet joint induces lower 
vertebral and capsule distraction, joint loading and facet capsule strain than injurious 
distraction (p<0.0001) (Fig. 5.13); a detailed summary of the mechanical data from the 
 
Fig. 5.13. Mechanical characterization of facet joint loading. (a) Injurious (Inj) 
loading imposes greater C6/C7 vertebral distraction and generates higher maximum 
principal strains (MPS) in the facet capsule than physiologic (Phys) loading. (b) 
Vertebral and capsule distraction, and (c) load across the facet joint are significantly 
higher during injurious loading than physiologic loading (*p<0.0001). 
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joint distraction for each rat is included in Appendix B. Neither injection of StrepII 
peptide with either sham or physiologic loading, nor injection of the non-sensitizing 20µg 
dose of TSP4 with sham loading, induce sensitivity (Fig. 5.14a). Those data confirm that 
non-sensitizing TSP4 and physiologic loading alone are insufficient to induce behavioral 
sensitivity. The combination of either 20µg or 60µg TSP4 with physiologic facet joint 
loading produces sustained hyperalgesia that persists through day 7 (p≤0.01) (Fig. 5.14a). 
However, the effects of TSP4 and facet joint loading on behavioral sensitivity are not 
 
Fig. 5.14. Spinal TSP4 facilitates hyperalgesia after facet joint loading.  Rats received 
non-sensitizing (20µg) or sensitizing (60µg) intrathecal TSP4, or a StrepII peptide 
control (Strep) three days before sham, physiologic (Phys), or injurious (Inj) facet 
joint distraction. (a) TSP4 potentiates the development of hyperalgesia after joint 
loading (*p≤0.01 60µg+Phys vs. baseline, #p≤0.0002 20µg+Phys vs. baseline, 
^p≤0.013 vs. Strep+Sham). (b) Sensitivity induced by TSP4 is not increased further 
by any magnitude of facet joint loading (*p≤0.01 60µg+Phys and 60µg+Inj vs. 
baseline, #p≤0.028 60µg+Sham vs. baseline, ^p≤0.028 vs. Strep+Sham).  
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cumulative – sensitivity develops after injection of 60µg TSP4 (p≤0.028), but is not 
increased further by physiologic or injurious joint loading (Fig. 5.14b). Appendix B 
presents the paw withdrawal thresholds for each rat on each day.  
Increased spinal TSP4 also potentiates the development of dorsal horn neuronal 
hyperexcitability at day 7 after facet joint loading. Neuronal firing evoked by light brush 
or noxious pinch increases over firing levels in the sham group when 20µg or 60µg TSP4 
is followed by physiologic loading (p≤0.0057) (Fig. 5.15). Likewise, von Frey filament 
stimulation (1.4, 4, 10, and 26g) also evokes greater firing when 20µg or 60µg TSP4 is 
followed by physiologic loading, compared to neuronal firing in the sham group 
(p≤0.013) (Fig. 5.15). Neuronal activity after either 20µg or 60µg TSP4 with physiologic 
joint loading is increased to the same level as when 60µg TSP4 is followed by injurious 
joint loading (Fig. 5.15). These results indicate that the facet joint loading that occurs 
during normal physiologic events can induce the same sustained neuronal 
hyperexcitability as a painful facet joint injury, when superimposed on preexisting 
increased spinal TSP4 levels. The effects of increased spinal TSP4 and facet loading on 
neuronal firing are not additive, because evoked firing after 60µg TSP4 with physiologic 
loading is not different from neuronal firing after 60µg TSP4 with injurious loading (Fig. 
5.15). Evoked spike counts for each neuron from each rat are itemized in Appendix E. 
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Fig. 5.15. Spinal TSP4 potentiates dorsal horn neuronal hyperexcitability after facet 
joint loading. (a) Representative neuronal firing in response to five stimulations with a 
noxious 26g von Frey filament for a subset of groups (Strep+Sham, 20µg+Phys, 
60µg+Phys, 60µg+Inj). (b) Neuronal firing in response to light brush and pinch is 
elevated when facet loading is preceded by non-sensitizing or sensitizing TSP4 
treatment (*p≤0.0057 vs. Strep+Sham). (c) Neuronal firing is also elevated over sham 
levels in response to 1.4, 4, 10, and 26g von Frey filaments when facet loading is 
preceded by non-sensitizing or sensitizing TSP4 treatment (*p≤0.008 for 20µg+Phys, 
#p≤0.013 for 60µg+Phys, ^p≤0.024 for 60µg+Inj). 
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5.5. Discussion 
Painful facet joint loading induces excitatory dorsal horn synaptogenesis along 
with dysregulation of thrombospondin-4 (TSP4) in both the DRG and spinal cord 
paralleling the time course of sustained mechanical hyperalgesia (Figs. 5.3-5.6). Of note, 
although this study only evaluates hyperalgesia through day 7, behavioral sensitivity 
persists for up to six weeks after the same injurious facet joint loading (Rothman et al., 
2008). Additional studies characterizing the long-term effects of painful facet joint 
loading on spinal TSP4 expression and dorsal horn hyperexcitability would provide 
insight into the chronic mechanisms that maintain persistent facet joint pain. Nonetheless, 
the peripheral and spinal treatments used in this collection of studies suggest a 
mechanism for the induction of structural plasticity in the spinal cord at day 7 after 
painful facet joint injury. Blocking afferent activity immediately after painful joint 
loading prevents injury-induced increases in spinal TSP4 and excitatory synapses (Figs. 
5.9 and 5.10). Blocking injury-induced TSP4 expression or antagonizing the 
synaptogenic activity of TSP4 attenuates dorsal horn synaptogenesis (Figs. 5.7 and 5.8). 
Together, these results suggest that astrocytic TSP4 expression is stimulated by afferent 
discharge from the facet joint early after painful joint loading, resulting in TSP4-
mediated excitatory synaptogenesis. That increase in excitatory synapses could contribute 
to the spinal neuronal hyperexcitability that is observed after painful facet joint injury 
(Crosby et al., 2013; Crosby et al., 2014a; Quinn et al., 2010b) by increasing the number 
of excitatory inputs on neurons in the dorsal horn and lowering the intensity of primary 
afferent stimulation required to activate those dorsal horn neurons. 
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The peripheral and central neurochemical changes associated with inflammatory 
and neuropathic pain can differ substantially (Honore et al., 2000), emphasizing the need 
to define those mechanisms for each pain state, especially for joint-mediated pain which 
often includes both inflammatory and neuropathic characteristics (Bove et al., 2006; 
Dong and Winkelstein, 2010; Kras et al., 2013b; Kras et al., 2014a; Lee and Winkelstein, 
2009; Quinn et al., 2010b). Although not a direct neural tissue insult, injurious facet joint 
distraction can produce pain through the induction of secondary axonal damage and 
increased discharge and afterdischarge of fibers innervating the facet joint (Crosby et al., 
2014a; Lu et al., 2005a; Kallakuri et al., 2008). In this study, the downregulation of TSP4 
in the DRG and upregulation of spinal astrocytic TSP4 after painful facet loading (Fig. 
5.5) are consistent with reports of TSP4 dysregulation in neuropathic pain after lumbar 
spinal nerve ligation, spinal cord contusion, and trigeminal nerve injury (Kim et al., 2012; 
Li et al., 2013; Zeng et al., 2013). TSP4 can also be expressed in neurons (Arber and 
Caroni, 1995); but although neuronal TSP4 could contribute to the increase in spinal 
TSP4 in this study, this is not likely since TSP4 expression occurs mostly in astrocytes 
and not neurons after painful nerve injury (Kim et al., 2012). The similarities in the 
spatiotemporal regulation of TSP4 in the DRG and spinal cord after painful joint loading 
and neural trauma strongly suggest that there are common mechanism(s) by which TSP4 
contributes to spinal sensitization and chronic pain, regardless of the inciting event. 
Therefore, blocking the upregulation or activity of TSP4 may serve as an effective 
therapeutic approach for a wide range of chronic pain conditions. 
Given the synaptogenic properties of thrombospondins (Christopherson et al., 
2005), upregulation of TSP4 in the superficial dorsal horn could lead to the increase in 
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the number of excitatory synapses that is observed in that region (Figs. 5.4-5.6). 
However, given that hyperalgesia is observed at day 1, the temporal mechanism by which 
this synaptogenesis develops is not known. Preventing TSP4 expression or blocking 
TSP4 activity with gabapentin abolishes injury-induced hyperalgesia and those increased 
synapses (Figs. 5.7 and 5.8), suggesting that increased spinal TSP4 is requisite for 
synaptogenesis through interaction with its neuronal receptor, α2δ-1. Gabapentin has also 
been shown to reduce spinal astrocytic activation and dorsal horn neuronal 
hyperexcitability in this same painful joint distraction model (Dong et al., 2013a), 
suggesting that gabapentin may prevent TSP4 activity that is critical for the development 
of facet-mediated pain. Gabapentin likely does not remain active until day 7 when 
synapse numbers were evaluated (Field et al., 1997). So, it is also possible that 
gabapentin given at the time of injury prevents the initial increase in spinal TSP4, similar 
to the administration of intra-articular bupivacaine early after injury (Fig. 5.9), rather than 
blocking TSP4 activity after its upregulation. 
The relative increase in excitatory synapses (1.56-fold) in the superficial dorsal 
horn after painful facet joint loading (Fig. 5.4) is similar to the range of increases in 
synapses reported in that spinal region after peripheral nerve injury (Jaken et al., 2010; Li 
et al., 2014b; Lin et al., 2011; Peng et al., 2010). Retinal ganglion cell cultures treated 
with TSP1 develop synapses that are post-synaptically silent due to a lack of functional 
AMPA glutamate receptors, despite normal structural appearance (Christopherson et al., 
2005). The synaptogenic domains of the TSP1 protein are conserved across all members 
of the TSP family (Eroglu et al., 2009), so it is possible that newly developed synapses in 
the dorsal horn induced by TSP4 after painful facet joint loading are similarly not 
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functional. In the current study, synaptic puncta are identified based only on labeling of 
pre- and post-synaptic structural components; future studies should electrophysiologically 
evaluate the functionality of synapses that are induced by TSP4 after joint loading 
(Christopherson et al., 2005; Ullian et al., 2001). 
An increase in functional excitatory synapses after painful facet joint loading 
could amplify nociceptive signals via increasing activation of second-order nociceptive 
neurons by the Aδ and C fibers that terminate in the superficial laminae of the dorsal horn 
(Basbaum et al., 2009). Alternately, nerve injury may induce sprouting of Aβ fibers from 
the deep dorsal horn into the superficial laminae (Woolf et al., 1992). Although the 
evidence supporting sprouting of Aβ fibers in the dorsal horn after nerve injury is 
disputed (Hughes et al., 2003), the increase in excitatory synapses could indicate new 
connections of low-threshold afferents into nociceptive pathways in the superficial dorsal 
horn, resulting in the hypersensitivity to innocuous mechanical stimuli that is observed 
after painful joint loading (Fig. 5.3). Additional studies of spinal structural plasticity are 
needed to determine which pre- and post-synaptic dorsal horn neuronal populations, if 
any, form aberrant connections during excitatory synaptogenesis. 
Bupivacaine treatment immediately after painful facet joint loading attenuates 
spinal TSP4 upregulation and excitatory synaptogenesis (Figs. 5.9 and 5.10). However, 
bupivacaine administered at day 4 after joint loading does not reduce spinal TSP4 or 
synaptogenesis (Figs. 5.9 and 5.10), indicating that joint afferent input is not required to 
maintain the increase in excitatory synapses after spinal hyperexcitability has already 
developed. Early afferent activity after painful facet joint loading induces other synaptic 
changes that promote neuronal excitability, including the upregulation of glutamate 
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receptors and downregulation of astrocytic glutamate transporters (Crosby et al., 2014a). 
Injury-induced afferent discharge may directly induce TSP-mediated synaptogenesis by 
increasing spinal astrocytic TSP4 expression, since excitatory signaling molecules like 
ATP have been shown to stimulate astrocyte release of other members of the 
thrombospondin family (Tran and Neary, 2006). The subsequent increase in excitatory 
synapses could contribute to increases in neuronal glutamate signaling proteins like 
mGluR5 and phosphorylated NR1 at day 7 after painful facet joint loading (Crosby et al., 
2014a). Together, the results of this study suggest that afferent discharge from the facet 
joint initiates TSP4-mediated synaptogenesis in the spinal cord, and the subsequent 
increase in excitatory synapses may underlie the potentiation of glutamatergic signaling 
and the spinal neuronal hyperexcitability that are observed after painful joint loading. 
Increased spinal TSP4 is sufficient to induce mechanical hyperalgesia, but it also 
potentiates the development of dorsal horn neuronal hyperexcitability after mechanical 
loading of the facet joint (Figs. 5.12-5.15). Low-threshold mechanosensitive and 
nociceptive afferents in the facet capsule are differentially activated by capsule strains 
produced during physiologic and injurious joint loading, respectively (Dong et al., 2012; 
Lu et al., 2005a). However, in the presence of increased spinal TSP4, even physiologic 
joint loading is sufficient to induce hyperalgesia and dorsal horn neuronal 
hyperexcitability (Fig. 5.14). These findings suggest that TSP4 sensitizes the non-
nociceptive spinal pathways that are activated by physiologic joint loading, possibly by 
facilitating presynaptic excitatory neurotransmitter release from Aβ afferents terminating 
in the dorsal horn (Kim et al., 2012). The specific mechanisms by which TSP4 facilitates 
excitatory neurotransmission remain unclear (Kim et al., 2012), but TSP-family proteins 
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have been shown to regulate calcium signaling at the plasma and endoplasmic reticular 
membranes (Duquette et al., 2014), and altering presynaptic calcium levels could enhance 
excitatory neurotransmitter release (Neher and Sakaba, 2008). Collectively, these results 
implicate increased spinal TSP4 in priming the spinal cord for the development of dorsal 
horn neuronal hyperexcitability in response to afferent activity induced by joint loading, 
and decreasing the mechanical threshold for pain from joint loading. Repeated exposure 
to joint loading that upregulates TSP4, or higher endogenous levels of spinal TSP4, may 
therefore present a higher risk for the development of persistent joint-mediated pain. 
 
5.6. Conclusions and Integration 
In summary, the studies in this chapter demonstrate that TSP4 plays an important 
role in the development and maintenance of persistent pain after facet joint loading. The 
dysregulation of TSP4 after painful joint loading, in conjunction with behavioral 
sensitivity and increased excitatory synapse density, indicates a relationship between 
TSP4 expression, spinal structural plasticity, and persistent joint-mediated pain. Evidence 
of excitatory synaptogenesis in the spinal dorsal horn in association with joint pain, and 
the absence of synaptogenesis with decreased TSP4 expression or analgesic gabapentin 
treatment, support a TSP4-mediated mechanism as driving the hyperalgesia and neuronal 
hyperexcitability that develop after painful facet joint loading. TSP4 also facilitates the 
mechanotransduction of joint loading to initiate hyperalgesia and spinal hyperexcitability. 
By lowering the threshold of mechanical loading to the joint that induces persistent pain, 
increased spinal TSP4 could increase risk for the development of facet joint-mediated 
pain in individuals undergoing any magnitude of facet loading. These findings suggest 
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that the spinal cord is sensitive to “priming” by pro-excitatory or pro-nociceptive 
molecules, like TSP4, that may lower the threshold for afferent firing-induced 
sensitization of dorsal horn neurons from any type of noxious stimulation, not just 
mechanical loading of the cervical facet joints. Identifying the molecules and the spinal 
concentrations of those molecules that may cause spinal cord priming is important to 
understand the relationships between noxious stimulation, including mechanical joint 
loading, and the development of persistent pain. 
This study also emphasizes the finding from Chapter 4 that peripheral 
intervention after painful facet joint injury is only effective for blocking hyperalgesia and 
spinal hyperexcitability when administered early after joint loading. In addition to 
synaptic changes that potentiate excitatory glutamatergic signaling (Chapter 4), the 
studies in this chapter indicate that structural changes develop in the spinal cord within 
the first seven days after painful joint loading that could permanently alter the spinal 
processing of non-nociceptive and nociceptive signals. Collectively, the studies in this 
thesis suggest that extensive spinal modifications underlie the onset of spinal neuronal 
hyperexcitability after painful joint injury, and spinal hyperexcitability can be difficult to 
effectively treat after it has developed. Spinal cord stimulation (SCS) is an effective 
therapy for chronic pain that directly modulates dorsal horn neuronal activity rather than 
pharmacologically targeting one or more of the spinal mechanisms that contribute to 
neuronal hyperexcitability (Compton et al., 2012; Guan, 2012). As such, Chapters 6 and 7 
evaluate the effectiveness and mechanisms of SCS for the attenuation of spinal neuronal 
hyperexcitability in models of cervical radiculopathy and painful facet joint injury. 
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CHAPTER 6 
 
Optimization of Burst Spinal Cord Stimulation 
Parameters in a Rat Model of Neuropathic Pain 
 
 
Parts of this chapter were adapted from: 
Crosby ND, Goodman-Keiser MD, Smith JR, Zeeman ME, Winkelstein BA. Stimulation 
parameters define the effectiveness of burst spinal cord stimulation in a rat model of 
neuropathic pain. Neuromodulation 2014; doi:10.1111/ner.12221. 
 
6.1. Overview 
Spinal neuronal hyperexcitability is a key feature of central sensitization that 
develops after many different types of neural or soft tissue injuries, including painful 
facet joint injury and compression of the dorsal nerve root that leads to cervical 
radiculopathy (Crosby et al., 2013; Hanai et al., 1996; Nicholson et al., 2014a; Quinn et 
al., 2010b; Smith et al., 2013; Zhang et al., 2013). Injury-induced spinal modifications, 
including potentiation of glutamatergic signaling and synaptogenesis detailed in Chapters 
4 and 5, can contribute to neuronal hyperexcitability by altering nociceptive signaling and 
excitatory neurotransmission (Crosby et al., 2014a; Dong et al., 2012; Kim et al., 2012). 
As a result, spinally-mediated pain that becomes chronic is often refractory to 
conventional treatments, such as physical therapy, neck immobilization, or 
pharmacological interventions, that fail to target the amplification of nociception at the 
spinal level (Peeters et al., 2001). Spinal cord stimulation (SCS) attenuates chronic pain 
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by directly modulating neuronal hyperexcitability in the spinal dorsal horn (Cameron, 
2004; Compton et al., 2012; Simpson, 1997). Despite the use of SCS to treat chronic 
pain, the mechanisms underlying its analgesic effects remain unknown. Because cervical 
radiculopathy is a common indication for SCS (Alo et al., 2002; De Ridder et al., 2013; 
Rizvi and Kumar, 2013), that injury is ideal for studying the potential mechanism(s) of 
action, and effectiveness, of SCS for treating chronic neuropathic pain. 
Traditional SCS stimulates the dorsal columns of the spinal cord with continuous, 
tonic pulses of current to inhibit nociception in the dorsal horn (Guan et al., 2010; Qin et 
al., 2012; Tang et al., 2014). The reported success rate of SCS for pain relief in clinical 
studies varies widely and, overall, has improved little in the last several decades 
(Cameron, 2004; Zhang et al., 2014). Recently, novel modes of stimulation have been 
developed to improve the effectiveness of SCS by modifying the delivery of stimulation 
in order to increase the inhibition of nociception in the spinal cord. Burst SCS is one 
mode of stimulation that shows greater clinical effectiveness than conventional tonic 
stimulation while also reducing paresthesia, a major side-effect of tonic SCS (De Ridder 
et al., 2010; De Vos et al., 2013). However, the optimization, effectiveness, and 
mechanisms of burst SCS are unclear, especially for cervical radiculopathy.  
Studies in this chapter and Chapter 7 evaluate burst SCS for modulating spinal 
neuronal firing after the development of persistent radicular pain. In particular, the 
studies in this chapter are outlined in Aim 3a, with the goal of optimizing the parameters 
and conditions of burst SCS for attenuating spinal hyperexcitability. Using an established 
rat model of C7 dorsal nerve root compression that induces radicular pain (Hubbard and 
Winkelstein, 2005; Zhang et al., 2013), burst SCS was applied to the C4 dorsal columns 
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to determine its effect on spinal neuronal firing. The effectiveness of SCS was measured 
by the reduction of dorsal horn neuronal activity during noxious mechanical stimulation 
of the forepaw. The optimization of the stimulation parameters in this study identifies the 
most effective settings for burst SCS for use in the studies presented in Chapter 7, in 
which the efficacy of burst and tonic SCS are compared for attenuating spinal neuronal 
hyperexcitability after painful nerve root compression or facet joint injury. 
 
6.2. Background 
Spinal cord stimulation (SCS) is used to treat a wide range of chronic pain 
conditions by administering electrical stimulation to the dorsal columns of the spinal 
cord. Traditional SCS uses a tonic paradigm to deliver continuous pulses of various 
frequencies, pulse widths, and intensities to the spinal cord and is commonly used to 
manage cervical and lumbar axial and radicular pain (Alo et al., 2002; Compton et al., 
2002; Stojanovic and Abdi, 2002). Those parameters can be modulated, along with 
electrode configuration and placement on the spinal cord, to maximize pain relief for 
individual patients (De Vos et al., 2013; Rizvi and Kumar, 2013). However, tonic 
stimulation induces paresthesia in the stimulated dermatomes. Although paresthesia can 
be used to guide electrode placement and SCS programming, many patients prefer 
paresthesia-free stimulation (De Vos et al., 2013). 
Burst SCS is an alternative mode of stimulation that uses small bursts of pulses of 
stimulation rather than continuous pulses. Burst SCS has been recently reported to reduce 
neuropathic pain better than tonic SCS without generating paresthesia in the majority of 
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patients (De Ridder et al., 2010; De Ridder et al., 2013; De Vos et al., 2013). De Ridder 
et al. (2013) found that burst SCS decreased visual analog scale (VAS) pain scores more 
than tonic SCS for back pain and general pain perception in patients undergoing brief 
trials with each stimulation modality, including those with cervical radicular pain. 
Patients report greater pain relief from burst SCS than from tonic SCS in a placebo-
controlled trial (De Ridder et al., 2013), as well as when burst SCS is introduced after at 
least six months of tonic stimulation (De Vos et al., 2013). Furthermore, burst SCS has 
been shown to be more effective than tonic SCS for attenuating visceral nociception in a 
rat model of colorectal distension (Tang et al., 2014). Although burst SCS has been 
postulated to provide improved pain relief over tonic SCS via delivering more charge per 
second to the spinal dorsal columns (De Ridder et al., 2010), the role of charge delivery 
in burst SCS has not been investigated. 
The burst SCS waveform is highly adaptable by modifying any of the parameters 
that control the shape of the waveform – the number of pulses per burst, the frequency of 
pulses within each burst, the pulse width, the frequency of bursting, or the amplitude 
(Fig. 6.1). To date, the clinical and preclinical studies using burst SCS have used the 
same stimulation parameters: 5 pulses per burst, 500Hz pulse frequency, 1ms pulse 
width, and 40Hz burst frequency (De Ridder et al., 2010; De Ridder et al., 2013; De Vos 
et al., 2013; Tang et al., 2014). Even though tonic SCS is frequently optimized for pain 
management on a patient-by-patient basis by adjusting pulse width, frequency, and 
amplitude (Alo et al., 1999; Smits et al., 2013), there have been no studies, clinical or 
preclinical, investigating the optimization of burst SCS for neuropathic pain with respect 
to any of the parameters defining the stimulation waveform or the charge delivery. 
 141 
 
Cervical radiculopathy and cervical brachialgia are neuropathic pain conditions 
that cause neck, shoulder, and arm pain from compression of the cervical spinal nerves 
and/or nerve roots, and are common indications for SCS (Alo et al., 2002; De Ridder et 
al., 2013; Rizvi and Kumar, 2013). However, the stimulation parameters associated with 
effective burst SCS have not been systematically evaluated for these indications. This 
study tests the hypotheses that burst SCS is effective in reducing dorsal horn neuronal 
firing associated with cervical radicular pain, and that altering burst SCS parameters 
modulates the effects of stimulation on neurons in the spinal dorsal horn. A model of 
nerve root compression that induces behavioral sensitivity and spinal neuronal 
hyperexcitability in the rat is used to evaluate neuronal activity immediately before and 
after application of burst SCS (Nicholson et al., 2014a; Smith et al., 2013; Zhang et al., 
2013). The effects of burst SCS are measured specifically in wide dynamic range (WDR) 
and high-threshold (HT) dorsal horn neurons, because those two dorsal horn neuronal 
populations are responsible for processing nociceptive signals (Steeds, 2009). In order to 
evaluate the sensitivity of burst SCS effectiveness to each burst parameter (Fig. 6.1), each 
parameter is varied across a range of several values that could be used for clinical 
 
 
Fig. 6.1. Schematic of a burst SCS waveform. Five parameters define the shape of the 
stimulation: pulse number, pulse frequency, pulse width, burst frequency, and 
amplitude. 
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application of burst SCS. This study also investigates the modulation of charge per burst 
as a potential mechanism for the sensitivity of burst SCS to changes in the stimulation 
parameters. 
 
6.3. Methods 
6.3.1. Nerve Root Compression Surgery 
Male Holtzman rats (386-466g) were housed under USDA- and AAALAC-
compliant conditions with free access to food and water. All experimental procedures 
were approved by the University of Pennsylvania Institutional Animal Care and Use 
Committee and carried out under the guidelines of the Committee for Research and 
Ethical Issues of the International Association for the Study of Pain (Zimmerman, 1983). 
Compression of the right C7 dorsal nerve root was performed with rats (n=8) 
under isofluorane inhalation anesthesia (4% for induction, 2-3% for maintenance) using 
procedures previously described (Hubbard and Winkelstein, 2005; Rothman and 
Winkelstein, 2007; Rothman and Winkelstein, 2010). With the rat in a prone position, the 
C6 and C7 vertebrae were exposed by making a midline incision from the base of the 
skull to the T2 vertebra and separating the overlying muscular tissue. A C6/C7 
hemilaminectomy and partial facetectomy on the right side exposed the C7 dorsal nerve 
root between the dorsal root ganglion and the spinal cord. A 10gf microvascular clip 
(World Precision Instruments; Sarasota, FL) was inserted through a small incision in the 
dura to compress the nerve root for 15 minutes. After the surgical procedure, incisions 
were closed using 3-0 polyester sutures and surgical staples. Rats were monitored during 
recovery in room air, and then returned to normal housing conditions. 
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6.3.2. Assessment of Mechanical Hyperalgesia 
Behavioral sensitivity was assessed by measuring mechanical hyperalgesia in 
both forepaws of each rat prior to surgery (baseline) and on days 1, 3, 5, and 7 after nerve 
root compression. Hyperalgesia was assessed separately in the ipsilateral and 
contralateral forepaws by quantifying the paw withdrawal threshold (PWT) during 
application of a series of weighted von Frey filaments (1.4, 2, 4, 6, 8, 10, 15, and 26g) to 
the plantar surface of the paw (Chang and Winkelstein, 2011; Hubbard and Winkelstein, 
2005; Zhang et al., 2013). Each filament was applied five times to determine if the rat 
displayed a positive response to that filament weight; a positive response was taken as 
withdrawing, licking, or shaking of the paw. If the rat displayed a positive response to 
two consecutive filaments, the lower of the two filament weights was recorded as the 
PWT. Rats not responding to any of the filaments were assigned the maximum PWT of 
26g. On each designated day, testing was repeated in three rounds separated by at least 
ten minutes, and the average threshold from the three rounds was calculated for each paw 
and each rat. A repeated-measures ANOVA compared the PWTs between the ipsilateral 
and contralateral forepaws at each time point. 
 
6.3.3. Electrophysiological Recordings and Burst Spinal Cord Stimulation 
After hyperalgesia testing on day 7, extracellular electrophysiological recordings 
were acquired in the spinal dorsal horn to measure neuronal firing before and after burst 
SCS. Rats were anesthetized with sodium pentobarbital (50mg/kg, i.p.) and given 
supplemental doses (5-10mg/kg, i.p.) as needed based on toe pinch, corneal, and 
palpebral reflexes (Field et al., 1993). A bilateral laminectomy and dural resection from 
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C3 to C7 were performed to expose the spinal cord. Rats were then immobilized on a 
stereotaxic frame (David Kopf Instruments; Tujunga, CA) using ear bars and a vertebral 
clamp at T2 to stabilize the cervical spine. Core temperature was maintained at 35-37ºC 
using a temperature controller with a rectal probe (Physitemp; Clifton, NJ), and the 
exposed spinal cord was bathed in 37ºC mineral oil for the duration of recording to 
prevent drying. 
A monopolar platinum ball electrode was placed on the surface of the dorsal 
columns at the C4 level (Fig. 6.2), and a grounding electrode was attached to the incised 
skin on the neck. Constant-current burst spinal cord stimulation was applied using an S48 
Grass stimulator with a photoelectric stimulus isolation unit (Grass Technologies; 
Warwick, RI). The motor threshold (MT) for each rat was identified as the stimulation 
 
 
Fig. 6.2. Stimulation protocol for burst SCS optimization. Burst SCS was applied to 
the dorsal columns at the C4, and neuronal firing was recorded in the C7 dorsal horn 
ipsilateral to the site of nerve root compression. (a) Spontaneous firing was recorded in 
a 10sec baseline (BL) period, followed 10sec of light brush and 10sec of noxious pinch 
at the forepaw. (b) Burst SCS was applied for 10sec. (c) A 10sec pinch was applied to 
the forepaw to record evoked firing immediately after SCS.   
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intensity at which small contractions were first observed in the paraspinal musculature or 
forelimbs. Extracellular potentials were recorded by lowering a carbon fiber electrode 
(Kation Scientific; Minneapolis, MN) into the C7 spinal dorsal horn on the side ipsilateral 
to the compressed nerve root. Signals were amplified with a gain of 10
3
 and conditioned 
using a bandpass filter between 0.3 and 3kHz (World Precision Instruments; Sarasota, 
FL). The signal was processed with a 60Hz HumBug adaptive filter (Quest Scientific; 
North Vancouver, BC), digitally sampled at 25kHz (Micro1401, CED; Cambridge, UK), 
monitored with a speaker for audio feedback (A-M Systems; Carlsborg, WA) and 
recorded using Spike2 software (CED; Cambridge, UK). 
The carbon fiber electrode was lowered into the spinal cord until a recording site 
in the dorsal horn was identified where evoked firing from mechanically-sensitive 
neurons was detected during light brushing and noxious pinch of the ipsilateral forepaw. 
To evaluate changes in neuronal activity due to burst SCS, the neuron (or neurons, if 
multiple waveforms could be differentiated at a single recording site) underwent multiple 
spinal cord stimulation trials (Fig. 6.2). Each stimulation trial consisted of: (1) at least ten 
seconds of recording to establish baseline spontaneous firing; (2) ten seconds of light 
brushing and ten seconds of noxious pinch of the forepaw by forceps in order to classify 
the neuron as WDR or HT, and to establish pre-SCS evoked firing; (3) ten seconds of 
burst spinal cord stimulation (Fig. 6.1); (4) ten seconds of noxious forepaw pinch to 
record post-SCS evoked firing; and, (5) at least 20 minutes of rest in order to allow the 
neuron to recover from the effects of burst SCS.  
For each recording site, the first stimulation trial applied burst SCS consisting of 7 
pulses per burst at 500Hz with a 1000µs pulse width, a burst frequency of 40Hz, and 
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amplitude of 90% MT. From that reference parameter set, each of the five parameters 
was varied individually in subsequent stimulation trials with the remaining four 
parameters held constant (Table 6.1). At least three separate values were tested for each 
parameter (Table 6.1), in consecutive stimulation trials at the same recording site.  The 
different values for each parameter were tested in a random order to avoid any effect of 
the order of application. At the lowest pulse frequency (250Hz), the inter-burst interval 
was not long enough for each burst to contain 7 pulses with 1000µs width, so bursts of 5 
pulses were applied when testing different pulse frequencies. 
 
6.3.4. Electrophysiological Data Analysis 
Voltage potentials from each recording site were spike-sorted using Spike2 (CED; 
Cambridge, UK) to differentiate waveforms from individual neurons. A detailed protocol 
for spike sorting is included in Appendix A. Each neuron was classified as either WDR, 
if firing was evoked by both light brush and noxious pinch, or HT, if firing was only 
evoked by a noxious pinch. Low threshold (LT) neurons responding only to light 
mechanical stimuli were not included in this study since LT neurons do not respond to 
noxious pinch, which was used as the test stimulus. Pre- and post-SCS firing were 
determined by counting the number of spikes evoked by noxious pinch in the ten seconds 
Table 6.1. Burst SCS conditions and parameter values. 
Pulse Number 
Pulse 
Frequency 
Pulse Width 
Burst 
Frequency 
Amplitude 
3 pulses 250Hz 250µs 20Hz 30% MT 
5 pulses 333Hz 500µs 40Hz* 60% MT 
7 pulses* 500Hz* 750µs 60Hz 90% MT* 
  1000µs*   
*reference parameter set; MT = motor threshold 
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before, and the ten seconds immediately following, the application of burst SCS. Voltage 
potentials during SCS were not visible due to the large artifacts from stimulation that 
masked neuronal activity; therefore, measurements of neuronal responses were only 
performed before and after SCS. Baseline spontaneous activity was subtracted from the 
spike counts for each pinch in order to isolate the neuronal response evoked by the 
noxious pinch itself. 
Two metrics of neuronal activity were used to evaluate the effects of burst SCS on 
dorsal horn neuronal firing. First, the percent change in evoked neuronal firing after burst 
SCS was calculated relative to the firing evoked before SCS. Neurons having a negative 
percent change in firing after burst SCS (i.e., a reduction in spikes) were considered to be 
responsive to burst SCS. The percentage of responsive neurons for each set of stimulation 
parameters was used as a second measure of SCS efficacy. A bivariate linear regression 
tested for correlation between each parameter and changes in neuronal firing among 
responsive neurons only. The effect of each parameter on the percentage of neurons 
responding to burst SCS was tested using Fisher’s exact test. 
The charge per burst delivered to the spinal cord was calculated for each 
parameter by integrating the waveform of the constant-current stimulation over time 
during a single burst. Changes in WDR and HT neuronal firing were averaged at each 
charge value across all stimulation trials. The correlations between charge per burst and 
percent changes in neuronal firing were then tested separately for WDR and HT neurons 
using bivariate linear regression. Percentages of responsive WDR and HT neurons in 
each stimulation trial were binned by charge per burst; bins were chosen to span the full 
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range of charge values, in ten equal increments of 0.1μC. All statistical analyses were 
performed with α=0.05 using JMP9 (SAS; Cary, NC). 
 
6.4. Results 
The paw withdrawal threshold (PWT) of the ipsilateral forepaw is significantly 
reduced from baseline on each of days 1, 3, 5, and 7 after injury (p<0.017) (Fig. 6.3). The 
contralateral PWT is not significantly different from baseline throughout the seven day 
period after injury (Fig. 6.3). In addition, the PWT of the ipsilateral forepaw is 
significantly lower than the PWT of the contralateral forepaw on all days following nerve 
root compression (p<0.019), despite the ipsilateral and contralateral PWTs not being 
different at baseline (Fig. 6.3). Appendix J includes the paw withdrawal thresholds for 
each rat on each day after nerve root compression. 
 
 
 
Fig. 6.3. Mechanical hyperalgesia after painful cervical nerve root compression. 
Nerve root compression induces a significant decrease in paw withdrawal threshold 
(PWT) for the ipsilateral forepaw compared to both baseline (*p<0.017) and the 
contralateral forepaw (#p<0.019) on each day after injury. 
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Neuronal firing was recorded at 25 different sites in the spinal cord (3.0±1.1 
recording sites per rat). At each recording site, 4.1±1.4 stimulation trials were performed. 
Each of the five burst parameters was tested at 6.8±1.8 separate recording sites. Of the 25 
recording sites, nine sites with stable signals were used to test multiple parameters 
consecutively. Neuronal firing evoked by noxious pinch is reduced to varying degrees 
based on the burst parameters (Fig. 6.4). Among the neurons that are responsive to burst 
SCS (n=191 neurons from all recording sites and stimulation trials), pulse number 
(p=0.0018), pulse width (p=0.0001), and amplitude (p=0.0086) are each significantly 
correlated to reductions in evoked neuronal firing after burst SCS (Fig. 6.5). Neuronal 
firing is reduced more with each increase in those parameters. Pulse frequency and burst 
frequency are not correlated to changes in neuronal firing after burst SCS (Fig. 6.5). 
Evoked spike counts for each neuron from each rat are included in Appendix D. 
 
 
 
Fig. 6.4. Attenuation of neuronal firing by burst SCS. Neuronal firing evoked by 
noxious pinch of the ipsilateral forepaw is attenuated by burst SCS to varying degrees 
depending on the burst parameters. In this representative neuron, activity is suppressed 
more as pulse width increases from (a) 250μs to (b) 500μs, (c) 750μs, and (d) 1000μs. 
In this case, the other parameters are fixed: pulse number=7; pulse frequency=500Hz; 
burst frequency=40Hz; amplitude=90% MT. 
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The percentage of responsive neurons exhibiting a reduction in firing after burst 
SCS is significantly related to the pulse frequency (p=0.05) and the amplitude of 
stimulation (p=0.023) (Fig. 6.6). As the pulse frequency and amplitude increase, the 
 
 
Fig. 6.5. Effect of burst parameters on the attenuation of neuronal firing. The change 
in neuronal firing for each set of parameters after burst SCS is shown as the percent 
change in spikes relative to pre-SCS baseline firing: (a) pulse number, (b) pulse 
frequency, (c) pulse width, (d) burst frequency, and (e) amplitude. Asterisks and 
arrows indicate significant negative correlations between each of pulse number 
(p=0.0018), pulse width (p=0.0001), and amplitude (p=0.0086), and the reduction in 
neuronal activity after burst SCS. 
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percentage of responsive neurons also increases. Although the percentage of responsive 
neurons also increases with higher pulse numbers (p=0.13) and pulse widths (p=0.078), 
those relationships are not significant (Fig. 6.6). Altering burst frequency has no effect on 
the percentage of responsive neurons (Fig. 6.6). 
 
 
 
Fig. 6.6. Effect of burst parameters on the percentage of responsive neurons. The 
percentage of neurons responding to burst SCS with a decrease in evoked firing is 
shown for each level of the burst parameters: (a) pulse number, (b) pulse frequency, 
(c) pulse width, (d) burst frequency, and (e) amplitude. Asterisks and arrows indicate 
significant positive correlations between each of pulse frequency (p=0.05) and 
amplitude (p=0.023), and the percentage of responsive neurons. 
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Charge per burst delivered to the spinal cord is highest for the reference parameter 
set (7 pulses, 500Hz pulse frequency, 1000µs pulse width, 40Hz burst frequency, 90% 
MT amplitude), ranging from 0.76-1.07μC, with some variation due to the differences in 
motor threshold between rats (Fig. 6.7a). Pulse number, pulse width, and amplitude are 
each directly proportional to the charge per burst, so changes in each of those parameters 
results in a wide range of charges per burst during stimulation trials (Fig. 6.7a). Pulse 
frequency and burst frequency do not affect charge per burst (Fig. 6.7a), aside from the 
variation due to motor threshold differences between rats. 
Charge per burst is negatively correlated with changes in neuronal firing among 
responsive WDR neurons (n=141) after burst SCS (R
2
=0.30, p=0.0017) (Fig. 6.7b). 
Among responsive HT neurons (n=50), neuronal firing also decreases as charge per burst 
increases, although that correlation is not significant (R
2
=0.14, p=0.13). The total 
percentage of neurons responding to SCS increases nonlinearly with charge per burst, 
exhibiting a step transition from 65% responding (35% not responding) at charges below 
0.5μC, to 80-85% of neurons responding (15-20% not responding) at charges above 
0.5μC (Fig. 6.7c). The percentage of WDR neurons responding to burst SCS remains 
high, averaging 83±6% across all charge values (Fig. 6.7c). But, the responsiveness of 
HT neurons exhibits a large increase from 45±4% at charges below 0.5μC to 78±7% at 
charges above 0.6μC; no HT neurons were recorded after stimulation having a charge per 
burst between 0.5μC and 0.6μC (Fig. 6.7c). 
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Fig. 6.7. Charge per burst determines the effectiveness of burst SCS. (a) Pulse 
number, pulse width, and amplitude have the greatest range of charges tested across 
the stimulation trials associated with each parameter. Charge is constant across all 
pulse frequencies and across all burst frequencies, aside from small variations due to 
motor threshold differences between rats. (b) Percent change in firing of wide 
dynamic range (WDR) and high threshold (HT) neurons is negatively correlated to 
charge per burst, but the correlation is significant only for WDR neurons (p=0.0017). 
(c) The percentage of WDR neurons responding to SCS is unchanged by charge per 
burst. The percentage of HT neurons and total percentage of all neurons responding to 
burst SCS exhibit a step response, increasing when charge per burst exceeds 0.5μC. 
No HT neurons were collected in the 0.5 to 0.6μC per burst range. 
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6.5. Discussion 
This study demonstrates that burst SCS reduces dorsal horn neuronal responses to 
noxious stimulation of the forepaw after painful compression of the cervical nerve root in 
rats (Figs. 6.3-6.5). Changes in neuronal activity following burst SCS are mediated by the 
stimulation parameters that define the burst waveform. Three parameters in particular – 
number of pulses per burst, pulse width, and amplitude – are each significantly correlated 
to the changes in evoked neuronal firing after burst SCS (Fig. 6.5). Pulse frequency has a 
significant effect on the percentage of recorded neurons responding to burst SCS (Fig. 
6.6). Furthermore, the charge per burst delivered to the spinal cord is correlated to the 
decrease in responses of both WDR and HT neurons after burst SCS (Fig. 6.7). Together, 
these findings show that the effects of burst SCS are highly dependent on the burst 
stimulation parameters, suggesting that the reduction of pain symptoms by burst SCS 
could be maximized by optimizing the burst parameters on a patient-by-patient basis. 
The effectiveness of burst SCS, as measured by changes in dorsal horn neuronal 
firing after stimulation, varies with the parameters and conditions of the burst stimulation. 
For example, the most effective burst SCS paradigm is found when using the reference 
parameter settings (7 pulses at 500Hz and 1000µs width, 40Hz bursts, and 90% MT 
amplitude), after which neuronal firing is reduced by 44.8±23.3% across the 84.7% of 
neurons that respond to SCS (Figs. 6.5 and 6.6). When the pulse width is adjusted from 
1000µs to 250µs, neuronal firing is reduced only 15.1±9.4%, with 65.4% of neurons 
responding to stimulation (Figs. 6.5 and 6.6). At its maximum effectiveness, burst SCS 
suppresses up to 44.8% of neuronal activity, which is comparable to the only other study 
that has applied burst SCS in an animal model of pain (Tang et al., 2014). That study 
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demonstrates that burst SCS reduces firing in lumbar dorsal horn neurons by up to 41.5% 
during noxious pinch and up to 22.6% during colorectal distension (Tang et al., 2014), 
suggesting that burst SCS may similarly suppress both nociceptive and chronic 
neuropathic pain. 
The attenuation of spinal neuronal firing in this study of neuropathic pain suggests 
that burst SCS reduces signaling in pain pathways in the dorsal horn that include WDR 
and HT secondary neurons. Inhibiting firing of WDR and HT neurons likely reduces 
aberrant nociception after neural tissue injury, because those are the two second-order 
neuronal populations in the dorsal horn that process painful signals (Steeds, 2009). Those 
findings are consistent with reductions in the visual analog scale (VAS) pain scores 
reported after burst SCS in a clinical study (De Ridder et al., 2013). Although burst SCS 
decreases neuronal activity by attenuating firing in dorsal horn neurons that exhibit 
hyperexcitability after nerve root compression (Nicholson et al., 2014a; Smith et al., 
2013; Zhang et al., 2013), studies measuring behavioral sensitivity after SCS are needed 
in order to draw more direct conclusions about the modulation of pain by burst SCS. 
The reduction in neuronal response to noxious pinch following burst SCS is 
significantly correlated to charge per burst delivered during stimulation (Fig. 6.7b). SCS 
causes antidromic signaling, in which stimulated axons in the dorsal columns conduct 
action potentials from the site of stimulation back into the dorsal horn (Oakley and 
Prager, 2002). Antidromic activation of spinal inhibitory interneurons by large-diameter 
Aβ fibers suppresses firing in dorsal horn neurons to block nociceptive signaling, as 
proposed by the gate theory of pain and supported by reports of attenuation of dorsal horn 
excitability by dorsal column stimulation (Daniele and MacDermott, 2009; Dubuisson, 
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1989; Guan, 2012; Guan et al., 2010; Linderoth and Foreman, 1999; Melzack and Wall, 
1965; Yakhnitsa et al., 1999). The current required to activate a stimulated axon increases 
with the distance of the axon from the point of stimulation (Brocker and Grill, 2013). 
Therefore, increased charge delivery may enhance current penetration and subsequent 
antidromic activation of large-diameter Aβ fibers in the dorsal columns (Compton et al., 
2012; Holsheimer, 2002), resulting in the increased attenuation of WDR and HT neuronal 
activity that is observed at higher charges (Figs. 6.5 and 6.7b). The charge per burst is 
also nonlinearly related to the percentage of neurons responding to burst SCS, most 
notably an increase in responsive HT neurons at higher charges (Fig. 6.7c). As charge 
delivery increases, stimulation may activate fibers of decreasing diameter that have 
higher activation thresholds (Holsheimer, 2002; Kreis and Fishman, 2009), increasing the 
number of active dorsal column fibers and overall inhibitory tone in the dorsal horn. The 
percentage of responsive WDR neurons remains constant and is higher than HT neurons 
at low charge values (Fig. 6.7c), suggesting that WDR neurons are more susceptible than 
HT neurons at low charges to the stimulation-induced attenuation of dorsal horn neuronal 
firing (Guan et al., 2010; Yakhnitsa et al., 1999). 
Despite the increase in responsive HT neurons observed at higher charges, a 
subset of neurons (15-40% of both WDR and HT neurons) never respond to burst SCS 
regardless of increasing burst parameters (Figs. 6.5 and 6.7c). Computational models of 
fiber recruitment during dorsal column stimulation suggest that SCS activates fibers that 
are located only near the surface of the dorsal columns (Holsheimer et al., 2002). It is 
possible that the unresponsive dorsal horn neurons may be those that are inhibited only 
by activity in deeper dorsal column fibers that are not recruited by burst SCS in this 
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study. However, additional computational models of dorsal column fiber activation 
during SCS suggest that multi-contact arrays can offer greater control of stimulation field 
breadth and depth and may activate deeper dorsal column fibers more efficiently to 
reduce firing in non-responsive dorsal horn neuronal populations (Manola et al., 2007; 
Sankarasubramanian et al., 2011). 
Among the individual parameters investigated here, pulse number, pulse width, 
and amplitude each have substantial influence on the effectiveness of burst SCS, 
correlating to reductions in neuronal firing and/or increases in the percentage of 
responsive neurons (Figs. 6.5 and 6.6). Pulse number, pulse width, and amplitude are also 
the only parameters that are directly proportional to charge per burst and have the greatest 
range of charges tested across stimulation trials (Fig. 6.7a). These results further support 
that modulation of charge per burst is the underlying factor that regulates the 
effectiveness of burst SCS. Increases in pulse frequency result in a greater percentage of 
neurons responding to burst SCS, especially at the highest pulse frequency (500Hz) (Fig. 
6.6b). Afferent fibers are activated in a frequency-specific fashion by sine-wave 
stimulation, with the large diameter Aβ fibers found in the dorsal columns progressively 
activated as stimulation frequencies increase from 5 to 250 to 2000Hz (De Ridder et al., 
2013; Koga et al., 2005; Tang et al., 2014). Studies of frequency-dependent neuronal 
activation have not been performed with the square-wave stimulation used in SCS. 
Nonetheless, increases in burst SCS pulse frequency may selectively activate more Aβ 
fibers in the dorsal columns and inhibit greater numbers of WDR and HT neurons in the 
dorsal horn without changing charge per burst. Yet, higher pulse frequencies do not 
directly result in a corresponding decrease in neuronal firing. Therefore, increased 
 158 
stimulation frequency may also require accompanying changes in other parameters that 
do increase charge per burst in order to enhance suppression of neuronal firing.  
This study investigates the parameters that collectively define the shape and 
intensity of burst stimulation, but other elements of SCS can be modified to adjust charge 
delivery. For example, monopolar electrodes deliver higher charge densities than bipolar 
and tripolar stimulation, suggesting that electrode configuration plays an important role in 
determining charge densities at the surface of the spinal cord (Wesselink and Boom, 
1998). Electrodes with small surface areas also yield higher charge densities by 
concentrating current delivery on a smaller contact area (Wesselink and Boom, 1998). It 
is also important to note that, as with any animal model, additional studies are needed to 
fully evaluate the optimization and relative effectiveness of burst SCS in the human. 
Although animal models enable focused evaluation of specific mechanisms, the findings 
do not always translate to the human, owing in part to the differences in the delivery of 
SCS in preclinical and clinical studies. This study used a monopolar ball-shaped 
electrode, which despite common use in preclinical studies (Tang et al., 2014; Yakhnitsa 
et al., 1999), may deliver current differently from the directed stimulation applied by 
insulated bipolar electrode arrays that are used clinically. Therefore, further studies are 
needed to characterize burst SCS using more clinically relevant stimulation, including 
larger multi-electrode arrangements with cathode and anode configurations that can steer 
current to optimize therapeutic outcomes in patients (Manola et al., 2007). 
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6.6. Conclusions and Integration 
The high variability in published outcomes after SCS treatment suggests that 
understanding of SCS parameters and optimization of stimulation are needed to 
effectively manage pain (Cameron, 2004; De Vos et al., 2013; Tang et al., 2014; Zhang et 
al., 2014). The studies in this chapter show that burst SCS is effective for reducing 
neuronal responses to noxious stimulation in the dorsal horn after painful nerve root 
compression (Figs. 6.4-6.6) (Crosby et al., 2014b). However, the attenuation of neuronal 
firing is highly dependent on the parameters of the burst stimulation. Charge per burst is 
significantly correlated to the effectiveness of burst SCS (Fig. 6.7), indicating that 
changing the parameters to increase the amount of charge delivered to the spinal cord 
may, in turn, increase pain relief in patients. This study indicates that patient-specific 
optimization of burst SCS by modulating its stimulation parameters may provide a 
greater range of therapeutic approaches for spinal cord stimulation. In studies evaluating 
the administration of tonic SCS for chronic pain, subjects unanimously preferred patient-
controlled stimulation in which amplitude, frequency, and electrode programming could 
be modified to individually maximize pain relief (Alo et al., 1998; Alo et al., 1999). The 
results of the current study suggest that, as burst SCS becomes more widely used, similar 
efforts should be made to maximize analgesia by optimizing, or giving patients more 
control over, the burst parameters that directly modulate the effectiveness of stimulation. 
This work characterizes the sensitivity of burst SCS to changes in the stimulation 
parameters (Crosby et al., 2014b), providing context for further studies of burst SCS for 
the treatment of persistent pain. Studies presented in Chapter 7 directly compare burst 
and tonic stimulation for the attenuation of dorsal horn hyperexcitability; those studies 
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also evaluate the role of GABAergic signaling in the mechanism of burst SCS. Previous 
preclinical and clinical studies of burst SCS efficacy used stimulation with bursts of 5 
pulses at 500Hz with a 1000µs pulse width, a burst frequency of 40Hz, and amplitude of 
90% MT (De Ridder et al., 2010; De Ridder et al., 2013; Tang et al., 2014). Although this 
work demonstrates that increasing the pulse number to 7 pulses per burst could further 
attenuate dorsal horn firing and reduce pain symptoms (Crosby et al., 2014b), additional 
studies of burst SCS in Chapter 7 use this parameter set with 5 pulses per burst to better 
compare findings in that study with previously published findings. 
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CHAPTER 7  
 
Evaluating Burst and Tonic Spinal Cord 
Stimulation for Attenuating Spinal 
Hyperexcitability 
   
 
Parts of this chapter were adapted from: 
Crosby ND, Weisshaar CL, Goodman-Keiser MD, Smith JR, Zeeman ME, Winkelstein 
BA. Burst & tonic spinal cord stimulation differentially activate GABAergic mechanisms 
to attenuate pain in a rat model of cervical radiculopathy. Submitted. 
 
7.1. Overview 
Spinal cord stimulation (SCS) is a neurostimulation therapy for chronic pain 
conditions that are refractory to conventional pharmacological therapies (Guan, 2012). 
Traditional tonic SCS directly modulates spinal neuronal activity by applying continuous 
pulses of electrical stimulation to the spinal dorsal columns (Compton et al., 2012). 
Animal models of persistent pain have offered significant insight into the mechanisms 
underlying tonic SCS (Linderoth and Foreman, 2006). For example, in a rat model of 
peripheral nerve injury, tonic SCS has been shown to attenuate the excitability of dorsal 
horn neurons by stimulating spinal release of the inhibitory neurotransmitter, γ-
aminobutyric acid (GABA) (Linderoth et al., 1994; Stiller et al., 1996). Those findings 
led to the use of GABA agonists to enhance SCS-induced analgesia in human patients 
(Lind et al., 2004). However, the success rate of tonic SCS varies widely in clinical 
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studies (Alo et al., 2002; Buyten et al., 2001; Cameron, 2004; Ohnmeiss et al., 1996), so 
novel modes of SCS have been developed to improve pain relief. Burst SCS, a novel 
mode of stimulation that applies periodic bursts of pulses rather than continuous pulses, 
has been shown to offer greater reduction of pain than tonic SCS (De Ridder et al., 2010; 
De Ridder et al., 2013; De Vos et al., 2014). However, the mechanisms underlying the 
analgesic effects of burst SCS and its reported increase in effectiveness over tonic SCS 
are poorly understood. 
The studies in this chapter address the objectives outlined in Aims 3b and 3c to 
evaluate the effectiveness of burst SCS and tonic SCS for attenuating spinal 
hyperexcitability in two established rat models of persistent pain from cervical spine 
trauma – nerve root compression and facet joint distraction. Because burst SCS reduces 
pain in patients more effectively than tonic SCS (De Ridder et al., 2010), it was 
hypothesized that burst SCS would be more effective than tonic SCS for attenuating 
spinal hyperexcitability. Since tonic SCS acts via GABAergic mechanisms in the dorsal 
horn to inhibit nociception (Cui et al., 1996; Linderoth et al., 1994), studies here evaluate 
the role of GABA signaling in the effects of burst SCS after nerve root compression to 
test the hypothesis that burst SCS also inhibits dorsal horn activity through GABA 
signaling. In Chapter 6, the effectiveness of burst SCS was found to depend on the 
parameters of the burst stimulation program. Studies in this chapter use the burst 
parameters from Chapter 6 that were determined to optimally attenuate dorsal horn 
neuronal firing, and that also match the parameters used in previous clinical and 
preclinical studies of burst SCS (De Ridder et al., 2010; Tang et al., 2014). Burst and 
tonic SCS were applied separately to the dorsal columns on day 7 after painful nerve root 
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compression to compare the effects of each mode of SCS on dorsal horn neuronal 
excitability. To determine whether GABA signaling is a necessary component of burst 
SCS-induced dorsal horn inhibition, GABAA or GABAB receptor antagonists were 
applied to the spinal cord during the administration of burst and tonic SCS on day 7 after 
painful nerve root compression. In separate rats, burst and tonic SCS were applied on day 
7 after painful facet joint injury to compare burst and tonic SCS for the modulation of the 
spinal hyperexcitability that develops after mechanical joint injury. 
 
7.2. Background 
Spinal cord stimulation has been in use for decades to manage chronic, intractable 
pain from a wide range of indications (Cameron, 2004), including neuropathic pain from 
injury of neural tissues. In particular, SCS is commonly used to manage chronic pain in 
the cervical and lumbar spines by delivering pulses of varying frequencies and intensities 
to the dorsal columns of the spinal cord (Alo et al., 2002; Compton et al., 2012; 
Stojanovic and Abdi, 2002). Despite many positive reports of SCS being effective for 
treating chronic pain, the reported success rate of SCS in clinical studies has improved 
little (Cameron, 2004; Zhang et al., 2014). Better understanding the neurophysiology of 
chronic pain and defining the mechanisms that underlie SCS-induced analgesia may help 
to more effectively design and administer SCS therapies. 
Conventional tonic SCS administers continuous pulses of stimulation to the dorsal 
columns from electrodes implanted on the dorsal surface of the spinal cord (Cameron, 
2004). Tonic SCS often induces paresthesias, which are aberrant cutaneous tingling or 
prickling sensations that develop in the anatomical regions where the stimulation is 
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applied (De Ridder et al., 2010; De Vos et al., 2014). In an effort to improve pain relief 
and to reduce such side-effects as paresthesia, novel modes of stimulation have been 
developed. Burst SCS is one such mode of SCS that uses periodic bursts of stimulation 
for pain management rather than the continuous pulses that are used in tonic SCS (De 
Ridder et al., 2010). Burst SCS reduces back pain and general pain more effectively and 
induces less paresthesia than tonic SCS (De Ridder et al., 2013). Furthermore, up to 60% 
of patients with diabetic neuropathy or failed back surgery syndrome experience greater 
pain reduction after switching from tonic SCS to burst SCS (De Vos et al., 2014). 
However, the mechanisms underlying the analgesic effects of burst SCS and its potential 
increase in effectiveness relative to tonic SCS are still unidentified. 
Many neurophysiological and neurochemical mechanisms have been proposed as 
responsible for the analgesic effects of SCS, including modulation of GABA signaling in 
the dorsal horn. GABA is the primary inhibitory neurotransmitter in the spinal cord, and 
acts through GABAA (ligand-gated) and GABAB (G-protein-coupled) receptors to inhibit 
neuronal activity (Malcangio and Bowery, 1996; Yaksh, 2006). Allodynia after nerve 
injury is often accompanied by decreased GABA levels in the dorsal horn (Drew et al., 
2004; Stiller et al., 1996), suggesting a disinhibition of neuronal firing. Tonic SCS has 
been shown to stimulate GABA release in the dorsal horn that inhibits neuronal firing and 
attenuates the release of excitatory neurotransmitters like glutamate (Cui et al., 1997; 
Linderoth et al., 1994).  
GABAA or GABAB receptor antagonists are commonly used to determine the 
separate roles of GABA signaling through each receptor subtype. Bicuculline is a 
competitive antagonist of GABAA receptors that prevents receptor activation by GABA 
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or a GABA agonist (Curtis et al., 1970). Bicuculline blocks the rapid synaptic inhibition 
that is typically mediated by GABAA receptors, resulting in the disinhibition of spinal 
motor reflexes (Sivilotti and Woolf, 1994). Similarly, CGP35348 has been used to 
selectively block GABAB receptor activation (Olpe et al., 1990). Although CGP35348 
does not induce rapid spinal disinhibition like bicuculline (Sivilotti and Woolf, 1994), 
blocking GABAB receptors can modulate the analgesic effects of tonic SCS (Cui et al., 
1997). Based on those findings, GABAB agonists like baclofen have been used clinically 
to enhance the effects of SCS, especially in patients that do not experience sufficient pain 
relief from SCS alone (Lind et al., 2004; Lind et al., 2008). Despite GABA signaling 
being implicated in the inhibition of nociception by SCS, studies have been performed 
only with tonic SCS, and the role of GABA signaling in the analgesic effects of burst 
SCS is unknown. 
Cervical radiculopathy and cervical brachialgia are neuropathic pain conditions 
that cause neck, shoulder, and arm pain from spinal nerve and/or nerve root compression, 
and are commonly treated with tonic SCS (Alo et al., 2002; De Ridder et al., 2010; Rizvi 
and Kumar, 2013). However, no study has directly investigated the relative effectiveness 
of burst and tonic SCS in modulating spinal neuronal hyperexcitability and dorsal horn 
inhibition in the context of radicular pain. Furthermore, despite the prevalence of 
persistent facet-mediated pain, few patients with that indication receive spinal cord 
stimulation therapies (Kirvela and Kotilainen, 1999; Van Buyten et al., 2001), and no 
study has evaluated burst SCS for the treatment of persistent facet joint-mediated pain. 
As such, the studies in this chapter directly compare burst and tonic SCS for the 
attenuation of dorsal horn neuronal activity in rat models of painful nerve root 
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compression and painful facet joint injury, both of which induce sustained hyperalgesia 
and spinal neuronal hyperexcitability (Lee and Winkelstein, 2009; Nicholson et al., 
2014a; Quinn et al., 2010b; Smith et al., 2013).  
In the first study (detailed in Section 7.3), rats underwent a painful nerve root 
compression and hyperalgesia was assessed through day 7. To evaluate the effects of 
burst and tonic SCS on spinal hyperexcitability on day 7, dorsal horn neuronal firing was 
evaluated before and at several times up to 15 minutes after administering each mode of 
SCS. Since SCS has been shown to attenuate hyperexcitability in wide dynamic range 
(WDR) neurons in the dorsal horn (Crosby et al., 2014b; Yakhnitsa et al., 1999), the 
effects of burst and tonic SCS were specifically evaluated in WDR neurons. In separate 
groups of rats, the role of GABA signaling in burst and tonic SCS was compared 
administering bicuculline or CGP35348 to the spinal cord prior to the application of SCS 
and recording of spinal neuronal activity. In a second study (detailed in Section 7.4), rats 
underwent painful facet joint injury and hyperalgesia was assessed through day 7. Both 
burst and tonic SCS were applied at day 7 after painful facet joint injury, as in the first 
study that evaluated both modes after painful nerve root compression. Dorsal horn 
neuronal firing was quantified before and at times up to 15 minutes after administering 
each mode of SCS to compare the effects of each on dorsal horn activity after a painful 
joint injury. 
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7.3. Burst and Tonic SCS after Painful Nerve Root Compression: The 
Role of GABA Signaling 
7.3.1. Methods 
Male Holzman rats (368-470g) were housed under USDA- and AAALAC-
compliant conditions with free access to food and water. All experimental procedures 
were approved by the University of Pennsylvania Institutional Animal Care and Use 
Committee and carried out under the guidelines of the Committee for Research and 
Ethical Issues of the International Association for the Study of Pain (Zimmerman, 1983).  
 
Painful Cervical Nerve Root Compression  
Compression of the right C7 dorsal nerve root was performed using procedures 
described in detail in Section 6.3.1 of Chapter 6, and have been previously reported 
(Hubbard et al., 2005; Rothman et al., 2007; Rothman et al., 2010). Briefly, rats (n=17) 
were anesthetized with inhaled isoflurane (4% for induction, 2-3% for maintenance). 
With the rat in a prone position, a midline incision was made along the back of the neck 
from the base of the skull to the T2 vertebra. After exposing the C6 and C7 vertebrae, a 
C6/C7 hemilaminectomy and partial facetectomy on the right side exposed the C7 dorsal 
nerve root between the dorsal root ganglion and the spinal cord. The nerve root was 
compressed for 15 minutes with a 10gf microvascular clip (World Precision Instruments; 
Sarasota, FL) inserted through a small incision in the dura (Fig. 7.1). Incisions were 
closed using 3-0 polyester suture and surgical staples, and rats were monitored during 
recovery.  
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Assessment of Mechanical Hyperalgesia 
Mechanical hyperalgesia was evaluated in the ipsilateral and contralateral 
forepaws of each rat prior to surgery (baseline) and at days 1, 3, 5, and 7 after nerve root 
compression. Detailed methods for behavioral testing after nerve root compression can be 
found in Section 6.3.2 of Chapter 6. Hyperalgesia was measured by applying a series of 
weighted von Frey filaments (1.4, 2, 4, 6, 8, 10, 15, and 26g) to the plantar surface of 
each forepaw to identify the paw withdrawal threshold (PWT) (Chang and Winkelstein, 
2011; Hubbard and Winkelstein, 2005). The average threshold from three rounds of 
 
 
Fig. 7.1. Schematic of a C7 nerve root compression and application of SCS. Painful 
nerve root (NR) compression was applied to the right C7 dorsal nerve root proximal to 
the dorsal root ganglion (DRG) with a microvascular clip. On day 7 after NR 
compression, monopolar burst and tonic SCS waveforms (inset) were applied to the 
dorsal columns of the C4 spinal cord using a monopolar ball electrode. Evoked 
neuronal firing was recorded in the C7 dorsal horn ipsilateral to the site of NR 
compression during mechanical stimulation of the forepaw. 
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testing was calculated separately for the ipsilateral and contralateral forepaws of each rat. 
A repeated-measures ANOVA compared PWTs to baseline and between the ipsilateral 
and contralateral forepaws at each time point. 
 
Electrophysiological Recordings and Spinal Cord Stimulation 
Extracellular electrophysiological recordings were acquired in the dorsal horn on 
day 7 after painful nerve root compression (n=8 rats) to assess neuronal firing before and 
after burst and tonic SCS. Rats were anesthetized with sodium pentobarbital (50mg/kg, 
i.p.) and given supplemental doses (5-10mg/kg, i.p.) as needed based on toe pinch 
reflexes. With the rat in a prone position, an incision was made along the back of the 
neck from the base of the skull to the T2 vertebra. A bilateral laminectomy and dural 
resection were performed to expose the spinal cord from C3 to C7. A tracheotomy was 
performed and rats were connected to a ventilator and CO2 monitor to control respiration 
throughout the recording session (CWE; Ardmore, PA). A lateral thoracotomy was also 
performed to alleviate intrathoracic pressure and to isolate the spinal cord from any 
movement of the rat during ventilation. Rats were immobilized on a stereotaxic frame 
(David Kopf Instruments; Tujunga, CA) using ear bars and a vertebral clamp at T2 to 
stabilize the cervical spine. The spinal cord was bathed in 37C mineral oil for the 
duration of recording, and core temperature was maintained at 35-37C using a 
temperature controller with a rectal probe (Physitemp; Clifton, NJ). 
A monopolar platinum ball electrode was placed over the C4 dorsal columns (Fig. 
7.1), and a grounding electrode was attached to the incised skin on the neck. Constant 
current stimulation was applied using a Grass stimulator with a photoelectric stimulus 
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isolation unit (S48 Stimulator; Grass Technologies; Warwick, RI). The motor thresholds 
for burst and tonic SCS were separately identified in each rat to be the stimulation 
intensities at which small contractions were first observed in the paraspinal musculature 
or forelimbs. Burst SCS was applied using parameters that were determined in Chapter 6 
to optimally attenuate spinal hyperexcitability: 40Hz burst frequency, 90% of the motor 
threshold (MT), and each burst contained 5 pulses per burst, 500Hz pulse frequency, 1ms 
pulse width, and 90% MT amplitude (Crosby et al., 2014b). Tonic SCS delivered pulses 
at 40Hz with a pulse width of 0.3ms and amplitude of 90% MT (Tang et al., 2014).  
A carbon fiber electrode (Carbostar-1, Kation Scientific; Minneapolis, MN) was 
lowered into the C7 spinal dorsal horn ipsilateral to the compressed nerve root using a 
micropositioner (Fig. 7.1) (Narishige; Tokyo, Japan). Extracellular potentials were 
amplified with a gain of 10
3
 and conditioned using a bandpass filter between 0.3kHz and 
3kHz (World Precision Instruments; Sarasota, FL). The signal was processed with a 60Hz 
HumBug adaptive filter (Quest Scientific; North Vancouver, BC), digitally sampled at 
25kHz (Micro1401, CED; Cambridge, UK). Voltage potentials were monitored with a 
speaker for audio feedback (A-M Systems; Carlsborg, WA) and recorded using Spike2 
software (CED; Cambridge, UK). 
As the electrode was lowered into the spinal cord, light brushing and noxious 
pinch of the ipsilateral forepaw were used to identify mechanically-sensitive wide 
dynamic range (WDR) neurons and their receptive fields on the paw. Once a neuron was 
identified, baseline evoked neuronal firing was recorded during mechanical stimulation 
of the forepaw consisting of five consecutive one-second applications of the non-noxious 
1.4g and noxious 26g von Frey filaments, and ten seconds of noxious pinch with forceps 
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(Fig. 7.2) (Hains et al., 2003a; Quinn et al., 2010b). A baseline period of two seconds was 
recorded before each stimulus to quantify spontaneous firing (Fig. 7.2). Burst SCS was 
then applied for five minutes, during which period the evoked firing could not be 
recorded because artifacts from the stimulation masked neuronal activity. After SCS, 
evoked activity was recorded during 1.4g von Frey, 26g von Frey, and pinch stimulation 
immediately (0 minutes) and recording was repeated again at 2, 5, 10, and 15 minutes 
post-SCS (Fig. 7.2). The stimulation protocol was then repeated in the same neuron using 
tonic SCS. The protocol was reversed to apply tonic SCS before burst SCS in alternating 
neurons in order to avoid any effects of the order of burst and tonic SCS application. 
 
 
 
 
Fig. 7.2. Stimulation protocol for recording evoked neuronal activity after burst or 
tonic SCS. (a) Evoked activity is recorded before SCS during (Pre-SCS Baseline) 1.4g 
von Frey (vF) filament, 26g vF, and noxious pinch stimulation. Baseline (BL) 
spontaneous firing is subtracted to isolate the evoked response. (b) Burst or tonic SCS 
is applied for 5 minutes. (c) Evoked firing is then recorded during 1.4g vF, 26g vF, 
and noxious pinch stimulation at 0, 2, 5, 10, and 15 minutes after the SCS application 
(Post-SCS). 
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Spinal Superfusion of GABA Receptor Antagonists 
Separate groups of rats received spinal application of either the GABAA receptor 
antagonist, bicuculline (n=2), or the GABAB receptor antagonist, CGP35348 (n=7), for 
the duration of the SCS and dorsal horn electrophysiological recordings on day 7 after a 
painful nerve root compression. Rats were mounted on the stereotaxic frame and the burst 
and tonic motor thresholds were determined. The exposed spinal cord from C3 to C7 was 
then covered with agar (1g agar/40mL 0.9% saline), but agar was cleared from the C7 
spinal cord to form a well for superfusion of the drug solutions. Agar was also cleared 
from the C4 spinal cord to allow contact of the stimulating electrode with the spinal cord. 
Bicuculline and CGP35348 (Abcam; Cambridge, MA) were solubilized in artificial 
cerebrospinal fluid (Harvard Apparatus; Holliston, MA). The concentrations of 
bicuculline (1mM) and CGP35348 (10mM) were chosen based on previous studies 
applying them to the dorsal spinal cord with effective modulation of spinal GABA 
signaling (Brumley et al., 2007; Buesa et al., 2006; Buesa et al., 2008; Wang et al., 2013). 
Peak dorsal horn drug concentrations have been shown to occur after 15-30 minutes of 
drug superfusion (Beck et al., 1995), so bicuculline or CGP35348 was applied to the C7 
spinal cord for 20 minutes before the stimulation and recording protocols were initiated; 
drug solutions were refreshed every 20-30 minutes throughout the recording session. 
 
Electrophysiology Analysis and Statistics 
Voltage potentials from each recorded neuron were sorted and counted using 
Spike2 software (CED; Cambridge, UK). Pre- and post-SCS firing were determined by 
counting the spikes evoked separately by the 1.4g filament, 26g filament, and noxious 
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pinch in the baseline period prior to SCS, and at each time point after SCS. Spontaneous 
firing was subtracted from the spike counts for each mechanical stimulus in order to 
isolate firing evoked by the forepaw stimulus. For each of the 1.4g filament, 26g 
filament, and pinch stimuli, a repeated-measures ANOVA was used to compare the 
number of evoked spikes between the pre-SCS baseline and evoked firing at each post-
SCS time point. Changes in neuronal firing immediately (0 minutes) after SCS were 
calculated as the percent change in spikes relative to the pre-SCS baseline (Crosby et al., 
2014b). For neurons in which both burst and tonic stimulation protocols were completed 
without losing the signal from the recorded neuron, paired Student’s t-tests compared the 
percent changes in evoked firing immediately after burst SCS to the changes in firing 
after tonic SCS. 
 
7.3.2. Results 
The PWT in the ipsilateral forepaw is significantly reduced from baseline at days 
1, 3, 5, and 7 after painful nerve root compression (p<0.0001) (Fig. 7.3). PWTs in the 
ipsilateral and contralateral forepaws are not different from each other at baseline, but the 
PWT decreases in the ipsilateral forepaw relative to the contralateral side on all days after 
painful nerve root compression (p<0.0001) (Fig. 7.3). The PWT in the contralateral 
forepaw is unchanged from baseline (Fig. 7.3). Individual PWTs for each rat on each day 
after painful nerve root compression are summarized in Appendix J. 
The average motor threshold is significantly lower for burst SCS relative to tonic 
SCS (p≤0.0002) (Table 7.1). A total of 49 neurons was recorded following burst SCS and 
51 neurons were recorded after tonic SCS (Table 7.1). In 39 of those neurons, paired 
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firing data were collected after both burst and tonic SCS. Firing evoked by the 26g 
filament is significantly reduced by 32±5% from baseline immediately after burst SCS  
(p<0.0001), and significantly reduced by 26±7% from baseline after tonic SCS  
(p=0.0014) (Fig. 7.4). Likewise, firing during noxious pinch decreases by 43±4% 
immediately after burst SCS (p<0.0001), and by 37±4% after tonic SCS (p<0.0001) (Fig. 
7.4). The percent reductions in firing after burst and tonic SCS are not different from 
 
Table 7.1. Summary of rat and SCS data for groups receiving painful nerve root 
compression or NR compression with GABA receptor antagonists. 
 
NRC = nerve root compression; Bic = bicuculline; CGP = CGP35348 
BL = baseline; SD = standard deviation 
*p<0.0001, Day 7 vs. BL; 
#
p<0.0002, Tonic vs. Burst 
Paw Withdrawal Threshold 
at Day 7 (% of BL)
Motor Threshold 
(µA)
Total # of Neurons Recorded 
(# per Rat±SD)
Group Rats Weight (g) Ipsilateral Contralateral Burst Tonic Burst Tonic
NRC n=8 412±36 33±11%* 76±26% 182±60 324±68# 49 (6.1±1.5) 51 (6.4±2.3)
NR + Bic n=2 433±52 20±8% 77±24% 160±0 270±14 10 (5.0±0.0) 10 (5.0±1.4)
NRC + CGP n=7 396±18 25±10%* 105±34% 183±23 319±58# 29 (4.1±1.3) 30 (4.3±1.7)
 
 
Fig. 7.3. Mechanical hyperalgesia after painful nerve root compression. Paw 
withdrawal threshold (PWT) decreases in the ipsilateral forepaw compared to baseline 
(*p<0.0001) and compared to the contralateral forepaw (#p<0.0001) after C7 nerve 
root compression. 
 
0
5
10
15
20
25
BL D1 D3 D5 D7
P
W
T
  
S
D
 (
g
)
*# *# *# *
#
L            Day 1          Day 3           Day 5          Day 7
Contralateral
Ipsilateral
 175 
each other during either the 26g filament or noxious pinch stimulation (Fig. 7.4). 
Neuronal firing evoked by 1.4g filament stimulation of the ipsilateral forepaw is not 
changed from baseline after either mode of stimulation (Fig. 7.4). 
 
 
Fig. 7.4. Evoked dorsal horn neuronal activity after burst and tonic SCS application. 
Neuronal firing was quantified in the C7 spinal cord before (Pre-SCS Baseline) and 
immediately after (0 min. Post-SCS) burst and tonic SCS at day 7 following painful 
nerve root compression in response to forepaw stimulation. (a) No change in neuronal 
firing is observed during stimulation of the ipsilateral forepaw by a 1.4g von Frey 
filament after burst or tonic SCS. Firing is significantly reduced after burst or tonic 
SCS during (b) 26g von Frey filament (*p≤0.0014) and (c) noxious pinch stimulation 
(*p<0.0001). 
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  The suppressive effects of both burst and tonic SCS on dorsal horn neuronal firing 
evoked by noxious stimulation are sustained for up to ten minutes after the cessation of 
SCS (Fig. 7.5). The number of spikes evoked by a 26g von Frey filament stimulation of 
the ipsilateral forepaw decreases from baseline levels immediately (at 0 minutes) and at 2 
minutes after burst SCS (p≤0.0004). However, after tonic SCS the evoked firing remains 
decreased during 26g filament stimulation at those times and also at 5 minutes and 10 
minutes (p≤0.035) (Fig. 7.5). The number of spikes evoked during noxious pinch 
 
 
Fig. 7.5. Evoked spike counts for up to 15 minutes after the cessation of burst and 
tonic SCS application following painful nerve root compression. (a) Burst and tonic 
SCS do not change firing evoked by 1.4g von Frey filament stimulation of the 
ipsilateral forepaw, relative to the pre-SCS baseline (BL) firing. (b) The 26g von Frey 
filament evokes fewer spikes than at baseline for up to two minutes following the 
application of burst SCS (*p≤0.0004), and up to ten minutes after tonic SCS 
(#p≤0.035). (c) Noxious pinch evokes fewer spikes than at baseline for up to ten 
minutes after burst SCS (*p≤0.034), and up to five minutes after tonic SCS 
(#p≤0.0016). 
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stimulation decreases from baseline at all of the time points measured up to 10 minutes 
after burst SCS (p≤0.034), although pinch-evoked firing decreases from baseline only at 
0 minutes, 2 minutes, and 5 minutes after tonic SCS (p≤0.0016) (Fig. 7.5). The number of 
spikes evoked by forepaw stimulation with the non-noxious 1.4g filament is not different 
from baseline at any recorded time point after burst or tonic stimulation (Fig. 7.5). Of 
note, despite differences in the duration of the effects of burst and tonic SCS on evoked 
neuronal activity, evoked firing is not different after burst SCS compared to tonic SCS 
for any mechanical stimulus at any pre- or post-SCS time point. 
The GABAA receptor antagonist, bicuculline, does not affect the attenuation of 
neuronal firing by burst or tonic SCS (Fig. 7.6). Ten neurons were recorded from rats that 
received spinal superfusion of bicuculline; all ten neurons had paired data after burst and 
tonic SCS (Table 7.1). After superfusion of the spinal cord with bicuculline, burst SCS 
significantly reduces neuronal firing by 27±11% during application of the 26g von Frey 
filament to the ipsilateral forepaw (p=0.012) and by 25±14% during noxious pinch 
(p=0.008) (Fig. 7.6a). Likewise, in the presence of bicuculline, tonic SCS significantly 
attenuates neuronal firing by 31±14% during 26g filament stimulation (p=0.028) and by 
31±18% during noxious pinch (p=0.021) (Fig. 7.6b). The attenuation of firing by burst or 
tonic SCS with bicuculline treatment is not different from the changes in firing following 
burst or tonic SCS without that GABAA receptor antagonist present (Fig. 7.6). 
The GABAB receptor antagonist, CGP35348, differentially modulates the effects 
of burst and tonic SCS in the dorsal horn. A total of 30 neurons were recorded from rats 
that received spinal superfusion of CGP35348, and 27 of those neurons had paired data 
for both burst and tonic SCS (Table 7.1). In the presence of CGP35348, burst SCS 
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significantly attenuates dorsal horn neuronal firing by 36±4% (p<0.0001) and by 44±4% 
(p<0.0001) during 26g filament and noxious pinch stimulation of the ipsilateral forepaw, 
respectively (Fig. 7.6a). That suppression of evoked firing is not different from the 
attenuation of neuronal activity after burst SCS with no GABA receptor antagonist (Fig. 
7.6a). However, CGP35348 abolishes the effects of tonic SCS, with no change from 
baseline firing during the 26g filament stimulation (4±8% change from baseline) or the 
 
Fig. 7.6. Effects of GABA receptor antagonists on the attenuation of dorsal horn 
neuronal firing by burst or tonic SCS. (a) Burst SCS alone, burst SCS with CGP35348 
(Burst+CGP), and burst SCS with bicuculline (Burst+Bic) treatment attenuate 
neuronal firing in response to noxious ipsilateral forepaw stimulation by both the 26g 
von Frey filament and pinch (*p≤0.017). (b) Tonic SCS alone and tonic SCS with 
bicuculline (Tonic+Bic) attenuate neuronal firing evoked by both 26g and pinch 
stimulation (*p≤0.028). However, tonic SCS with CGP35348 (Tonic+CGP) does not 
induce any change in neuronal firing from baseline, and that percent change from 
baseline is significantly less than the percent change after tonic SCS alone (#p≤0.049). 
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noxious pinch (0.2±7.3%) (Fig. 7.6b). The reduction in firing after tonic SCS with 
CGP35348 is significantly less than the attenuation of firing after tonic SCS with no 
GABAB receptor antagonist for all mechanical stimuli (p≤0.049) (Fig. 7.6b). Raw spike 
counts for each dorsal horn neuron from each rat are included in Appendix E. 
 
7.4. Burst and Tonic SCS after Painful Facet Joint Injury 
7.4.1. Methods 
Painful Facet Joint Injury and Assessment of Mechanical Hyperalgesia 
Male Holtzman rats (338-450g) underwent injurious distraction of the C6/C7 
facet joints (n=8) as previously described (Crosby et al., 2013; Crosby et al., 2014a; Lee 
and Winkelstein, 2009). Detailed methods for the bilateral facet joint distraction can be 
found in Section 3.3.1 of Chapter 3. Briefly, under isoflurane anesthesia (4% for 
induction, 2-3% for maintenance), the C6 and C7 vertebrae were exposed and attached to 
a custom loading device using microforceps. The C6 vertebra was then distracted 0.7mm 
rostrally to stretch the bilateral facet capsules across the facet joints. Incisions were 
closed using 3-0 polyester suture and surgical staples, and rats were monitored during 
their recovery in room air. Hyperalgesia was assessed bilaterally in the forepaws before 
(baseline) and at days 1, 3, 5, and 7 after joint injury using methods described in detail in 
Section 7.3.1, in order to confirm the development of hyperalgesia after joint distraction. 
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Electrophysiological Recordings and Spinal Cord Stimulation 
On day 7 after painful facet joint injury, extracellular electrophysiological 
recordings were acquired using the methods described in Section 7.3.1. Briefly, rats were 
anesthetized with sodium pentobarbital (50mg/kg, i.p.) and given supplementary doses 
(5-10mg/kg, i.p.) as needed. The spinal cord was exposed from C3 to C7 and a 
monopolar platinum ball electrode was placed over the C4 dorsal columns. The motor 
thresholds were identified during the application of burst SCS and tonic SCS using a 
Grass stimulator with a photoelectric stimulus isolation unit (S48 Stimulator, Grass 
Technologies; Warwick, RI). Burst SCS parameters (5 pulses per burst, 500Hz pulse 
frequency, 1ms pulse width, 40Hz burst frequency, 90% MT amplitude) were chosen 
based on the optimization of burst stimulation for attenuating dorsal horn neuronal firing 
in Chapter 6 (Crosby et al., 2014b). Tonic SCS parameters (40Hz pulse frequency, 0.3ms 
pulse width, 90% MT amplitude) were based on previous studies evaluating tonic SCS in 
animal models of neuropathic pain (Qin et al., 2012; Tang et al., 2014).  
A carbon fiber electrode (Carbostar-1; Kation Scientific; Minneapolis, MN) was 
lowered into the C6/C7 spinal dorsal horn to record neuronal activity. Baseline evoked 
firing of dorsal horn neurons was recorded during mechanical stimulation of the forepaw 
consisting of five consecutive one-second applications of 1.4g and 26g vF filaments, and 
ten seconds of noxious pinch with forceps (Fig. 7.2). Spontaneous firing was recorded for 
two seconds before each new mechanical stimulus. Burst SCS was then applied for five 
minutes, and evoked activity was recorded during 1.4g, 26g, and pinch stimulation 
immediately (0 minutes) and again at 2, 5, 10, and 15 minutes post-SCS (Fig. 7.2). The 
stimulation protocol was repeated in the same neuron using tonic SCS. The order of 
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application of burst SCS and tonic SCS was reversed in alternating neurons to avoid any 
effects of the order of application on neuronal firing. Spontaneous firing was subtracted 
from the spike counts for each mechanical stimulus to isolate evoked firing. Changes in 
neuronal firing were calculated as the percent change in spikes immediately after SCS 
relative to the pre-SCS baseline. Paired Student’s t-tests compared the percent changes in 
neuronal firing immediately after burst SCS to the changes after tonic SCS. A repeated-
measures ANOVA was used to compare the number of evoked spikes between the pre-
SCS baseline and evoked firing at 0, 2, 5, 10, and 15 minutes after SCS.  
 
7.4.2. Results 
The paw withdrawal threshold is significantly reduced from baseline on days 1, 3, 
5, and 7 after painful facet joint injury (p<0.0001) (Fig. 7.7). PWTs for each rat on each 
day after painful facet joint injury are summarized in Appendix B. The average motor 
threshold is significantly lower for burst SCS than for tonic SCS in rats undergoing 
electrophysiological recordings on day 7 after painful facet joint injury (p<0.0001) (Table 
 
 
Fig. 7.7. Mechanical hyperalgesia after painful facet joint injury. Paw withdrawal 
threshold (PWT) significantly decreases relative to baseline (BL) after painful facet 
joint injury (*p<0.0001). 
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7.2). A total of 35 neurons was recorded after burst SCS and 38 neurons were recorded 
after tonic SCS (Table 7.2). In 31 of those neurons, paired firing data were collected after 
both burst and tonic SCS. Immediately after burst SCS, neuronal firing evoked by the 26g 
filament decreases by 24±5% (p<0.0001), and firing evoked by the noxious pinch 
decreases by 42±4% (p<0.0001) (Fig. 7.8). Tonic SCS reduces neuronal firing by 31±4% 
(p<0.0001) and 42±4% (p<0.0001) during 26g filament and pinch stimulation, 
respectively (Fig. 7.8). The reductions in firing after burst and tonic SCS are not different 
from each other during either the 26g filament stimulation or the noxious pinch (Fig. 7.8). 
Firing evoked by 1.4g stimulation is unchanged after burst and tonic SCS. 
 
 
Neuronal firing evoked by noxious stimulation is reduced for a longer time after 
tonic SCS than after burst SCS, but only burst SCS reduces firing evoked by non-noxious 
stimulation. The number of spikes evoked by the 26g filament (p≤0.037) and the noxious 
pinch (p<0.0001) decreases significantly from baseline at 0, 2, and 5 minutes after burst 
Table 7.2. Summary of rat and SCS data after a painful facet joint injury. 
 
SD = standard deviation; *p<0.0001 vs. Burst 
Motor Threshold (μA) # of Neurons Recorded
Rat # Weight (g) Burst Tonic Burst Tonic
213 438 145 290 3 3
214 422 170 280 4 5
217 338 150 270 5 5
218 378 120 200 8 8
219 370 165 290 6 7
220 376 150 250 4 4
221 360 145 255 3 4
222 450 150 260 2 2
Avg  SD 392±40 149±15 262±29*
4.4±1.9 
(35 total)
4.8±2.0
(38 total)
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SCS (Fig. 7.9). Tonic SCS reduces firing evoked by the 26g filament (p≤0.0011) and 
noxious pinch (p≤0.042) for at least 10 minutes after stimulation, a longer period of time 
than after burst SCS (Fig. 7.9). The total number of spikes evoked by the 1.4g filament 
stimulation decreases from baseline values at all times after burst SCS (p≤0.041) (Fig. 
7.9a). Tonic SCS does not induce any change in firing evoked by the 1.4g filament. 
However, the number of spikes recorded at each time after burst SCS is not different 
from the firing recorded after tonic SCS for any mechanical stimulus. Raw spike counts 
for each dorsal horn neuron from each rat are listed in Appendix E.  
 
Fig. 7.8. Representative firing and quantification of neuronal activity after burst and 
tonic SCS on day 7 following painful facet joint injury. (a) Representative firing 
evoked by noxious pinch before (Pre-SCS Baseline) and immediately after (0 min. 
Post-SCS) burst and tonic SCS. (b) No change in neuronal firing is observed during 
stimulation with the 1.4g von Frey filament after burst or tonic SCS. Firing is 
significantly reduced after burst and tonic SCS during (c) 26g von Frey filament 
(*p<0.0001) and (d) noxious pinch stimulation (*p<0.0001).   
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7.5. Discussion 
Burst SCS reduces neuronal firing during noxious mechanical stimulation of the 
forepaw seven days after painful compression of the C7 dorsal nerve root (Figs. 7.3-7.6) 
and seven days after painful C6/C7 facet joint injury (Figs. 7.7-7.9). However, the 
attenuation of neuronal firing in the dorsal horn after burst SCS is not different from the 
decreases in firing that occur after tonic SCS for either injury model (Figs. 7.4 and 7.8). 
Tonic SCS is believed to activate GABA signaling in the dorsal horn as a primary 
mechanism of action (Linderoth et al., 1994; Cui et al., 1996), which is supported by the 
 
 
Fig. 7.9. Evoked spike counts for up to 15 minutes after the cessation of burst and 
tonic SCS application following painful facet joint injury. (a) Burst SCS reduces the 
number of spikes evoked by 1.4g stimulation (*p≤0.041). (b) Stimulation with the 26g 
von Frey filament evokes fewer spikes after application of burst SCS (*p≤0.037) or 
tonic SCS (#p≤0.0011). (c) Pinch stimulation evokes fewer spikes after application of 
burst SCS (*p<0.0001) or tonic SCS (#p≤0.042). 
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ineffectiveness of tonic SCS in the presence of the GABAB receptor antagonist (Fig. 
7.6b). However, the effects of burst SCS are not abolished by either of the GABAA or 
GABAB receptor antagonists (Fig. 7.6a). Collectively these results suggest that, despite 
similar attenuation of spinal hyperexcitability by burst and tonic SCS, GABA signaling 
does not contribute to burst SCS-induced analgesia after painful nerve root compression. 
Burst SCS reduces neuronal hyperexcitability seven days after painful cervical 
nerve root compression or painful facet joint injury. Each of those injuries in the cervical 
spine induces increased evoked dorsal horn neuronal firing during noxious stimulation of 
the forepaw by between two and three times the neuronal activity normally observed in 
controls (Crosby et al., 2014a; Dong et al., 2013a; Nicholson et al., 2014a; Quinn et al., 
2010b). But, each of burst and tonic SCS significantly reduces that hyperexcitability in 
dorsal horn WDR neurons (Figs. 7.4 and 7.8). This attenuation of neuronal 
hyperexcitability has also been reported for pharmacological interventions that attenuate 
behavioral hypersensitivity after nerve root compression and joint injury in the rat 
(Crosby et al., 2014a; Dong et al., 2013a; Nicholson et al., 2014a; Nicholson et al., 
2014b; Smith et al., 2013). Tonic SCS has been reported to reduce allodynia after 
peripheral nerve injury by normalizing the responses of hyperexcitable WDR neurons to 
mechanical stimulation (Yakhnitsa et al., 1999). The relationship between dorsal horn 
neuronal activity and behavioral hypersensitivity during tonic SCS suggests that the 
attenuation of WDR neuronal activity in the dorsal horn likely contributes to the 
analgesic effects of burst SCS as well (Figs. 7.4-7.5 and 7.8-7.9). However, dorsal horn 
neuronal firing was quantified in this study immediately after the cessation of SCS 
because artifacts from the electrical stimulation prevented the recording of voltage 
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potentials during SCS. Pairing electrophysiological recordings of dorsal horn neuronal 
activity with studies that actively assess pain-related behaviors during stimulation would 
more directly relate changes in spinal neuronal activity to burst SCS-induced analgesia. 
After painful facet joint injury, dorsal horn neuronal firing evoked by 1.4g 
filament stimulation decreases from baseline levels at all times through 15 minutes after 
burst SCS, but firing is unchanged from baseline levels after tonic SCS (Fig. 7.9). The 
attenuation of firing in response to innocuous stimulation may reflect the inhibition of 
WDR neuronal activity, because WDR neurons receive low-threshold input in addition to 
their role in nociceptive processing (Steeds, 2009). However, when considered as a 
percent change from baseline, no differences in 1.4g filament-evoked firing are observed 
after either burst or tonic SCS (Fig. 7.8). Furthermore, firing in response to 1.4g filament 
stimulation is not consistently elevated over control firing levels after painful facet joint 
injury (Crosby et al., 2014a; Nicholson et al., 2014b; Quinn et al., 2010b), so any 
decrease in 1.4g filament-evoked spikes after burst SCS likely does not contribute to 
SCS-induced analgesia. 
The burst SCS-induced reduction of evoked neuronal activity by up to 43% after 
painful nerve root compression and up to 42% after painful facet joint injury is similar to 
the only other study that has applied burst SCS in an animal model of pain, in which burst 
SCS reduced lumbar dorsal horn neuronal firing by 41.5% in response to noxious 
cutaneous pinch (Tang et al., 2014). SCS has been proposed to inhibit activity in the 
spinal cord by activating Aβ fibers in the dorsal columns that synapse with inhibitory 
interneurons in the dorsal horn (Dubuisson, 1989; Guan, 2012). Aβ fiber stimulation can 
directly activate inhibitory interneurons in the superficial laminae of the dorsal horn and 
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reduce activity in the nociceptive neurons in that dorsal horn region (Daniele and 
MacDermott, 2009). These findings support that SCS may act, at least in part, by the gate 
theory of pain, which proposes that low-threshold stimulation induces dorsal horn 
inhibition to attenuate nociception (Melzack and Wall, 1965; Mendell, 2014). Persistent 
pain states can differ greatly in their pathophysiology and peripheral and spinal 
mechanisms, potentially altering the spinal mechanisms that induce dorsal horn 
inhibition. For example, nerve root compression causes axonal degeneration and 
neuroinflammation in the injured nerve root itself (Chang and Winkelstein, 2011; 
Hubbard and Winkelstein, 2008), whereas mechanical facet joint injury induces extensive 
synaptic and structural changes in the dorsal horn that enhance spinal neuronal 
excitability (Chapters 3-5) (Crosby et al., 2014a; Crosby et al., 2014c; Dong et al., 2012; 
Weisshaar et al., 2010). However, regardless of the etiology of pain, nociceptive signals 
from the periphery are transmitted by Aδ and C fiber nociceptors that synapse with 
second-order WDR and nociceptive-specific (NS) neurons in the dorsal horn (Basbaum et 
al., 2009). The comparable reduction of spinal neuronal activity by burst SCS in animal 
models of nociceptive pain (Tang et al., 2014), neuropathic pain (Fig. 7.4), and joint pain 
(Fig. 7.8) suggests that, at the cellular level, burst stimulation attenuates nociception in 
the dorsal horn to a similar extent regardless of the inciting event and the specific altered 
peripheral or central nervous system functions that may contribute to pain. 
Burst SCS may therefore provide an effective therapy for patients with chronic 
pain conditions that are currently infrequently treated with SCS, including persistent facet 
joint-mediated pain. However, studies are needed to assess the cost-effectiveness of SCS 
for the treatment of less commonly indicated pain conditions that may benefit from 
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increased use of SCS. For example, evaluations of the cost-effectiveness of SCS for the 
treatment of failed back surgery syndrome, the most common indication for SCS, show 
that SCS becomes more cost-effective than conventional pain therapies within 2-3 years 
after implantation of a stimulator (Bell et al., 1997; Kumar et al., 2002). Similar cost-
benefit analyses for other chronic pain conditions would ultimately determine whether 
burst SCS offers utility for their treatment, relative to conventional therapeutic 
approaches. 
Burst and tonic SCS differ in the relative duration of their effects on the neuronal 
firing evoked by noxious stimulation after painful nerve root compression. For example, 
burst SCS reduces pinch-evoked spikes compared to baseline levels for up to ten minutes 
after the cessation of SCS, but tonic SCS reduces firing for only up to five minutes (Fig. 
7.5). During 26g filament stimulation, the opposite is observed, with burst SCS reducing 
the number of evoked spikes for up to two minutes and tonic SCS reducing the number of 
evoked spikes for a longer period, up to ten minutes after the SCS ends (Fig. 7.5). Similar 
differences between burst and tonic SCS are observed after painful facet joint injury (Fig. 
7.9). However, despite these apparent differences in the duration of the effects of each 
mode of SCS after nerve root compression or facet joint injury, the evoked spike counts 
are not different between burst and tonic SCS for any noxious or non-noxious stimulus at 
any of the post-SCS times (Figs. 7.5 and 7.9). Neuronal activity was only quantified for 
up to 15 minutes after the end of SCS; but, since firing returned to baseline levels by 15 
minutes (Figs. 7.5 and 7.9) no differences between burst and tonic SCS would be 
expected at any later time point. These results suggest that, overall, neither mode of SCS 
is more or less effective at attenuating spinal neuronal hyperexcitability. 
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Burst SCS was hypothesized to reduce neuronal firing more effectively than tonic 
SCS, because burst SCS reduces VAS pain scores significantly more than does tonic SCS 
in patients with chronic neuropathic pain (De Ridder et al., 2010; De Ridder et al., 2013; 
De Vos et al., 2014). However, no differences were observed between burst and tonic 
SCS for attenuating spinal neuronal excitability after nerve root or facet joint injury (Figs. 
7.4-7.5 and 7.8-7.9). This study used a single electrode for monopolar stimulation, 
whereas patients often receive bipolar stimulation from large arrays of implanted 
electrodes (Alo et al., 1998; Manola et al., 2007). Monopolar and multipolar stimulation 
can differ significantly in their delivery of electrical current; for example, monopolar 
electrodes deliver higher charge densities than bipolar and tripolar stimulation (Wesselink 
and Boom, 1998). The unexpected similarity between the two modes of SCS in this study 
may, therefore, be due to the use of monopolar stimulation instead of more clinically 
relevant electrode configurations. Furthermore, using the same monopolar stimulation as 
this study, Tang et al. (2014) reported no significant differences in the effects of burst and 
tonic SCS on lumbar dorsal horn neuronal firing in response to noxious pinch. However, 
that study found visceromotor reflexes to be more attenuated after burst SCS than after 
tonic SCS (Tang et al., 2014). That finding suggests that additional metrics other than 
evoked dorsal horn neuronal firing may be more sensitive to differences in burst and 
tonic stimulation, as was detected by their dissimilar activation of GABA signaling in the 
dorsal horn (Fig. 7.6) and reduction of chronic neuropathic pain in patients (De Ridder et 
al., 2010; De Ridder et al., 2013). 
The electrophysiological metrics used in the current study describe the neuronal 
effects of burst and tonic SCS in hyperalgesic rats; however, patient-reported pain scores 
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incorporate additional factors that were not explicitly studied here, including spontaneous 
pain, emotional perceptions of pain, and the presence or absence of paresthesia during 
SCS (De Vos et al., 2014; Fernandez and Turk, 1992; Price, 2000). Paresthesia may play 
a particularly important role in determining pain outcomes during SCS because of the 
widely varying positive and negative experiences patients associate with paresthetic 
sensation (De Vos et al., 2014). For example, many patients favor paresthesia-free modes 
of stimulation, but some patients that switch from tonic to burst SCS report a preference 
for paresthesia as desirable feedback for adjusting stimulation parameters or as a 
distraction from underlying pain (De Vos et al., 2014). In studies of SCS using animal 
models of pain, additional behavioral assessments that incorporate measures of 
paresthesia, spontaneous pain, and the affective dimensions of pain may better evaluate 
those effects of burst SCS that are more clinically relevant and capture all aspects of pain. 
  Tonic SCS has been reported to attenuate nociception in the dorsal horn by 
stimulating the release of GABA (Cui et al., 1996). Aβ fiber stimulation can activate 
GABAergic interneurons in the superficial dorsal horn (Daniele and MacDermott, 2009), 
producing GABA release and facilitating the spinal inhibition of nociceptive signals 
(Dubuisson, 1989; Stiller et al., 1996). However, the attenuation of dorsal horn neuronal 
firing after tonic SCS with spinal superfusion of the GABAA antagonist, bicuculline, is 
not different from the effects of SCS alone on day 7 after painful nerve root compression 
(Fig. 7.6). These findings are consistent with a previous study that found the effects of 
SCS to be independent of signaling through GABAA receptors after nerve injury (Cui et 
al., 1996). Although some GABAA receptors can be found in the dorsal horn, they are 
more abundant in the ventral horn in association with motoneurons, and the analgesic 
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effects of GABAA receptor agonists like muscimol are attributed to supraspinal 
mechanisms, not inhibition of firing in the dorsal horn (Malcangio and Bowery, 1996). 
As such, bicuculline was administered during SCS in only two rats, but blocking GABAA 
receptors did not modulate the effectiveness of either burst or tonic SCS (Fig. 7.6), so 
further experiments with superfusion of bicuculline were not pursued. 
  In contrast to the role of GABAA receptors, tonic SCS activates GABAB receptors 
to inhibit nociception in the dorsal horn (Cui et al., 1996; Cui et al., 1997). The GABAB 
receptor antagonist, CGP35348, abolishes the effects of tonic SCS (Fig. 7.6b), further 
supporting the role of GABAB receptor activation in tonic SCS-induced spinal inhibition. 
However, neuronal firing is significantly reduced from baseline after burst SCS despite 
the spinal superfusion of CGP35348 (Fig. 7.6a), indicating that GABAB receptor 
activation is not required for burst SCS-induced inhibition in the dorsal horn. Burst SCS 
has a significantly lower motor threshold than tonic SCS (Tang et al., 2014) which was 
also determined in our study (Tables 7.1 and 7.2), and burst SCS requires a lower 
amplitude than tonic SCS to relieve pain in patients (De Ridder et al., 2010). It is possible 
that the burst SCS amplitudes that attenuate dorsal horn neuronal firing are too low to 
activate the release of GABA in the spinal dorsal horn, and instead activate other non-
GABAergic mechanisms to inhibit nociception in the spinal cord. 
Spinal superfusion of drug solutions can lead to steep drug concentration 
gradients in the dorsal horn, which can be greatly affected by metabolism or uptake of the 
drug (Beck et al., 1995). Because CGP35348 reduces the effectiveness of tonic SCS on 
dorsal horn WDR neuronal firing (Fig. 7.6b) the effective concentration in the deep 
dorsal horn was taken as sufficient to inhibit GABA signaling. However, other drug 
 192 
delivery methods, like intrathecal injection or dorsal horn microdialysis (Cui et al., 1996; 
Cui et al., 1997), may produce more uniform drug concentrations and inhibition of 
GABA signaling. Nonetheless, based on studies with a radiolabeled neuropeptide 
showing that peak dorsal horn concentrations occur after 15-30 minutes of superfusion 
(Beck et al., 1995), GABA receptor antagonist solutions were refreshed every 20-30 
minutes in order to maintain drug concentrations in the dorsal horn. Furthermore, burst 
and tonic SCS were applied sequentially during recording of the same dorsal horn 
neurons, so any differential effects of the two modes of SCS are not due to differences in 
drug penetration or efficacy between rats. 
In addition to inducing GABA release, tonic SCS also stimulates release of 
serotonin, acetylcholine, and noradrenaline, each of which contribute to the inhibitory 
effects of SCS on dorsal horn neurons (Levin and Hubschmann, 1980; Linderoth et al., 
1992; Schechtmann et al., 2008). Many of the inhibitory effects of those additional 
neurotransmitters are attributed to secondary activation of GABAergic interneurons in the 
dorsal horn (Chen and Pan, 2004; Song et al., 2011; Zhang et al., 2009), and those effects 
would also be blocked by the GABA receptor antagonists administered in this study. 
However, serotonin and noradrenaline can exhibit direct inhibitory effects on dorsal horn 
projection neurons (Grudt et al., 1995; North and Yoshimura, 1984; Sonohata et al., 
2004), so it is possible that burst SCS attenuates nociception by activating inhibitory 
neurotransmitter systems that partially act independently of GABA signaling. Dorsal 
column stimulation can also directly inhibit dorsal horn neuronal firing, either by 
presynaptically depolarizing primary afferents to block excitatory neurotransmission, or 
producing hyperpolarizing inhibitory potentials in dorsal horn neurons (Narikawa et al., 
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2000; Shimoji et al., 1982). Further studies are required to determine what non-
GABAergic neurotransmitter systems or neurophysiological mechanisms may be 
activated during burst SCS to inhibit nociception in the dorsal horn. 
 
7.6. Conclusions and Integration 
Overall, studies in this chapter demonstrate that burst SCS attenuates dorsal horn 
neuronal firing after both painful nerve root compression and painful facet joint injury, 
supporting burst SCS as an effective therapy for persistent pain from cervical neural 
tissue and mechanical joint injuries. However, burst and tonic SCS reduce neuronal firing 
to the same degree in both models of persistent pain. Those findings do not support the 
hypothesis that burst SCS attenuates spinal hyperexcitability more effectively than tonic 
SCS. That hypothesis was based on clinical data showing increased effectiveness of burst 
SCS over tonic SCS for reducing chronic pain (De Ridder et al., 2013; De Vos et al., 
2014), but patient-reported pain scores in clinical studies incorporate many additional 
dimensions of pain that are not directly quantified here. The behavioral and dorsal horn 
neuronal responses to mechanical stimulation that were used in this study measure spinal-
level reflexes and electrophysiology, but do not account for any potential cognitive, 
affective, or other supraspinal contributions to pain perception (Fernandez and Turk, 
1992; Price, 2000). It is possible that behavioral testing that more comprehensively 
assesses spontaneous pain and/or the psychosocial aspects of chronic pain may show 
burst SCS to be more effective than tonic SCS in animal models of persistent cervical 
spine pain. 
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The similarities between SCS modes in their suppression of dorsal horn neuronal 
activity suggest that their neurophysiological mechanisms of action in the spinal cord 
may be similar. However, GABA receptor antagonists do not alter the effects of burst 
SCS, so that mode likely does not rely on GABA release and activation of GABA 
receptors to inhibit spinal neuronal firing. Therefore, these results do not support the 
hypothesis that burst SCS activates GABAergic mechanisms to reduce nociception in the 
spinal dorsal horn. Other neurochemical and neurophysiological mechanisms may reduce 
spinal neuronal firing during burst SCS, either by stimulating non-GABAergic inhibitory 
neurotransmitter release or directly blocking firing in dorsal horn projection neurons. 
Although continued studies are needed to elucidate the specific mechanisms underlying 
the effects of burst stimulation, the work in this chapter demonstrates that burst SCS is an 
effect modulator of dorsal horn neuronal activity and, by attenuating spinal 
hyperexcitability, can inhibit the aberrant nociception that develops in multiple different 
models of chronic pain. 
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CHAPTER 8 
 
Synthesis and Future Work 
   
 
8.1. Introduction 
Excessive loading of the facet joint has been implicated as a likely mechanism to 
produce pain during abnormal motions of the cervical spine, based on biomechanical 
studies that demonstrate excessive loading of the cervical facet joints during neck trauma 
(Deng et al., 2000; Kaneoka et al., 1999; Ono et al., 1997; Siegmund et al., 2001; 
Yoganandan et al., 2001). Clinical studies have identified the facet joint as a primary 
source of whiplash-associated pain, further supporting that mechanical facet joint loading 
can lead to chronic pain (Barnsley et al., 1995; Lord et al., 1996). Many patients with 
whiplash-associated disorders exhibit symptoms that are characteristic of central 
sensitization, including decreased pain thresholds both at the back of the neck and 
shoulders and at the upper and lower limbs (Banic et al., 2004; Curatolo et al., 2004; 
Herren-Gerber et al., 2004). 
Facet joint loading in the rat that induces pain also induces spinal neuronal 
hyperexcitability, possibly through the potentiation of glutamatergic signaling (Dong et 
al., 2012; Quinn et al., 2010; Rothman et al., 2008; Weisshaar et al., 2010). Because 
structural modifications in the spinal cord can contribute to central sensitization, painful 
facet joint loading could also initiate excitatory synaptogenesis in the dorsal horn, as 
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occurs after peripheral nerve injury (Jaken et al., 2010; Kim et al., 2012). Elucidating the 
mechanisms in the spinal cord that promote neuronal hyperexcitability can lead to more 
effective treatments for persistent pain after joint injuries, like those that result from 
excessive facet joint loading. Therefore, the purpose of this thesis was to define the 
temporal establishment and maintenance of spinal neuronal hyperexcitability after painful 
facet joint injury, and to evaluate the use of spinal cord stimulation to modulate neuronal 
activity in the dorsal horn for the attenuation of cervical spine pain. 
 
8.2. Summary and Synthesis of Major Findings 
Painful facet joint injury induces both mechanical hyperalgesia and dorsal horn 
neuronal hyperexcitability within the first day after injury, despite evidence that neither is 
evident six hours after joint injury (Chapter 3) (Crosby et al., 2013). The timing of the 
development of spinal hyperexcitability in the rat is consistent with the clinical 
experience of many patients that do not exhibit pain symptoms until hours or days after 
neck trauma (Chien et al., 2010). However, intra-articular injection of the fast-acting 
anesthetic, bupivacaine, in the bilateral facet joints is only effective for preventing the 
development of pain when that treatment is administered before 8 hours after injurious 
facet joint loading in the rat (Chapter 4) (Crosby et al., 2014a). These results suggest that 
the timing of any localized joint intervention is a crucial consideration for the effective 
treatment of sustained joint-mediated pain. This temporal importance of interventional 
therapy after facet joint injury is supported by the finding that early systemic treatment 
with corticosteroids (up to 8 hours after injury) is effective for reducing long-term 
disability in patients with whiplash-associated pain (Pettersson et al., 1998). Although the 
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studies in this thesis only evaluated behavioral sensitivity through day 7, a preliminary 
study showed that paw withdrawal threshold decreases significantly through day 14 after 
painful facet joint injury (Fig. 8.1). Furthermore, although the temporal development and 
maintenance of sensitivity in the rat may not directly translate to chronic pain in humans 
due to lifespan differences between the two species (Sengupta, 2013), the hyperalgesia 
that is evident at day 7 after facet joint injury in the rat continues, and does not diminish, 
for at least six weeks (Rothman et al., 2008), so the behavioral sensitivity at day 7 that is 
observed in the studies in this thesis can be considered as “persistent” pain. 
 
The primary afferent fibers that innervate the joint are activated by strain in the 
facet capsule in a goat model of tensile facet joint loading (Chen et al., 2006; Lu et al., 
2005a). Low-threshold fibers are activated at strains as low as 10%, and nociceptor firing 
is maximally activated at 44% strain (Lu et al., 2005a). In the studies in this thesis that 
evaluate the role of primary afferent firing in the induction of facet joint-mediated pain, 
 
 
Fig. 8.1. Quantification of hyperalgesia through day 14 after painful facet joint injury. 
Rats underwent painful facet joint injury (n=6) or sham procedures (n=5). Paw 
withdrawal threshold (PWT) decreases significantly through day 14 after painful facet 
joint injury relative to baseline (*p<0.0001). PWT also decreases relative to sham on 
days 3, 5, 7, 10, and 14 (#p≤0.037). 
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injurious joint distraction of 0.7mm generates average maximum principal strains of 
27±12% and peak maximum principal strains of 45±25% on the surface of the facet 
capsule (Chapter 4) (Crosby et al., 2014a). Those strains in the capsule, which are similar 
to the strains measured in other studies of painful facet joint loading in the rat (Dong et 
al., 2012; Lee et al., 2004a), are of sufficient magnitude to activate and saturate firing in 
both the low-threshold and nociceptive afferents that innervate the joint (Lu et al., 
2005a). Because of the demonstrated role of afferent discharge in the initiation of 
neuropathic pain after peripheral nerve injury, this firing in facet joint afferents presents a 
likely mechanism for the induction of facet-mediated pain. 
Excessive primary afferent activation induced by painful facet joint injury is 
associated with neuronal and astrocytic modifications, including the potentiation of 
glutamatergic signaling and the upregulation of astrocytic TSP4, that promote spinal 
neuronal hyperexcitability (Fig. 8.2) (Chapters 4 and 5) (Crosby et al., 2014a; Crosby et 
al., 2014c). Overstimulation of dorsal horn neurons increases intracellular calcium 
concentrations that can trigger secondary signaling pathways to alter the expression of 
glutamatergic signaling proteins (Kawasaki et al., 2004; Latremoliere and Woolf, 2009). 
That mechanism may contribute to the increases in mGluR5, pNR1, and pERK, and the 
decreases in GLT1 that are observed after painful joint loading (Fig. 8.2) (Chapter 4) 
(Crosby et al., 2014a; Dong et al., 2012; Weisshaar et al., 2010). Astrocytes also express 
receptors for excitatory neurotransmitters like glutamate and ATP (Milligan and Watkins, 
2009), so in addition to neuronal excitation, injury-induced afferent discharge may 
directly stimulate astrocytes in the dorsal horn. 
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Fig. 8.2. Temporal development of synaptic and structural modifications in the spinal 
cord that promote spinal hyperexcitability and behavioral sensitivity after facet joint 
injury. The time course of peripheral and spinal mechanisms contributing to persistent 
pain after facet joint injury (green) are compared with the mechanisms of neuropathic 
pain after nerve injury (red). Injurious facet capsule stretch induces primary afferent 
activity, followed by the onset of spontaneous activity in the first 24 hours that persists 
at least through day 7 after injury. Ectopic firing was measured by proxy using the 
spontaneous activation of neurons in the dorsal horn. These peripheral mechanisms are 
similar to the injury-induced afferent discharge and ectopic activity that are believed 
to promote neuropathic pain after a peripheral nerve injury. In the spinal cord, 
hyperexcitability develops within 24 hours after facet joint injury and also persists 
through at least day 7. The onset of spinal hyperexcitability after nociceptor activation 
can be rapid, but the exact timeline of the development of sensitization in the first 24 
hours after facet joint injury remains unclear. Behavioral sensitivity develops 
concurrently with spinal hyperexcitability at day 1, and persists. Spinal 
hyperexcitability is promoted by neuronal and astrocytic modifications that were 
measured at day 7 after injury, including the potentiation of glutamatergic signaling, 
spinal TSP4 upregulation, and TSP4-mediated synaptogenesis. 
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Once activated, astrocytes can contribute directly to neuronal hyperexcitability by 
increasing spinal levels of excitatory neurotransmitters, neuropeptides (i.e., substance P), 
growth factors, and prostaglandins, each of which has sensitizing effects on dorsal horn 
neurons (Watkins et al., 2001). In particular, excitatory neurotransmitter release by 
astrocytes activates AMPA receptors on neurons that contribute to neuronal firing in the 
spinal dorsal horn (Watkins et al., 2001). Similarly, astrocyte activation by excitatory 
neurotransmission can lead to the increase in astrocytic TSP4 that is observed after 
painful facet joint injury (Fig. 8.2) (Chapter 5) because expression of TSP1, a 
thrombospondin-family protein that is closely related to TSP4, has been shown to be 
induced by the excitatory neurotransmitter, ATP (Tran and Neary, 2006). Astrocytic 
TSP4 can enhance the neuronal release of excitatory neurotransmitters, like glutamate 
(Kim et al., 2012). Increased glutamate release in the dorsal horn may overactivate 
second-order dorsal horn neurons, especially after the downregulation of GLT1 (Chapter 
4), which is the primary glutamate transporter responsible for clearing excess synaptic 
glutamate (Danbolt, 2001). By facilitating the activation of dorsal horn neurons through 
excitatory neurotransmitter and TSP4 release, astrocyte activation may substantially 
contribute to the increases in neuronal excitability that occur after painful joint injury. 
TSP4 plays a particularly important role in the development of behavioral 
sensitivity and spinal hyperexcitability after painful facet joint injury. TSP4 has 
synaptogenic properties (Eroglu et al., 2009), and blocking injury-induced spinal TSP4 
expression prevents excitatory synaptogenesis (Chapter 5) (Crosby et al., 2014c). As 
such, elevated spinal TSP4 likely causes the increase in excitatory synapses that is 
observed in the dorsal horn at day 7 after painful facet joint injury (Fig. 8.2) (Chapter 5) 
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(Crosby et al., 2014c). TSP4 is upregulated in the spinal cord at day 7 after painful facet 
joint loading, but nerve injury-induced synapse development has been reported to occur 
over the course of at least 3-5 days (Lo et al., 2011). Spinal TSP4 levels exhibit similar 
trends at day 1 as at day 7, so the observed increase in synapses at day 7 may be induced 
by increases in TSP4 that are observed beginning at day 1 (Chapter 5). Although new 
excitatory synapses may require several days to develop after painful facet joint injury, 
spinal hyperexcitability and behavioral sensitivity develop within the first day after 
injury. Together, these results indicate that TSP4-mediated synaptogenesis contributes to 
behavioral sensitivity and spinal hyperexcitability by day 7 after painful facet joint injury. 
But, the temporal development of hyperexcitability in the first day after injury precludes 
the involvement of synaptogenesis in the initial induction of facet joint-mediated pain. 
The studies in this thesis demonstrate that the potentiation of glutamate signaling 
and the excitatory synaptogenesis that are both induced by primary afferent discharge 
contribute to persistent facet joint-mediated pain. But, multiple different signaling 
pathways can lead to the development of spinal hyperexcitability (Latremoliere and 
Woolf, 2009). For example, painful facet joint injury leads to an increase in expression of 
nerve growth factor (NGF) in the facet capsule and the DRG, which can initiate the later 
development of prostaglandin-mediated inflammatory pain (Kras et al., 2014a; Kras et 
al., 2014b). NGF is an inflammatory mediator that can also directly sensitize primary 
afferent nociceptors (McMahon, 1996), potentially increasing afferent input to the dorsal 
horn and contributing to the development of spinal hyperexcitability (Kras et al., 2014b). 
Spinal inflammation can also contribute to astrocyte activation by stimulating astrocytic 
receptors for pro-inflammatory cytokines like IL-1 and TNFα (Benveniste, 1992; 
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Milligan and Watkins, 2001). Indeed, blocking IL-1 and TNFα receptors prevents the 
spinal upregulation of GFAP after painful facet joint injury (Dong, 2013); however, 
blocking IL-1 and TNFα does not attenuate hyperalgesia after facet injury (Dong, 2013). 
Furthermore, spinal GFAP expression remains increased despite the attenuation of 
hyperalgesia and spinal hyperexcitability by intra-articular injection of bupivacaine 
immediately after injury (Chapter 4) (Crosby et al., 2014a). Therefore, astrocyte 
activation after painful facet joint injury is likely due, at least in part, to inflammatory 
mechanisms that are independent of injury-induced afferent discharge. 
Both peripheral and spinal interventions can prevent or reduce persistent pain 
after facet joint injury by modulating joint afferent firing and/or the sensitization of spinal 
neurons (Fig. 8.3). However, those treatments are most effective when administered 
immediately or early after facet joint injury. Intra-articular bupivacaine administered up 
to 4 hours after joint injury prevents the development of hyperalgesia and spinal 
hyperexcitability by blocking the potentiation of glutamatergic signaling, TSP4 
upregulation, and excitatory synaptogenesis. But, if bupivacaine treatment is not 
administered until after spinal hyperexcitability develops, it is ineffective at attenuating 
joint-mediated pain (Fig. 8.3) (Chapters 4 and 5) (Crosby et al., 2014a; Crosby et al., 
2014c). Similarly, spinal administration of gabapentin at the time of injury prevents the 
development of hyperalgesia, spinal hyperexcitability, astrocyte activation, and the 
increase in excitatory synapses that are all observed after painful facet injury (Fig. 8.3) 
(Chapter 5) (Crosby et al., 2014c; Dong et al., 2013a). Since gabapentin binds to the α2δ-
1 subunit of voltage-dependent calcium channels and has been reported to inhibit calcium 
influx (Dooley et al., 2002; Stefani et al., 1998), it may attenuate spinal hyperexcitability 
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by reducing calcium currents in dorsal horn neurons and preventing the calcium-mediated 
changes in excitatory glutamatergic signaling that would be induced by afferent 
discharge. Gabapentin also blocks the synaptogenic activity of TSP4 through that α2δ-1 
subunit (Eroglu et al., 2009; Luo et al., 2002), so it may also reduce persistent pain by 
antagonizing the activity of TSP4 (Fig. 8.3). However, that mechanism is less probable 
 
 
Fig. 8.3. Timing of peripheral and spinal interventions and effects on hyperalgesia and 
spinal neuronal hyperexcitability. The timing of peripheral and spinal interventions is 
a significant factor in determining whether they are effective (red) or ineffective 
(green) in attenuating hyperalgesia and/or spinal neuronal hyperexcitability. 
Immediate, but not delayed, intra-articular bupivacaine blocks injury-induced afferent 
discharge, preventing the subsequent development of hyperalgesia and spinal 
hyperexcitability. Anti-NGF antibodies are also effective when given immediately 
after injury, indicating that inflammatory mechanisms also contribute to the 
development of facet joint pain. In contrast, anti-inflammatory treatments like 
ketorolac are effective at day 1, but not when given immediately after injury. In the 
spinal cord, daily intrathecal antisense oligonucleotides (ASO) prevent TSP4 
expression, and reduce subsequent excitatory synaptogenesis. Intrathecal gabapentin 
given at the time of injury and again at day 1 blocks the synaptogenic activity of TSP4 
to prevent synaptogenesis, and may also reduce calcium influx in dorsal horn neurons 
to attenuate the potentiation of glutamatergic signaling. 
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because TSP4 is not significantly upregulated at day 1 when the gabapentin treatment 
likely ceases to be effective (Fig. 8.2) (Chapter 5) (Crosby et al., 2014c). 
Localized joint interventions that target NGF-mediated inflammatory pain can 
also reduce behavioral sensitivity and spinal hyperexcitability. Intra-articular injection of 
an anti-NGF antibody at the time of facet joint injury effectively prevents the 
development of behavioral sensitivity and spinal hyperexcitability (Kras et al., 2014b). 
However, intra-articular injection of the nonsteroidal anti-inflammatory drug ketorolac, is 
not effective when administered at the time of injury, while it does reduce sensitivity 
when administered at day 1 (Fig. 8.3) (Dong et al., 2013b). Ketorolac disrupts the 
synthesis of prostaglandins (Dong et al., 2013b). As such, these results indicate that NGF 
is likely an early mediator of facet joint pain, but additional mechanisms, like 
prostaglandin synthesis, may contribute to the maintenance of inflammatory pain at later 
times. Both spinal and local joint interventions can reduce facet joint-mediated pain by 
targeting one of several neuropathic and inflammatory mechanisms that converge to 
promote central sensitization. However, blocking joint afferent activity after afferent 
discharge has already induced spinal plasticity is ineffective (Chapter 4) (Crosby et al., 
2014a), just as blocking prostaglandin synthesis before prostaglandins contribute to pain 
does not reduce sensitivity (Fig. 8.3) (Dong et al., 2013b). Therefore, the timing of each 
intervention relative to the temporal development of the targeted mechanism is a crucial 
consideration for effective treatment of facet joint pain. 
The magnitudes of facet joint distraction and the resulting local strain in the facet 
capsule play a key role in the induction of facet joint-mediated pain, because the afferent 
fibers that innervate the joint are activated in a strain-dependent manner (Chen et al., 
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2006; Lu et al., 2005a). Low-threshold mechanosensitive and nociceptive afferents in the 
facet capsule are differentially activated by the capsule strains that are produced during 
physiologic and injurious joint loading, respectively (Dong et al., 2012; Lu et al., 2005a). 
Physiologic joint loading alone does not initiate behavioral sensitivity, or the dorsal horn 
neuronal hyperexcitability or inflammatory cascades that promote pain (Dong et al., 
2011; Lee and Winkelstein, 2009; Quinn et al., 2010). However, when spinal TSP4 levels 
are increased, physiologic loading of the facet joint does induce sustained behavioral 
sensitivity and spinal hyperexcitability (Chapter 5) (Crosby et al., 2014c). In addition to 
its synaptogenic properties, TSP4 can potentiate the pre-synaptic release of excitatory 
neurotransmitters (Kim et al., 2012), possibly by strengthening the pre-synaptic calcium 
currents that stimulate neurotransmitter release (Neher and Sakaba, 2008). Increased 
spinal TSP4 may enhance excitatory neurotransmitter release at the synapses between 
primary afferents and dorsal horn neurons, increasing the temporal and spatial summation 
of excitatory post-synaptic potentials and the likelihood of dorsal horn neuronal 
activation. This priming of dorsal horn neuronal firing may facilitate the initiation of 
spinal hyperexcitability in response to the non-noxious primary afferent signals that are 
typically induced by physiologic joint loading. Spinal TSP4 can be upregulated by 
painful facet joint loading (Crosby et al., 2014c) or peripheral nerve injury (Kim et al., 
2012; Li et al., 2014a), but it remains unclear whether nonpainful mechanical loading of 
joint or neural tissue is sufficient to increase spinal TSP4 levels. Nonetheless, higher 
spinal TSP4 levels prime the development of neuronal hyperexcitability in response to 
cervical spine motions and/or facet capsule strains that are within the normal, physiologic 
range. Therefore, higher endogenous levels of spinal TSP4, or increased spinal TSP4 
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from either previous nerve injury or injurious joint loading, may present a higher risk for 
the development of joint-mediated pain. 
Central sensitization often involves hyperexcitability of the wide dynamic range 
(WDR) neurons in the spinal dorsal horn that integrate non-nociceptive and nociceptive 
signals from primary afferents (Basbaum et al., 2009; Christensen and Hulsebosch, 1997; 
Hains et al., 2003c; Hao et al., 1992; Zhang et al., 2005). Dorsal horn WDR neurons are 
sensitized within one day after painful facet joint injury (Chapter 3) (Crosby et al., 2013), 
and WDR hyperexcitability persists for at least seven days (Quinn et al., 2010b). Since 
neuronal hyperexcitability can amplify nociceptive signals in the dorsal horn, direct 
modulation of the excitability of dorsal horn neurons can effectively reduce aberrant 
nociception. That strategy is exemplified by the use of spinal cord stimulation (SCS) to 
modulate spinal neuronal activity for attenuating pain symptoms (Guan et al., 2010; 
Yakhnitsa et al., 1999). Conventional tonic SCS reduces behavioral sensitivity after 
peripheral nerve injury by attenuating WDR neuronal hyperexcitability (Yakhnitsa et al., 
1999). Studies in this thesis evaluated burst SCS, a novel mode of stimulation, to 
determine potential mechanisms that may underlie its analgesic effects. Similar to tonic 
SCS, the anti-nociceptive effects of burst SCS are likely related to its attenuation of 
WDR hyperexcitability, because burst SCS inhibits neuronal activity most effectively in 
WDR neurons (Chapter 6) (Crosby et al., 2014b). 
Burst SCS reduces neuronal hyperexcitability in the spinal dorsal horn after a 
painful nerve root compression. However, the burst stimulation waveform is defined by 
five parameters (pulse number, pulse frequency, pulse width, burst frequency, and 
amplitude), and the reduction in neuronal activity is highly dependent on the values of 
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those parameters (Chapter 6) (Crosby et al., 2014b). Although individual parameters can 
alter the effectiveness of burst SCS, modulating the charge delivery to the spinal cord is 
the underlying factor that determines the effectiveness of burst SCS (Chapter 6) (Crosby 
et al., 2014b). Burst SCS was originally hypothesized to reduce pain more than tonic SCS 
because burst stimulation delivers significantly more charge over time than traditional 
tonic SCS (De Ridder et al., 2010). The amount of charge delivered per burst is 
correlated to the attenuation of neuronal activity, but a 50% increase or decrease in burst 
frequency, and therefore in the amount of charge per second, does not alter the 
effectiveness of burst SCS (Chapter 6) (Crosby et al., 2014b). The insensitivity of spinal 
neuronal activity to changes in burst frequency suggests that charge delivery over time is 
less important for burst-SCS induced analgesia than charge delivery during each 
individual burst. These results showing the sensitivity of burst SCS to charge delivery 
provide a framework for the optimization of burst SCS on a patient-by-patient basis by 
indicating those parameters that have the greatest effect on SCS efficacy, but further 
comparisons between burst and tonic SCS are needed to evaluate the role of charge 
delivery in the differential effects of the two SCS modes for reducing chronic pain. 
Burst SCS reduces spinal neuronal hyperexcitability to the same extent in rat 
models of painful cervical nerve root compression and mechanical facet joint injury 
(Chapter 7). Dorsal column stimulation has been proposed to inhibit neuronal activity in 
the dorsal horn by activating Aβ fibers that collateralize into the dorsal horn and synapse 
with inhibitory interneurons (Guan et al., 2010; Yaksh and Luo, 2006). Inhibitory 
interneurons that are activated by Aβ fiber stimulation can directly influence the activity 
of dorsal horn projection neurons, especially the nociceptive-specific neurons in the 
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superficial laminae and the WDR neurons in the deeper laminae that contribute to pain 
signaling (Daniele and MacDermott, 2009; Dubuisson, 1989; Yakhnitsa et al., 1999). 
Burst SCS has been evaluated in a limited number of clinical studies, most commonly in 
patients with back pain from failed back surgery syndrome (FBSS) (De Ridder et al., 
2010; De Ridder et al., 2013; De Vos et al., 2014), and studies are needed to test the 
effectiveness of burst SCS in patients with indications other than FBSS. However, dorsal 
horn neuronal firing is attenuated by burst SCS to the same extent in rat models of 
neuropathic pain and joint pain (Chapter 7), and in a model of acute nociceptive pain 
(Tang et al., 2014). Therefore, the mechanisms of SCS-induced dorsal horn inhibition are 
likely conserved regardless of the pathophysiological basis of the pain, and burst 
stimulation may be effective for analgesia in patients with a wide range of chronic pain 
conditions. 
Studies in this thesis indicate that burst SCS does not reduce dorsal horn neuronal 
hyperexcitability more than tonic SCS after painful cervical nerve root compression or 
painful cervical facet joint injury (Chapter 7). Therefore, it was hypothesized that burst 
and tonic stimulation act through a similar mechanism, namely the activation of 
inhibitory GABA signaling in the dorsal horn. GABAB receptor antagonists abolish the 
effects of tonic SCS but not burst SCS (Chapter 7), indicating that, unlike with tonic SCS 
(Cui et al., 1996), burst stimulation-induced analgesia is not mediated by GABA 
signaling. Burst SCS requires a significantly lower amplitude than tonic SCS for effective 
analgesia (Chapter 7) (De Ridder et al., 2010), so it has been proposed that burst SCS 
inhibits dorsal horn firing via subthreshold stimulation of Aβ fibers (i.e., without 
inducing firing of the Aβ fibers) (De Ridder et al., 2010). Therefore, it is possible that 
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burst SCS inhibits neuronal activity in the dorsal horn with subthreshold stimulation that 
does not activate the inhibitory interneurons that release GABA. Instead, burst SCS may 
increase the dorsal horn levels of other neurotransmitters that potentially have lower 
thresholds for release during stimulation. Serotonin, for example, is increased in the 
dorsal horn during tonic SCS (Linderoth et al., 1992) and can have inhibitory effects on 
nociceptive dorsal horn neurons (Grudt et al., 1995). Selective antagonism of serotonin 
receptors in the dorsal horn during the application of SCS in rats with neuropathic pain 
indicates that a subset of receptors are activated and contribute to dorsal horn inhibition 
during tonic SCS, independent of GABA signaling (Song et al., 2011); however, the role 
of serotonin signaling in the effects of burst SCS are unknown. Future studies should 
continue to evaluate these potential inhibitory mechanisms of burst SCS, because 
understanding the mechanisms underlying the effects of that mode of stimulation is 
necessary to improve its effectiveness as a treatment for chronic pain. 
 
8.3. Limitations and Future Work 
The studies presented in this thesis demonstrate that afferent firing from the facet 
joint early after joint loading induces potentiation of glutamatergic signaling and 
excitatory synaptogenesis in the dorsal horn that collectively promote spinal neuronal 
hyperexcitability. However, neuronal hyperexcitability can be directly modulated by 
spinal cord stimulation to inhibit aberrant nociception in the dorsal horn. This work 
contributes to a better understanding of the mechanisms underlying the development and 
treatment of persistent pain from mechanical loading of tissues in the cervical spine, but 
there are several assumptions and limitations that require consideration. As such, this 
 210 
section addresses important limitations and also outlines additional studies that could be 
performed to build upon the findings in this thesis. 
The ectopic activity that develops within one day after painful facet joint injury 
(Chapter 3) (Crosby et al., 2013) may promote spontaneous pain by activating 
nociceptive neurons in the dorsal horn in the absence of peripheral afferent stimulation 
(Devor, 2009; Djouhri et al., 2000). Indeed, spontaneous pain, or ongoing pain, is 
observed in a majority of patients with whiplash-associated disorders (Kosek and 
Januszewska, 2008). However, the presence or severity of spontaneous pain was not 
measured in the studies in this thesis. Ongoing pain has been evaluated in rat models of 
neuropathic pain and formalin-induced pain by quantifying abnormal spontaneous 
behaviors like lifting or licking of the affected forepaw (Djouhri et al., 2006; Kawasaki-
Yatsugi et al., 2012; Shi et al., 2010). Operant behavioral assessments may also reveal the 
presence of ongoing pain, including conditioned place preference (CPP) testing, in which 
rats are conditioned to environments that are linked to positive (i.e., analgesic) or 
negative (i.e., aversive) stimuli (Sufka, 1994). In that testing paradigm, rats with 
spontaneous pain show an increased preference for an environment that has previously 
been associated with an analgesic treatment (Davoody et al., 2011; King et al., 2009). 
However, difficulties in reliably, sensitively, and quantitatively measuring spontaneous 
pain in rats have prevented the acceptance of a consensus methodology for acquiring 
such data (Mogil and Crager, 2004). As better measures are developed to objectively 
measure spontaneous pain in animal models, future studies should evaluate spontaneous 
pain as a potentially important component of joint-mediated pain after facet injury. 
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A large majority of animal studies of pain and analgesia have historically included 
only male subjects, despite the fact that the prevalence of clinical pain conditions is 
higher in women (Greenspan et al., 2006; Mogil and Chanda, 2005). This effect is 
observed for whiplash-associated pain as well, since pressure pain thresholds are lower 
for women than for men both at the site of injury in the neck and at distant sites in the 
upper limbs (Sterling et al., 2003). The sex-dependent differences in pain thresholds after 
rear impacts may be due in part to different cervical spine kinematics; women experience 
greater facet joint shear loading and joint distraction than men, especially at the lower 
cervical levels (Stemper et al., 2004). The studies in this thesis used only male rats, and 
the findings may, therefore, be limited by their exclusion of female animals. Future 
studies including both female and male subjects are needed in order to evaluate if there 
are any potential sex differences in the mechanisms that promote facet-mediated pain. 
Although injury-induced afferent activity from the facet joint has been shown to 
initiate spinal hyperexcitability and sustained behavioral sensitivity (Chapter 4) (Crosby 
et al., 2014a), the specific roles of subpopulations of primary afferent fibers in the 
induction of spinal hyperexcitability were not evaluated in this thesis. A fibers and C 
fibers are believed to have distinct contributions to the temporal development of central 
sensitization after nerve injury (Devor, 2009), so understanding the temporal 
contributions of primary afferent fiber subpopulations to the induction and maintenance 
of persistent facet-mediated pain may be critical for effective timing and targeting of 
analgesic treatments. C fiber nociceptors in the facet joint may play a particularly 
important role in the development of central sensitization, because selective chemical 
ablation of spinal peptidergic C fibers prior to painful facet joint injury prevents the 
 212 
development of behavioral sensitivity (Weisshaar et al., 2014). Peptidergic C fibers also 
mediate the sensitivity that is induced by intra-articular NGF (Kras et al., 2014b). 
However, degeneration of C fibers can trigger secondary structural changes in the spinal 
dorsal horn (Bailey and Ribeiro-Da-Silva, 2006), so ablating C fibers at their central 
terminals may cause unanticipated modifications in the spinal processing of pain signals 
that confound any determination of the contributions of the ablated afferent population to 
persistent pain. Instead, future studies could use pharmacological compounds that 
selectively and transiently block subpopulations of afferent fibers, like substance P 
antagonists that inhibit peptidergic C fiber activity (Xu et al., 1992), to determine the 
individual roles of fiber types in the development and maintenance of pain after injurious 
facet joint loading.  
Excitatory synaptogenesis contributes to persistent facet joint-mediated pain, but 
the studies in this thesis only evaluated synapses at day 7. The temporal development of 
excitatory synaptogenesis and the potential contributions of other synapse populations 
(i.e., inhibitory synapses) to spinal hyperexcitability are unknown. Synapses in 
hippocampal neuron cultures begin to develop by day 4 after plating the neurons, but do 
not reach maturity for 10-12 days (Basarsky et al., 1994), and synaptogenesis occurs over 
the course of several weeks after CNS injury (Wells and Tripp, 1987). Based on those 
timelines for the development of synapses in the CNS, a preliminary study evaluated 
excitatory and inhibitory synapses at day 14 after painful facet joint injury to determine 
whether structural modifications continue to develop after day 7. Excitatory synapses 
were identified by immunolabeling bassoon, a pre-synaptic structural protein, and homer, 
as described in Section 5.3.5 of Chapter 5. Inhibitory synapses were quantified by 
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immunolabeling bassoon and the inhibitory post-synaptic marker, gephyrin, which is a 
structural protein that organizes GABA and glycine receptors at inhibitory synapses 
(Tretter et al., 2012; Zeilhofer, 2005). Excitatory synapse density significantly increases 
in the superficial dorsal horn by 1.40-fold over sham levels at day 14 after painful facet 
joint injury (p=0.019) (Fig. 8.4a). The increase in excitatory synapses at day 14 is similar 
to the 1.56-fold increase at day 7 (Chapter 5), showing that the structural changes in the 
spinal cord that promote spinal hyperexcitability are sustained and likely contribute to the 
persistence of behavioral sensitivity at day 14 (Fig. 8.1). 
 
 
 
Fig. 8.4. Quantification of excitatory and inhibitory synapses at day 14 after painful 
facet joint injury. (a) Representative images showing the immunolabeling of bassoon 
(green) and homer (red) in the superficial dorsal horn at day 14 after painful facet 
joint injury (n=6) or sham surgery (n=5); excitatory synaptic puncta (yellow, arrows) 
are increased over sham levels (*p=0.019). (b) The number of inhibitory synapses, 
identified by colocalization (yellow, arrows) of bassoon (green) and gephyrin (red) 
decreases at day 14 (*p<0.0001). 
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Inhibitory synapse density decreases to 51% of sham levels in the superficial 
dorsal horn at day 14 after painful facet joint injury (p<0.0001) (Fig. 8.4b), suggesting a 
decrease in spinal inhibition that could amplify nociceptive signals by potentiating 
neuronal firing in response to excitatory afferent input (Zeilhofer, 2005). Decreases in 
gephyrin-labeled synaptic puncta in the dorsal horn could indicate fewer functional 
GABA and/or glycine receptors at inhibitory synapses, or complete degeneration of those 
inhibitory synapses (Todd, 2010). However, peripheral nerve injury induces spinal 
disinhibition without any change in immunolabeling of GABA or GABAA receptors 
(Moore et al., 2002; Polgar and Todd, 2008), so the loss of gephyrin-positive puncta in 
this preliminary study may instead correspond to a decrease in glycinergic synapses. The 
decrease in inhibitory synapses at day 14 shows that structural changes in the spinal cord 
persist for at least two weeks after facet joint injury, and likely contribute to the 
hyperalgesia that is sustained at that time point (Fig. 8.1). If the numbers of excitatory 
and inhibitory synapses change concurrently, it could indicate a shift of inhibitory 
synapses to an excitatory phenotype rather than degeneration of inhibitory synapses and 
development of new excitatory terminals. Alternately, it is possible that excitatory 
synaptogenesis precipitates the loss of inhibitory synapses, and spinal disinhibition 
develops in response to the hyperexcitability of dorsal horn neurons. Ultimately, further 
studies are needed to define the temporal development of both excitatory and inhibitory 
structural modifications in the spinal cord after painful facet joint injury. 
One of the greatest impediments to characterizing injury-induced synapse growth 
or loss in vivo is differentiating preexisting synapses from those that develop after injury. 
Mouse models have been increasingly used for the study of pain (Mogil, 2009), though 
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recapitulating a model of painful facet joint injury in the mouse would be complicated by 
physiological and behavioral differences between species. For example, some 
considerations that are intended to reduce stress-related changes in nociception in the rat, 
like handling the rats to habituate them for behavioral testing, may actually increase 
stress in mice and confound the use of behavioral assays to measure nociception (Wilson 
and Mogil, 2001). Nonetheless, the powerful genetic technologies available in mice may 
overcome some of the obstacles to the in vivo study of synaptogenesis (Holtmaat et al., 
2013). The use of fluorescent reporter genes like GFP or tdTomato with cell-type-specific 
expression patterns may allow the determination of which primary afferent and/or dorsal 
horn neuronal populations are involved in the gain or loss of synapses after injury 
(Cavanaugh et al., 2009; Holtmaat et al., 2013; Kain et al., 1995). Alternately, synaptic 
proteins can be identified in a cell-type-specific fashion using Synaptic Tagging with 
Recombination (STaR), a transgenic approach that alters selected synaptic proteins to 
include a GFP reporter or a small peptide tag that can be detected by immunolabeling 
(Chen et al., 2014). Increases in synaptic proteins within one neuronal subpopulation 
after injury may indicate the development of new synapses associated with those neurons.  
The studies in this thesis did not consider supraspinal changes that could 
contribute to spinal hyperexcitability and/or persistent pain. Descending pathways from 
the brain have dual inhibitory and facilitatory roles in spinal dorsal horn processing of 
nociceptive signals (Millan, 2002; Vanegas and Schaible, 2004). Chronic pain is often 
associated with concurrent disinhibition and increased facilitation from descending 
pathways that collectively promote spinal neuronal hyperexcitability (Blom et al., 2014; 
Porreca et al., 2002; Vanegas and Schaible, 2004). The brain can also contribute to 
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persistent pain by amplifying ascending nociceptive signals from the spinal dorsal horn. 
Nociceptive neurons project from the spinal dorsal horn to the thalamus (Basbaum et al., 
2009), and thalamic neurons can become hyperexcitable after peripheral nerve injury in 
rats, promoting behavioral sensitivity (Fischer et al., 2009; Miki et al., 2000). As such, 
future studies of facet joint injury should consider these potentially multifaceted 
supraspinal contributions to persistent pain by electrophysiologically assessing neuronal 
activity in the thalamus and the brain regions that modulate descending facilitation and 
inhibition, like the rostroventral medulla and the periaqueductal gray (Porreca et al., 
2002; Vanegas and Schaible, 2004). 
Another recently developed technology, Time-Specific Tagging for the Age 
Measurement of Proteins (TimeSTAMP), uses protease degradation of an engineered 
epitope tag to allow detection of only recently translated proteins (Lin et al., 2008). 
TimeSTAMP has been employed to identify newly developing synapses in vitro, and 
may provide the ability to characterize injury-induced synaptogenesis in vivo (Lin et al., 
2008). To date, STaR and TimeSTAMP have been developed for use in vitro or in vivo in 
Drosophila, so significant work would be required to adapt these technologies to 
investigate synaptogenesis in rodent models of persistent pain. Nonetheless, these 
technologies could provide insight about the time course of injury-induced 
synaptogenesis and the neuronal populations that develop new excitatory synapses or lose 
inhibitory input. 
The application of spinal cord stimulation in the different pain models used in this 
thesis contrasts substantially with the delivery of stimulation that is used clinically. A 
single, monopolar, ball-shaped electrode was used to administer electrical pulses to the 
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dorsal columns in the studies in this thesis (Chapters 6 and 7) (Crosby et al., 2014b), 
based on previous techniques for the administration of SCS in animal models of acute 
nociceptive pain (Qin et al., 2012; Tang et al., 2014). However, humans often receive 
implantation of arrays of up to 16 electrodes that can be programmed in different patterns 
as cathodes, anodes, or inactive terminals. Electrode arrangement and programming is 
known to be a significant variable in the effectiveness of stimulation by altering the 
charge density and steering the depth and location of current delivery (Alo et al., 1998; 
Alo et al., 1999; Manola et al., 2007; Shankarasubramanian et al., 2011; Wesselink and 
Boom, 1998). As such, the attenuation of dorsal horn neuronal firing by monopolar burst 
SCS in rats may not directly correspond to the effects of burst SCS in humans that 
receive multielectrode stimulation. Furthermore, dorsal horn neuronal firing was 
quantified immediately after the cessation of SCS because artifacts from the electrical 
stimulation prevented the recording of voltage potentials during SCS. In clinical studies, 
pain scores are reported during stimulation (De Ridder et al., 2010; De Vos et al., 2013). 
Although SCS is a clinically-approved therapy for many chronic pain conditions, studies 
in rodent models of pain form the foundation of understanding the mechanisms that 
underlie SCS-induced analgesia and provide potential insight for improved effectiveness 
of SCS. As such, due to those limitations listed above, the electrophysiological 
recordings of dorsal horn neuronal activity in these rat studies should be considered 
together with studies that employ more clinically-relevant stimulation, like bipolar 
stimulation from an implanted electrode array, and actively assess pain-related behaviors 
during stimulation.  
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Clinical studies of the effectiveness of SCS often rely on patient-reported pain 
scores to determine whether stimulation attenuates pain symptoms (De Ridder et al., 
2010; De Vos et al., 2013; Van Buyten et al., 2001). Some measures, like the visual-
analog scale (VAS), require patients to rate their pain on a linear scale (Downie et al., 
1978), whereas other methods, like the McGill Short Form, seek to differentiate the 
sensory and affective components of pain (Melzack, 1987). The affective dimension of 
pain includes the unpleasant emotional associations with pain that lead to aversive 
behavior (Price, 2000). Psychosocial and affective dimensions are important contributors 
to chronic pain in both humans and rats (Johansen et al., 2001; LaBuda and Fuchs, 2000; 
Price, 2000), including those with whiplash-associated disorders (Drottning et al., 1995). 
The measurements of mechanically-evoked hyperalgesia and dorsal horn neuronal 
activity used in this thesis assess the spinal integration of sensory signals, but those 
outcomes likely do not fully characterize the effects of SCS on pain. More 
comprehensive behavioral assays may better evaluate SCS-induced analgesia by 
incorporating the psychosocial and affective components of pain (Vierck et al., 2008). 
CPP testing offers one potential behavioral assay to evaluate the effects of an analgesic 
treatment like SCS without relying on reflexive nociceptive behaviors to indicate the 
severity or presence of pain (Sufka, 1994). CPP has not been employed in a rodent model 
of pain to study the effectiveness of spinal cord stimulation, but its use could significantly 
increase the clinical relevance of studies using SCS in animal models of pain. 
In summary, the studies presented in this thesis define the mechanisms that 
contribute to spinal hyperexcitability after mechanical facet joint injury. Painful facet 
joint injury produces afferent discharge from the facet joint that initiates spinal neuronal 
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hyperexcitability. The initiation of spinal hyperexcitability by facet joint afferent activity 
is similar to the mechanisms that induce central sensitization after a peripheral nerve 
injury. In one respect, the studies in this thesis are important because of the demonstrated 
similarities between the development of spinal neuronal hyperexcitability after facet joint 
injury and peripheral nerve injury. Those similarities support the potential application of 
therapies, like gabapentin administration, that have been used previously to successfully 
treat neuropathic pain in order to treat patients with facet joint-mediated pain. However, 
it is also important to continue to separately evaluate mechanisms of injury, nociception, 
and central sensitization after mechanical facet joint loading because injurious facet joint 
distraction induces soft tissue damage and inflammation that may lead to differences 
from neuropathic pain that are not defined in this thesis.  
Joint afferent discharge induces synaptic plasticity in the dorsal horn by day 7 that 
potentiates excitatory glutamatergic signaling and amplifies pain sensation. Injury-
induced afferent activity also leads to the dysregulation of TSP4 expression in the DRG 
and spinal cord, possibly as early as day 1, which can stimulate TSP4-mediated 
excitatory synaptogenesis. Synaptogenesis likely develops over the course of several 
weeks, and coincides with a loss of inhibitory synapses in the dorsal horn; together these 
spinal structural modifications contribute to the maintenance, but not the initial 
development, of spinal hyperexcitability. Additional work is needed to further evaluate 
the development of spinal hyperexcitability and its contribution to the initiation and 
maintenance of pain. In particular, more comprehensive behavioral assays are needed to 
characterize the spontaneous, evoked, and affective components of persistent pain after 
facet joint injury. 
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The studies in this thesis also show that burst spinal cord stimulation is an 
effective treatment to modulate spinal hyperexcitability. Despite its apparent clinical 
effectiveness (De Ridder et al., 2013; De Vos et al., 2014), additional studies are still 
needed to elucidate the mechanisms underlying the analgesic effects of burst SCS, 
because defining those mechanisms can lead to novel uses of the stimulation to improve 
analgesia. For example, the role of GABA signaling in the analgesic effects of tonic SCS 
was not reported until nearly 40 years after the first implanted electrodes were used to 
deliver tonic SCS (Cameron, 2004; Cui et al., 1996; Linderoth et al., 1994). After the 
importance of GABA signaling was discovered, intrathecal delivery of the GABA 
agonist, baclofen, was used to enhance the effects of tonic SCS, especially in patients that 
were previously non-responsive to SCS alone (Lind et al., 2004; Lind et al., 2008). 
Overall, this work provides a foundation for future investigations into the synaptic and 
structural mechanisms that promote hyperexcitability of dorsal horn neurons after painful 
facet joint injury. With a more comprehensive understanding of the peripheral and spinal 
sequelae that cause persistent pain from excessive facet joint loading, better 
pharmacological or electrical stimulation therapies can be developed to modulate spinal 
hyperexcitability and effectively treat chronic pain. 
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APPENDIX A 
 
Protocols for Electrophysiological Recordings and 
Analysis 
 
 
This appendix details the protocols for identifying and recording evoked 
potentials from dorsal horn neurons (Section A.1), and sorting spikes to quantify 
spontaneous and evoked neuronal firing (Section A.2). These protocols were used for the 
studies of dorsal horn neuronal excitability in Chapters 3-5. These protocols were also 
modified for use in studies of the effects of spinal cord stimulation on spinal neuronal 
excitability Chapters 6 and 7; detailed methods for those studies can be found in Section 
6.3 of Chapter 6 and Section 7.3 of Chapter 7. In addition, the electrophysiological data 
from the studies in Chapters 3-7 are summarized in Appendix D. 
 
A.1. Protocol for Identification and Recording of Dorsal Horn Neurons 
1. In preparation for making spinal dorsal horn recordings, surgically expose the spinal 
cord, mount the rat on a stereotaxic frame, and instrument the rat for monitoring and 
control of body temperature and respiration (see Section 3.3.3 of Chapter 3 for 
detailed surgical methods) (Crosby et al., 2013; Crosby et al., 2014a).  
2. Initialize the Spike2 program (CED; Cambridge, UK) for data acquisition and record 
continuously for the duration of the recording session. The recording file should 
include one channel for input from the recording electrode in the spinal cord, one 
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channel for input from the load cell, and one channel to record keystrokes for internal 
notation. The Spike2 Training Course Manual includes detailed information for 
customization of data acquisition. 
3. Beginning at the C6 spinal cord, create a small hole in the pia mater using a sharp 
Dumont forceps, approximately midway in the mediolateral direction between the 
midline and the dorsal rootlets. Lower a carbon fiber electrode (Carbostar-1, Kation; 
Minneapolis, MN) using a micropositioner until the tip of the electrode reaches the 
surface of the spinal cord just above the hole in the pia mater.  
4. Brush the forepaw continuously with a cotton swab while slowly lowering the 
electrode into the spinal cord in increments of 25-50µm. Once a mechanically-evoked 
response is identified in the audio feedback from the electrode, optimize the position 
of the electrode to maximize the signal-to-noise ratio of the evoked response in the 
voltage channel of Spike2.  
5. Identify the location of the receptive field on the forepaw that evokes the maximal 
neuronal response and mark that location with a felt-tip pen to ensure that mechanical 
stimuli are applied consistently in that same location.  
6. Record the identification number of the neuron in the keystroke channel to denote the 
beginning of the stimulation protocol. Acquire 30 seconds of baseline spontaneous 
firing data by passively recording neuronal activity without mechanically stimulating 
the forepaw or moving the rat. 
7. Apply ten brush strokes to the plantar surface of the forepaw at the previously marked 
location in the receptive field of the neuron at a rate of approximately one stroke per 
second. Synchronize each brush stroke with a tap on the load cell to denote the time 
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of each brush stroke in the load cell channel. Wait 30 seconds before applying the 
next stimulus. 
8. Apply a series of von Frey filaments to the forepaw that span the range of the 
filaments used for behavioral testing (1.4, 4, 10, and 26g). Apply each filament five 
times for one second, with a one-second rest in between each application. Tap the 
load cell during each application to denote the time of the stimulation in the load cell 
channel. Wait 30 seconds between the applications of different filament strengths. 
9. Apply noxious pinch to the forepaw for ten seconds using a 60g vascular clip. Press 
the load cell during noxious pinch to denote the time of the stimulation in the load 
cell channel. 
10. Once pinch stimulation ends and the stimulation protocol is complete, continue 
lowering the electrode to search for another neuron. To avoid recording from the 
same neuron, a second evoked response in the same spinal cord location must be 
separated from the first recorded neuron by at least 100µm of depth, and/or have a 
different receptive field on the forepaw. If the electrode reaches the boundary of the 
dorsal horn approximately 1000µm below the pial surface, return to Step 3 and begin 
the search and recording protocol at a new location caudal to the previous hole in the 
pia mater. 
11. After recording 10-15 neurons from the C6/C7 spinal cord in each rat, terminate the 
surgery and collect the cervical spinal cord if tissue analysis will be performed. 
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A.2. Protocol for Sorting and Counting Spikes 
Once data collection is complete, spike sorting can be performed offline to 
identify and quantify firing from individual neurons. The Spike2 Training Course Manual 
provides a detailed tutorial for spike sorting, but a brief protocol is outlined here.  
1. The Spike2 file for each rat includes all neurons from a recording session. Export the 
voltage potential, load cell, and keyboard channels into a separate file for each 
individual neuron. 
2. Apply a digital bandpass filter to the voltage potential channel with a passband of 0.3-
3kHz. Create a new channel that contains the filtered voltage data. Perform all 
subsequent spike sorting steps on the filtered data. 
3. Identify a detection threshold in the voltage channel for identifying spikes. The 
threshold should be above the noise in the system, but low enough such that evoked 
spikes surpass the threshold. A detection threshold can also be set to detect the 
downward deflection of voltage potentials, below the noise level of the voltage 
recording. The threshold should be separately adjusted to an appropriate level for 
each individual neuron. 
4. Voltage potentials are sorted as individual spikes called WaveMarks, which can be 
counted to quantify neuronal firing. Create a new WaveMark channel to generate 
spike templates and sort the voltage potentials according to those templates. In the 
WaveMark dialogue box, set the detection threshold to the level identified in Step 3, 
and set the template width from -0.3ms to +0.4ms (Fig. A.1). Set the sensitivity of 
spike template generation and matching of evoked potentials to those templates using 
the settings in Fig. A.2. 
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Fig. A.2. Spike template parameter dialogue box. The parameters in the “New 
template” section of this dialogue box control the generation of spike templates based 
on the spike shapes detected in the voltage recording. Parameters in the section 
labeled “Matching a spike to a template” control the sensitivity of the matching of 
voltage potentials to spike templates. The parameter values displayed here were used 
for spike sorting in all of the studies in this thesis.  
 
 
 
 
Fig. A.1. Spike template detection. This dialogue box controls the detection of spikes 
and the creation of a new WaveMark channel. Set a detection threshold in the voltage 
channel to discriminate spikes from noise in the system. The detection threshold (red) 
should be adjusted for each individual neuron. Set the time range (green) to adjust the 
width of spike templates to -0.3ms to +0.4ms. 
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5. If Spike2 generates multiple similar templates, they can be combined by clicking and 
dragging one template and releasing it on top of the similar template in the 
WaveMark dialogue box. 
6. Choose the spike template that represents the neuronal firing evoked by mechanical 
stimulation of the forepaw. For quantification of the spikes, create a new channel that 
contains only the spikes assigned to that template. 
7. Quantify the number of spikes evoked by ten seconds of light brushing. Record the 
number of spikes in the two seconds immediately before brushing as the baseline 
spontaneous firing. 
a. Use the load cell channel to identify the beginning and end of each 
stimulus (Fig. A.3). Slide two vertical cursors to the beginning and end of 
the stimulation period to quantify the number of spikes in between the two 
cursors (Fig. A.3). 
8. Quantify the number of spikes evoked during the application of the von Frey 
filaments. Each evoked response includes the spikes during the one-second filament 
application plus the subsequent one-second rest period (Fig. A.3). Each filament 
weight, therefore, includes five separate evoked spike counts, one for each application 
of the filament (Fig. A.3). Record the number of spikes in the two seconds 
immediately before each filament weight as baseline spontaneous firing. 
9. Quantify the number of spikes evoked during ten seconds of noxious pinch. Record 
the number of spikes in the two seconds immediately before noxious pinch as the 
baseline spontaneous firing. 
10. Repeat Steps 2-9 for each individual neuron. 
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Fig. A.3. Quantification of evoked firing during von Frey filament stimulation. Shown 
is the Spike2 interface that is displayed after creation of a new WaveMark channel. 
Neuronal firing is shown for five applications of a von Frey filament, denoted by each 
displacement in the load cell channel (#1-5). Spontaneous firing is quantified in the 
two-second baseline period. Evoked firing is counted for each filament application, 
including the one-second stimulus plus the subsequent one-second rest period. 
Vertical cursors are used to mark the beginning and end of each filament application 
(shown here for filament application #5), and evoked spikes are counted for the time 
enclosed by the vertical cursors. 
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APPENDIX B 
 
Facet Joint Distraction Mechanics and Facet 
Capsule Strains 
 
 
This appendix includes the force, displacement, and strain data measured across 
the C6/C7 facet joint for each rat that underwent mechanical joint distraction. The load 
was measured by a load cell attached to the C7 forceps on the facet joint distraction 
device. Vertebral and capsule distraction magnitudes were determined during joint 
displacement based on the relative changes in the position of bead markers that were 
placed on the laminae of the C6 and C7 vertebrae and the C6/C7 facet capsule. Maximum 
and average maximum principal strains (MPS), strains in the rostral-caudal direction (x-
strain), and strains in the medial-lateral direction (y-strain) were also calculated on the 
surface of the facet capsule. Strains were calculated using LS-DYNA (LSTC; Livermore, 
CA) based on the relative positions of the bead markers on the facet capsule before joint 
displacement and at the time of maximum vertebral distraction, as described previously 
(Dong and Winkelstein, 2010; Lee et al., 2004b). 
In Table B.1, the mechanical data are presented for rats that were tested for 
hyperalgesia and neuronal hyperexcitability at 6 hours (Injury-6h) or 1 day (Injury-d1) 
after painful facet joint injury in the studies presented in Chapter 3. Table B.2 lists the 
mechanical data for all rats that underwent sham or painful facet joint injury followed by 
intra-articular injection of bupivacaine (BP) or saline vehicle (VEH) immediately (inj-
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BP0h, inj-VEH0h), 4 hours (inj-BP4h), 8 hours (inj-BP8h), 1 day (inj-BPd1) or 4 days 
(inj-BPd4, inj-VEHd4) after injury, in the studies presented in Chapter 4. Lastly, Table 
B.3 summarizes the mechanical data for the rats that underwent either physiologic or 
injurious facet joint loading with intrathecal TSP4 treatment three days prior to joint 
distraction in the studies presented in Chapter 5. 
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Table B.1. Facet joint distraction mechanics for rats that were tested for 
hyperalgesia at 6 hours or 1 day after painful facet joint injury (Chapter 3). 
  
Group Rat #
Load 
(N)
Vertebral 
Distraction 
(mm)
Average 
Capsule 
Distraction 
(mm)
Maximum 
MPS      
(%)
Average 
MPS    
(%)
Maximum              
x-strain 
(%)
Average                    
x-strain 
(%)
Maximum                 
y-strain 
(%)
Average                   
y-strain 
(%)
30 3.94 0.86 0.43 84.28 40.79 32.40 6.39 31.42 4.98
31 4.37 0.25 0.20 21.19 11.89 16.52 6.72 16.90 1.83
32 2.72 0.73 0.35 38.08 20.40 32.44 13.15 12.54 5.07
33 2.14 0.28 0.17 32.11 11.74 16.36 6.39 5.55 2.21
13 3.37 0.87 0.49 119.68 52.99 96.57 26.67 27.25 7.22
18 4.59 0.56 0.16 64.71 30.59 32.10 14.21 27.60 5.54
20 4.47 0.54 0.28 37.50 24.40 27.00 16.50 21.30 3.81
21 4.84 0.47 0.29 26.50 20.40 21.90 14.80 5.50 2.64
27 3.82 0.69 0.33 31.62 15.53 15.81 10.11 18.33 6.82
Injury-d1
Injury-6h
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Table B.2. Facet joint distraction mechanics for bupivacaine treatment study 
(Chapter 4). 
Group Rat #
Load 
(N)
Vertebral 
Distraction 
(mm)
Average 
Capsule 
Distraction 
(mm)
Maximum 
MPS (%)
Average 
MPS 
(%)
Maximum              
x-strain 
(%)
Average                    
x-strain 
(%)
Maximum                 
y-strain 
(%)
Average                   
y-strain 
(%)
45 4.58 0.70 0.28 22.0 17.4 21.1 15.5 8.8 1.2
48 4.45 0.77 0.28 18.7 13.7 11.5 5.8 10.4 5.2
50 5.51 0.46 0.38 36.1 25.3 33.0 16.8 17.4 2.6
52 5.10 0.66 0.24 36.2 25.8 18.7 14.5 15.9 8.1
53 3.76 1.07 0.48 62.4 33.2 44.4 26.5 12.1 3.8
54 4.21 0.83 0.41 44.7 38.1 32.2 22.3 5.7 -2.7
72 3.33 0.76 0.35 15.8 13.5 14.1 11.2 4.3 -1.0
52a 3.50 0.65 0.35 40.0 30.8 30.8 18.9 7.4 0.5
54a 3.36 0.80 0.44 63.3 43.1 41.5 29.5 7.2 -0.9
66 3.04 0.65 0.37 22.7 19.2 19.4 13.6 -1.1 -2.8
69 2.38 0.73 0.40 38.3 34.8 22.6 18.5 5.3 1.1
71 3.05 0.65 0.24 29.6 27.8 9.6 7.9 16.7 13.0
41 4.89 0.66 0.29 53.4 26.1 23.0 9.9 10.5 3.8
42 4.03 0.63 0.23 93.8 33.6 49.0 18.3 48.0 6.7
43 4.47 0.89 0.38 85.9 28.7 70.4 18.1 25.8 4.6
46 5.09 0.60 0.31 27.9 18.3 24.4 13.6 13.0 6.0
49 4.59 0.86 0.31 28.9 19.4 24.0 12.7 12.7 3.7
51 2.95 1.09 0.24 54.8 38.9 29.4 17.3 33.0 5.3
88 2.73 1.11 0.89 123.7 76.4 89.4 52.4 29.6 10.1
89 3.50 0.64 0.30 27.2 22.2 19.2 12.0 16.8 8.6
90 3.84 0.62 0.25 29.9 19.6 15.9 13.6 22.6 7.5
91 3.18 0.73 0.15 46.8 30.4 34.1 10.5 33.2 12.1
92 3.39 0.74 0.28 23.1 17.9 18.7 11.7 16.8 10.6
93 3.60 0.58 0.27 55.3 27.8 29.0 11.2 44.5 14.3
117 3.30 0.66 0.23 23.5 15.1 18.1 10.2 3.3 -1.7
118 3.16 0.57 0.43 106.5 42.3 106.2 40.7 6.9 -4.1
111 3.31 0.70 0.37 59.6 36.7 55.3 22.4 18.9 10.1
112 3.05 0.73 0.45 18.8 16.8 35.9 15.1 6.0 -7.8
113 3.77 0.45 0.19 55.0 23.4 12.6 5.3 37.0 10.1
114 3.16 0.90 0.44 52.9 34.3 31.7 23.2 25.5 4.6
124 3.28 0.54 0.37 34.4 17.8 31.4 14.9 2.7 -0.4
125 2.62 0.99 0.60 54.4 30.5 51.1 27.6 6.8 -7.0
126 3.06 0.71 0.27 39.3 24.9 25.5 13.0 32.3 3.5
127 2.89 0.71 0.32 61.2 23.9 57.8 16.6 7.5 2.1
128 3.63 0.57 0.40 78.3 24.6 78.0 20.7 2.0 -4.7
82 4.14 0.58 0.26 35.2 21.3 17.6 11.3 27.6 10.3
83 3.68 0.66 0.20 81.0 42.0 33.8 18.9 33.0 8.2
84 4.08 0.53 0.15 43.6 22.4 9.3 4.2 35.7 15.3
85 3.33 0.60 0.21 35.3 21.4 21.4 12.0 9.8 5.8
86 3.76 0.45 0.21 37.4 18.7 29.3 9.2 35.3 9.5
87 3.19 0.76 0.37 25.1 17.0 25.0 14.0 8.4 0.8
119 2.94 1.01 0.61 73.8 57.2 69.8 51.0 7.3 -3.1
120 2.94 0.70 0.37 22.7 18.2 20.9 13.9 8.9 1.8
122 3.68 0.49 0.23 19.2 13.3 17.6 10.1 6.6 -0.5
53a 3.83 0.53 0.29 43.2 22.3 42.9 14.9 17.5 4.0
56 3.20 0.78 0.35 30.4 25.9 17.5 15.2 3.3 1.4
63 3.87 0.55 0.17 21.2 15.9 15.1 8.8 11.1 5.2
64 2.93 0.89 0.52 70.1 53.7 30.0 18.1 15.8 1.7
67 3.03 0.54 0.24 15.2 12.8 10.1 8.6 8.3 4.4
70 4.11 0.51 0.28 21.3 15.9 8.7 6.4 12.6 5.9
inj-BP8h
inj-BPd1
inj-BP0h
inj-VEH0h
inj-BPd4
inj-VEHd4
inj-BP4h
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Table B.3. Facet joint distraction mechanics for TSP4 treatment study (Chapter 5). 
 
  
Group Rat #
Load 
(N)
Vertebral 
Distraction 
(mm)
Average 
Capsule 
Distraction 
(mm)
Maximum 
MPS (%)
Average 
MPS (%)
Maximum              
x-strain 
(%)
Average                    
x-strain 
(%)
Maximum                 
y-strain 
(%)
Average                   
y-strain 
(%)
245 1.35 0.14 0.12 6.9 4.7 2.5 0.9 6.4 2.0
246 0.72 0.21 0.10 11.4 7.1 0.8 -1.2 11.2 5.2
247 0.71 0.41 0.11 31.8 17.0 24.0 2.2 2.8 -14.0
248 1.12 0.07 0.13 0.0 -2.5 24.6 4.3 19.8 10.1
271 1.68 0.20 0.18 25.8 14.0 18.4 9.3 2.0 -1.1
274 1.39 0.25 0.12 10.2 9.2 6.5 4.7 4.6 1.8
275 1.46 0.22 0.12 9.9 8.8 7.6 6.6 2.5 2.2
280 1.53 0.12 0.05 8.8 6.8 2.5 -1.2 2.3 -0.3
282 1.76 0.21 0.13 12.8 9.3 10.0 6.1 4.7 3.3
283 1.93 0.16 0.09 8.5 6.8 5.4 3.7 6.0 -0.2
284 2.08 0.13 0.09 6.5 4.2 2.5 2.2 0.4 -3.0
288 1.70 0.25 0.12 12.6 9.4 6.9 5.3 4.7 -0.4
289 1.39 0.27 0.12 15.0 11.6 7.7 5.6 8.1 3.7
290 1.55 0.30 0.14 13.8 10.1 9.5 6.1 1.6 0.5
296 1.35 0.36 0.21 10.2 9.1 9.6 7.1 0.4 -2.3
297 2.26 0.06 0.05 3.1 1.9 1.5 0.6 1.4 1.1
298 1.33 0.25 0.14 8.3 7.6 6.4 2.7 4.2 2.4
299 1.61 0.13 0.09 3.8 2.8 3.1 1.9 0.6 -1.2
226 3.18 0.57 0.27 24.6 14.8 38.2 16.8 7.0 1.9
227 3.63 1.25 0.34 34.2 22.3 30.5 14.8 7.0 1.9
228 3.54 0.94 0.42 60.4 33.9 36.9 25.7 20.5 0.2
253 3.17 0.67 0.38 36.3 27.5 14.6 8.3 17.6 10.6
254 3.81 0.65 0.31 26.7 21.6 19.9 16.2 -2.1 -7.8
255 3.65 0.58 0.41 33.9 25.2 31.3 22.8 -0.6 -4.4
256 4.48 0.78 0.17 18.1 15.7 12.6 1.9 10.3 5.8
257 4.13 0.49 0.13 40.5 31.3 12.3 3.1 19.5 11.2
258 3.77 0.50 0.23 25.0 21.0 11.6 8.3 10.7 6.6
259 4.05 0.59 0.28 35.8 29.7 24.5 18.1 8.6 4.3
260 3.35 0.77 0.38 29.6 24.9 21.6 19.4 16.7 6.1
261 4.08 0.61 0.47 64.6 36.6 32.1 20.6 8.3 -12.8
262 4.04 0.41 0.18 12.0 10.1 8.6 7.3 0.4 -2.6
263 3.04 0.81 0.47 98.9 60.4 67.7 35.6 9.9 6.5
264 4.02 0.53 0.13 27.7 19.0 10.2 7.1 17.9 10.9
281 3.55 0.58 0.29 26.6 24.0 20.3 15.7 7.1 6.1
291 3.27 0.66 0.29 26.6 22.8 14.0 11.4 6.8 4.8
292 3.44 0.76 0.45 93.4 42.9 49.7 30.6 6.7 -2.4
293 3.84 0.54 0.18 27.3 16.4 9.7 7.9 11.3 1.8
Injurious 
Joint 
Loading
Physiologic 
Joint 
Loading
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APPENDIX C 
 
Mechanical Hyperalgesia after Facet Joint Injury  
 
 
This appendix summarizes the results for the assessment of mechanical 
hyperalgesia for each rat included in the studies in Chapters 3-7. Mechanical hyperalgesia 
is reported as the average of the left and right paw withdrawal thresholds (PWT) for each 
rat over three rounds of testing on each day. Table C.1 details the PWTs at baseline and 
at 6 hours or day 1 after a sham or painful facet joint injury (Chapter 3). Table C.2 
includes PWTs for the rats that underwent sham or painful facet joint injury followed by 
intra-articular bupivacaine (BP) or vehicle (VEH) injections immediately (inj-BP0h, inj-
VEH0h, sham-VEH0h), or at 4 hours (inj-BP4h), 8 hours (inj-BP8h), day 1 (inj-BPd1), or 
day 4 (inj-BPd4, inj-VEHd4, sham-VEHd4) after injury, for the studies presented in 
Chapter 4. For those studies, hyperalgesia was assessed prior to injury (BL) and on days 
1, 3, 5, and 7 after injury.  
The PWTs for the rats that underwent sham or painful facet joint injury for the 
characterization of DRG and spinal TSP4 expression at day 1 or day 7 after injury in 
Chapter 5 are summarized in Table C.3. Those rats were originally tested by Ling Dong 
and the behavioral responses have been previously published (Dong et al., 2011; Dong et 
al., 2012; Dong and Winkelstein, 2010). The PWTs for the rats that received daily 
intrathecal TSP4 antisense or mismatch oligonucleotides beginning three days before 
painful facet joint injury (Chapter 5) are presented in Table C.4. For those studies, 
 234 
hyperalgesia was assessed through day 7 after the injury. Table C.5 details the PWTs at 
baseline, day 1, and day 7 after painful facet joint injury for the rats that received 
gabapentin (Inj-GBP) or vehicle treatment (Inj-VEH) in the studies presented in Chapter 
5 that evaluate the effect of gabapentin on TSP4-induced synaptogenesis. Those rats were 
originally tested by Ling Dong and the behavioral responses were previously published 
(Dong et al., 2013a). The PWTs for the rats that received intrathecal injection of 20µg, 
30µg, 45µg, or 60µg TSP4 or 60µg StrepII peptide to characterize the dose-response of 
TSP4 and mechanical hyperalgesia (Chapter 5) are listed in Table C.6. Hyperalgesia was 
assessed daily for ten days following injections.  
Based on the PWTs in Table C.6, two doses were identified for use in the TSP4 
treatment studies reported in Chapter 5 to evaluate the role of increased spinal TSP4 in 
facilitating spinal hyperexcitability after facet joint loading – a non-sensitizing dose 
(20µg) and a sensitizing dose (60µg). Table C.7 presents the PWTs for the rats in those 
studies that received a single intrathecal injection of 20µg or 60µg TSP4 after baseline 
testing, three days before either a sham, physiologic (Phys), or injurious (Inj) loading of 
the facet joint (20µg TSP4+Sham, 20µg TSP4+Phys, 60µg TSP4+Sham, 60µg 
TSP4+Phys, 60µg TSP4+Inj). Hyperalgesia was then assessed on days 1, 3, 5, and 7 after 
joint loading. Separate rats received 60µg intrathecal injections of StrepII peptide prior to 
sham or physiologic loading of the facet joint (60µg StrepII+Sham, 60µg StrepII+Phys), 
to control for the presence of the StrepII tag on the recombinant TSP4 protein. Lastly, 
Table C.8 details the PWTs for the rats included in the studies in Chapter 7 using burst or 
tonic spinal cord stimulation; painful facet joint injury was applied seven days before 
 235 
spinal cord stimulation, and hyperalgesia was assessed at baseline (BL) and on days 1, 3, 
5, and 7 after injury. 
 
Table C.1. Paw withdrawal thresholds at 6 hours or day 1 after sham or painful 
facet joint injury (Chapter 3).   
Group Rat # BL 6h 
6 hours 
Sham 
34 12.50 18.83 
37 15.17 10.67 
38 9.17 17.00 
39 7.67 5.33 
Injury 
30 8.33 9.33 
31 4.67 6.00 
32 14.33 14.00 
33 7.00 11.67 
Group Rat # BL D1 
Day 1 
Sham 
6 26.00 26.00 
17 24.78 26.00 
24 6.33 3.33 
26 4.50 5.67 
28 8.00 6.00 
29 18.67 9.67 
Injury 
13 8.78 3.67 
18 22.33 11.17 
20 4.00 2.33 
21 7.67 8.83 
27 19.67 7.67 
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Table C.2. Paw withdrawal thresholds for bupivacaine treatment study (Chapter 4). 
Group Rat # BL D1 D3 D5 D7 
inj-
VEH0h 
45 18.40 5.33 5.00 5.00 9.33 
48 12.50 10.67 6.50 6.33 5.00 
50 10.00 5.00 4.33 8.00 6.00 
52 7.83 1.60 2.47 1.80 1.70 
53 8.25 4.00 3.43 4.00 3.33 
54 6.25 2.13 2.23 2.23 2.13 
72 17.33 6.67 6.00 7.67 7.67 
sham-
VEH0h 
78 14.75 11.83 11.00 11.83 16.83 
79 7.83 6.00 8.67 8.33 8.33 
80 14.25 9.50 11.50 16.83 8.83 
81 8.50 10.67 10.33 10.67 10.33 
133 8.92 11.00 10.50 11.33 16.00 
134 12.33 10.50 12.67 9.33 11.00 
inj-
BP0h 
41 16.75 10.17 14.33 13.33 16.83 
42 11.20 7.67 7.67 5.33 10.33 
43 12.30 12.50 7.00 7.67 5.67 
46 7.17 8.00 8.33 7.00 9.17 
49 9.86 4.67 6.50 7.00 6.67 
51 20.08 6.50 15.17 13.33 10.17 
inj-
VEHd4 
52 13.42 7.00 6.33 7.00 6.67 
54a 7.58 3.33 9.17 3.67 5.00 
65 7.83 2.90 4.67 4.67 3.67 
66 10.50 3.33 4.67 5.33 5.33 
69 20.50 6.33 8.00 5.67 4.00 
71 14.75 5.00 8.00 7.67 7.67 
sham-
VEHd4 
135 12.42 12.50 12.67 13.00 11.33 
136 10.00 11.50 9.00 9.00 10.17 
137 14.75 13.00 12.17 10.67 9.33 
138 12.00 12.17 14.17 10.67 13.00 
139 12.08 11.33 12.17 11.83 11.83 
140 13.83 13.67 12.50 16.17 16.83 
inj-
BPd4 
53 18.33 5.00 8.83 10.17 7.00 
56 11.94 7.33 8.00 6.00 6.67 
63 23.25 5.67 15.83 7.00 6.00 
64 17.00 9.83 9.33 8.00 6.50 
67 17.92 4.67 6.33 7.00 3.67 
70 7.67 1.70 3.00 2.67 2.03 
inj-
BP4h 
91 8.42 7.67 8.67 9.00 7.00 
92 9.92 7.67 8.67 9.00 8.33 
93 16.50 14.17 14.17 16.00 11.33 
117 8.00 7.83 8.33 9.75 8.83 
118 17.00 19.67 16.00 13.75 17.83 
inj-
BP8h 
124 10.17 3.33 2.50 4.00 4.00 
125 16.92 9.75 7.33 4.67 5.67 
126 16.83 8.50 7.00 8.00 7.00 
127 13.83 8.50 7.00 7.00 7.00 
128 11.67 7.50 12.50 7.00 7.00 
inj-
BPd1 
83 7.50 4.00 1.50 1.50 1.50 
86 13.33 5.00 2.67 4.33 3.00 
87 18.75 11.83 19.00 14.33 14.50 
119 10.08 5.67 6.33 5.50 5.00 
120 22.42 7.67 6.67 8.00 6.00 
122 9.92 6.00 3.00 4.00 5.00 
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Table C.3. Paw withdrawal thresholds after sham or painful facet joint injury for 
characterization of TSP4 expression (Chapter 5). 
Group Rat # BL D1 D3 D5 D7 
Sham 
LD50 25.39 24.17 22.33 26.00 23.33 
LD55 17.25 18.83 17.00 15.17 15.17 
LD56 25.08 26.00 24.17 24.17 26.00 
LD60 16.92 18.67 15.17 19.67 18.67 
LD252 14.17 8.33 12.50 11.00 10.17 
LD253 13.00 12.50 14.17 14.17 14.17 
LD256 16.83 11.33 9.83 14.00 14.17 
LD257 7.83 6.33 8.83 8.83 7.33 
LD262 16.83 14.17 8.67 10.17 13.83 
LD263 13.33 14.17 8.67 12.50 12.17 
LD267 14.17 19.67 18.67 12.17 12.50 
LD270 24.17 20.50 13.33 15.00 15.17 
LD272 18.67 16.00 --- --- --- 
LD274 8.33 8.50 --- --- --- 
LD275 14.33 16.00 --- --- --- 
LD281 16.83 16.00 --- --- --- 
LD293 18.67 17.00 --- --- --- 
LD300 16.00 11.50 --- --- --- 
Injury 
 
LD47 15.17 7.00 4.00 5.00 3.67 
LD48 17.33 5.67 7.67 8.33 8.00 
LD49 18.25 8.00 8.33 7.00 7.67 
LD52 21.72 6.33 8.33 8.67 7.00 
LD53 18.58 12.50 9.50 7.00 8.67 
LD54 9.75 4.57 3.57 4.33 5.67 
LD254 13.33 6.33 7.33 9.83 10.17 
LD255 15.17 13.00 11.83 8.00 7.00 
LD248 15.00 5.33 6.33 4.67 6.67 
LD249 9.33 3.67 5.00 2.67 2.67 
LD264 16.83 4.67 3.33 2.90 3.67 
LD265 17.83 9.67 7.00 6.00 8.33 
LD266 20.50 9.00 10.83 10.50 10.67 
LD268 26.00 6.33 5.33 5.33 8.00 
LD271 16.83 5.67 5.33 6.00 6.67 
LD273 8.67 4.67 --- --- --- 
LD278 15.17 5.33 --- --- --- 
LD279 6.67 2.57 --- --- --- 
LD280 11.00 3.67 --- --- ---  
LD287 20.50 10.33 --- --- ---  
LD292 12.50 6.67 --- --- ---  
LD296 12.50 9.50 --- --- ---  
LD299 12.17 6.00 --- --- ---  
Note – Spinal cord and DRGs were harvested on day 1 from rats #272-300 in the Sham 
group and rats #273-299 in the Injury group, so those rats only underwent behavioral 
testing at baseline (BL) and post-operative day 1 (D1). Rat numbers in this table refer to 
animals originally tested and presented by Ling Dong (LD) (Dong et al., 2011; Dong et 
al., 2012; Dong and Winkelstein, 2010). 
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Table C.4. Paw withdrawal thresholds after painful facet joint injury with 
administration of TSP4 antisense or mismatch oligonucleotides (Chapter 5). 
Group Rat # BL D-2 D-1 D0 D1 D3 D5 D7 
Injury + TSP4 
Antisense    
Oligonucleotides 
229 14.67 14.83 14.17 13.33 13.33 14.17 10.17 9.17 
236 10.75 8.33 8.67 8.33 7.00 8.00 8.00 8.00 
231 10.33 12.17 13.33 13.00 11.00 10.17 10.17 9.83 
237 15.08 13.75 16.00 13.75 12.50 12.00 12.00 12.50 
241 14.67 12.50 12.50 13.75 13.33 10.50 11.25 10.17 
253 17.75 20.50 15.25 12.50 17.50 15.00 14.17 14.17 
254 12.50 10.00 9.50 10.00 9.67 9.33 10.83 9.00 
255 13.42 15.00 15.00 15.00 12.17 18.67 18.67 17.83 
256 12.00 13.00 13.75 15.00 14.17 12.17 12.67 12.67 
259 14.25 13.33 12.50 15.00 11.67 9.00 11.67 12.50 
260 9.33 9.83 15.00 11.25 12.50 15.17 14.33 11.33 
Injury + TSP4 
Mismatch          
Oligonucleotides 
232 13.58 15.00 16.83 13.33 7.33 7.33 4.00 3.67 
233 15.08 16.00 13.33 16.83 6.33 7.00 7.33 7.33 
234 8.17 8.67 9.00 9.50 4.33 3.00 4.00 3.33 
238 9.83 9.50 11.25 10.75 6.67 4.33 4.00 6.33 
239 12.92 15.00 13.75 13.75 8.00 7.50 5.00 8.33 
240 12.83 12.00 12.50 12.00 5.33 6.33 7.00 4.67 
257 12.33 12.50 13.75 12.50 5.33 6.00 6.00 6.33 
258 13.17 19.25 16.50 16.50 7.33 9.83 8.00 6.00 
261 11.75 9.00 7.00 15.25 3.00 3.33 3.00 3.00 
262 9.42 10.75 13.75 8.00 5.33 4.33 3.00 5.00 
263 14.67 13.75 17.75 15.00 6.67 7.00 6.33 7.67 
264 13.33 13.75 12.50 10.75 6.33 4.00 5.00 5.33 
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Table C.5. Paw withdrawal thresholds for gabapentin treatment study (Chapter 5). 
Group Rat # BL D1 D3 D5 D7 
Inj-GBP 
LD301 14.83 10.50 14.17 17.83 14.17 
LD303 11.67 9.67 10.00 9.67 10.50 
LD305 16.83 9.00 11.67 16.00 12.50 
LD306 14.17 11.67 13.00 12.17 9.67 
LD307 12.17 7.33 9.83 13.33 8.67 
LD308 12.17 7.00 11.67 16.00 13.33 
LD355 9.33 7.33 8.67 8.67 7.00 
LD356 8.00 8.00 14.17 12.50 16.83 
Inj-VEH 
LD302 15.17 7.00 7.33 6.00 7.00 
LD304 13.00 6.00 6.33 3.67 3.67 
LD337 17.83 4.67 5.33 6.33 5.00 
LD338 15.17 7.00 9.33 9.67 8.00 
LD339 10.83 3.67 5.00 4.67 5.33 
LD341 10.17 4.67 4.33 5.67 5.67 
LD357 13.33 7.67 7.00 7.00 8.83 
LD358 11.67 4.33 5.67 5.33 6.33 
LD359 11.67 8.00 6.33 5.67 4.00 
Note – Rat numbers in this table refer to animals originally tested and presented by Ling 
Dong (LD) (Dong et al., 2013).  
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Table C.6. Paw withdrawal thresholds for TSP4 dose-response study (Chapter 5). 
 
Rat # BL D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 
20µg 
TSP4 
141 9.33 14.17 9.75 12.00 15.00 9.50 13.75 15.00 14.17 13.75 13.33 
142 11.33 14.33 5.00 12.00 12.50 15.00 13.75 13.75 10.00 13.25 13.33 
143 11.33 11.00 3.50 13.75 15.00 13.75 12.00 9.50 11.83 10.75 13.33 
202 11.88 10.75 7.50 11.25 11.50 7.00 10.75 10.75 10.75 12.00 15.00 
204 11.50 5.50 10.00 12.00 5.50 6.50 8.50 7.50 6.00 7.00 7.50 
206 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 
30µg 
TSP4 
186 8.83 7.50 4.50 9.00 8.00 8.00 6.50 6.50 6.00 --- 7.50 
187 10.17 7.50 6.50 5.50 7.00 3.50 7.00 7.00 9.00 --- 8.00 
188 10.17 7.00 7.00 7.50 6.00 7.00 9.50 7.00 12.00 --- 9.75 
190 12.63 8.50 7.50 7.50 7.00 4.50 7.50 9.00 8.00 10.25 8.00 
192 13.75 10.75 8.50 8.00 8.50 8.50 8.50 15.00 9.00 15.00 15.00 
194 7.75 6.00 6.50 5.50 5.00 6.00 7.50 8.00 8.00 7.50 7.00 
45µg 
TSP4 
144 13.33 8.67 10.25 9.50 6.00 10.25 4.50 7.50 11.00 10.75 10.17 
145 15.00 12.17 10.75 7.50 9.75 13.25 10.25 9.75 12.50 13.75 14.17 
146 8.33 6.33 11.25 8.00 6.50 12.00 9.75 10.00 12.67 12.50 9.83 
201 11.38 8.50 7.00 7.00 6.00 6.00 7.00 7.50 12.50 12.50 12.50 
203 7.75 6.00 4.50 4.00 4.00 2.00 3.00 4.50 10.25 5.00 6.50 
205 7.50 3.50 4.50 6.00 3.00 4.50 7.00 8.50 7.50 15.00 10.25 
60µg 
TSP4 
183 8.67 6.00 6.50 2.50 5.00 4.00 4.50 7.00 7.00 --- 6.50 
184 10.67 7.50 4.00 3.50 7.00 6.00 8.00 9.00 8.50 --- 8.50 
185 13.33 12.50 8.50 4.50 5.00 6.00 5.50 6.00 8.00 --- 8.50 
189 11.63 7.50 9.00 8.00 7.00 6.50 7.00 8.00 8.00 9.50 9.00 
191 7.75 7.00 5.00 3.00 2.50 6.00 4.00 7.00 8.00 8.00 8.00 
193 7.00 4.50 2.50 3.50 2.50 2.50 4.50 4.50 6.00 7.00 6.00 
60µg 
StrepII  
195 15.00 13.75 12.50 13.75 12.50 12.00 12.50 12.50 13.75 15.00 12.50 
196 8.75 7.50 9.00 7.50 8.00 8.50 8.50 9.00 8.00 9.00 9.00 
197 8.50 8.50 13.25 9.75 7.00 8.50 8.00 6.00 5.50 5.50 6.50 
198 15.00 15.00 12.50 12.50 12.50 12.50 13.75 11.25 10.25 8.50 11.25 
199 9.38 13.75 13.75 13.75 13.75 15.00 15.00 15.00 15.00 15.00 15.00 
200 7.50 13.75 12.00 12.00 12.50 13.75 11.25 15.00 15.00 11.25 10.75 
Note – Hyperalgesia responses on day 9 for rats #183-188 are not available due to the 
confounding effects of excessive noise in the behavior testing environment. 
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Table C.7. Paw withdrawal thresholds for TSP4 treatment study (Chapter 5). 
 Rat # BL D-2 D-1 D0 D1 D3 D5 D7 
20µg TSP4 + 
Sham 
272 9.00 9.50 11.25 13.75 12.50 15.00 10.50 12.00 
273 11.83 12.50 12.00 12.50 12.50 10.50 13.33 13.75 
302 8.33 8.00 8.00 10.00 8.67 10.00 7.33 8.00 
303 9.75 9.00 9.50 12.50 9.17 8.00 12.17 9.00 
304 10.58 13.75 12.50 12.50 13.33 12.50 12.50 13.75 
305 12.17 15.00 11.25 13.75 12.17 12.00 14.17 15.00 
20µg TSP4 + 
Phys 
243 9.92 9.33 11.50 9.17 5.00 4.33 4.00 3.67 
246 9.50 8.67 11.25 10.83 7.00 5.33 4.67 5.67 
248 14.17 14.17 13.75 14.17 7.00 8.67 10.17 8.33 
274 14.17 13.75 13.75 13.75 7.33 5.00 5.33 6.33 
282 12.42 12.17 12.00 13.75 11.83 6.33 5.33 6.00 
283 14.58 15.00 15.00 13.75 14.17 9.00 5.67 4.33 
284 9.00 .9.00 9.50 8.50 8.67 4.00 3.33 2.67 
60µg TSP4 + 
Sham 
277 12.33 6.00 9.00 7.50 9.33 8.67 11.33 11.83 
278 9.50 6.00 3.50 3.00 2.67 4.67 6.67 6.67 
279 13.33 9.00 7.00 5.50 6.33 8.67 9.50 9.83 
285 13.33 8.83 6.50 6.00 5.67 7.67 10.50 10.50 
286 11.42 5.33 5.50 4.50 3.33 3.67 6.00 4.33 
287 14.58 7.67 9.00 8.00 8.33 9.00 11.67 12.17 
60µg TSP4 + 
Phys 
244 13.75 7.00 7.00 4.67 5.00 7.00 6.00 4.00 
245 14.58 10.17 8.50 9.83 7.00 7.33 6.67 8.00 
280 11.83 7.00 3.50 4.50 2.33 1.90 2.03 1.70 
288 8.50 5.00 4.50 3.50 3.33 3.67 2.67 3.33 
289 12.75 13.25 7.00 8.50 5.33 8.00 6.33 6.33 
290 10.92 5.50 5.50 5.00 4.00 4.33 4.33 2.67 
60µg TSP4 +  
Inj 
223 14.17 8.00 7.83 6.67 7.67 4.33 6.33 4.33 
227 11.33 11.83 5.33 9.83 4.33 4.00 3.33 2.67 
281 8.50 5.50 4.00 3.50 3.67 4.00 2.80 3.23 
291 14.58 7.50 7.00 6.00 7.33 5.67 7.00 5.33 
292 10.33 4.50 2.50 3.00 3.33 3.00 3.67 2.67 
293 14.17 9.00 7.50 7.50 8.00 7.67 5.67 8.33 
60µg StrepII 
+ Sham  
270 8.33 7.50 6.50 6.50 7.00 7.67 7.67 8.00 
276 15.00 15.00 15.00 15.00 14.17 15.00 15.00 14.17 
294 10.67 11.25 13.75 12.50 12.50 14.17 13.33 13.75 
295 14.58 12.50 10.75 15.00 15.00 13.33 14.17 13.75 
300 13.33 12.50 13.75 15.00 12.67 13.75 14.17 13.25 
301 12.33 8.50 12.00 8.50 9.67 12.50 10.83 12.00 
60µg StrepII 
+ Phys 
271 11.33 12.50 13.75 12.00 12.50 12.17 12.50 13.75 
275 13.33 12.00 9.00 10.25 9.83 7.67 8.67 9.50 
296 14.17 13.75 13.75 13.75 15.00 14.17 15.00 15.00 
297 9.17 9.75 11.25 13.25 9.67 10.17 9.67 9.00 
298 14.58 12.50 8.50 12.50 9.33 13.33 11.67 13.25 
299 13.17 13.75 13.75 13.25 15.00 13.33 13.33 15.00 
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Table C.8. Paw withdrawal thresholds after painful facet joint injury for spinal cord 
stimulation at day 7 (Chapter 7). 
 
Rat # BL D1 D3 D5 D7 
Injury 
213 12.42 5.67 5.67 4.00 3.33 
214 14.50 6.33 7.33 8.00 9.17 
217 8.00 2.33 3.33 3.00 2.67 
218 13.75 7.33 6.33 4.00 2.67 
219 7.17 2.00 2.33 2.67 3.00 
220 17.00 6.33 8.17 7.67 7.00 
221 14.17 5.67 6.00 5.33 4.67 
222 8.17 3.23 2.33 2.67 3.33 
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APPENDIX D 
 
Quantification of Dorsal Horn Neuronal Firing  
 
 
This appendix lists the dorsal horn neuronal firing data for all of the rats in the 
studies presented in Chapters 3-7. A detailed protocol for the recording and analysis of 
these electrophysiological data is included in Appendix A. In the following tables, 
neurons are listed by the group and rat from which they were recorded. The depth column 
indicates the location depth in the dorsal horn where the electrode was placed for 
recording each neuron (µm below the pial surface of the spinal cord). The evoked spike 
counts are listed for each mechanical stimulus applied to the forepaw of each rat, 
including ten seconds of light brushing (Brush), five applications of each of four different 
von Frey (vF) filaments (1.4g, 4g, 10g, and 26g), and ten seconds of noxious pinch 
(Pinch). Baseline firing counts (BL) are presented for each mechanical stimulus as well. 
Missing cells in each table reflect that, for those neurons, the signal was lost during 
recording before completing the stimulation protocol. 
Table D.1 lists the spike counts for the neurons recorded at 6 hours or day 1 after 
sham (Sham 6h, Sham D1) or painful facet joint injury (Injury 6h, Injury D1), in the 
studies presented in Chapter 3. Table D.2 presents the neuronal firing data on day 7 for 
the rats that underwent sham or painful facet joint injury followed by intra-articular 
bupivacaine (BP) or vehicle (VEH) injections immediately (inj-BP0h, inj-VEH0h, sham-
VEH0h), or at 4 hours (inj-BP4h), 8 hours (inj-BP8h), day 1 (inj-BPd1), or day 4 (inj-
 244 
BPd4, inj-VEHd4, sham-VEHd4) after injury (from Chapter 4). Table D.3 details the 
neuronal firing data on day 7 for the rats that received intrathecal TSP4 treatments (20µg 
or 60µg) followed by sham, physiologic (Phys), or injurious (Inj) loading of the facet 
joint (20µg+Phys; 60µg+Phys; 60µg+Inj), for the studies presented in Chapter 5. That 
table also includes neuronal firing data on day 7 for the rats that received intrathecal 
injections of 60µg StrepII peptide before sham surgery (Strep+Sham). 
Table D.4 lists the neuronal firing data for the optimization of the burst spinal 
cord stimulation (SCS) parameters on day 7 after painful nerve root compression in the 
studies presented in Chapter 6. The Stim Number column refers to the order in which 
each set of SCS parameters was applied to the neuron. The SCS parameters included 
pulse number (Pulse #), pulse frequency (Pulse Hz), pulse width (Pulse Width), burst 
frequency (Burst Hz), and amplitude (Amplitude). The charge per burst is also listed for 
each of the SCS parameter sets. In addition, the waveform identification codes from 
Spike2 (Spike2 Waveform ID) are presented for each neuron. The spikes associated with 
multiple waveforms were counted together if they corresponded to the same recorded 
neuron, and the waveform codes are indicated together (i.e., 01+02). Detailed methods 
for sorting spikes and combining waveforms are summarized in Appendix A.  
Neurons were classified as wide dynamic range (WDR), if they fired in response 
to non-noxious and noxious stimuli, or high threshold (HT), if they fired only in response 
to noxious stimuli. Neurons that did not exhibit characteristic WDR or HT firing patterns 
were not classified (NC). Finally, baseline spontaneous firing (BL) and pre-SCS and 
post-SCS spike counts are listed based on the neuronal firing recorded in response to ten 
seconds of noxious pinch before and immediately following burst SCS. 
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Tables D.5-D.8 list the spike counts for all of the neurons recorded in the studies 
of burst and tonic SCS presented in Chapter 7. In each table, the spike counts are listed 
for each neuron during pre-SCS stimulation consisting of ten seconds of light brushing 
(Br), five applications of the 1.4g von Frey filament (1.4g vF) and the 26g von Frey 
filament (26g vF), and ten seconds of noxious pinch (Pinch). Baseline spontaneous firing 
counts are included for each mechanical stimulus (BL). Spike counts are also listed for 
1.4g, 26g, and pinch stimuli applied at 0, 2, 5, 10, and 15 minutes post-SCS. Table D.5 
lists the neuronal firing data after burst or tonic SCS on day 7 following painful nerve 
root compression. Table D.6 presents the spike counts after burst or tonic SCS on day 7 
following painful nerve root compression with spinal superfusion of the GABAA receptor 
antagonist, bicuculline. Table D.7 presents the spike counts after burst or tonic SCS on 
day 7 following painful nerve root compression with spinal superfusion of the GABAB 
receptor antagonist, CGP35348. Lastly, Table D.8 details the spike counts after burst or 
tonic SCS on day 7 following painful facet joint injury, for studies presented in in 
Chapter 7. 
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Table D.1. Spike counts at 6 hours or 1 day after sham or painful facet injury 
(Chapter 3).   
 
Note – Table is continued on the next page. 
 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
34 2 630 2 68 5 4 9 5 4 8 6 14 8 6 6 8 6 8 9 9 16 6 3 21 24 25 27 20 3 110
34 3 470 0 48 0 2 2 2 0 2 0 5 2 5 6 4 0 5 7 3 4 8 0 4 8 4 2 8 0 73
34 4 600 3 163 9 23 12 23 6 17 8 40 37 44 24 23 9 53 23 31 18 10 9 36 13 10 2 6 0 5
34 6 530 3 103 2 26 19 9 22 15 0 13 10 12 5 0 0 18 14 13 21 12 2 11 17 18 10 3 0 29
34 7 610 0 205 10 25 21 15 20 18 10 49 24 27 26 26 5 62 51 40 31 35 7 64 45 74 52 39 0 263
34 8 480 0 140 0 11 3 6 6 5 0 14 10 9 16 18 0 23 14 19 11 7 0 4 20 35 15 23 0 13
37 1 800 13 117 9 12 13 17 13 8 12 18 15 17 14 11 16 23 15 10 18 13 10 19 14 14 8 12
37 2 550 0 52 0 2 6 1 0 10 0 10 6 4 8 7 0 6 6 6 7 3 0 12 3 8 10 6 0 26
37 3 780 4 222 14 31 31 25 20 26 2 42 25 26 26 25 10 53 52 29 36 24 12 37 33 44 34 22 5 207
37 4 400 0 83 0 4 0 8 3 5 1 15 8 7 9 4 0 15 17 9 19 13 1 18 10 8 16 9 0 14
37 5 770 21 135 15 18 14 20 18 16 18 29 23 18 19 23 20 34 23 19 24 21 5 44 32 26 25 29 8 106
37 6 470 0 57 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 2 1 0 0 0 1 2 2 0 1
37 7 600 0 264 0 7 4 2 3 8 1 40 40 25 30 26 0 50 35 29 24 20 1 76 47 40 33 37 0 288
37 8 575 0 52 0 0 0 0 0 0 0 0 0 0 0 0 0 5 3 0 3 1 0 4 5 2 6 10 0 10
37 9 750 13 166 5 23 21 21 21 20 9 21 24 21 9 21 13 40 38 30 28 38 8 23 30 26 35 21 11 191
37 10 825 6 101 12 26 11 14 14 12 6 23 9 7 14 13 9 20 27 17 19 28 9 25 24 35 34 26 6 64
37 11 510 0 357 0 1 6 1 6 3 0 38 45 31 35 16 0 63 44 91 97 78 0 94 84 54 43 48 0 187
38 1 650 0 78 0 0 0 0 0 0 0 3 0 0 1 0 0 33 15 7 7 7 1 26 22 42 22 9 1 52
38 2 600 1 69 3 6 3 6 3 8 6 6 5 5 6 6 4 9 11 12 9 10 6 15 14 9 8 16 4 71
38 3 1120 8 123 4 18 17 21 19 32 24 32 20 22 21 21 6 80 18 17 32 10 6 38 26 22 60 39 0 212
38 4 600 0 51 1 2 4 5 0 2 0 6 4 1 6 1 0 9 3 3 8 4 0 3 1 6 1 2 0 26
38 5 300 0 38 2 3 11 8 3 6 0 8 3 29 3 7 0 17 19 11 13 7 0 28 20 12 11 11 0 121
38 6 600 0 61 2 3 1 8 7 6 1 2 5 6 5 4 4 8 7 5 4 5 3 6 5 8 7 16 8 41
38 7 640 23 184 0 6 2 2 3 2 0 0 3 2 9 0 0 8 3 2 1 7 0 3 7 5 5 8 0 129
39 1 450 3 139 8 9 12 16 10 10 7 58 37 43 28 36 0 88 51 31 36 28 3 28 44 38 34 35 2 110
39 2 595 0 202 0 2 2 1 1 5 0 16 10 7 5 8 0 19 24 19 18 18 0 31 27 24 30 29 0 130
39 3 760 0 41 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 1 4 0 4 2 4 0 1 0 6
39 4 590 0 193 1 29 3 7 61 18 0 25 28 16 19 22 1 26 51 42 17 19 1 39 34 32 38 24 0 10
39 5 800 0 70 0 2 4 3 5 3 0 7 1 4 3 3 0 12 8 6 9 7 0 11 13 9 7 6 0 18
39 6 610 1 74 2 10 9 4 6 4 2 15 15 9 11 13 4 22 14 12 17 12 6 24 24 25 14 11 4 84
39 7 830 0 88 0 1 2 3 1 4 0 7 14 8 9 6 0 12 9 10 7 1 0 12 11 14 11 10 0 24
39 8 1010 0 394 0 31 70 61 43 64 0 74 120 102 99 47 0 86 52 35 44 68 0 89 104 64 77 37 0 339
39 10 690 0 30 0 14 8 7 7 4 2 10 14 5 5 19 0 12 11 7 5 8 0 6 14 11 10 7 0 67
39 11 710 0 41 0 0 2 0 0 1 0 0 2 1 1 2 0 2 1 0 0 0 0 4 1 2 1 1 0 1
39 12 650 0 119 0 6 1 4 3 4 0 14 5 7 8 7 2 9 9 11 8 18 0 15 14 10 15 4 0 36
39 13 1050 0 34 0 0 0 0 0 1 0 0 2 0 3 2 0 11 11 8 5 4 0 7 4 4 7 4 0 5
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
30 1 250 0 49 0 0 1 0 0 1 0 22 12 14 9 12 0 31 35 24 32 32 0 33 33 27 32 11 0 83
30 2 560 5 60 4 13 7 14 3 2 3 19 10 10 9 7 3 8 6 15 19 40 3 25 29 33 45 28 2 86
30 3 300 0 111 0 0 0 1 0 0 0 0 0 0 0 1 0 1 1 1 0 2 0 10 29 23 23 18 0 126
31 1 300 0 22 0 1 1 0 1 0 0 0 0 2 2 3 1 1 1 0 1 1 0 1 0 0 4 0 0 1
31 2 400 0 32 0 0 0 1 0 1 0 3 3 2 1 0 0 2 4 3 4 2 0 6 6 5 5 2 0 7
31 3 400 0 3 0 0 0 0 0 0 0 2 3 0 0 2 0 7 1 3 3 3 0 11 26 12 7 15 0 48
31 4 650 4 60 3 7 2 4 1 0 0 1 0 0 3 0 2 8 6 3 5 4 0 9 11 12 15 4 0
31 5 600 0 242 0 5 2 4 2 4 0 13 11 8 5 8 1 19 3 10 9 7 1 38 33 43 33 20 1 37
31 6 370 0 210 0 25 9 20 8 15 0 20 4 14 17 11 0 24 22 16 20 16 0 28 16 17 18 12 0 27
31 7 560 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 1 1 0 8 5 8 11 4 0 10
31 8 770 0 49 0 0 0 0 0 0 0 0 0 0 0 0 0 7 9 5 6 5 0 8 7 5 6 3 0 4
31 9 550 0 169 0 10 11 17 13 13 0 33 6 26 26 22 0 20 17 19 40 41 0 32 35 52 28 29 0 57
31 10 640 1 33 1 5 4 8 4 2 0 23 3 8 8 5 0 27 26 13 17 28 1 58 24 29 35 41 0 273
32 1 580 1 39 2 3 2 2 3 3 1 2 5 9 2 6 0 6 4 4 4 4 3 18 4 6 6 7 5 95
32 3 830 15 281 19 26 30 21 18 33 9 44 31 45 29 34 6 74 65 48 56 49 6 53 55 53 36 39 10 298
32 4 970 0 80 1 2 1 1 3 3 0 2 4 2 1 3 0 1 5 4 3 4 0 12 10 6 9 8 0 56
32 5 360 3 106 7 22 20 18 16 17 4 15 13 34 21 25 20 52 52 42 42 32 2 66 59 33 50 42 2 257
32 6 710 23 219 34 37 43 49 39 36 40 36 34 27 35 28 40 40 27 51 33 41 56 64 59 63 56 56 31 283
32 7 850 0 34 0 0 0 0 0 0 0 1 0 0 1 0 0 5 5 4 3 1 0 5 6 5 5 6 0 38
32 8 400 0 62 9 19 31 25 20 26 12 18 12 14 15 16 14 8 19 21 21 16 8 13 10 12 14 28 0 110
32 9 550 2 345 5 11 6 6 7 6 0 7 1 20 7 7 0 24 13 12 9 8 0 20 14 32 15 15 0 142
32 10 500 0 157 1 1 3 2 4 2 0 15 12 8 4 9 0 7 4 11 10 10 1 16 22 15 10 14 0 57
32 11 720 0 195 4 10 19 8 12 9 7 50 31 53 35 42 3 57 48 38 15 45 4 22 33 33 24 33 10 143
32 12 670 2 43 1 4 3 4 3 4 0 9 10 3 4 5 0 7 5 14 5 9 0 10 15 9 10 5 0 60
32 13 950 0 131 0 0 0 0 0 0 0 0 1 1 1 0 0 30 35 24 15 16 0 28 29 14 18 18 0
32 14 650 0 161 0 10 4 3 2 22 0 24 33 13 12 17 0 30 21 11 14 15 0 16 15 16 5 14 0 49
32 15 700 6 63 7 7 11 14 7 10 5 9 13 14 6 7 0 15 6 3 8 7 0 9 2 8 6 10 0 33
33 1 450 5 184 3 9 6 7 8 12 7 24 25 22 13 16 6 73 51 29 36 27 3 61 47 46 51 68 4 149
33 2 590 27 178 23 54 42 64 35 70 20 52 40 33 39 42 22 56 56 31 24 29 17 55 32 14 11 14 12 136
33 3 775 0 59 0 1 0 2 2 0 0 4 1 5 1 1 0 10 2 5 6 5 0 12 12 13 7 12 0 74
33 4 530 0 98 0 2 2 0 3 6 0 10 14 4 6 7 0 6 5 8 2 11 0 10 11 8 14 21 0 134
33 5 720 0 63 0 0 0 1 0 1 0 11 4 4 5 8 0 9 10 10 5 14 0 14 6 11 7 21 0 93
33 6 830 0 217 0 42 18 37 23 30 0 46 32 38 49 34 0 69 72 42 51 55 14 69 54 85 76 114 54 350
33 8 500 0 52 3 1 3 8 3 3 0 7 5 8 8 2 3 22 28 28 29 17 9 16 22 17 13 14 5 68
33 9 680 0 156 0 3 2 3 1 6 0 2 3 2 1 1 0 35 27 31 27 24 0 27 34 40 29 50 0 233
33 10 625 0 4 0 0 0 0 0 1 0 1 1 1 0 0 0 3 3 3 4 5 0 3 4 14 14 18 0 13
33 11 710 0 24 1 2 0 0 1 7 0 3 8 5 4 8 0 11 8 9 14 7 0 36 29 28 32 33 1 142
33 12 570 1 48 0 0 0 1 0 1 1 2 4 3 4 2 0 2 1 1 2 5 0 8 11 11 5 2 0 20
33 13 810 0 114 0 0 2 3 0 0 2 4 3 5 7 2 0 15 6 6 4 6 0 51 41 62 18 25 0 105
33 14 830 0 20 0 0 1 0 1 0 0 6 6 4 4 3 0 3 2 2 6 5 1 6 5 3 18 8 1 25
33 15 770 0 21 0 0 0 0 0 1 0 0 1 1 0 3 0 4 4 1 5 2 0 4 5 2 4 1 0 7
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
6 3 370 1 14 0 1 2 2 3 0 2 7 7 8 9 6 1 18 20 13 13 10 0 25 11 10 12 9 1 0
6 4 450 0 6 0 0 0 0 0 0 0 0 0 1 1 0 0 3 3 2 1 3 0 4 3 3 1 5 0 0
6 5 600 0 61 1 0 0 0 1 0 1 2 2 0 2 1 0 12 8 5 5 5 2 23 12 9 15 15 0 0
6 6 770 0 39 0 1 2 2 0 1 0 1 2 1 1 0 0 7 2 3 4 4 1 10 5 7 4 2 0 0
6 7 550 0 30 0 0 0 0 0 0 0 0 0 0 0 0 0 3 4 3 4 0 0 10 7 1 2 7 0 0
6 10 450 0 29 0 0 0 0 0 0 0 1 0 0 2 0 1 4 1 1 1 2 0 7 7 5 2 4 0 1
6 11 700 0 12 0 0 0 0 0 1 0 0 1 1 1 0 0 2 8 1 6 4 2 5 5 9 13 23 1 1
17 1 780 2 22 1 1 0 2 1 2 1 1 1 1 2 2 1 2 1 4 6 4 0 8 4 2 2 5 0 10
17 2 850 4 13 2 1 2 0 0 1 1 3 5 4 3 8 3 5 4 2 4 5 2 6 3 6 3 4 5 18
17 3 600 0 71 4 5 3 4 6 4 2 4 5 1 2 2 8 13 9 3 2 6 2 2 5 1 2 3 0 23
17 4 430 0 26 0 1 2 1 1 0 0 4 1 0 0 1 0 3 3 2 2 3 0 7 0 5 2 1 0 8
17 5 550 0 44 0 0 0 1 0 2 0 3 0 4 1 0 0 6 5 4 3 5 0 5 6 1 7 7 0 23
17 6 500 0 61 0 7 4 2 7 4 0 3 0 3 1 3 0 12 15 5 8 7 2 6 11 15 12 12 5 50
17 7 650 0 40 0 5 3 3 1 2 0 10 8 3 5 3 1 7 4 6 5 6 1 7 15 8 6 1 0 20
17 8 750 0 78 0 19 28 15 10 7 2 9 6 10 16 14 0 16 19 10 8 11 0 25 4 14 10 6 5 20
17 9 450 0 121 2 2 2 1 1 2 1 4 2 4 4 3 0 8 3 7 6 3 2 15 6 14 16 8 1 16
17 10 580 1 51 0 1 1 1 0 0 0 2 4 2 2 2 0 5 9 8 1 5 1 18 19 26 16 24 1 81
17 11 700 0 101 0 4 3 2 0 1 1 5 7 5 5 3 0 5 5 8 6 9 0 19 20 49 23 25 1 113
17 12 450 0 39 0 0 0 1 0 0 0 1 1 0 1 0 0 2 0 0 3 2 0 6 2 5 4 6 0 7
24 1 530 0 169 0 2 3 5 1 0 0 2 1 3 2 2 0 3 1 6 5 3 0 7 5 9 2 5 3 48
24 3 280 0 43 0 0 0 0 0 1 0 0 10 3 6 4 0 11 1 2 1 2 0 7 5 4 2 9 0 17
24 5 1000 0 16 0 0 1 0 2 0 0 0 1 1 0 4 0 0 1 1 2 5 0 8 3 12 4 3 1 3
24 6 380 0 25 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 2 0 2 0 2 2 1 0 1 0 13
26 1 470 1 82 0 4 3 1 0 1 1 7 2 4 8 3 0 6 5 5 3 2 1 15 8 4 11 12 2 79
26 2 625 0 130 0 7 5 6 5 5 0 11 13 9 11 6 0 18 12 16 14 11 1 20 16 15 14 17 0 74
26 3 700 0 66 0 0 0 2 2 1 1 3 5 1 6 3 0 7 7 6 3 0 0 9 6 7 11 6 0 21
26 4 310 1 82 2 5 6 3 5 1 4 4 5 9 6 6 1 4 2 2 5 5 3 9 9 14 12 10 0 34
26 5 970 0 31 0 2 1 3 2 2 2 3 5 4 3 6 0 1 5 6 2 3 2 8 16 15 21 15 8 60
26 6 510 0 81 0 0 0 0 0 0 0 1 1 2 1 2 0 6 4 0 1 0 0 0 6 2 4 4 0 11
26 7 700 0 66 0 1 1 0 1 0 0 2 0 1 2 0 0 4 2 3 1 4 0 9 4 4 4 0 0 5
26 8 460 0 184 0 10 5 17 13 5 0 8 4 9 9 10 0 10 12 13 14 17 0 13 9 15 21 20 2 31
26 9 570 0 75 0 2 8 9 6 3 1 8 9 12 8 3 2 19 17 20 16 16 2 29 19 30 32 24 3 128
26 10 700 1 99 0 4 4 2 2 8 0 11 8 14 14 5 0 13 27 27 12 11 0 34 39 46 36 29 0 60
26 11 450 0 129 0 2 12 0 0 1 0 60 64 67 11 60 0 112 92 101 115 82 0 75 101 95 85 88 0 109
28 1 550 0 37 0 0 0 0 0 1 0 1 0 1 2 3 0 3 2 4 3 7 0 40 9 8 18 16 0 50
28 2 700 0 88 0 0 0 2 3 2 0 1 4 0 1 1 1 2 8 5 11 8 0 5 0 11 3 2 0 11
28 3 670 0 29 0 0 0 0 0 0 0 4 5 3 0 0 0 3 1 8 6 5 0 2 3 0 0 1 0 8
28 4 540 1 11 0 1 1 0 0 0 0 2 0 0 2 1 0 1 4 1 1 3 1 2 2 1 1 3 1 20
28 5 750 0 31 0 2 0 2 2 4 0 2 3 2 0 1 1 1 2 3 1 4 0 4 1 3 1 0 0 3
28 6 800 0 64 0 0 2 2 2 6 0 6 4 0 4 2 0 6 10 3 3 7 1 5 10 3 1 7 0 33
28 7 910 0 138 0 32 0 0 0 19 0 13 6 4 0 15 0 30 17 39 9 10 0 23 19 16 10 25 0 86
29 1 720 0 17 0 2 0 3 1 2 0 0 0 0 1 1 0 2 0 3 3 2 3 5 2 4 10 8 1 21
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Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
13 1 650 0 147 0 2 3 0 2 2 2 12 6 6 13 7 0 12 8 8 8 10 1 49 8 13 26 40 3 137
13 2 900 2 32 2 1 2 2 1 1 2 7 2 4 3 2 3 10 7 5 2 2 0 8 8 7 16 14 0 55
13 3 750 0 49 2 1 3 2 2 3 3 5 2 4 1 5 2 7 6 3 4 2 2 10 8 3 5 5 3 27
13 4 800 3 100 0 11 6 9 12 3 0 11 4 6 2 4 0 6 17 6 2 7 4 9 18 11 7 9 2 15
13 5 650 1 101 1 4 1 4 2 1 3 14 6 11 5 10 2 20 11 10 8 3 2 38 23 16 31 17 2 15
13 6 910 1 55 0 1 5 3 1 0 2 3 1 2 4 0 1 22 21 22 13 11 1 28 13 9 12 6 1 58
13 8 850 1 32 2 6 0 2 1 3 1 6 6 3 5 7 2 8 9 8 8 2 25 24 15 11 0 32
13 9 450 2 62 1 13 16 14 13 8 2 7 3 9 7 8 1 15 10 6 9 9 1 8 12 10 10 21 2 36
13 9 450 2 33 0 6 3 2 2 4 2 9 5 9 7 3 0 10 9 18 2 4 2 14 20 20 18 9 2 73
18 1 630 0 57 0 4 1 2 1 1 0 12 3 5 6 8 0 6 7 5 5 5 2 10 5 4 8 13 0 73
18 2 470 0 92 0 2 1 0 1 1 0 2 4 4 3 3 0 8 5 7 5 8 0 22 13 17 14 12 0 29
18 3 650 2 78 1 4 4 4 2 2 1 3 0 3 1 2 2 17 2 7 3 8 2 10 14 23 14 10 2 70
18 5 630 0 39 0 1 0 0 2 2 0 2 0 6 3 0 0 3 1 2 2 2 0 5 6 3 3 1 0 28
18 8 585 0 50 0 4 1 0 8 5 0 5 5 3 10 9 0 9 7 7 6 9 0 10 10 6 12 5 0 28
20 1 530 0 57 1 0 2 0 2 1 1 3 4 8 10 8 1 6 8 6 7 11 1 17 14 11 13 18 3 79
20 2 700 0 55 0 1 0 0 0 1 0 1 1 2 1 1 0 4 1 4 4 12 0 26 20 66 59 62 1 151
20 3 760 1 86 0 1 0 0 0 0 0 1 8 2 0 1 0 6 10 2 5 15 1 79 85 76 55 39 0 126
20 4 570 0 151 0 0 0 0 0 0 0 0 0 0 0 0 0 11 7 10 8 7 0 6 4 4 8 5 0 26
20 5 650 0 80 0 4 5 6 3 4 0 4 5 3 3 0 0 7 4 5 3 7 0 14 6 4 2 3 0 48
20 6 820 0 88 0 0 1 1 1 1 0 6 7 10 3 14 0 6 4 4 2 9 0 14 20 18 18 15 0 111
20 8 550 28 357 13 17 16 15 20 14 9 34 35 42 34 26 16 48 40 38 34 31 11 102 84 76 46 56 17 527
20 9 670 0 62 1 5 4 14 5 4 0 9 2 3 10 6 0 15 11 6 5 5 0 9 8 4 7 7 0 23
20 11 650 2 110 1 0 4 5 12 11 0 9 1 6 3 4 0 15 20 27 11 9 1 34 29 61 7 11 3 429
21 1 870 2 75 2 2 4 4 17 5 2 12 13 10 5 15 0 23 12 7 13 5 1 35 35 28 22 26 16 139
21 2 810 0 161 3 8 19 19 17 20 3 30 23 21 15 13 2 23 19 13 27 20 0 28 14 20 21 19 1 51
21 3 370 0 57 0 0 8 3 1 1 0 6 10 4 4 8 1 10 14 10 14 7 0 18 19 7 13 9 1 58
21 4 450 0 107 1 13 5 14 5 8 1 16 13 13 22 26 1 29 39 30 25 38 1 45 42 41 27 25 5 85
21 5 550 0 99 0 2 1 6 4 3 1 9 4 3 7 8 0 11 18 21 8 13 1 23 12 22 18 21 1 51
21 6 700 0 57 0 4 11 10 7 9 0 22 22 11 16 14 0 23 32 27 23 16 0 27 28 22 29 19 12 90
21 8 550 0 96 1 4 6 13 3 4 0 18 12 6 6 8 2 10 7 12 12 7 2 34 24 20 8 15 4 91
21 9 570 0 66 0 0 0 1 0 0 0 1 0 0 0 0 0 3 0 1 4 1 0 11 10 9 11 6 0 5
25 1 730 0 46 2 3 2 7 2 9 2 7 9 0 4 4 0 3 5 9 8 7 1 17 15 5 9 11 1 42
25 2 500 2 155 0 1 0 1 0 2 0 1 1 1 2 2 0 53 40 36 60 55 1 59 57 48 42 46 1 20
25 3 650 0 118 1 26 12 16 3 17 0 59 70 54 65 57 0 104 99 85 41 84 0 130 62 72 17 18 3 91
25 4 750 1 154 3 13 13 14 14 13 4 28 24 20 18 13 14 27 28 37 32 37 0 47 37 36 36 32 2 174
25 5 330 0 99 0 4 4 2 5 6 0 6 1 2 1 7 0 13 3 7 4 4 0 7 9 6 10 5 1 11
25 6 1020 65 606 26 35 38 47 71 73 36 54 52 54 45 31 30 69 64 57 50 50 35 111 93 76 60 75 16 353
25 7 630 0 124 0 0 0 0 5 0 0 33 24 0 30 1 0 53 3 16 69 20 0 46 24 43 27 26 0 181
27 1 540 0 144 0 1 3 3 2 3 0 4 7 5 2 3 0 9 7 5 1 7 0 5 13 4 6 8 0 22
27 2 630 0 87 0 1 1 0 0 0 0 3 1 2 1 2 0 10 0 2 0 1 0 15 6 1 1 4 0 18
27 3 800 18 74 16 10 9 15 11 14 11 16 22 21 18 16 19 13 23 8 19 13 9 16 21 14 21 11 6 46
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Table D.2. Spike counts on day 7 for bupivacaine treatment study (Chapter 4).   
 
Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
45 1 590 3 97 5 10 8 2 2 2 2 7 5 7 14 9 4 10 5 11 10 8 9 34 19 18 25 19 8 65
45 2 300 0 81 0 1 5 6 1 2 0 2 5 4 4 8 0 10 8 5 6 4 0 8 9 7 14 16 0 15
45 3 670 1 116 3 16 3 7 7 8 1 13 7 5 10 8 0 31 31 45 26 18 2 43 36 43 13 20 5 57
45 4 630 0 384 0 6 9 5 3 5 4 21 11 1 21 16 0 5 23 74 88 84 0 41 45 31 41 69 0 179
45 5 820 0 61 0 0 1 0 0 0 0 18 8 0 6 13 0 38 28 17 26 20 0 18 24 19 14 18 0 47
45 6 550 2 118 5 5 2 8 4 5 6 8 4 10 6 10 1 11 6 10 8 5 1 31 33 27 34 26 2 116
45 7 650 3 64 0 1 4 2 3 0 2 8 9 5 3 6 0 12 0 3 3 0 4 10 12 9 11 7 1 66
45 8 770 2 146 1 3 2 2 0 4 1 8 0 2 2 2 0 10 8 10 13 3 2 20 17 26 20 24 1 92
45 9 830 0 82 0 0 0 1 3 1 1 13 10 13 8 4 3 42 33 37 32 17 1 52 44 25 51 45 0 69
45 10 680 0 107 4 3 3 5 4 4 0 7 4 6 0 5 1 31 11 11 12 11 0 40 38 24 25 19 1 102
45 11 680 0 90 0 9 3 1 3 3 1 4 8 7 3 3 0 6 4 8 5 5 0 8 8 9 8 14 0 21
48 1 900 8 151 11 11 13 13 11 11 11 14 13 11 8 9 12 9 16 11 10 8 10 12 17 9 8 7 6 44
48 2 500 5 141 0 9 15 14 10 19 0 16 20 22 18 10 0 31 34 25 28 26 0 40 16 33 26 19 0 40
48 3 480 0 198 2 0 3 1 0 3 0 3 7 9 7 4 0 6 2 7 2 1 0 10 4 2 1 2 0 44
48 4 640 0 24 0 2 0 1 1 0 5 3 6 8 11 4 4 9 6 11 9 6 2 11 6 11 5 11 0 48
48 5 320 0 134 1 5 8 1 4 3 0 15 13 21 18 16 1 7 8 3 5 6 0 10 10 7 6 17 1 53
48 6 610 0 136 0 17 16 16 15 11 0 26 17 31 21 24 0 17 20 16 20 14 1 13 5 9 8 9 0 15
48 7 800 0 73 0 1 6 6 9 4 0 5 2 3 4 6 0 9 12 0 3 6 0 11 15 17 15 13 3 42
48 8 950 2 264 7 11 7 10 9 12 8 12 15 11 13 18 2 20 16 26 17 27 2 31 13 32 16 24 1 51
48 9 940 0 171 1 1 2 2 1 1 0 13 6 11 11 12 3 29 35 23 18 17 1 46 35 51 33 26 2 136
50 1 650 4 115 2 4 6 7 8 6 4 11 10 10 11 10 12 32 25 15 25 19 6 24 51 28 29 34 2 148
50 2 710 4 227 5 5 7 4 2 0 5 16 13 8 10 11 10 91 32 49 76 73 6 129 72 109 73 78 1 183
50 3 770 8 113 3 4 8 4 8 7 1 13 12 12 12 5 3 17 12 4 4 10 13 32 37 39 22 21 0 118
50 4 730 3 75 4 9 9 7 10 14 1 21 21 11 16 12 2 20 26 18 33 30 2 31 42 51 37 31 3 171
50 5 810 17 208 8 18 11 17 18 14 11 29 30 24 17 19 6 55 44 31 54 36 10 109 73 69 48 53 7 149
50 6 650 0 75 0 38 28 26 31 21 0 44 35 33 36 29 0 44 51 40 31 40 0 50 51 70 44 21 1 278
50 7 840 0 144 0 4 4 16 22 9 1 12 14 27 20 5 1 37 8 24 22 14 0 29 27 19 24 28 3 185
50 8 900 3 48 1 6 2 5 5 3 0 4 4 5 3 2 4 31 19 13 6 19 1 32 23 30 20 47 1 155
50 9 360 0 153 0 16 5 7 14 12 0 20 24 21 22 27 0 30 25 19 20 23 1 26 19 18 20 9 0 25
50 11 510 0 122 1 0 2 2 2 0 0 10 6 10 6 2 0 82 83 49 79 66 0 101 138 98 104 110 0 117
50 12 770 3 114 1 13 10 6 3 4 3 5 13 7 6 8 0 21 13 15 6 17 1 38 39 24 17 31 3 115
50 13 560 5 135 6 7 5 12 7 12 7 13 12 12 14 15 10 30 21 21 24 14 18 36 32 27 25 25 14 138
52 1 620 4 44 3 13 11 6 8 4 3 18 17 14 14 20 6 18 31 30 64 45 4 48 65 78 78 71 4 472
52 2 790 10 153 8 28 26 28 17 13 8 49 45 50 42 44 9 81 55 52 50 47 6 65 69 74 61 74 5 369
52 3 690 3 314 4 59 61 45 43 48 6 91 73 68 57 58 10 77 59 30 30 45 4 405
52 4 900 0 34 0 2 3 2 1 1 0 3 5 4 6 4 0 7 6 7 3 7 0 29 37 41 31 35 0 209
52 5 710 3 77 6 24 11 10 5 2 9 24 21 11 13 32 0 54 48 51 40 41 0 74 56 55 49 62 0 270
52 6 690 0 62 0 13 7 6 4 7 0 8 9 20 7 15 0 30 12 15 27 18 0 40 30 39 34 28 1 117
52 7 750 2 122 6 14 20 10 14 17 3 20 17 25 19 15 0 30 36 32 31 22 0 40 31 26 26 21 1 71
52 8 850 0 144 0 0 0 3 4 0 2 16 5 4 2 19 0 28 21 12 15 15 0 46 43 56 51 43 2 289
52 9 770 0 74 0 4 2 1 2 4 0 1 2 2 6 4 0 7 6 6 5 9 0 13 10 12 15 16 0 36
52 10 880 0 334 0 65 60 44 37 34 0 57 69 49 59 42 0 12 60 55 53 59 1 79 76 60 55 51 0 96
52 11 600 0 245 0 11 4 7 2 6 0 84 91 77 84 82 10 145 83 154 143 163 106 262 217 189 191 # 18 459
53 1 600 10 81 6 11 15 15 20 13 6 3 5 16 17 8 2 10 10 6 3 3 2 9 11 15 8 15
53 2 850 0 95 0 0 0 0 36 0 0 111 43 58 43 42 0 47 30 31 16 24 0 32 25 11 9 3 0 54
53 3 680 0 160 5 38 42 34 30 34 2 31 47 64 84 62 1 55 69 61 86 135 0 196 210 65 25 5 11 313
53 4 660 0 31 0 0 0 3 5 3 0 9 2 1 2 5 0 5 12 6 14 15 0 18 25 23 238 29
53 5 370 15 99 0 3 3 4 7 4 0 1 2 5 6 3 12 22 11 14 4 11 1 11 13 9 7 8 0 50
53 6 380 2 49 0 68 36 35 34 38 1 102 45 88 2 87 0 68 6 93 74 59 0 103 78 70 96 2 0 188
54 1 470 0 105 0 2 9 4 6 9 1 13 10 9 16 8 0 8 9 7 7 4 0 8 10 9 4 8 0 22
54 2 750 12 417 1 19 7 9 11 12 0 19 18 26 24 20 0 9 30 24 22 25 1 53 40 34 19 36 0 67
54 3 470 0 37 2 2 3 0 1 1 0 5 4 1 4 5 1 7 8 11 4 5 0 9 1 12 3 5 0 14
54 4 580 0 82 0 5 3 0 8 4 0 5 10 5 3 2 0 24 26 17 11 8 0 25 8 15 20 12 0 21
54 5 550 0 22 0 1 0 1 1 0 0 1 2 1 1 2 0 7 9 7 4 7 0 19 14 32 24 44 0 15
54 6 710 0 111 0 8 1 5 2 3 0 10 8 7 5 6 0 33 20 17 4 22 0 26 29 10 22 14 0 116
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
54 7 410 0 31 0 0 0 2 0 0 0 0 0 0 0 3 0 1 1 5 1 2 0 0 3 1 3 4 0 9
54 8 870 0 58 0 2 3 2 4 1 0 2 3 6 3 9 0 4 3 6 6 6 0 16 9 16 21 25 0 47
72 2 720 10 284 16 42 32 27 53 46 19 80 74 62 63 56 20 76 67 60 68 59 13 74 65 63 50 45 19 400
72 3 570 3 234 3 27 23 30 28 29 4 21 35 28 26 26 3 57 35 46 47 39 0 54 60 72 58 52 1 393
72 4 490 0 143 0 3 1 0 9 0 0 5 9 7 8 6 1 46 27 44 47 31 0 75 73 67 70 56 2 221
72 5 620 18 297 17 26 23 18 26 26 17 45 50 41 33 38 10 47 46 44 41 37 9 75 59 93 69 65 24 913
72 6 500 8 213 15 20 24 32 31 31 10 43 35 32 14 24 18 52 31 30 28 25 15 66 54 30 42 18 7 127
72 7 680 0 46 0 0 0 0 0 0 0 9 1 5 5 6 0 17 16 14 7 3 0 7 10 10 8 3 0 2
72 9 680 0 127 0 3 7 2 6 3 0 11 8 5 7 9 0 18 12 13 7 16 0 33 31 25 29 15 0 103
72 10 830 2 246 3 33 29 21 33 33 5 66 35 97 91 40 3 65 54 51 52 61 8 76 47 46 67 58 0 253
72 11 910 7 264 3 47 30 20 16 9 9 37 52 36 30 15 6 89 53 46 48 50 3 85 65 62 72 80 3 309
79 1 600 10 62 17 21 22 17 16 18 16 31 22 25 24 12 22 26 35 18 10 16 8 31 35 16 17 14 10 175
79 2 710 3 35 1 8 4 8 6 8 5 4 18 7 9 7 1 8 12 6 3 5 2 14 18 19 13 11 0 101
79 3 750 1 89 3 5 3 0 4 2 0 5 2 1 1 4 3 5 11 9 8 2 1 10 10 11 4 3 4 84
79 4 550 0 110 0 1 7 5 3 2 0 9 6 6 2 1 3 23 17 18 18 12 6 55 50 55 36 42 0 221
79 5 710 32 367 29 38 26 26 8 32 38 41 64 61 55 55 19 94 79 79 61 164 36 152 128 114 79 80 24 1280
79 6 870 9 143 6 2 11 4 5 6 4 11 10 13 9 11 8 20 16 16 19 13 6 57 49 36 43 37 5 252
79 8 760 3 60 2 16 7 5 12 11 4 7 15 10 2 4 4 5 6 4 8 5 2 14 8 17 25 21 2 52
79 9 880 2 117 4 4 10 9 8 16 5 51 24 31 42 37 2 63 61 35 38 34 0 37 56 47 44 54 7 138
79 11 665 4 125 10 28 16 17 18 19 13 52 30 21 35 7 6 36 43 32 31 24 16 52 33 26 21 20 25 241
79 12 460 0 95 0 2 2 0 1 1 0 3 2 1 3 5 0 2 8 5 1 0 0 9 8 4 3 4 0 9
79 13 580 3 108 3 7 10 0 5 5 0 8 4 17 5 8 0 12 15 18 10 16 0 18 15 15 23 13 6 110
79 14 600 0 156 2 18 12 10 14 13 2 9 14 16 11 13 8 26 21 18 25 22 5 25 17 22 30 23 10 88
79 16 830 0 142 2 21 11 3 1 4 1 19 9 12 10 12 5 36 10 22 18 12 0 28 48 43 25 14 4 163
80 1 790 5 136 9 38 19 23 13 17 13 25 32 32 26 42 10 57 57 32 38 26 6 54 29 17 13 20 15 182
80 2 900 0 78 0 0 0 1 1 0 0 1 1 0 0 0 0 1 1 2 0 3 0 15 11 6 19 20 0 58
80 3 600 0 31 2 4 9 17 6 4 1 8 8 17 13 13 1 18 10 10 9 9 3 28 30 20 16 23 2 120
80 4 710 0 32 0 0 0 0 0 1 0 3 1 0 1 0 0 4 3 6 5 2 0 9 21 26 10 22 0 134
80 5 830 0 63 0 3 4 2 5 3 2 31 12 24 13 7 1 58 41 43 39 37 0 77 83 56 75 55 0 286
80 6 730 0 64 1 5 9 4 7 1 1 16 13 11 11 4 0 29 21 16 31 26 1 34 36 29 32 32 0 139
80 8 520 1 139 4 8 8 9 10 4 5 16 10 19 9 12 1 22 19 18 17 17 1 19 31 24 19 23 1 90
80 9 380 0 65 0 0 1 2 1 0 0 6 5 5 6 3 0 25 21 22 13 16 0 33 35 30 35 27 0 48
80 11 850 0 20 1 1 3 3 3 4 3 6 5 7 7 1 4 3 13 12 13 11 6 12 20 22 16 9 3 105
80 12 350 2 62 1 2 0 0 0 2 0 4 7 6 7 4 0 11 8 8 7 3 0 24 31 17 19 17 0 108
80 13 950 7 114 5 27 25 30 23 18 7 26 20 22 30 21 9 40 26 31 34 32 17 83 85 93 92 66 2 835
81 1 270 0 78 0 1 1 1 0 1 0 5 1 4 2 4 0 16 15 5 14 17 0 17 17 12 7 7 0 48
81 2 400 8 90 6 8 8 11 5 5 3 19 9 19 5 13 4 22 24 16 24 11 4 43 29 30 21 12 5 77
81 3 610 5 183 11 17 27 26 16 31 14 41 32 17 25 33 22 32 29 30 34 18 10 43 41 50 37 45 7 184
81 4 750 0 70 1 4 1 5 2 2 3 3 4 3 3 2 3 6 9 9 13 7 3 3 12 11 16 17 0 79
81 5 870 17 129 18 22 16 14 18 11 12 29 17 13 23 22 9 28 34 18 24 31 7 30 35 32 39 38 4 213
81 7 820 0 185 1 3 2 10 4 4 0 21 10 13 18 7 1 65 39 39 40 51 0 96 43 47 23 30 2 305
81 8 430 0 44 0 6 3 3 1 3 0 14 8 12 8 13 0 21 11 17 16 20 1 23 17 26 25 14 3 142
81 9 610 0 61 0 0 0 1 0 0 0 1 5 0 0 0 0 15 9 5 3 2 0 34 31 21 11 16 0 160
81 10 630 0 84 0 0 2 1 1 3 0 3 4 3 5 1 0 9 5 4 3 6 0 9 6 5 5 9 0 9
81 11 780 0 66 0 2 1 2 0 1 0 3 2 5 5 1 0 9 8 11 6 4 0 14 11 21 14 14 0 46
81 12 890 5 283 8 8 13 10 5 10 6 21 17 16 16 18 4 46 71 35 70 50 6 134 145 142 106 # 7 176
81 13 840 3 128 8 8 23 15 11 7 2 15 39 15 32 32 4 25 27 19 12 26 7 33 28 21 17 28 1 50
133 1 700 7 248 4 16 8 21 10 8 3 14 20 17 10 15 5 30 23 22 32 32 6 21 4 13 13 6 4 32
133 2 870 0 62 0 9 19 9 3 1 0 5 2 0 2 0 0 20 13 15 10 9 0 51 54 70 48 57 0 87
133 3 640 12 99 24 17 27 32 29 27 24 37 22 30 18 27 37 37 37 41 37 32 20 37 46 34 53 49 28 501
133 5 690 2 106 3 10 16 13 12 16 2 19 20 16 24 22 1 24 24 29 17 21 2 11 16 16 3 8 2 94
133 6 330 0 32 0 0 2 0 0 0 0 5 4 4 2 3 1 18 3 8 2 4 1 11 5 8 9 12 0 60
133 7 440 6 126 0 8 2 11 6 10 1 22 18 16 15 16 4 28 27 39 24 46 1 53 44 40 41 44 1 102
133 8 570 0 52 0 3 5 4 0 4 1 6 5 9 0 1 0 17 19 12 23 10 0 11 10 12 7 10 1 56
133 9 620 0 81 0 5 9 5 2 13 0 8 12 5 15 6 0 18 11 15 12 5 0 10 13 23 19 17 0 111
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
133 10 720 0 47 0 0 0 0 0 0 0 0 0 1 1 1 0 7 2 8 3 8 0 18 9 12 9 18 0 34
133 12 790 8 205 22 37 32 29 30 20 11 44 40 29 25 27 11 50 43 27 33 25 14 74 62 39 62 49
133 13 830 1 61 3 6 9 7 7 6 0 6 14 6 8 3 1 17 4 12 5 10 2 8 13 5 9 5 3 55
134 1 170 0 68 0 1 1 0 1 0 0 2 0 9 3 2 0 1 2 0 1 4 0 5 4 5 16 8 0 45
134 2 580 10 270 11 34 35 20 24 21 17 47 39 32 28 32 18 57 49 42 31 36 11 62 63 69 52 88 14 479
134 3 780 0 54 0 0 0 0 0 0 0 0 0 0 0 0 0 2 3 1 3 3 0 5 1 5 3 3 0 4
134 4 460 1 54 1 9 8 7 7 10 0 2 3 1 2 3 0 9 2 5 6 2 1 15 19 8 5 8 0 69
134 5 595 0 141 0 12 9 6 13 8 0 14 15 14 16 8 0 13 9 13 13 13 0 14 9 17 16 18 0 30
134 8 640 2 42 3 5 5 1 6 6 7 14 8 5 6 6 1 13 11 14 14 6 0 18 22 31 31 39 0 62
134 9 780 26 143 16 19 16 18 17 12 9 25 19 12 13 14 6 24 39 24 23 18 3 78 74 84 97 98 2 224
134 10 770 8 78 0 2 0 6 4 8 4 17 20 12 9 13 0 43 33 27 25 28 0 62 67 51 61 65 0 65
134 11 520 0 33 0 1 1 1 2 2 0 4 3 5 0 1 0 13 4 2 2 4 0 13 15 14 12 9 0 21
134 12 560 0 90 0 0 0 0 0 0 0 4 6 8 2 1 0 5 5 4 5 6 0 9 6 7 5 5 0 22
134 13 590 5 121 4 10 22 7 17 8 3 25 33 34 26 22 9 43 65 42 32 46 6 70 50 77 85 47 2 447
41 1 370 3 44 2 2 3 4 3 2 3 2 2 2 1 6 2 2 9 1 2 1 4 8 3 4 11 5 2 23
41 2 820 0 27 0 0 0 0 0 0 0 1 1 0 0 0 0 19 11 10 9 9 0 32 22 21 17 18 0 77
41 4 320 0 11 1 6 5 2 0 2 0 9 3 3 9 2 0 3 3 2 3 4 1 6 3 4 1 2
41 5 450 21 128 45 41 32 35 22 21 16 18 20 25 23 20 23 26 20 30 32 22 20 23 34 33 35 45 17 144
41 6 400 0 67 0 2 3 8 5 5 0 3 2 0 0 0 0 7 8 6 15 9 0 43 18 24 25 46 1 204
41 7 580 0 45 0 2 1 1 1 2 1 1 0 4 1 14 1 2 3 3 2 3 0 6 3 8 5 6 0 152
41 8 700 2 66 0 4 9 2 7 9 1 15 26 6 0 3 0 31 30 48 39 32 0 32 40 40 37 41 1 225
41 9 500 0 31 0 1 2 4 0 1 0 3 4 2 3 0 0 3 12 1 3 4 2 17 5 7 10 7 0 31
41 10 520 0 53 1 1 3 2 0 1 2 3 4 5 5 3 2 6 8 10 7 8 0 19 6 6 8 7 0 9
42 1 410 7 100 6 5 3 5 11 10 4 23 17 8 6 11 4 33 30 35 27 22 6 26 29 34 31 20 4 274
42 2 500 4 60 3 4 9 8 4 8 1 21 17 10 19 18 2 24 17 8 19 19 5 19 24 21 21 18 5 111
42 3 620 2 203 4 8 7 3 8 12 3 21 18 27 13 4 9 27 20 10 19 18 3 30 23 17 23 12 6 119
42 4 570 0 223 0 0 0 0 0 0 0 8 8 9 4 3 0 15 16 10 6 1 0 50 46 47 47 28 0 186
42 5 890 0 12 0 1 0 0 0 0 0 0 2 0 0 1 0 2 2 2 3 1 0 0 3 0 1 4 0 4
42 6 340 0 118 0 3 5 2 2 3 0 15 8 9 3 4 0 10 15 9 11 10 0 14 16 13 14 18 0 41
42 7 720 15 524 12 47 33 24 27 24 18 114 67 72 74 56 4 121 87 60 59 79 18 107 77 47 62 69 22 129
42 8 720 0 21 3 5 1 1 1 2 0 0 3 3 18 1 4 10 7 1 1 7 3 10 17 5 6 5 11 117
42 9 520 0 35 0 1 0 0 0 0 0 2 1 1 1 5 0 1 0 1 1 1 0 3 2 1 0 2 0 7
42 10 600 0 29 0 0 2 0 0 0 0 3 4 3 1 6 0 8 10 10 8 11 2 16 15 11 16 10 0 60
42 11 810 2 41 0 3 1 1 1 0 0 1 1 0 1 0 0 5 6 5 6 3 0 13 21 9 8 6 0 25
43 1 510 0 12 0 2 1 0 1 2 0 2 3 1 5 2 0 1 2 4 3 1 0 5 5 5 3 4 0 26
43 2 810 0 53 1 4 2 1 3 1 0 1 2 4 4 4 0 14 7 9 10 10 0 18 11 12 10 11 0 25
43 3 950 3 33 3 1 2 1 2 3 3 5 1 5 2 4 4 6 7 8 4 8 0 3 2 1 3 2 1 10
43 4 720 1 50 0 4 2 1 2 1 2 6 5 3 3 0 3 9 3 12 3 8 0 31 16 9 11 21 0 42
43 5 720 2 69 5 10 8 6 9 10 10 18 13 16 12 17 4 29 24 26 24 37 0 30 21 21 24 19 7 202
43 6 480 0 112 0 7 1 6 3 3 0 1 3 5 5 20 0 29 21 23 14 17 0 19 10 7 0 11 0 0
43 7 730 3 95 4 18 23 22 17 13 3 8 13 12 11 14 1 11 9 12 17 16 5 17 18 10 11 16 3 81
43 8 720 0 55 0 3 2 1 5 2 0 3 1 2 2 2 1 10 6 6 6 3 0 9 8 6 11 3 0 5
43 8 720 14 151 5 2 20 20 22 10 3 0 23 38 28 21 4 55 66 44 36 28 14 70 61 59 40 57 1 130
43 9 350 0 63 0 1 9 12 5 6 0 2 29 28 31 6 0 39 39 21 17 7 0 40 37 65 25 66 0 27
43 10 690 0 91 0 9 17 20 10 10 3 35 34 22 18 12 0 43 45 47 38 28 5 42 48 45 48 32 2 178
43 11 480 0 113 0 2 1 1 2 3 0 2 0 2 2 1 0 0 0 0 1 2 0 0 2 3 2 2 0 9
46 1 520 1 22 5 3 3 6 6 7 2 4 1 5 7 20 2 12 5 7 12 3 2 19 15 12 12 12 7 56
46 2 610 2 146 0 4 4 4 3 1 0 7 6 3 3 8 2 6 6 6 7 10 1 9 9 16 7 12 1 78
46 3 810 0 55 0 0 0 0 1 0 0 9 9 8 3 3 0 26 20 26 17 13 0 36 25 29 24 16 0 81
46 4 440 3 107 1 1 0 4 6 6 0 10 9 37 10 11 0 27 41 10 48 43 0 41 29 44 44 44 1 95
46 5 670 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 1 0 1 2 0 15
46 6 590 7 169 3 9 8 10 12 3 2 11 9 9 7 5 1 42 68 39 67 27 2 106 107 97 83 70 0 170
46 7 530 0 85 0 0 2 4 1 9 0 19 17 20 26 8 0 22 9 12 8 20 2 16 18 23 35 42 7 101
46 8 710 0 63 0 3 4 6 4 6 0 10 7 2 4 8 0 24 29 21 16 21 0 43 32 35 35 35 0 164
46 9 620 0 69 0 2 4 1 0 2 0 2 0 1 1 3 0 6 3 2 2 4 0 8 5 5 10 9 0 42
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
46 10 750 0 74 0 0 1 0 1 0 0 0 0 0 0 0 0 1 1 3 3 1 0 9 6 12 8 6 0 29
46 11 500 0 68 0 10 7 8 5 10 0 18 17 28 14 7 0 31 34 64 52 44 0 39 31 31 43 28 0 283
46 12 650 0 97 0 1 2 0 0 2 0 3 1 1 0 2 0 0 1 5 2 0 1 18 26 11 8 31 0 25
49 1 800 0 150 0 2 1 0 0 0 0 2 1 0 0 0 0 1 0 0 2 1 0 0 0 4 2 0 0 3
49 2 550 0 29 0 0 0 0 0 0 0 3 1 4 4 2 0 1 1 1 1 2 0 9 12 11 23 2 0 91
49 3 580 0 65 0 17 4 4 1 2 0 14 4 15 22 11 0 32 22 38 33 27 0 35 52 57 32 33 0 49
49 4 410 10 173 23 41 38 34 33 38 3 41 21 41 45 42 11 49 40 25 67 57 5 85 85 91 85 118 3 116
49 5 300 1 35 0 1 0 1 0 1 1 1 1 1 0 0 0 9 4 2 1 3 0 5 13 9 17 12 0 18
49 6 320 0 32 0 0 0 0 0 0 0 9 1 12 5 9 6 11 8 7 9 12 0 17 20 20 14 15 0 18
49 7 870 0 21 0 0 1 0 0 5 0 23 3 9 12 7 0 20 19 20 26 16 0 24 33 32 30 19 0 88
49 8 650 0 53 0 0 2 0 4 1 0 4 1 2 5 0 0 3 3 2 1 3 0 4 3 5 6 6 0 5
49 9 460 0 51 0 0 0 0 0 3 0 2 1 2 2 1 0 12 4 2 6 4 0 9 7 5 11 10 1 69
51 1 320 0 31 5 3 1 4 4 5 8 5 6 8 9 6 5 5 9 11 7 6 3 10 7 2 4 14 6 67
51 2 1020 3 65 2 6 5 6 8 6 4 29 27 11 21 15 4 40 20 31 29 19 1 43 39 27 24 18 7 167
51 3 260 0 130 0 33 26 24 24 30 0 38 33 27 25 31 0 25 18 22 22 25 0 34 39 27 28 35 0 58
51 4 620 32 254 16 42 38 32 28 23 27 71 71 72 51 51 24 64 74 64 69 58 17 83 91 69 72 63 21 454
51 5 830 0 15 0 2 2 3 3 4 1 14 8 8 9 7 2 22 31 27 11 11 3 24 37 17 29 18 7 280
51 6 950 1 39 5 3 0 0 3 3 2 7 8 9 3 6 5 33 18 10 13 16 6 49 27 55 12 30 4 72
51 7 480 3 123 4 11 12 15 2 20 3 16 12 11 6 10 1 19 19 13 22 12 6 48 32 27 45 32 3 156
51 8 650 0 3 0 2 0 1 0 1 0 4 3 9 7 4 1 12 22 43 8 34 0 42 18 27 21 32 3 142
51 9 520 0 62 0 1 2 5 3 7 0 2 2 3 6 5 1 11 7 8 8 12 0 20 14 11 9 12 1 32
51 10 670 0 140 0 0 0 0 0 0 0 39 6 2 35 11 0 6 1 7 8 4 1 13 15 8 6 8 0 33
51 11 410 0 36 0 0 0 0 0 0 1 10 8 2 4 0 1 24 17 16 8 18 0 31 28 27 20 23 0 10
51 12 720 0 19 2 1 2 2 1 2 0 2 2 1 3 2 0 2 3 2 0 1 0 4 2 2 3 4 0 8
52b 1 490 1 85 1 2 5 3 3 7 1 2 9 5 5 4 0 5 8 2 3 3 0 6 4 3 4 4 0 4
52b 2 650 0 35 0 0 0 0 0 0 0 1 1 2 2 0 0 3 1 5 6 0 0 5 10 1 6 5 0 6
52b 4 670 1 47 1 11 8 8 4 6 0 18 8 13 7 17 0 8 13 14 19 22 0 23 19 14 13 17 1 111
52b 5 855 0 45 0 1 8 8 16 13 1 10 5 16 11 14 0 7 6 13 8 9 0 12 2 5 4 11 0 6
52b 6 425 0 107 0 3 3 5 1 2 1 7 4 7 5 8 0 17 14 9 26 21 1 33 38 25 16 22 1 98
52b 7 580 0 117 4 13 3 5 6 9 0 23 11 9 14 8 0 18 20 20 13 8 0 21 32 18 11 24 1 60
52b 8 590 0 139 0 19 14 15 8 20 3 40 32 22 23 12 0 28 19 38 51 51 2 47 48 39 24 26 0 87
52b 9 410 30 439 9 42 38 20 28 25 2 56 47 29 34 40 0 34 44 48 36 33 1 37 42 46 42 28 0 91
52b 10 630 0 71 4 25 24 20 11 19 4 10 13 20 17 11 2 8 10 19 10 19 0 20 11 8 15 12 3 141
52b 11 710 0 140 0 8 12 4 10 8 2 14 10 15 24 4 0 24 6 14 5 8 0 14 27 7 39 8 0 123
52b 12 740 0 59 3 15 27 15 16 21 0 21 15 14 16 23 4 13 11 17 10 5 1 17 17 17 14 5 0 46
52b 13 800 6 70 11 6 6 6 8 13 6 6 1 14 14 11 5 12 17 9 7 11 6 18 18 15 19 15 1 91
54b 1 930 0 30 0 0 0 0 0 0 0 6 0 3 3 4 0 9 9 14 10 8 0 9 8 10 10 11 0 1
54b 2 610 3 113 4 13 21 15 15 20 11 26 17 25 31 30 8 33 87 114 88 112 14 137 126 163 150 92 10 688
54b 4 270 0 153 4 25 25 22 14 18 0 34 30 41 27 23 0 21 23 27 27 17 2 40 43 47 26 15 0 65
54b 5 470 0 55 1 11 7 13 13 6 3 14 15 16 13 10 0 14 14 10 10 12 0 8 14 7 12 11 3 39
54b 6 285 0 29 0 26 28 23 20 15 0 37 17 39 29 41 0 49 44 35 37 28 0 58 42 36 39 46 0 37
54b 7 640 1 79 3 6 21 8 15 7 1 31 33 23 18 19 3 41 21 34 76 43 2 50 50 93 77 71 1 498
54b 8 715 0 423 0 21 33 44 26 17 0 19 13 31 31 23 1 33 26 20 24 25 1 55 47 53 55 40 1 114
54b 9 625 0 196 0 12 19 8 9 21 3 33 5 25 21 29 0 57 61 45 53 49 0 80 67 67 77 71 2 277
54b 11 920 0 291 0 1 10 0 0 1 0 33 11 15 18 19 1 95 70 48 64 36 1 57 55 56 34 43 0 150
54b 12 620 0 87 0 0 0 0 0 0 0 1 4 0 2 7 0 4 8 10 7 15 0 19 14 19 21 11 0 28
54b 13 950 2 80 6 11 4 11 9 7 1 25 9 11 12 9 3 39 50 49 39 38 6 45 41 42 44 38 9 268
66 1 600 5 177 5 13 4 6 14 6 8 14 15 9 11 22 6 36 32 40 42 32 2 42 55 35 32 32 4 224
66 2 750 4 53 0 8 8 5 3 8 0 16 14 8 8 5 0 27 22 13 10 7 2 47 35 26 27 33 0 117
66 3 820 2 145 0 2 13 10 4 12 2 4 10 1 7 9 0 17 23 24 24 17 1 30 25 24 28 27 3 49
66 4 450 1 187 0 2 4 3 1 2 0 14 20 0 17 17 7 21 21 14 22 5 3 63 45 41 51 51 2 65
66 5 370 0 108 0 2 2 3 3 1 0 2 2 5 2 3 0 2 4 2 3 3 0 1 1 2 1 2 0 7
66 6 690 0 62 0 1 1 3 2 1 0 4 2 1 1 2 0 4 1 1 1 1 0 3 1 3 3 5 0 13
66 7 790 0 120 0 51 33 41 35 40 0 56 80 85 46 77 0 79 56 85 69 53 0 52 46 62 47 77 0 62
66 8 555 0 112 0 6 4 3 4 4 0 36 27 32 24 29 1 23 44 57 15 9 0 53 60 37 56 63 5 86
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
66 10 450 2 130 4 32 17 15 17 9 0 29 19 26 18 14 0 48 37 26 26 28 0 58 45 52 55 61 0 154
66 12 440 0 456 0 12 8 13 10 14 0 14 14 9 23 16 0 21 16 16 30 15 0 52 49 39 42 30 0 54
66 13 500 0 114 4 12 10 12 10 5 0 12 6 18 10 11 0 16 17 8 14 10 0 12 14 31 21 24 0 71
66 14 640 0 185 0 6 4 10 8 5 0 15 16 9 14 11 0 60 62 70 75 63 0 134 114 121 102 110 0 119
66 15 850 4 133 7 13 14 7 15 8 17 14 22 25 14 19 9 23 23 21 36 32 19 51 38 34 38 54 12 180
66 16 280 0 66 0 44 33 76 32 47 0 54 # 82 89 76 0 89 107 100 146 12 0 48 87 74 71 64 0 80
66 18 670 0 157 0 3 2 1 2 5 0 11 4 5 2 6 0 25 11 14 9 6 0 35 33 30 24 22 0 95
66 19 450 0 65 0 2 0 3 4 2 0 4 1 3 7 1 0 8 18 13 10 14 0 18 20 8 10 14 0 31
66 21 570 4 151 1 2 1 3 3 1 0 11 15 4 9 11 5 14 13 22 15 13 0 44 30 33 20 19 0 42
69 1 570 8 85 11 11 0 2 7 11 5 10 2 14 7 2 0 3 9 5 9 2 9 24 14 16 12 17 4 42
69 2 570 5 358 4 11 10 7 5 10 1 36 27 21 27 16 4 48 55 64 60 55 3 91 124 112 111 101 18 934
69 4 400 0 157 1 4 6 12 13 1 0 28 28 24 36 36 0 29 20 44 25 39 0 47 36 30 22 24 0 151
69 5 490 0 188 0 0 0 0 1 0 0 7 9 7 7 12 0 28 25 21 15 16 0 30 17 25 15 23 0 20
69 6 650 0 209 2 14 12 10 4 5 0 14 21 21 19 9 0 21 10 15 10 8 0 41 33 29 21 32 0 124
69 7 760 0 448 0 29 12 17 3 8 0 40 26 21 8 9 0 49 27 17 11 16 0 98 109 83 71 70 0 221
69 8 500 19 240 15 26 18 20 21 17 23 33 33 19 27 25 13 32 23 33 39 41 20 56 54 67 52 53 13 170
69 10 900 0 130 1 1 1 0 1 1 0 5 5 7 5 2 1 12 18 15 14 13 0 26 24 31 16 17 0 83
71 1 535 21 151 14 23 28 20 21 18 16 41 27 32 29 28 16 91 71 72 67 50 24 107 102 78 84 79 14 163
71 2 450 1 157 2 7 11 12 12 8 2 38 14 46 46 54 4 50 56 39 62 38 0 42 53 32 32 56 1 103
71 3 600 11 132 10 31 41 17 21 16 10 43 27 25 32 14 21 61 36 34 30 34 11 41 53 25 31 37 13 471
71 4 770 0 52 1 0 1 3 2 6 3 21 26 19 26 23 0 24 24 28 22 21 5 41 28 37 42 26 2 126
71 6 690 6 112 3 17 22 13 12 6 1 32 27 22 19 15 1 54 29 38 29 19 2 56 37 43 40 37 1 94
71 7 760 3 416 1 56 53 63 68 66 6 132 110 98 117 94 1 166 162 143 187 116 1 219 197 175 147 # 3 493
71 8 480 1 172 0 11 3 5 10 17 0 24 9 19 27 18 0 35 35 32 16 24 0 36 40 45 52 42 1 84
71 9 650 9 192 9 11 11 9 9 6 5 2 16 25 19 15 8 41 41 28 12 16 5 41 23 20 13 17 12 206
71 10 530 2 70 0 6 6 9 3 6 0 7 7 9 5 6 0 15 19 12 23 21 1 30 30 23 33 23 0 145
71 11 700 0 112 0 2 0 2 2 1 0 1 3 3 1 3 0 14 11 6 6 11 0 38 29 18 26 27 0 97
135 1 620 0 63 0 3 5 6 5 8 0 17 10 10 15 11 0 37 27 26 24 24 0 53 47 48 38 39 0 56
135 2 880 0 93 0 3 1 0 1 3 0 21 18 16 11 19 0 14 25 29 22 39 0 37 41 40 38 29 0 25
135 3 660 0 19 0 1 2 2 2 1 1 5 2 2 2 1 0 5 7 1 1 4 0 5 2 3 3 8 0 14
135 4 50 0 42 0 2 5 2 3 1 0 7 4 5 4 5 0 4 16 9 4 7 0 14 11 11 12 4 0 12
135 5 750 0 82 0 1 0 0 0 1 0 11 3 6 4 6 0 26 34 17 30 19 0 24 27 30 11 25 0 13
135 6 525 1 21 2 7 3 4 5 7 2 11 4 9 7 3 4 10 7 21 11 15 1 11 22 17 26 21 0 134
135 7 700 0 86 0 3 5 3 4 5 1 32 8 15 10 12 0 19 22 17 23 31 0 39 27 16 23 13 2 51
135 8 320 0 119 0 12 13 12 9 9 0 5 2 6 8 6 0 19 17 17 13 24 0 25 44 39 42 18 0 30
135 9 90 0 76 0 0 0 0 0 0 0 1 1 1 0 1 0 10 10 3 7 27 0 7 17 3 3 33 0 79
135 10 250 3 175 6 18 5 16 10 14 9 23 32 26 29 24 1 57 69 66 77 70 4 57 66 97 57 38
136 1 720 5 81 20 31 23 26 8 28 19 36 17 19 18 29 7 28 32 28 21 13 7 29 38 20 24 35 8 157
136 2 480 0 45 0 3 3 0 3 3 0 3 2 2 6 1 0 7 3 0 5 5 0 7 8 9 7 3 0 11
136 3 550 4 119 3 21 15 12 11 14 5 16 19 19 16 11 5 16 8 10 13 9 6 16 25 29 27 11 7 169
136 4 650 0 149 0 10 4 1 0 1 0 4 3 2 8 6 0 2 2 0 1 5 0 3 9 10 7 9 0 33
136 5 620 0 61 3 2 7 3 7 2 4 11 7 4 4 5 1 14 16 11 16 18 7 32 34 20 47 22 0 116
136 6 710 0 115 1 7 9 6 5 6 0 8 5 7 6 7 0 11 13 11 11 9 0 25 19 18 10 17 0 91
136 7 630 3 43 9 12 10 10 7 5 2 5 10 6 8 10 6 20 17 16 8 15 2 20 7 18 3 15 5 72
136 9 210 0 68 0 3 1 1 0 0 0 5 6 3 2 7 0 10 4 3 13 15 0 11 8 6 3 13 0 16
136 10 410 0 76 0 0 0 1 0 0 0 2 3 0 1 2 0 2 4 3 1 2 0 27 10 22 18 5 0 9
136 11 590 1 39 0 12 6 7 10 16 1 9 9 14 17 18 1 13 2 17 9 7 1 19 10 5 9 12 2 96
136 12 650 8 154 6 5 1 0 3 2 7 40 7 15 14 10 6 31 30 33 31 37 9 49 42 19 28 56 5 183
137 1 500 0 29 1 5 5 6 4 4 0 8 3 4 6 5 0 8 4 3 6 1 0 9 9 9 8 8 0 24
137 2 800 25 150 12 26 36 22 17 39 13 47 10 32 40 30 33 65 33 35 31 34 21 65 54 32 64 47 19 432
137 4 600 0 90 0 5 6 3 9 9 0 20 14 7 13 23 0 33 18 15 21 21 1 17 27 18 19 23 0 19
137 5 750 4 81 9 15 20 13 6 11 11 21 17 19 26 20 5 30 18 19 30 26 11 25 38 28 32 31 3 109
137 7 450 0 139 0 10 6 6 6 3 0 5 7 7 8 11 0 10 5 8 9 3 0 6 11 11 9 9 0 0
137 8 740 0 66 0 5 3 3 4 2 0 6 1 0 5 1 0 21 7 11 8 12 0 12 12 25 8 11 0 50
137 9 770 0 141 0 7 1 5 4 6 0 9 6 5 12 8 0 20 16 14 9 10 0 31 20 27 22 11 0 30
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
137 10 650 4 96 3 29 23 19 9 8 6 17 22 17 18 11 4 28 42 38 15 20 1 45 38 36 37 35 2 137
137 11 525 1 47 3 15 6 16 3 17 2 14 28 15 21 19 11 34 27 19 38 7 7 28 27 34 48 32 0 114
137 12 540 0 180 10 41 11 15 20 11 7 18 33 20 19 26 9 29 36 18 9 23 2 40 28 30 47 32 14 137
138 1 720 1 58 3 1 5 6 13 4 4 5 9 7 8 5 4 17 15 9 7 8 3 7 4 8 7 14 4 47
138 2 520 0 14 0 1 1 0 1 2 1 10 5 3 7 6 1 12 10 7 8 8 0 10 7 11 12 13 0 42
138 3 620 0 203 0 24 15 6 4 9 0 39 19 14 30 21 0 35 46 54 20 29 0 43 40 23 26 37 0 81
138 4 740 0 22 0 0 0 0 0 0 0 0 1 1 3 0 0 4 7 2 4 2 0 10 9 6 8 2 0 11
138 5 350 2 60 1 3 2 3 3 9 3 6 6 7 9 7 1 15 21 22 24 22 0 14 9 2 0 0
138 6 500 0 61 0 4 4 1 0 4 0 5 3 3 3 10 0 14 17 6 4 12 0 13 17 22 21 12 0 37
138 7 450 1 92 1 0 1 1 4 2 0 23 9 9 5 11 0 33 39 26 31 21 0 89 88 82 77 65 0 115
138 8 750 0 90 0 3 0 4 0 0 0 6 2 2 1 4 0 1 1 8 3 1 0 11 11 8 10 8 0 2
138 9 650 0 66 0 25 23 21 17 15 1 19 24 26 16 22 0 20 11 17 13 16 0 20 9 9 23 23 0 25
139 1 700 3 66 0 5 4 8 5 6 0 14 6 12 7 8 1 23 12 12 16 23 3 33 31 19 34 28 1 97
139 2 850 0 27 0 0 0 1 0 0 0 1 1 2 1 1 0 6 2 1 6 3 0 3 3 5 2 1 0 5
139 3 510 0 93 0 14 5 7 7 8 0 27 25 20 27 29 0 33 28 36 26 32 0 37 33 23 26 24 0 102
139 4 620 0 52 0 4 6 3 3 2 0 16 5 7 6 5 0 20 13 17 8 11 0 28 31 27 17 15 0 39
139 5 750 0 96 0 1 1 0 0 0 0 12 6 11 4 1 0 11 12 10 18 13 0 15 22 13 11 10 0 10
139 6 280 0 59 0 5 0 3 5 2 0 19 5 8 5 1 0 19 39 10 15 13 2 41 22 20 58 58 6 81
139 7 320 0 73 0 0 3 0 1 1 0 9 4 4 3 9 0 12 4 11 9 6 0 12 8 3 6 6 0 227
139 8 710 1 70 4 15 11 10 11 8 4 23 21 21 17 11 4 14 11 9 9 7 6 7 7 11 17 8 2 155
139 9 820 3 101 1 13 20 9 10 8 2 7 14 15 2 8 0 15 13 4 9 9 0 44 41 45 43 31 0 203
139 10 720 0 53 0 9 2 2 8 5 0 12 6 6 1 14 0 22 19 11 15 17 0 30 27 45 27 33 0 72
139 11 810 0 92 0 7 5 11 4 4 0 11 8 6 16 6 0 21 23 27 20 32 0 26 28 39 27 28 0 21
140 1 700 0 42 0 1 0 2 2 0 0 1 2 5 0 2 0 2 14 6 1 3 0 25 24 17 13 11 0 16
140 2 600 3 156 6 9 7 10 17 9 7 33 29 25 15 17 12 15 32 25 16 29 13 15 14 28 19 28 9 142
140 3 650 9 204 21 19 20 17 11 18 10 66 45 36 52 64 26 62 59 89 70 90 20 118 115 104 112 # 9 564
140 4 425 0 96 0 10 7 2 3 10 0 16 16 11 13 7 0 7 18 8 11 10 0 9 10 14 8 6 0 30
140 6 600 8 319 0 5 12 27 10 7 0 34 34 37 8 37 0 86 61 57 33 42 0 144 115 121 106 # 0 361
140 9 610 2 72 19 39 50 54 37 31 30 34 43 33 27 22 14 33 24 17 12 13 10 23 27 23 22 18 3 109
140 10 720 0 61 0 7 9 6 7 13 0 4 3 5 9 2 0 6 14 10 10 8 0 12 4 13 12 9 0 57
140 11 680 2 91 10 16 13 11 9 9 5 13 12 14 16 13 8 12 17 16 15 25 3 15 12 12 12 16 5 52
140 12 760 0 43 0 0 0 0 0 0 0 5 6 4 2 3 0 27 6 9 5 5 0 45 27 30 21 15 0 80
53b 1 890 0 124 0 15 37 23 21 9 0 16 15 3 14 17 0 3 4 14 14 17 0 7 3 10 6 15 0 25
53b 2 890 0 160 0 27 27 18 12 13 0 36 22 35 41 25 0 35 27 36 42 23 0 39 44 39 44 12 4 120
53b 4 880 0 10 0 1 0 1 0 1 0 2 1 0 0 1 0 1 0 2 1 2 0 3 0 2 3 5 0 5
53b 5 660 1 48 2 5 4 9 5 6 0 15 16 7 7 6 0 5 4 10 9 6 2 10 7 9 11 11 0 21
53b 6 760 2 134 1 12 12 23 17 4 4 22 16 26 19 9 3 31 30 22 16 17 3 32 36 35 32 20 2 160
53b 7 830 0 110 2 8 9 6 7 4 0 10 7 11 8 9 2 16 15 27 16 15 0 44 32 26 30 28 1 110
53b 8 610 0 93 0 3 3 2 3 1 0 4 0 4 2 1 0 4 4 2 2 1 0 14 4 2 3 3 0 3
53b 9 1000 0 119 0 1 3 0 2 1 0 0 4 0 1 2 2 18 12 7 17 11 0 19 11 11 12 13 0 28
53b 10 790 3 133 1 7 5 10 7 2 0 10 7 10 7 1 0 9 11 12 10 7 1 18 13 18 8 13 0 38
53b 11 890 0 191 1 5 3 3 1 6 0 8 6 6 4 12 1 11 10 11 15 11 0 8 13 14 12 8 0 35
53b 12 800 2 102 10 12 15 18 18 20 11 19 17 16 13 16 10 49 50 46 32 41 10 64 80 89 82 72 7 558
56 1 780 9 169 14 9 12 11 4 14 8 19 19 13 18 25 10 25 35 41 32 33 7 33 42 25 32 25 8 118
56 2 870 13 117 14 22 30 25 23 28 12 21 18 19 19 19 17 36 25 17 24 20 6 44 46 47 32 36 10 200
56 3 830 21 324 21 48 34 33 36 24 17 33 42 43 37 34 24 79 70 105 93 113 22 148 137 126 116 78 20 634
56 4 1040 0 135 0 1 9 3 7 5 0 10 4 4 2 5 0 10 18 20 13 4 0 30 17 14 36 45 0 34
56 5 430 0 43 1 0 0 1 1 3 0 6 2 7 7 2 0 6 5 5 16 9 1 25 23 56 20 23 2 53
56 6 720 0 42 0 10 13 8 8 6 0 8 5 9 10 11 2 19 7 12 9 5 0 8 8 10 18 15 0 41
56 7 840 11 177 11 27 34 18 26 14 5 28 36 31 31 18 9 60 43 32 26 20 6 75 49 57 51 44 15 167
56 8 650 1 35 2 3 2 3 1 4 0 4 2 6 2 2 0 17 19 6 6 11 1 20 18 15 10 16 1 72
56 9 460 2 74 0 0 0 0 0 0 0 2 2 3 3 2 0 3 3 4 4 5 1 11 15 18 25 19 2 33
56 10 600 0 68 2 9 2 15 12 3 0 18 17 10 18 13 0 10 11 16 11 10 0 15 18 22 7 13 0 92
56 11 740 2 121 0 2 3 2 2 1 0 4 3 0 3 4 0 15 6 4 6 2 0 12 19 11 10 9 0 12
56 12 745 2 61 1 1 2 2 3 2 0 1 1 2 1 2 4 3 9 2 4 3 0 19 15 11 27 30 1 15
sh
am
-V
EH
d
4
in
j-
B
P
d
4
R
at
 #
N
e
u
ro
n
D
e
p
th Brush 1.4g vF 4g vF 10g vF 26g vF Pinch
 256 
 
Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
63 1 600 0 51 1 7 8 5 4 3 3 14 8 5 8 4 2 17 6 6 5 6 1 7 8 4 8 12 3 26
63 2 760 3 112 6 18 16 7 7 14 9 19 21 15 18 6 14 21 18 14 19 24 13 36 33 35 21 25 8 111
63 3 870 1 288 0 42 30 31 24 37 1 58 42 46 30 31 0 54 42 36 31 21 0 54 43 30 32 27 3 139
63 4 875 41 607 37 78 65 # 47 60 19 82 78 68 52 65 35 115 98 90 90 78 22 101 101 105 101 # 13 360
63 5 950 25 130 0 7 0 7 6 2 7 29 24 11 14 21 1 34 38 34 48 37 2 56 56 57 52 55 4 155
63 6 310 0 96 0 0 0 0 0 0 0 28 18 16 17 10 0 50 53 48 48 40 0 57 32 40 40 42 0 38
63 7 310 1 76 1 8 6 11 5 8 6 24 19 21 18 16 2 29 32 35 31 29 5 32 40 36 33 34 3 127
63 8 720 6 255 18 20 19 20 25 34 21 35 57 38 41 31 12 43 47 67 49 59 7 87 68 60 58 97 3 261
63 9 550 5 153 1 19 34 13 10 14 0 37 33 39 19 18 4 60 38 39 32 31 5 42 62 51 46 26 9 256
63 10 540 1 175 0 7 1 2 0 2 0 41 7 11 4 6 0 54 34 28 34 21 3 31 39 35 22 25 0 73
64 1 670 5 240 3 18 28 27 15 25 7 12 24 20 16 23 2 51 41 48 69 70 3 49 77 86 65 39 1 352
64 3 680 1 258 7 21 22 32 29 36 9 45 45 48 67 60 1 41 40 37 34 54 6 48 59 43 148 65 6 591
64 4 780 1 188 6 25 24 17 31 27 0 19 14 18 17 16 1 25 21 18 16 29 0 32 20 34 27 24 4 168
64 5 620 0 43 1 7 4 6 4 2 6 10 9 3 5 20 0 12 4 5 4 6 0 8 12 14 14 9 0 72
64 6 810 9 278 0 9 6 4 29 30 3 44 30 35 37 16 6 54 41 46 85 39 4 86 55 40 45 41 4 192
64 7 950 2 76 0 5 5 1 1 1 0 5 1 0 6 3 0 4 9 1 3 1 0 6 10 13 11 13 1 38
64 8 500 42 279 37 40 56 50 57 51 29 60 50 57 46 50 39 99 84 68 74 49 38 104 101 86 67 # 40 358
64 9 780 0 53 1 6 20 0 2 1 0 21 37 19 41 31 0 35 45 61 37 74 0 34 26 16 11 58 0 42
67 2 650 5 293 0 18 18 35 15 24 0 45 23 36 45 23 1 112 126 58 108 96 1 63 87 101 75 65 5 411
67 3 740 1 148 0 6 3 2 1 2 1 37 22 29 20 16 0 79 55 44 45 44 2 84 53 45 41 48 9 167
67 4 270 0 152 1 22 21 11 7 15 0 30 27 29 27 28 0 45 38 39 35 49 0 67 43 39 50 62 0 60
67 5 400 9 193 10 22 22 21 22 22 9 36 33 34 29 36 11 60 58 55 60 56 9 57 32 49 43 50 7 211
67 7 800 1 367 0 17 50 61 37 24 1 60 59 65 63 57 0 69 61 66 58 68 0 99 66 61 55 57 3 85
67 8 910 0 334 0 5 22 16 13 3 0 27 28 25 28 47 0 32 42 30 34 34 0 37 31 42 30 36 4 201
67 9 600 4 174 6 101 87 99 82 96 5 92 96 112 105 96 0 89 98 75 94 100 2 92 76 101 78 95 2 359
67 10 830 0 62 0 2 0 1 1 0 0 3 3 2 1 2 0 11 6 7 9 10 0 17 25 15 8 13 0 18
67 11 200 1 249 0 5 3 1 3 0 0 12 20 8 23 8 0 23 12 22 10 20 0 14 8 15 17 12 0 6
67 12 310 0 94 0 0 0 0 0 0 0 6 3 1 1 3 0 11 4 3 5 1 0 13 10 14 4 6 0 67
67 13 650 5 96 3 12 7 5 12 5 0 8 6 5 3 10 4 16 12 23 17 9 4 40 27 27 36 22 1 155
67 14 780 0 94 0 2 3 2 3 1 0 8 5 1 4 1 0 30 33 20 34 23 0 32 34 28 24 17 0 41
70 1 550 1 131 0 7 0 3 2 2 1 4 5 4 5 0 0 8 16 5 8 15 0 9 12 11 17 18 0 67
70 2 650 0 222 0 1 9 9 4 10 0 18 10 19 23 17 0 49 27 26 34 15 0 66 71 41 54 62 0 57
70 3 900 0 321 0 12 6 0 0 0 0 31 16 22 16 17 0 65 20 30 50 85 0 86 88 69 60 35 0 165
70 4 670 9 246 6 46 29 32 21 30 9 31 44 38 75 37 2 86 58 53 46 50 6 78 42 45 41 52 3 302
70 5 650 2 77 3 3 8 0 1 5 2 10 4 5 5 3 3 9 16 5 5 15 1 20 25 13 19 16 0 80
70 6 775 0 227 3 4 6 2 7 3 4 11 10 7 13 11 0 14 34 15 12 10 0 21 10 15 8 12 0 99
70 7 775 0 511 0 37 31 26 20 25 0 53 42 27 39 27 0 95 64 91 67 66 0 124 135 115 106 95 0 438
70 8 770 0 137 0 1 2 1 1 1 0 3 4 1 1 2 0 3 1 4 0 1 1 5 5 8 14 3 1 23
70 9 500 0 54 1 2 3 4 6 6 0 8 11 4 7 1 0 14 16 5 10 9 0 23 20 12 19 28 0 144
70 10 700 0 106 7 22 20 30 15 22 3 32 32 20 16 14 6 41 37 46 42 23 5 31 37 37 40 19 1 115
91 1 850 0 54 0 0 0 0 0 0 0 7 7 6 8 4 0 21 13 19 6 7 0 26 22 10 11 21 0 16
91 2 850 3 105 3 6 6 9 7 6 2 19 15 15 8 6 4 25 32 12 30 28 9 48 38 52 49 48 2 184
91 3 900 4 73 8 7 7 4 8 5 5 21 7 17 8 13 8 15 17 6 12 16 5 17 20 15 13 18
91 4 1090 0 26 0 9 6 8 4 3 3 12 7 3 12 7 0 31 38 22 18 28 3 69 49 56 25 33 1 271
91 5 520 6 63 8 6 20 10 9 3 3 10 16 22 16 9 3 14 6 22 26 11 3 12 8 16 18 12 2 150
91 6 650 1 57 0 2 2 2 2 1 1 5 14 6 3 4 2 25 28 22 29 15 3 25 31 26 31 33 0 52
91 7 770 0 37 0 2 1 2 1 1 0 4 6 9 2 17 0 18 14 28 16 14 3 28 14 21 15 19 3 167
91 8 350 2 112 2 10 9 7 8 21 1 31 19 14 16 16 0 22 20 19 24 26 1 35 38 33 33 33 2 100
91 9 440 4 122 2 4 5 6 7 1 5 17 22 18 12 13 5 39 34 29 21 33 4 64 28 44 61 60 3 110
91 10 570 0 114 0 13 9 8 17 6 4 30 20 26 15 25 0 22 31 21 17 12 0 24 22 30 26 21 1 95
91 11 760 2 59 1 12 5 10 6 4 1 14 11 13 15 5 2 21 11 8 7 13 2 33 26 45 36 28 2 127
91 13 960 0 42 0 0 1 0 0 2 0 2 2 2 0 2 0 8 8 5 1 4 0 9 3 8 9 13 0 4
92 2 610 2 40 15 16 15 13 14 18 14 39 23 21 18 11 13 45 43 38 33 25 11 29 52 43 57 50 1 160
92 3 540 0 110 0 6 0 10 2 0 1 7 6 2 2 1 0 12 10 5 3 10 2 14 20 13 14 9 0 14
92 4 790 3 200 2 9 3 3 3 0 1 8 8 5 2 15 1 18 25 14 15 3 0 30 35 23 24 9
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Note – Table is continued on the next page. 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
92 5 640 3 127 5 7 3 13 7 11 3 27 29 38 12 17 5 42 38 37 59 38 6 60 47 67 72 63 5 129
92 6 950 1 46 1 5 8 4 2 2 1 9 5 5 9 10 0 12 10 13 11 15 1 11 18 24 28 23 3 145
92 7 500 0 105 0 3 1 6 0 4 0 9 4 4 7 3 0 23 37 14 38 40 0 23 11 5 14 23 0 5
92 10 700 0 31 0 1 0 0 0 0 0 3 3 2 4 7 16 24 18 10 11 11 0 29 16 9 9 3 0 9
93 1 840 41 314 45 50 30 36 31 36 19 75 64 60 50 48 22 50 89 62 79 36 17 61 68 65 66 31 22 488
93 2 450 0 23 0 0 0 0 0 0 0 0 1 0 0 0 0 7 0 0 0 0 0 3 0 0 0 0 0 1
93 3 520 0 22 0 1 5 2 5 1 0 5 5 3 1 2 0 14 6 9 5 3 0 15 8 7 5 9 0 69
93 5 720 2 70 1 12 6 8 4 7 1 18 9 11 14 10 1 18 10 8 11 6 1 18 15 11 16 11 2 147
93 6 900 0 80 1 3 2 0 5 1 0 5 5 3 8 2 0 23 13 7 7 8 0 26 9 32 12 14 2 70
93 7 600 0 19 0 3 4 2 2 2 0 5 3 2 3 3 0 10 9 5 3 3 0 15 6 11 9 7 0 40
93 8 850 1 76 5 8 5 12 24 17 6 26 23 23 17 20 2 9 11 6 12 13 2 10 5 18 15 18 0 38
93 9 770 0 72 0 5 3 8 6 4 0 6 16 9 11 12 0 36 8 21 10 10 0 21 17 11 17 19 0 35
93 10 840 1 120 3 11 8 8 5 8 3 12 29 13 14 6 5 12 25 7 2 7 4 16 20 21 16 16 3 69
93 11 940 0 32 0 8 4 2 4 3 0 14 11 10 9 7 0 35 35 34 24 28 0 41 55 72 70 58 0 171
93 13 600 3 122 6 9 3 15 18 9 12 24 14 26 17 23 4 38 34 36 33 30 3 49 32 35 19 30 5 134
93 13 600 2 65 5 5 4 14 11 4 6 22 12 15 11 9 10 29 33 30 22 17 9 34 21 32 19 11 6 51
117 1 120 0 112 0 4 1 1 3 3 0 5 4 9 1 8 0 14 8 13 7 12 0 11 12 8 6 17 0 8
117 2 320 0 59 0 6 4 5 5 5 0 10 9 10 8 9 0 13 17 17 16 19 0 25 27 19 21 16 0 8
117 3 710 0 113 1 15 20 28 14 26 4 27 29 25 34 34 2 53 52 27 28 27 4 82 84 67 59 54 4 292
117 4 720 0 91 0 6 2 9 8 3 0 7 7 4 9 7 0 27 24 24 16 6 0 21 10 17 25 17 0 100
117 5 615 15 135 15 66 31 30 28 34 16 34 39 20 32 22 18 20 33 24 19 6 20 35 40 47 47 73 13 218
117 7 700 0 140 0 4 9 3 3 5 0 12 10 5 6 12 0 19 20 26 24 20 0 33 33 29 22 28 0 67
117 8 520 11 97 8 8 8 20 17 11 17 9 21 13 24 26 10 22 24 18 27 22 10 16 34 31 29 37 8 81
117 9 650 1 112 2 12 4 1 6 3 1 21 10 4 9 5 0 28 19 19 19 20 2 38 61 45 31 40 2 113
117 10 580 14 69 11 31 31 20 31 30 12 48 25 38 27 15 12 38 28 22 34 27 12 26 26 20 27 12 17 145
117 11 680 0 56 0 4 1 0 0 1 0 11 16 9 7 9 0 22 9 6 9 5 0 26 12 9 17 12 0 13
117 12 490 1 92 3 11 8 8 15 16 4 25 18 20 19 16 12 22 23 18 17 18 11 20 15 25 25 21 7 131
117 13 550 0 94 0 5 3 2 6 4 1 11 6 12 6 16 1 20 16 10 13 15 2 24 19 18 17 12 0 29
117 14 465 9 53 12 14 6 3 15 6 14 8 10 16 20 12 7 13 10 12 9 9 7 12 24 14 17 19 8 64
118 1 580 11 145 8 47 38 12 37 12 16 49 58 33 33 18 8 33 39 40 34 52 20 85 63 85 64 65 7 401
118 2 825 0 31 0 1 3 3 2 0 0 3 1 2 2 4 0 1 0 2 3 4 0 3 4 3 3 1 0 3
118 3 450 1 83 0 8 11 10 11 13 4 30 1 2 4 8 2 17 5 8 19 19 2 31 33 48 35 35 0 75
118 4 750 0 7 1 6 11 2 3 2 0 8 22 13 17 9 0 24 15 7 10 13 0 25 20 23 23 16 1 217
118 5 880 17 113 13 18 14 11 20 16 14 24 21 22 11 15 22 20 25 23 22 29 19 17 21 16 18 19 18 101
118 6 420 0 67 0 6 10 5 4 0 1 15 23 16 19 12 4 24 18 21 15 10 1 36 15 11 23 34 2 25
118 7 650 1 176 2 16 9 38 6 9 0 35 17 14 12 13 1 19 22 37 27 21 0 59 52 61 84 70 8 651
118 8 780 0 97 0 1 2 3 0 1 3 21 13 6 13 8 0 28 22 18 19 17 0 46 36 26 28 37 0 122
118 9 680 4 106 9 33 25 13 21 25 2 14 18 15 13 26 12 75 41 38 34 26 10 37 22 13 17 11 7 98
118 10 720 5 87 5 9 17 14 16 21 5 38 17 22 29 16 5 47 26 36 47 21 7 58 53 68 62 54 6 315
118 12 620 3 88 4 11 11 11 7 6 4 15 26 29 26 12 4 20 30 27 18 18 4 18 52 56 44 36 10 144
118 13 800 0 57 0 2 2 3 4 1 0 8 7 5 7 3 0 4 9 8 8 10 0 9 11 10 6 8 0 36
118 14 670 1 44 0 7 8 6 3 5 0 6 5 19 12 13 1 24 21 22 23 23 1 17 14 17 13 18 1 67
124 1 450 16 438 12 65 65 69 48 40 16 90 83 88 64 83 7 103 96 83 85 91 6 126 109 123 115 129 4 461
124 2 520 3 44 5 7 10 7 10 6 4 19 30 11 27 26 8 20 38 25 33 22 6 41 53 45 33 32 2 164
124 3 650 1 196 1 14 11 7 12 6 1 16 23 9 11 21 0 25 25 20 16 14 0 28 27 17 26 31 0 82
124 5 810 13 215 19 24 35 17 26 29 20 38 31 31 19 31 17 35 32 25 39 30 12 49 45 38 32 38
124 6 320 0 225 0 0 0 0 0 0 0 69 60 75 44 66 0 63 78 55 78 45 0 68 83 59 70 69 0 241
124 7 720 13 145 4 12 10 13 20 10 9 36 33 24 21 23 7 25 18 17 21 23 7 39 39 41 39 52 3 79
124 8 680 14 225 4 22 39 22 15 19 6 53 73 70 68 64 3 70 53 70 39 69 8 63 34 49 50 43 1 230
124 9 530 3 46 8 47 40 53 38 36 3 41 52 46 34 36 7 65 65 70 49 61 1 53 68 36 22 47 3 300
124 10 520 3 183 9 24 18 10 20 16 2 21 18 17 25 10 10 36 39 31 30 28 12 74 69 71 47 65 13 376
125 1 450 19 124 30 67 33 58 42 74 11 76 97 58 91 71 20 95 78 73 66 75 8 73 68 59 42 37 12 186
125 3 390 0 135 0 5 6 8 5 5 0 11 12 10 7 8 0 13 10 14 10 10 0 16 16 18 12 10 0 27
125 4 450 6 156 6 35 18 11 4 8 13 26 34 41 25 28 6 41 34 34 27 27 7 42 68 35 74 57 6 105
125 5 470 1 85 0 34 12 8 14 14 3 25 13 6 17 34 2 45 27 28 24 19 7 59 45 14 30 37 2 88
in
j-
B
P
8
h
in
j-
B
P
4
h
R
at
 #
N
e
u
ro
n
D
e
p
th Brush 1.4g vF 4g vF 10g vF 26g vF Pinch
 258 
 
Note – Table is continued on the next page. 
 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
125 6 600 3 99 0 13 2 13 6 13 0 25 17 13 15 22 1 46 45 46 44 50 1 55 99 66 68 31 1 512
125 7 550 3 160 4 13 4 8 4 7 7 16 11 10 8 25 1 38 39 50 47 39 2 50 75 105 93 71 2 616
125 8 540 7 179 5 44 48 45 34 28 5 73 50 56 70 47 1 68 58 45 58 50 5 85 97 83 62 62 1 580
125 9 600 4 190 1 12 17 13 13 17 1 89 # 93 75 64 2 42 23 34 34 20 1 72 55 70 76 85 1 229
125 11 560 2 164 2 40 31 30 42 38 7 28 57 61 46 35 7 50 49 66 61 69 17 37 58 46 49 49 4 244
125 12 530 2 66 2 29 19 24 12 21 3 24 47 31 26 28 5 20 38 31 13 30 3 11 24 27 39 24 3 66
125 13 400 0 333 0 2 6 6 1 3 0 9 10 5 12 7 7 19 20 24 29 18 4 19 17 35 20 13 0 36
126 1 425 8 79 6 15 5 11 10 8 8 16 13 14 8 3 3 9 4 11 8 23 12 10 6 13 11 14 12 118
126 2 1000 27 344 36 31 47 34 26 45 21 71 85 84 77 64 41 93 97 91 93 92 20 126 139 129 127 142 7 390
126 3 820 7 153 9 46 30 17 21 15 4 31 30 24 34 19 13 29 40 29 19 16 8 29 35 31 28 19 14 351
126 6 560 0 78 0 13 11 6 4 5 3 24 19 19 7 25 1 27 29 24 26 26 0 31 28 31 27 30 0 133
126 7 750 0 131 1 25 20 43 15 8 3 47 54 56 51 63 2 80 47 44 63 58 3 58 58 51 32 33 3 155
126 8 820 0 75 0 3 5 9 5 2 4 9 15 13 11 15 0 18 26 21 14 26 2 36 24 18 38 33
126 9 450 0 383 0 1 0 3 1 0 0 2 5 4 1 2 0 11 34 37 38 40 0 16 23 18 18 23 0 76
126 10 440 0 132 0 2 6 2 7 1 0 15 57 22 26 23 0 43 60 41 30 47 0 56 37 38 37 17 0 153
126 11 650 0 78 0 4 5 3 1 2 0 1 0 0 1 3 0 11 3 5 4 6 0 15 24 15 8 15 0 119
126 12 900 0 97 0 1 3 3 4 7 0 10 13 26 28 32 0 28 44 35 37 47 0 25 39 46 33 26 0 11
127 1 720 26 206 29 22 37 24 22 38 28 31 29 30 30 27 21 38 37 36 27 44 18 44 42 38 39 30 3 304
127 2 870 14 240 33 33 27 33 34 22 28 58 50 50 26 46 33 95 65 77 73 66 24 121 103 99 105 120 44 375
127 3 950 0 113 0 1 1 2 1 2 0 0 3 0 3 1 0 20 9 7 6 6 0 49 45 23 18 15 0 112
127 4 1020 0 92 0 2 0 1 1 0 0 4 1 2 2 1 0 13 8 3 4 2 0 30 39 44 10 32 0 93
127 5 900 9 456 17 29 15 14 14 30 7 29 44 53 33 28 6 52 72 55 37 46 8 65 54 41 45 37 7 137
127 7 800 0 137 1 8 4 2 1 1 1 14 24 11 23 11 3 48 44 43 36 36 0 60 42 46 75 73 1 315
127 8 900 0 99 0 24 14 16 13 18 0 24 21 16 9 14 0 16 16 13 8 6 0 11 6 9 6 7 0 34
127 9 780 9 176 10 11 5 11 24 10 11 37 40 21 29 40 10 67 76 109 124 131 40 149 127 170 175 161 3 367
127 10 900 0 29 0 2 1 0 5 2 0 1 9 5 3 0 4 20 49 34 17 43 0 50 69 62 72 69 0 413
127 12 810 9 92 8 15 15 16 9 10 4 13 15 11 13 18 11 21 14 10 15 12 4 34 24 24 25 39 17 136
127 13 860 10 179 7 22 13 20 14 10 7 33 23 23 27 11 10 60 41 49 44 42 10 65 60 50 54 55 17 232
128 1 440 2 134 3 17 21 12 27 18 2 28 31 29 20 37 2 31 39 47 29 41 1 35 46 45 39 30 0 203
128 2 570 0 220 3 19 16 14 12 9 3 24 29 27 27 30 1 47 45 37 43 51 18 78 86 70 65 57 6 340
128 4 700 1 137 0 5 7 9 9 11 0 13 14 10 6 11 0 7 6 3 5 7 0 13 3 11 7 10 0 14
128 5 800 0 97 0 4 0 2 1 0 0 11 8 6 6 6 0 50 48 48 48 40 1 35 40 41 44 24 0 106
128 6 360 0 203 0 10 19 13 13 12 0 66 12 63 51 63 0 68 63 42 44 35 0 69 92 102 104 102 0 169
128 7 775 6 225 6 18 23 24 11 18 6 34 26 35 28 31 6 18 12 17 25 16 7 15 23 36 27 44 8 274
128 8 925 2 75 4 23 22 23 34 27 2 33 22 27 42 36 1 61 43 42 32 48 4 59 63 52 45 53 1 199
128 9 1010 0 110 1 5 10 11 5 8 0 6 6 7 10 12 1 24 14 19 29 26 1 63 68 62 49 48 0 368
128 10 450 0 27 0 8 10 9 7 8 0 11 23 16 16 20 1 26 21 29 19 24 0 16 36 33 31 20 0 230
128 11 550 2 181 0 7 14 6 7 14 1 20 18 24 17 8 0 32 33 30 34 23 7 32 28 42 36 24 3 139
128 13 780 12 270 9 16 23 30 28 22 16 35 25 28 28 34 8 97 60 65 86 80 24 87 115 84 104 107 5 440
83 1 670 0 129 3 6 11 11 12 9 7 16 12 23 19 16 4 20 18 22 30 28 8 43 27 44 32 42 5 329
83 2 620 8 362 1 7 21 19 12 21 6 16 36 50 21 21 3 28 35 36 41 51 1 51 66 68 73 53 4 245
83 3 620 0 139 4 10 10 10 10 9 3 27 16 20 20 18 3 20 24 17 11 16 5 21 16 14 19 19 0 34
83 4 470 1 81 0 2 2 1 5 1 3 18 5 7 10 10 2 27 36 19 35 23 11 74 62 84 74 69 7 355
83 5 830 0 42 0 0 0 0 0 0 0 2 1 3 0 1 0 23 27 23 33 22 0 53 55 57 56 51 0 308
83 6 620 0 100 0 10 6 5 9 6 0 19 9 17 11 11 0 31 16 22 32 14 0 80 46 34 54 44 0 75
83 8 420 2 15 2 10 5 2 5 4 0 3 5 3 6 5 2 6 6 7 5 6 1 16 13 21 19 16 2 41
83 9 480 10 129 12 27 19 13 41 25 7 49 38 40 35 54 13 39 75 75 77 67 13 64 83 78 69 90 5 640
83 10 670 4 276 0 20 29 15 18 18 2 32 30 29 31 37 1 46 55 48 39 39 1 54 54 47 50 62 0 238
83 11 780 0 193 0 22 16 13 25 15 0 19 12 16 12 11 0 74 58 58 40 63 0 45 83 97 44 105 0 340
86 4 500 1 163 0 20 23 19 17 13 0 30 29 20 19 20 4 33 30 25 17 23 0 51 29 29 21 23 0 185
86 5 760 5 178 10 12 18 29 19 34 8 39 46 40 39 32 9 35 46 35 33 38 6 34 57 44 63 56 21 432
86 6 800 1 134 0 2 1 2 1 1 0 3 5 2 9 3 0 10 15 5 16 9 3 51 42 51 41 42 2 161
86 7 520 2 216 1 13 11 7 7 6 1 37 14 6 12 24 3 39 22 26 29 27 1 51 58 48 53 59 2 157
86 8 720 0 204 0 19 6 21 26 18 1 36 48 44 19 55 0 75 48 48 59 33 0 38 50 39 38 47 0 257
86 9 830 4 213 3 2 15 2 2 2 0 9 6 15 8 4 2 4 11 5 13 11 1 15 18 11 9 18 0 65
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Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol. 
 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
86 10 700 1 298 1 27 12 30 7 8 8 68 61 36 25 42 3 43 60 50 43 70 0 68 78 28 64 63 7 354
86 11 820 0 60 0 3 4 7 7 4 0 10 10 12 9 4 0 19 18 21 18 14 0 27 25 21 17 15 0 58
87 1 710 0 48 0 1 3 2 2 1 0 2 2 4 1 1 0 4 12 3 5 8 0 5 4 6 8 5 0 9
87 2 350 0 131 0 0 0 0 0 0 0 14 17 17 6 18 0 29 36 42 35 40 0 41 33 28 31 33 0 59
87 3 560 0 193 0 5 3 2 2 5 0 4 8 3 6 4 0 28 20 13 20 21 0 28 17 15 23 27 0 14
87 4 820 0 251 0 0 2 8 5 3 0 9 14 12 7 10 0 13 22 55 21 34 0 24 30 39 34 19 0 257
87 5 410 0 195 0 4 3 6 3 3 0 12 13 17 4 15 0 35 10 31 15 7 0 27 29 17 21 16 0 70
87 6 750 0 236 0 11 10 7 7 3 0 24 19 20 29 11 0 77 38 43 27 48 0 66 59 50 47 56 0 288
87 7 0 52 0 1 1 1 1 1 0 2 0 2 2 3 0 6 7 4 7 5 0 9 6 4 5 5 0 8
87 8 700 0 111 0 2 3 1 0 1 0 17 16 12 16 21 0 13 16 40 28 14 0 28 14 29 17 33 0 68
119 1 370 0 77 0 4 4 1 3 3 0 3 4 1 4 3 0 9 19 15 15 17 0 50 36 17 19 24 1 497
119 2 790 0 52 0 1 2 0 3 0 0 10 6 3 1 3 0 39 26 20 35 24 0 45 57 45 59 44 1 206
119 3 720 0 136 0 8 11 3 5 3 0 32 22 16 30 20 0 36 27 31 31 33 0 58 38 61 48 31 0 214
119 4 660 1 41 3 4 3 5 5 5 1 11 7 11 9 9 0 29 11 17 18 22 0 40 20 57 59 55 0 225
119 5 830 0 142 0 8 0 3 3 1 0 23 10 5 8 14 0 80 55 30 34 43 0 47 56 55 60 59 0 292
119 6 300 0 148 0 42 43 34 28 30 0 26 59 48 41 40 0 58 56 37 50 42 0 44 41 24 27 7 0 3
120 1 520 0 113 0 1 4 2 9 7 0 8 14 7 15 7 0 43 21 68 39 25 0 38 31 58 39 31 2 46
120 2 680 4 155 4 7 8 7 4 11 1 17 2 3 4 4 5 33 72 65 89 122 3 65 75 79 72 97 1 307
120 3 800 34 321 21 41 39 48 36 44 15 64 68 62 57 53 11 92 65 63 69 75 14 94 120 127 112 119
120 4 740 0 134 0 5 4 3 6 2 0 8 9 5 7 16 0 39 28 10 14 16 0 59 34 19 21 12 0 36
120 5 740 1 211 0 14 10 6 10 7 0 34 21 39 16 19 1 51 41 29 22 30 2 55 66 61 43 53 5 178
120 6 520 1 109 1 16 18 15 49 31 1 37 30 30 41 56 5 54 76 42 72 40 0 21 8 26 12 13 0 309
120 7 740 0 231 0 67 51 15 2 0 0 7 0 0 0 0 0 29 34 23 26 26 0 56 45 49 43 48 0 37
120 8 570 3 227 1 4 8 9 9 7 0 17 12 16 14 8 0 30 34 29 17 24 1 65 54 48 43 48 0 318
120 9 590 12 188 7 5 11 12 6 19 7 64 29 18 19 16 5 64 57 48 35 40 11 73 63 64 54 76 3 412
120 10 750 0 160 0 5 6 5 5 2 1 11 7 10 4 10 1 25 12 14 25 16 0 35 26 34 30 29 0 98
120 11 500 0 262 0 40 47 40 34 29 0 59 52 34 25 33 0 41 42 46 44 49 0 45 48 36 41 41 2 206
120 12 730 0 69 0 3 5 1 0 1 0 29 26 23 21 20 0 25 30 35 24 23 0 36 48 28 20 27 0 101
120 13 710 3 302 0 22 40 43 7 28 3 37 27 19 34 9 2 48 39 41 73 75 0 33 35 39 52 52 0 131
122 1 440 10 106 9 17 8 18 9 14 5 18 13 11 19 5 6 19 27 23 25 24 4 24 29 23 30 26 2 76
122 2 520 1 82 0 1 6 2 1 0 1 7 3 6 6 0 1 29 16 12 6 13 0 29 20 23 21 18 3 124
122 3 560 1 154 0 3 5 5 6 8 8 33 24 17 16 14 3 38 31 20 24 35 3 72 44 55 38 32 3 177
122 4 640 5 179 6 6 10 7 9 6 8 28 24 40 15 16 4 41 24 24 24 21 4 40 28 27 24 34 4 280
122 7 625 0 145 0 2 2 6 2 4 0 11 11 8 10 8 0 29 34 39 30 40 0 70 75 77 71 72 0 271
122 8 720 0 133 0 5 8 5 9 3 2 13 11 2 29 14 0 34 31 15 14 24 1 26 47 42 30 19
122 10 520 7 72 12 11 10 18 17 12 8 15 14 18 12 12 9 12 15 14 22 23 3 41 38 39 50 60 3 216
122 11 570 16 306 13 45 64 63 54 37 16 90 87 61 54 81 28 53 61 69 62 46 53 111 73 65 59 72 13 284
122 12 500 1 81 3 24 17 23 11 14 9 39 32 22 25 31 6 31 35 34 30 24 2 53 41 53 33 44 11 191
122 13 750 0 59 0 1 0 0 0 0 0 25 7 16 24 19 0 58 65 52 45 47 0 53 56 49 60 55 0 307
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Table D.3. Spike counts on day 7 for TSP4 treatment study (Chapter 4). 
 
Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol. 
 
BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL 1 2 3 4 5 BL
270 1 970 0 32 0 2 0 0 4 2 0 12 7 5 5 3 0 16 23 17 13 15 0 35 37 32 29 29 0 41
270 2 610 9 58 8 16 9 13 7 7 7 17 11 10 7 14 8 14 11 8 14 20 4 10 6 6 8 13 5 120
270 3 670 22 124 26 34 32 38 33 42 20 22 68 37 53 32 22 34 34 51 34 47 16 59 55 75 62 62 41 417
270 4 740 0 22 0 0 0 0 1 1 0 0 0 0 1 3 0 13 8 9 3 8 0 15 22 16 35 35 0 105
270 5 870 3 30 7 4 6 6 8 6 3 11 11 7 7 9 2 17 10 13 9 16 3 31 17 16 18 18 3 24
270 6 600 17 173 17 13 19 9 5 10 8 17 25 9 14 12 0 6 8 4 4 8 14 25 42 35 36 35 1 155
270 7 770 0 44 0 0 1 0 1 0 0 0 0 0 1 0 0 13 4 9 10 10 6 16 18 16 34 20 0 345
270 8 780 9 140 14 21 25 21 20 18 6 25 23 25 13 26 8 37 30 19 36 26 10 53 38 30 30 20 12 87
270 9 800 6 60 8 7 9 8 8 10 8 14 21 16 14 14 9 20 16 13 18 19 13 21 18 18 17 17 5 102
270 10 940 0 158 1 5 1 3 2 1 0 2 8 1 9 8 1 7 8 4 11 20 0 14 14 18 14 16 1 74
270 11 590 9 52 16 19 24 13 7 16 16 21 24 17 12 11 15 20 17 9 13 13 13 24 34 20 13 26 1 48
270 12 660 19 189 32 44 18 20 35 19 21 26 21 15 13 29 23 45 29 29 31 27 16 37 42 42 40 39 12 271
270 13 700 0 98 0 10 7 3 3 1 0 14 22 15 8 6 0 35 43 24 21 13 0 33 36 24 26 20 0 168
270 14 800 0 300 0 15 10 13 8 7 0 16 14 14 17 9 0 48 40 51 57 27 0 55 34 33 30 23 0 103
274 1 530 0 90 0 3 2 5 3 2 0 6 1 8 5 3 0 21 11 13 11 10 0 17 9 12 11 8 0 23
274 2 800 0 110 0 3 0 3 3 1 0 8 14 6 10 18 0 33 27 28 29 34
274 4 550 22 349 2 38 25 20 11 38 13 51 39 38 34 41 3 34 31 25 28 26
274 5 730 5 286 4 21 15 9 34 13 14 35 31 58 41 37 18 77 52 49 79 60 11 102 63 89 50 60 9 474
274 6 620 11 131 12 15 24 9 16 12 6 33 19 21 17 16 14 34 24 32 27 29 5 31 46 33 51 45 10 592
274 7 600 10 177 7 12 11 12 14 9 11 20 34 41 43 33 2 59 57 42 64 50 2 65 64 59 50 67 3 200
274 8 140 1 94 0 4 0 2 2 1 0 25 13 12 9 19 0 12 9 6 6 8 0 29 58 24 39 27 0 519
274 9 650 10 295 2 42 22 31 28 26 8 55 38 35 48 48 13 49 47 33 56 54 23 68 76 76 74 84 23 379
274 10 450 25 322 36 47 52 39 39 60 35 58 76 84 41 52 33 68 76 73 59 68 34 77 86 72 62 67 25 376
274 11 500 1 332 0 29 7 10 9 6 0 30 22 24 31 27 0 57 67 51 41 85 0 96 68 62 80 54 2 507
274 12 640 3 431 4 11 20 22 34 11 1 51 46 42 47 65 8 102 86 91 92 86 2 110 108 99 108 114 2 597
274 13 510 1 170 9 11 13 19 19 22 9 42 32 30 49 27 15 57 55 49 45 52 10 55 70 36 51 47 6 155
274 14 710 0 620 0 23 84 45 15 40 0 57 107 48 56 58 0 46 93 111 68 72 0 133 108 105 102 100 0 496
274 15 510 0 319 0 2 2 5 5 4 0 42 36 51 75 78 1 97 93 88 84 78 1 107 144 100 116 124 0 554
280 1 615 1 186 4 14 12 26 35 6 6 24 17 23 15 20 3 36 38 40 43 31 5 34 32 32 64 24 1 345
280 2 760 0 98 0 4 9 10 14 10 0 22 13 7 15 11 0 26 16 18 21 16 0 26 23 26 24 18 0 505
280 3 300 1 74 3 6 7 4 3 3 4 16 25 20 11 22 3 50 34 44 44 21 2 65 75 79 94 96 1 439
280 4 600 21 402 24 40 26 38 41 37 23 68 64 104 97 76 11 97 167 96 104 57 2 55 58 58 47 59 0 184
280 5 660 8 157 5 24 4 20 13 28 3 38 23 14 20 25 4 30 25 30 24 43 0 49 52 34 53 40 0 228
280 6 670 11 224 26 27 29 24 52 27 28 27 32 32 37 38 28 34 41 38 50 31 18 59 64 83 67 81 16 890
280 7 530 3 147 7 15 15 17 19 9 5 28 33 30 28 41 5 54 54 44 34 45 7 65 67 59 55 57 7 393
280 8 600 5 235 4 59 59 44 53 58 1 69 56 55 34 55 1 51 36 39 43 43 0 51 43 20 32 33 1 137
280 9 750 5 257 20 52 48 46 45 33 15 58 48 50 50 45 13 59 51 43 51 54 2 70 47 50 32 50 14 172
280 10 970 0 118 0 0 1 15 0 1 0 26 1 23 15 25 0 36 24 24 30 25 0 30 31 28 24 32 0 137
280 11 1000 1 116 0 0 4 1 3 1 0 30 26 13 22 29 0 35 46 42 39 25 0 60 40 50 55 57 0 149
280 12 470 2 399 2 28 18 41 26 24 1 78 43 69 56 43 0 108 104 83 87 107 3 140 116 118 124 92 0 305
280 13 820 1 47 0 1 2 0 1 0 0 11 8 6 13 15 1 19 18 15 13 13 0 23 23 20 20 22 0 142
281 1 860 0 19 0 0 3 1 0 1 0 17 13 13 7 12 0 32 17 28 19 13 0 35 32 16 24 25 0 234
281 2 860 2 201 0 14 35 49 35 39 3 35 68 45 49 58 4 61 47 62 33 70 6 48 65 78 51 82 0 177
281 3 970 1 81 1 2 2 0 1 0 2 6 15 6 12 5 1 35 41 47 28 30 1 61 32 40 43 51 2 183
281 4 610 0 441 1 36 18 21 6 31 0 55 45 43 45 48 1 64 70 62 37 56 2 65 80 84 75 71 0 351
281 5 780 1 292 4 46 36 37 32 33 0 56 65 45 56 52 7 52 47 62 39 35 2 78 63 63 48 39 1 261
281 6 700 10 353 29 45 40 37 30 39 15 64 74 74 86 56 25 84 51 51 69 58 15 70 53 78 74 59 7 451
281 7 550 0 188 1 3 9 4 9 5 1 24 25 35 23 18 2 62 45 51 49 46 4 78 75 70 74 76 4 410
281 8 830 3 91 4 12 12 10 12 10 4 13 15 11 20 19 9 33 33 22 24 24 2 30 20 20 22 20 12 240
281 9 800 0 229 0 6 9 19 26 20 0 72 56 49 42 37 0 54 69 58 66 60 0 89 53 52 55 41 0 88
281 10 560 3 208 0 10 6 2 3 7 0 34 27 16 34 38 0 76 65 63 45 48 0 73 64 76 39 54 0 279
281 11 650 11 154 8 8 10 12 13 12 9 67 62 94 49 46 7 84 76 113 67 124 7 180 172 138 178 175 4 671
281 12 700 17 284 9 34 12 28 25 22 7 60 58 43 41 29 7 82 68 68 74 69 8 110 108 91 85 101 15 484
4g vF 10g vF 26g vF Pinch
St
re
p
 +
 S
h
am
D
e
p
th Brush 1.4g vF
2
0
µ
g 
TS
P
4
 +
 P
h
ys
6
0
µ
g 
TS
P
4
 +
 P
h
ys
6
0
µ
g 
TS
P
4
 +
 I
n
j
R
at
 #
N
e
u
ro
n
 261 
Table D.4. Spike counts for optimization of burst SCS parameters on day 7 after 
painful nerve root compression (Chapter 6).  
 
Note – Table is continued on the next page. 
Rat # Neuron 
Stim 
#
Pulse 
#
Pulse 
Hz
Pulse 
Width
Burst 
Hz
Amplitude
Charge 
per  
Burst
Spike2 
Waveform 
ID
Neuron 
Type
BL
Pre-
SCS
Post-
SCS
69 2 1 7 500 1000 40 90% 8.82 01 WDR 14 190 94
69 2 1 7 500 1000 40 90% 8.82 02 WDR 7 98 78
69 2 1 7 500 1000 40 90% 8.82 04 WDR 66 466 234
69 2 1 7 500 1000 40 90% 8.82 05 WDR 4 82 76
69 2 1 7 500 1000 40 90% 8.82 06 WDR 6 99 100
69 2 2 5 500 1000 40 90% 6.30 01 WDR 11 156 137
69 2 2 5 500 1000 40 90% 6.30 02 WDR 6 175 126
69 2 2 5 500 1000 40 90% 6.30 04 WDR 24 142 122
69 2 2 5 500 1000 40 90% 6.30 05+07 WDR 22 98 105
69 2 2 5 500 1000 40 90% 6.30 06 WDR 1 56 30
69 2 2 5 500 1000 40 90% 6.30 08 WDR 5 64 56
69 3 1 5 500 1000 40 90% 6.30 01 WDR 9 200 178
69 3 1 5 500 1000 40 90% 6.30 02 WDR 5 75 51
69 3 1 5 500 1000 40 90% 6.30 03 HT 0 30 19
69 3 1 5 500 1000 40 90% 6.30 05 WDR 8 77 63
69 3 2 7 500 1000 40 90% 8.82 01 NC 0 94 29
69 3 2 7 500 1000 40 90% 8.82 02 NC 6 158 104
69 3 2 7 500 1000 40 90% 8.82 03 NC 8 105 128
69 3 2 7 500 1000 40 90% 8.82 05 NC 0 13 43
69 3 2 7 500 1000 40 90% 8.82 06 NC 0 30 8
69 3 2 7 500 1000 40 90% 8.82 07 NC 2 43 4
69 3 2 7 500 1000 40 90% 8.82 09 NC 3 78 46
69 3 3 3 500 1000 40 90% 3.78 02 NC 0 82 84
69 3 3 3 500 1000 40 90% 3.78 03 NC 7 271 461
69 3 3 3 500 1000 40 90% 3.78 05 NC 4 41 24
69 3 5 7 500 500 40 90% 8.82 02 NC 16 143 67
69 3 5 7 500 500 40 90% 8.82 03 NC 3 613 477
69 3 5 7 500 500 40 90% 8.82 04 NC 3 121 60
69 3 5 7 500 500 40 90% 8.82 06 NC 10 113 65
71 4 1 5 500 1000 40 90% 6.30 02 WDR 1 56 50
71 4 1 5 500 1000 40 90% 6.30 0F HT 35 68 75
71 4 2 7 500 1000 40 90% 8.82 01 WDR 0 58 19
71 4 2 7 500 1000 40 90% 8.82 02 HT 61 152 116
71 4 3 3 500 1000 40 90% 3.78 02 WDR 2 42 33
71 4 4 7 500 500 40 90% 4.41 01 NC 11 142 79
71 4 4 7 500 500 40 90% 4.41 02+03 NC 32 144 118
71 5 1 7 500 1000 40 90% 8.82 01 HT 0 73 34
71 5 1 7 500 1000 40 90% 8.82 02 HT 2 22 16
71 5 2 5 500 1000 40 90% 6.30 01 HT 1 239 107
71 5 2 5 500 1000 40 90% 6.30 02 HT 10 64 72
71 5 3 3 500 1000 40 90% 3.78 01 HT 0 192 230
71 6 1 7 500 500 40 90% 4.41 01 WDR 22 300 238
71 6 1 7 500 500 40 90% 4.41 02 WDR 47 521 277
71 6 1 7 500 500 40 90% 4.41 03 WDR 37 292 208
71 6 1 7 500 500 40 90% 4.41 07 HT 5 56 20
71 6 1 7 500 500 40 90% 4.41 09 WDR 34 355 307
71 6 1 7 500 500 40 90% 4.41 0A WDR 14 222 125
71 6 1 7 500 500 40 90% 4.41 0B HT 3 151 176
71 6 2 7 500 1000 40 90% 8.82 0E WDR 34 155 61
71 6 2 7 500 1000 40 90% 8.82 0F WDR 26 177 110
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Note – Table is continued on the next page. 
Rat # Neuron 
Stim 
#
Pulse 
#
Pulse 
Hz
Pulse 
Width
Burst 
Hz
Amplitude
Charge 
per  
Burst
Spike2 
Waveform 
ID
Neuron 
Type
BL
Pre-
SCS
Post-
SCS
71 6 2 7 500 1000 40 90% 8.82 10 WDR 13 137 60
71 6 2 7 500 1000 40 90% 8.82 16 HT 5 50 10
71 6 2 7 500 1000 40 90% 8.82 17 WDR 5 28 17
71 6 3 7 500 750 40 90% 6.62 01+07 NC 43 129 121
71 6 3 7 500 750 40 90% 6.62 02+04 NC 38 134 79
71 6 3 7 500 750 40 90% 6.62 06 NC 37 128 99
71 6 5 7 500 250 40 90% 2.21 01+06 NC 74 177 140
71 6 5 7 500 250 40 90% 2.21 02 NC 12 77 67
71 6 5 7 500 250 40 90% 2.21 03 NC 6 40 27
71 6 5 7 500 250 40 90% 2.21 04 NC 27 105 91
71 6 5 7 500 250 40 90% 2.21 05 NC 0 25 31
71 6 5 7 500 250 40 90% 2.21 07 NC 10 22 24
71 7 1 7 500 250 40 90% 2.21 01 WDR 14 625 599
71 7 1 7 500 250 40 90% 2.21 02 WDR 28 308 309
71 7 1 7 500 250 40 90% 2.21 03 WDR 1 46 44
71 7 1 7 500 250 40 90% 2.21 06 WDR 2 62 51
71 7 1 7 500 250 40 90% 2.21 08 NC 0 53 54
71 7 2 7 500 1000 40 90% 8.82 01+03 NC 2 542 322
71 7 2 7 500 1000 40 90% 8.82 02 NC 4 170 200
71 7 2 7 500 1000 40 90% 8.82 05 NC 3 99 65
71 7 2 7 500 1000 40 90% 8.82 06 NC 2 118 51
71 7 2 7 500 1000 40 90% 8.82 07 NC 4 52 39
71 7 3 7 500 500 40 90% 4.41 01 NC 4 371 296
71 7 3 7 500 500 40 90% 4.41 02 NC 2 197 116
71 7 3 7 500 500 40 90% 4.41 03+06 NC 4 132 69
71 7 3 7 500 500 40 90% 4.41 04 NC 5 55 38
71 7 3 7 500 500 40 90% 4.41 07 NC 2 218 174
71 7 4 7 500 750 40 90% 6.62 01+03 NC 12 814 609
71 7 4 7 500 750 40 90% 6.62 05 NC 7 101 86
71 7 4 7 500 750 40 90% 6.62 06 NC 5 42 23
71 7 4 7 500 750 40 90% 6.62 08 NC 2 61 36
73 8 1 7 500 750 40 90% 6.14 01 HT 3 667 548
73 8 1 7 500 500 40 90% 4.10 01 HT 7 681 610
73 8 1 7 500 250 40 90% 2.05 01 HT 10 525 470
73 8 1 7 500 1000 40 90% 8.19 01 HT 7 246 287
73 9 1 7 500 250 40 90% 2.05 02 NC 9 99 136
73 9 1 7 500 250 40 90% 2.05 03 NC 2 17 16
73 9 1 7 500 250 40 90% 2.05 05 NC 3 79 146
73 9 1 7 500 250 40 90% 2.05 06 NC 1 39 24
73 9 2 7 500 1000 40 90% 8.19 01 NC 1 151 77
73 9 2 7 500 1000 40 90% 8.19 03 NC 0 52 17
73 9 2 7 500 1000 40 90% 8.19 06 NC 0 48 30
73 9 2 7 500 1000 40 90% 8.19 07 NC 1 45 35
73 9 2 7 500 1000 40 90% 8.19 08 NC 0 104 60
73 9 4 7 500 500 40 90% 4.10 01 NC 1 82 55
73 9 4 7 500 500 40 90% 4.10 02 NC 7 98 83
73 9 4 7 500 500 40 90% 4.10 03 NC 6 114 43
73 9 4 7 500 500 40 90% 4.10 0E NC 6 60 65
73 9 5 7 500 750 40 90% 6.14 01 NC 11 71 46
73 9 5 7 500 750 40 90% 6.14 04 NC 5 176 134
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Note – Table is continued on the next page. 
Rat # Neuron 
Stim 
#
Pulse 
#
Pulse 
Hz
Pulse 
Width
Burst 
Hz
Amplitude
Charge 
per  
Burst
Spike2 
Waveform 
ID
Neuron 
Type
BL
Pre-
SCS
Post-
SCS
73 9 5 7 500 750 40 90% 6.14 07 NC 0 32 22
73 9 5 7 500 750 40 90% 6.14 0C NC 5 150 134
73 9 6 7 500 1000 60 90% 8.19 02 NC 2 84 106
73 9 6 7 500 1000 60 90% 8.19 03 NC 13 502 376
73 9 6 7 500 1000 60 90% 8.19 04 NC 0 19 28
73 9 6 7 500 1000 60 90% 8.19 0D NC 1 25 35
88 1 1 7 500 1000 40 90% 7.70 01 WDR 8 252 215
88 1 1 7 500 1000 40 90% 7.70 02 WDR 40 477 422
88 1 1 7 500 1000 40 90% 7.70 03 WDR 10 233 222
88 1 1 7 500 1000 40 90% 7.70 04 WDR 18 251 226
88 1 1 7 500 1000 40 90% 7.70 05 WDR 25 285 246
88 1 2 5 500 1000 40 90% 5.50 01+05 WDR 72 451 349
88 1 2 5 500 1000 40 90% 5.50 02 WDR 35 137 147
88 1 2 5 500 1000 40 90% 5.50 03+04 WDR 67 259 238
88 1 2 5 500 1000 40 90% 5.50 06 WDR 8 43 40
88 1 2 5 500 1000 40 90% 5.50 07 WDR 47 326 257
88 1 3 3 500 1000 40 90% 3.30 01 WDR 48 254 192
88 1 3 3 500 1000 40 90% 3.30 02 WDR 80 530 367
88 1 3 3 500 1000 40 90% 3.30 03 HT 12 102 66
88 1 3 3 500 1000 40 90% 3.30 04 WDR 26 235 151
88 2 1 7 500 500 40 90% 3.85 01 WDR 47 322 228
88 2 1 7 500 500 40 90% 3.85 03+07 WDR 58 321 157
88 2 1 7 500 500 40 90% 3.85 06 WDR 14 251 189
88 2 1 7 500 500 40 90% 3.85 0A WDR 3 67 31
88 2 2 7 500 1000 40 90% 7.70 01+03 WDR 92 659 506
88 2 2 7 500 1000 40 90% 7.70 02 WDR 10 56 47
88 2 2 7 500 1000 40 90% 7.70 06 WDR 18 174 129
88 2 3 7 500 250 40 90% 1.93 01 WDR 4 145 124
88 2 3 7 500 250 40 90% 1.93 02 WDR 26 298 272
88 2 3 7 500 250 40 90% 1.93 03 WDR 10 118 94
88 2 3 7 500 250 40 90% 1.93 06 WDR 2 107 95
88 2 4 7 500 750 40 90% 5.77 01 WDR 7 171 121
88 2 4 7 500 750 40 90% 5.77 02 WDR 28 209 131
89 1 1 7 500 1000 40 90% 9.45 01+06 WDR 16 630 291
89 1 1 7 500 1000 40 90% 9.45 03 WDR 11 824 108
89 1 1 7 500 1000 40 90% 9.45 08 HT 0 48 12
89 1 1 7 500 1000 40 90% 9.45 09 WDR 17 59 172
89 1 2 3 500 1000 40 90% 4.05 01+05 WDR 10 640 609
89 1 2 3 500 1000 40 90% 4.05 02 WDR 6 255 286
89 1 2 3 500 1000 40 90% 4.05 03 WDR 10 320 362
89 1 3 5 500 1000 40 90% 6.75 01+02 WDR 20 539 353
89 1 3 5 500 1000 40 90% 6.75 03 WDR 15 296 219
89 1 3 5 500 1000 40 90% 6.75 04 HT 5 75 48
89 1 4 7 500 1000 60 90% 9.45 01+06 WDR 47 689 195
89 1 4 7 500 1000 60 90% 9.45 03+05 WDR 13 821 870
89 1 5 7 500 1000 40 90% 9.45 01+06 WDR 33 597 448
89 1 5 7 500 1000 40 90% 9.45 02 WDR 4 168 130
89 1 5 7 500 1000 40 90% 9.45 04 HT 5 101 118
89 1 5 7 500 1000 40 90% 9.45 05 HT 0 36 25
89 2 1 7 500 1000 20 90% 9.45 01 HT 118 250 139
SCS Parameters Spikes/10sec
 264 
 
Note – Table is continued on the next page. 
Rat # Neuron 
Stim 
#
Pulse 
#
Pulse 
Hz
Pulse 
Width
Burst 
Hz
Amplitude
Charge 
per  
Burst
Spike2 
Waveform 
ID
Neuron 
Type
BL
Pre-
SCS
Post-
SCS
89 2 2 7 500 1000 40 90% 9.45 01 HT 44 145 102
89 2 3 7 500 1000 60 90% 9.45 01 HT 77 277 183
89 3 1 5 333 1000 40 90% 6.75 01 WDR 31 360 337
89 3 1 5 333 1000 40 90% 6.75 02 WDR 38 121 119
89 3 1 5 333 1000 40 90% 6.75 03 WDR 9 181 162
89 3 1 5 333 1000 40 90% 6.75 04 HT 7 30 22
89 3 1 5 333 1000 40 90% 6.75 05 WDR 7 108 65
89 3 2 5 250 1000 40 90% 6.75 01 WDR 12 200 140
89 3 2 5 250 1000 40 90% 6.75 02 WDR 27 154 138
89 3 2 5 250 1000 40 90% 6.75 04 WDR 14 173 190
89 3 2 5 250 1000 40 90% 6.75 05 WDR 2 31 99
89 3 2 5 250 1000 40 90% 6.75 06 WDR 11 92 98
89 3 3 5 500 1000 40 90% 6.75 01 WDR 38 316 195
89 3 3 5 500 1000 40 90% 6.75 02 WDR 15 460 274
89 3 3 5 500 1000 40 90% 6.75 03 WDR 14 302 195
89 3 3 5 500 1000 40 90% 6.75 07 WDR 6 139 101
89 3 4 7 500 1000 60 90% 9.45 01 WDR 102 371 300
89 3 4 7 500 1000 60 90% 9.45 02+03 WDR 16 316 303
89 3 4 7 500 1000 60 90% 9.45 04 WDR 24 727 375
89 3 5 7 500 1000 20 90% 9.45 01+06 WDR 23 433 374
89 3 5 7 500 1000 20 90% 9.45 03 WDR 4 139 83
89 3 5 7 500 1000 20 90% 9.45 04+07 WDR 62 596 592
89 3 5 7 500 1000 20 90% 9.45 05 WDR 5 126 74
89 3 6 7 500 1000 40 90% 9.45 02 WDR 238 861 716
89 3 6 7 500 1000 40 90% 9.45 04 WDR 17 207 154
89 3 6 7 500 1000 40 90% 9.45 07 HT 31 165 96
89 4 1 7 500 1000 40 90% 9.45 01 HT 0 404 373
89 4 1 7 500 1000 40 90% 9.45 02 HT 0 95 77
89 4 1 7 500 1000 40 90% 9.45 03 HT 0 337 387
89 4 1 7 500 1000 40 90% 9.45 04 HT 0 140 85
89 4 1 7 500 1000 40 90% 9.45 05 HT 0 110 88
89 4 2 7 500 500 40 90% 4.73 01+05 HT 0 210 137
89 4 2 7 500 500 40 90% 4.73 03 HT 0 124 162
89 4 2 7 500 500 40 90% 4.73 04 HT 0 243 297
89 4 2 7 500 500 40 90% 4.73 07 HT 0 185 304
89 4 3 7 500 750 40 90% 7.09 01 HT 0 322 196
89 4 3 7 500 750 40 90% 7.09 02 HT 0 177 146
89 4 3 7 500 750 40 90% 7.09 03 HT 0 109 119
89 4 3 7 500 750 40 90% 7.09 05 HT 0 96 34
89 4 3 7 500 750 40 90% 7.09 06 HT 0 182 120
89 4 3 7 500 750 40 90% 7.09 08 HT 0 97 40
89 4 4 7 500 250 40 90% 2.36 01+05 HT 0 266 215
89 4 4 7 500 250 40 90% 2.36 02 HT 0 56 66
89 4 4 7 500 250 40 90% 2.36 03 HT 0 121 146
89 4 4 7 500 250 40 90% 2.36 04 HT 0 219 253
89 4 4 7 500 250 40 90% 2.36 08 HT 0 115 108
89 4 5 5 500 1000 40 90% 6.75 01 HT 0 224 181
89 4 5 5 500 1000 40 90% 6.75 02 HT 0 184 80
89 4 5 5 500 1000 40 90% 6.75 03 HT 0 116 54
89 4 5 5 500 1000 40 90% 6.75 05 HT 0 226 170
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Rat # Neuron 
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#
Pulse 
#
Pulse 
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Pulse 
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Burst 
Hz
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per  
Burst
Spike2 
Waveform 
ID
Neuron 
Type
BL
Pre-
SCS
Post-
SCS
89 4 5 5 500 1000 40 90% 6.75 08 HT 0 265 177
89 4 6 5 250 1000 40 90% 6.75 01 HT 0 318 255
89 4 6 5 250 1000 40 90% 6.75 02 HT 0 147 139
89 4 6 5 250 1000 40 90% 6.75 03 HT 0 200 276
89 4 6 5 250 1000 40 90% 6.75 04 HT 0 100 107
89 4 6 5 250 1000 40 90% 6.75 05 HT 0 243 219
89 4 7 5 333 1000 40 90% 6.75 01 HT 0 399 393
89 4 7 5 333 1000 40 90% 6.75 02 HT 0 139 158
89 4 7 5 333 1000 40 90% 6.75 04 HT 0 73 55
89 4 7 5 333 1000 40 90% 6.75 05 HT 0 343 400
89 4 7 5 333 1000 40 90% 6.75 06 HT 0 164 186
90 1 1 7 500 1000 20 90% 10.70 01 WDR 0 417 167
90 1 2 7 500 1000 40 90% 10.70 01 WDR 0 644 170
90 2 1 7 500 1000 40 90% 10.70 01 WDR 23 438 115
90 2 1 7 500 1000 40 90% 10.70 02+04 WDR 8 487 151
90 2 1 7 500 1000 40 90% 10.70 03 HT 14 75 135
90 2 1 7 500 1000 40 90% 10.70 05 WDR 54 283 217
90 2 2 7 500 1000 40 60% 7.14 01+03 WDR 54 597 595
90 2 2 7 500 1000 40 60% 7.14 02 WDR 38 505 549
90 2 2 7 500 1000 40 60% 7.14 04 WDR 2 94 63
90 2 3 7 500 1000 40 30% 3.57 01 WDR 47 272 348
90 2 3 7 500 1000 40 30% 3.57 02 WDR 89 558 394
90 2 3 7 500 1000 40 30% 3.57 03 WDR 26 324 287
90 2 3 7 500 1000 40 30% 3.57 05 WDR 28 243 221
90 3 1 5 333 1000 40 90% 7.65 01+04+05 WDR 13 477 543
90 3 1 5 333 1000 40 90% 7.65 02 WDR 0 33 21
90 3 1 5 333 1000 40 90% 7.65 03 HT 1 19 31
90 3 2 5 500 1000 40 90% 7.65 01+03+06 WDR 18 367 343
90 3 2 5 500 1000 40 90% 7.65 02 WDR 10 379 270
90 3 2 5 500 1000 40 90% 7.65 04 WDR 11 156 81
90 3 3 5 250 1000 40 90% 7.65 01+03+06 WDR 6 315 218
90 3 3 5 250 1000 40 90% 7.65 02 WDR 4 79 61
90 3 3 5 250 1000 40 90% 7.65 04 HT 0 61 53
90 3 4 7 500 1000 40 60% 7.14 01+03 WDR 6 415 208
90 3 4 7 500 1000 40 60% 7.14 02 WDR 2 91 51
90 3 4 7 500 1000 40 60% 7.14 06 HT 0 63 27
90 3 4 7 500 1000 40 60% 7.14 05 WDR 0 89 97
90 3 5 7 500 1000 40 30% 3.57 01 WDR 10 526 446
90 3 5 7 500 1000 40 30% 3.57 02 WDR 0 45 26
90 3 5 7 500 1000 40 30% 3.57 06 WDR 0 93 53
90 4 1 7 500 1000 40 90% 10.70 01 WDR 13 132 111
90 4 1 7 500 1000 40 90% 10.70 02 WDR 1 35 22
90 4 2 7 500 1000 60 90% 10.70 01 WDR 24 100 104
90 4 2 7 500 1000 60 90% 10.70 04 WDR 3 88 80
90 4 3 7 500 1000 20 90% 10.70 01 WDR 8 119 35
90 4 3 7 500 1000 20 90% 10.70 02 WDR 31 104 81
90 4 3 7 500 1000 20 90% 10.70 04 WDR 5 77 72
91 1 1 7 500 1000 40 60% 6.72 01+03 WDR 0 307 232
91 1 1 7 500 1000 40 60% 6.72 02 HT 0 217 231
91 1 3 7 500 1000 40 30% 3.36 01 HT 0 65 34
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Rat # Neuron 
Stim 
#
Pulse 
#
Pulse 
Hz
Pulse 
Width
Burst 
Hz
Amplitude
Charge 
per  
Burst
Spike2 
Waveform 
ID
Neuron 
Type
BL
Pre-
SCS
Post-
SCS
91 1 3 7 500 1000 40 30% 3.36 02 WDR 26 84 63
91 1 3 7 500 1000 40 30% 3.36 03 WDR 1 46 51
91 1 3 7 500 1000 40 30% 3.36 04 WDR 13 55 46
91 1 4 7 500 1000 40 90% 10.10 01 WDR 48 237 149
91 1 4 7 500 1000 40 90% 10.10 02 WDR 4 240 186
91 1 4 7 500 1000 40 90% 10.10 05 WDR 30 69 33
91 1 4 7 500 1000 40 90% 10.10 06+07 HT 24 257 159
91 2 1 7 500 1000 20 90% 10.10 01+02 HT 0 117 24
91 2 1 7 500 1000 20 90% 10.10 03+05 WDR 2 200 180
91 2 1 7 500 1000 20 90% 10.10 04 WDR 20 109 51
91 2 2 7 500 1000 40 90% 10.10 01 WDR 1 229 237
91 2 2 7 500 1000 40 90% 10.10 02 HT 10 37 18
91 2 2 7 500 1000 40 90% 10.10 03 HT 3 113 59
91 2 2 7 500 1000 40 90% 10.10 05 WDR 13 103 70
91 3 1 5 500 1000 40 90% 7.20 01+02 WDR 11 575 428
91 3 2 5 333 1000 40 90% 7.20 01 WDR 19 331 264
91 3 3 5 250 1000 40 90% 7.20 01 WDR 22 725 444
91 3 4 7 500 1000 40 90% 10.10 01 WDR 35 470 371
91 3 5 3 500 1000 40 90% 4.32 01+03 WDR 20 423 228
91 3 5 3 500 1000 40 90% 4.32 02 WDR 16 193 177
91 4 1 7 500 1000 40 60% 6.72 01 HT 28 119 84
91 4 1 7 500 1000 40 60% 6.72 02 WDR 8 22 19
91 4 2 7 500 1000 40 90% 10.10 01 WDR 20 268 234
91 4 2 7 500 1000 40 90% 10.10 02+03 HT 12 252 166
91 4 2 7 500 1000 40 90% 10.10 05 WDR 0 105 53
91 4 3 7 500 1000 40 30% 3.36 01+07 WDR 10 93 208
91 4 3 7 500 1000 40 30% 3.36 02 WDR 36 103 139
91 4 3 7 500 1000 40 30% 3.36 03 WDR 6 26 43
91 4 4 7 500 1000 60 90% 10.10 01+03 HT 49 129 94
91 4 4 7 500 1000 60 90% 10.10 06+07 WDR 12 73 123
91 4 4 7 500 1000 60 90% 10.10 08 WDR 6 122 73
91 4 5 7 500 1000 20 90% 10.10 01 WDR 80 354 468
91 4 5 7 500 1000 20 90% 10.10 02 WDR 48 347 460
91 4 5 7 500 1000 20 90% 10.10 05+07 WDR 20 326 428
92 1 1 7 500 1000 40 90% 9.10 01 WDR 0 74 28
92 1 2 7 500 750 40 90% 6.83 01 WDR 0 69 57
92 1 3 7 500 500 40 90% 4.55 01 WDR 0 154 133
92 1 4 7 500 250 40 90% 2.28 01+02+04 WDR 0 211 178
92 1 5 7 500 1000 60 90% 9.10 01 WDR 0 118 77
92 1 6 7 500 1000 20 90% 9.10 01+02 WDR 0 82 88
92 2 1 7 500 1000 40 90% 9.10 01 WDR 15 134 65
92 2 1 7 500 1000 40 90% 9.10 02+03+04 WDR 48 318 269
92 2 2 7 500 1000 40 60% 6.02 01 WDR 12 59 58
92 2 2 7 500 1000 40 60% 6.02 02 WDR 64 554 491
92 2 3 7 500 1000 40 30% 3.01 01 WDR 111 171 194
92 2 3 7 500 1000 40 30% 3.01 02 WDR 89 272 249
92 2 3 7 500 1000 40 30% 3.01 03+06 WDR 96 216 250
92 2 4 5 500 1000 40 90% 6.50 01 WDR 77 257 192
92 2 4 5 500 1000 40 90% 6.50 03+09 WDR 29 205 184
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Rat # Neuron 
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#
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#
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Waveform 
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Neuron 
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92 2 4 5 500 1000 40 90% 6.50 04 WDR 27 240 134
92 2 5 5 333 1000 40 90% 6.50 01+04 WDR 31 309 287
92 2 5 5 333 1000 40 90% 6.50 02 WDR 18 200 253
92 2 5 5 333 1000 40 90% 6.50 03 WDR 18 194 123
92 2 6 5 250 1000 40 90% 6.50 01+02 WDR 30 335 181
92 2 6 5 250 1000 40 90% 6.50 04 WDR 22 126 90
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Table D.5. Spike counts after burst or tonic SCS on day 7 following painful nerve 
root compression (Chapter 7).   
 
Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 1 582 2 5 9 5 2 54 75 41 67 55 1 694 4 6 10 14 7 8 4 54 41 45 47 46 14 308
3 0 86 6 6 6 6 3 52 45 33 39 43 0 195 0 6 7 7 5 6 0 35 44 40 20 31 0 185
4 0 13 0 2 0 0 0 4 2 7 4 4 0 63 0 0 1 2 2 0 1 6 5 4 3 3 0 38
4 2 224 12 11 12 13 7 64 54 55 62 76 14 481 2 6 9 6 8 8 0 41 35 25 25 16 8 292
5 2 9 0 0 0 0 1 6 4 1 2 4 0 57 0 2 0 1 0 0 1 0 5 0 4 3 2 58
5 6 86 7 6 14 13 15 22 37 39 17 49 2 255 0 5 6 2 6 2 0 13 24 6 27 13 16 217
6 3 332 4 27 3 4 29 87 77 85 76 82 5 498 3 2 7 3 15 3 0 26 44 26 41 27 3 264
7 10 165 16 22 17 29 23 37 33 32 49 34 21 357 1 13 15 9 5 7 1 14 27 21 19 15 16 168
9 0 161 9 13 17 13 9 50 45 42 41 33 0 175 1 10 14 13 13 6 2 44 33 37 51 39 4 235
10 0 147 5 8 4 4 6 29 23 22 27 38 0 165 0 4 2 1 1 3 0 18 4 7 13 6 0 105
11 10 258 20 27 15 24 20 107 91 83 78 118 8 881 7 7 12 9 15 13 7 60 86 89 94 50 3 690
12 2 26 6 6 6 2 2 10 19 21 16 16 2 144 2 7 3 4 1 2 4 11 11 13 7 15 2 45
14 0 140 3 2 4 6 2 50 44 40 48 47 0 243 1 6 4 6 6 4 2 13 14 15 15 12 0 51
14 3 173 7 4 3 6 6 27 12 21 16 22 2 79 0 4 3 3 2 3 0 4 8 2 6 7 0 29
15 0 16 4 2 2 2 4 7 6 20 5 8 0 205 0 4 2 2 1 1 1 26 8 21 15 5 0 135
16 6 157 6 9 22 22 5 56 72 61 49 49 7 193 14 16 15 14 7 18 7 45 49 39 67 39 11 167
17 2 50 2 2 1 5 2 14 6 24 22 16 1 308 15 15 14 10 10 10 7 15 12 10 13 13 15 289
17 2 123 8 4 3 5 4 27 19 27 28 29 0 183 3 2 8 4 4 9 4 18 16 14 13 17 3 60
18 14 305 48 36 35 43 43 68 65 83 56 68 20 822 2 4 12 4 9 7 5 25 11 12 33 16 10 285
19 1 200 33 28 28 23 27 38 65 58 45 82 6 380 3 17 17 9 14 16 0 36 38 29 29 19 2 183
21 4 341 11 5 7 22 10 100 73 67 73 72 4 673 7 12 17 12 16 4 11 66 67 59 51 58 22 553
22 7 92 11 9 11 9 9 32 28 20 25 32 3 752 13 22 18 15 16 12 26 45 42 39 37 31 4 262
23 2 260 11 12 12 9 17 67 68 72 68 48 0 212 5 26 30 17 14 21 5 46 62 46 44 37 5 260
24 2 24 6 5 1 3 3 24 9 11 12 8 2 310 0 2 0 0 1 1 0 15 23 31 26 16 0 163
24 2 24 5 3 3 1 4 12 12 11 19 17 12 138 0 7 2 5 2 3 3 14 9 13 12 13 11 112
25 18 289 50 70 48 49 34 114 126 110 95 136 19 872 22 54 29 25 32 31 7 74 91 64 106 77 19 611
26 0 32 2 4 9 9 3 53 63 50 44 43 0 301 1 2 6 1 3 0 1 40 45 49 45 42 3 250
27 13 264 83 35 30 90 86 148 148 137 133 103 14 890 1 15 41 12 45 65 5 56 97 80 102 46 8 663
29 5 17 4 3 3 3 8 12 7 14 12 12 3 153 3 1 1 6 4 2 1 19 8 6 6 5 3 101
29 21 106 41 23 24 24 27 43 42 28 36 35 10 322 2 8 5 10 7 15 6 20 11 14 23 15 13 278
30 1 53 3 14 8 10 5 26 19 24 16 19 2 247 0 4 5 3 1 2 0 33 17 17 12 22 2 159
31 8 124 7 25 15 7 13 47 36 31 41 44 9 301 1 8 8 4 0 2 7 21 16 18 14 16 3 156
33 2 64 5 1 1 8 11 58 48 53 34 35 0 512 14 31 17 22 17 16 36 67 45 39 30 55 5 331
34 0 95 4 4 4 3 2 14 9 15 13 21 2 221 3 2 1 0 7 2 3 14 17 8 15 11 4 255
34 4 65 13 8 7 7 8 18 15 13 9 20 1 359 0 7 7 7 7 9 12 26 22 14 18 22 10 275
35 1 105 12 3 3 8 18 111 77 84 61 64 7 676 20 21 18 35 30 34 14 48 37 32 31 34 10 203
36 5 175 6 10 19 18 12 52 93 54 50 51 7 561 20 34 22 30 27 30 16 67 43 42 37 35 30 534
37 2 60 5 9 11 11 9 25 33 22 29 24 1 243 6 9 9 6 6 3 1 42 34 33 29 28 15 209
38 0 3 0 0 0 0 0 0 1 0 0 1 0 240 0 0 0 0 1 0 0 0 2 1 0 0 0 196
39 0 17 1 1 1 1 2 27 39 39 28 35 0 494 0 1 0 0 2 0 0 11 21 11 5 13 0 38
41 8 86 9 8 17 21 4 49 34 24 45 41 5 824 7 14 16 13 8 8 6 21 34 33 27 31 6 358
42 4 44 4 8 5 12 20 73 86 77 68 87 8 544 8 1 10 16 8 15 5 30 61 27 51 63 22 349
43 1 110 0 30 19 9 12 46 42 41 35 36 1 223 0 3 11 7 15 7 0 21 19 44 20 17 9 203
44 8 30 13 5 9 17 10 83 97 63 64 65 6 615 3 5 1 6 7 7 3 72 71 70 61 33 4 323
45 0 0 0 0 0 0 0 74 68 64 68 52 0 791 0 0 0 0 0 0 0 48 55 53 68 66 0 452
46 1 84 4 2 1 6 2 39 30 25 24 35 1 509 2 3 2 2 0 4 2 21 20 11 18 10 1 202
47 0 5 0 0 0 0 0 7 4 4 4 5 0 159 0 0 0 0 0 0 0 1 0 2 1 0 0 110
48 0 30 4 7 2 3 11 17 17 15 7 24 0 196 1 3 0 3 2 2 0 11 8 10 6 29 0 32
49 2 99 8 4 1 2 8 27 28 18 18 23 0 431 0 0 10 8 3 12 2 21 13 16 15 28 1 135
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 9 26 20 18 29 17 9 58 56 41 45 56 3 419 5 67 34 38 38 39 5 71 84 78 58 72 5 281
3 0 8 6 9 6 7 0 37 22 34 22 27 0 97 0 3 6 11 7 5 0 26 17 26 21 22 0 139
4 0 2 1 3 0 0 2 6 12 6 8 10 1 49 0 0 1 0 0 1 1 5 5 7 10 10 0 46
4 3 28 10 11 12 6 8 46 26 35 41 37 0 297 3 18 8 6 6 10 4 34 31 32 38 41 2 361
5 1 0 0 0 0 0 0 1 11 2 1 6 0 57 1 3 1 0 0 0 0 11 8 3 4 7 2 85
5 4 8 3 13 10 3 0 41 45 33 21 52 3 139 2 5 7 3 4 8 3 41 31 50 42 50 5 243
6
7 3 8 7 7 6 5 5 28 25 15 17 18 2 61 2 12 6 10 7 9 5 71 52 31 33 38 3 253
9 1 10 15 7 13 14 1 47 52 53 37 49 7 267 1 26 15 12 17 3 4 41 28 33 39 54 1 184
10 0 3 1 6 2 4 0 4 6 10 5 6 2 66 0 2 1 2 0 8 0 21 7 4 16 27 0 147
11 6 21 17 12 19 16 6 73 101 97 80 87 10 541 12 25 24 28 32 24 13 100 87 113 88 78 9 828
12 1 9 9 6 4 4 6 30 21 19 19 22 2 138 2 8 4 16 9 5 6 29 21 26 21 31 4 178
14 0 8 6 4 4 2 0 23 18 8 20 14 0 93 0 9 5 2 3 5 0 29 19 24 21 15 0 88
14 0 5 3 4 1 1 0 6 9 7 10 3 1 33 0 4 2 1 0 4 0 6 9 7 10 7 0 28
15 0 5 6 3 3 8 1 22 15 18 21 24 0 151 0 5 9 3 3 7 0 33 20 39 20 23 0 162
16 12 2 10 25 9 7 12 51 48 46 41 41 8 185 2 12 12 6 11 9 7 41 38 40 46 37 19 235
17 5 5 2 6 4 6 3 20 12 8 15 15 0 192 6 10 6 2 3 2 3 23 13 7 3 6 0 210
17 1 9 7 1 4 4 1 22 21 11 10 16 0 84 0 5 1 4 7 5 3 30 18 14 9 15 1 68
18 11 20 24 16 13 19 4 59 65 32 44 40 5 417 2 9 7 4 4 11 3 19 23 28 28 16 3 193
19 0 24 27 17 23 17 1 49 33 65 43 51 6 456 3 21 27 18 9 12 0 44 35 32 23 37 2 467
21 6 20 13 8 22 8 0 58 58 51 62 49 0 502 6 11 14 3 10 20 14 75 80 72 62 62 20 737
22 1 14 9 10 9 9 3 37 17 19 21 17 4 298 1 7 7 9 4 7 0 28 26 18 17 18 2 318
23 1 22 13 17 16 17 3 61 38 43 36 38 8 249 3 46 45 33 34 35 5 225
24 0 1 1 6 2 1 3 18 30 14 9 6 1 205 2 1 6 3 4 2 1 12 5 8 24 18 5 329
24 4 6 2 7 3 3 2 14 13 10 12 5 6 123 10 2 5 9 2 5 17 28 25 20 28 28 19 152
25 24 50 49 53 35 61 16 73 77 71 69 91 20 808 16 34 61 50 36 49 13 116 89 108 114 95 23 813
26 2 3 7 8 5 4 2 47 62 46 56 56 2 296 0 1 0 0 2 0 3 36 60 75 63 53 1 299
27 1 24 62 40 77 45 4 92 119 95 100 100 2 1035 6 30 52 64 45 58 2 122 137 121 131 116 12 1033
29 5 7 1 5 4 4 2 12 8 7 13 11 8 65 2 13 3 6 7 3 7 23 18 21 19 14 5 197
29 6 14 3 12 9 12 12 26 16 15 32 18 20 151 6 7 6 9 9 14 4 18 15 23 13 18 11 195
30 0 6 7 3 4 2 1 22 27 18 18 18 0 128 1 5 8 13 9 17 0 26 32 27 16 26 16 581
31 2 5 4 6 4 7 4 16 20 12 19 14 4 200
33 19 17 18 19 11 14 23 44 46 28 30 45 34 505 12 9 14 17 7 10 3 16 20 26 24 24 8 433
34 10 21 21 17 13 23 4 185 6 8 19 5 7 4 5 22 20 30 33 31 2 240
34 4 30 22 20 20 34 0 206 6 10 16 11 13 7 16 27 29 43 36 36 0 263
35 0 7 0 11 4 9 12 111 57 45 45 12 31 598 0 5 5 8 5 13 0 61 71 48 73 54 1 273
36 28 35 26 26 30 34 21 60 57 48 69 55 30 333 31 39 40 36 42 35 39 98 85 90 80 66 39 595
37 2 8 10 7 21 10 3 41 36 39 36 29 9 222 2 38 31 38 34 29 1 262
38 0 0 1 0 0 1 0 1 0 0 1 0 0 233 0 0 0 0 1 0 0 0 0 1 0 0 0 255
39 0 0 0 2 2 1 0 15 44 8 4 5 0 211 0 3 2 3 2 1 0 83 51 35 38 31 0 235
41 5 12 13 7 25 9 14 23 22 20 17 22 7 458 4 12 9 27 13 25 5 41 32 42 50 23 15 638
42 5 12 3 8 3 5 6 50 60 49 61 51 5 547 6 37 6 6 12 22 5 119 69 69 81 83 4 644
43 1 12 8 12 17 11 1 40 26 29 22 18 0 104 0 10 7 20 25 15 1 35 23 25 44 22 1 147
44 5 3 6 6 4 13 6 64 73 69 74 55 4 414 2 1 4 12 8 12 6 87 68 74 65 66 6 557
45 0 0 0 0 0 0 7 58 52 56 53 49 92 773 0 0 0 0 0 0 0 65 53 48 50 54 0 564
46 3 7 1 2 3 4 2 30 32 20 25 21 5 411 1 0 3 0 6 3 3 22 28 22 33 20 1 401
47 0 0 0 0 0 0 0 1 0 1 3 2 0 76 0 0 0 1 0 0 0 8 4 1 3 3 0 164
48 0 2 5 6 5 4 0 22 13 20 18 26 0 96 2 6 3 5 10 13 3 29 22 23 40 25 1 157
49 0 10 6 8 3 6 2 36 17 14 22 21 4 308 0 6 9 4 7 6 1 25 21 20 25 28 3 338
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 11 74 35 72 47 51 11 134 132 150 66 83 15 668 16 59 53 47 45 52 16 114 78 102 81 78 17 450
3 0 4 7 4 7 5 0 18 22 23 21 17 0 142 1 13 6 7 11 6 0 38 30 28 28 35 4 217
4 1 1 1 1 2 2 0 8 7 20 8 11 1 81 4 0 0 1 0 1 0 6 5 10 5 8 0 38
4 6 14 10 11 17 12 4 39 30 51 47 33 3 490 0 6 5 4 7 5 1 42 50 31 43 46 0 330
5 0 1 0 0 1 1 1 7 4 3 4 5 0 103 0 1 3 5 5 0 0 5 3 2 6 6 0 94
5 6 9 9 10 8 11 4 31 34 37 24 31 0 321 2 9 8 10 4 6 1 26 22 23 43 24 1 189
6
7 5 25 15 14 13 17 4 51 59 73 65 42 6 230 1 18 8 12 11 7 3 36 49 54 50 55 1 217
9 3 31 30 22 20 6 4 56 43 43 42 41 9 285 4 11 20 26 16 30 7 51 50 49 28 45 9 322
10 3 2 2 4 10 1 8 39 32 15 49 10 4 85 0 6 9 5 7 5 6 35 20 22 36 16 5 106
11 2 25 29 30 25 23 4 104 111 91 108 79 7 506 15 60 55 44 39 72 13 95 115 158 151 78 13 920
12 6 21 18 8 22 9 6 10 7 2 6 9 10 261 4 5 2 12 6 8 6 16 12 28 11 6 8 187
14 0 9 9 6 11 3 3 43 46 36 26 43 1 162 3 21 4 12 7 3 1 35 29 42 44 18 1 104
14 1 13 12 19 12 5 6 24 16 15 16 17 6 174 6 18 9 21 10 8 2 28 13 18 19 14 4 153
15 0 6 2 7 4 5 2 35 20 31 21 12 0 216 3 12 6 4 2 3 4 48 41 23 27 21 3 324
16 6 13 8 8 10 4 6 46 49 32 42 43 8 300 9 16 10 10 6 12 6 64 48 52 50 47 9 355
17 4 6 7 2 9 2 0 18 9 15 11 5 5 333 11 11 11 4 7 10 1 23 20 51 33 22 2 410
17 0 5 4 4 11 0 0 23 19 20 17 13 7 111 2 13 7 3 10 6 0 39 17 28 18 21 1 157
18 4 11 7 6 7 14 6 48 37 42 51 45 4 408 7 36 27 11 20 17 13 63 38 49 47 53 9 545
19 5 23 17 18 29 11 0 54 56 64 70 55 4 415 11 28 22 39 30 20 2 49 49 47 46 52 3 390
21 7 10 8 18 15 13 11 58 78 64 57 45 7 522 10 12 27 7 3 14 5 67 78 47 52 69 3 626
22 0 8 7 8 3 1 0 21 16 18 12 19 3 386 0 8 4 8 7 5 1 40 27 41 27 29 11 449
23 1 19 20 19 15 11 2 31 54 38 37 34 4 212 2 16 16 15 16 22 5 36 42 40 27 29 6 223
24 0 4 1 3 1 2 2 29 13 11 11 4 2 342 0 1 4 2 1 0 0 12 32 9 17 25 4 304
24 4 1 5 2 3 7 7 23 21 14 16 13 4 206 1 6 2 2 3 3 8 26 18 14 17 27 10 199
25 26 42 36 41 33 44 22 139 130 112 109 104 32 1010 27 43 44 39 29 50 17 175 141 137 96 111 41 1032
26 1 0 0 0 0 0 0 65 47 55 57 99 0 373 0 1 0 1 0 0 2 68 64 73 67 76 2 254
27
29 2 2 6 5 5 5 2 19 9 10 13 16 8 97 0 6 1 1 5 3 2 16 19 17 6 14 0 128
29 8 20 21 23 30 26 10 35 42 36 69 82 13 336 16 14 16 16 25 18 25 78 57 48 26 81 18 402
30 14 19 29 19 16 13 33 59 73 69 63 65 21 523 17 27 22 16 19 19 16 57 53 61 54 54 6 419
31
33 12 22 14 15 11 9 18 39 40 42 40 36 3 544 12 14 16 14 6 14 12 41 32 33 26 35 3 616
34 0 6 11 2 1 1 2 20 27 35 18 22 2 162
34 11 17 21 15 11 9 13 48 55 38 34 37 1 295
35 1 3 2 2 4 0 1 32 43 29 30 19 3 290 3 3 13 7 7 8 0 46 31 32 33 35 3 335
36 33 37 42 53 33 43 51 79 71 63 50 60 51 568 25 24 20 26 32 24 33 46 57 53 49 38 26 404
37 6 15 15 9 8 10 7 29 35 28 28 24 14 225 5 7 5 7 6 11 7 34 20 28 28 32 18 174
38 1 0 0 1 0 0 1 1 3 1 4 2 0 224 0 0 1 0 0 2 0 7 2 3 4 1 0 183
39 0 2 3 1 0 8 0 21 48 35 36 36 0 311 0 2 1 2 5 5 0 64 55 54 45 45 0 288
41 13 13 14 17 16 18 9 42 46 26 52 37 12 471 10 12 9 14 14 16 18 34 28 47 49 34 12 553
42 6 14 23 11 7 10 16 77 77 64 65 58 13 564 7 25 26 12 19 8 11 70 60 78 63 65 14 571
43 0 4 17 13 8 18 0 28 33 25 38 11 0 160 6 26 27 14 27 28 5 41 60 46 46 57 3 236
44 5 10 15 6 16 12 11 86 78 70 60 65 5 448 3 7 8 14 6 9 4 90 64 63 78 60 7 475
45 0 0 0 0 0 0 0 42 45 49 52 42 0 572 0 0 0 0 0 0 0 44 47 52 50 54 0 650
46 4 1 4 5 2 7 7 39 38 30 32 36 4 367 4 3 4 3 6 1 2 41 41 33 31 25 6 524
47 0 1 1 0 0 2 0 2 7 5 4 6 0 168 0 0 0 0 0 1 0 6 6 3 5 4 0 128
48 1 12 11 8 5 8 3 34 30 28 22 24 0 160 1 11 13 7 4 9 2 34 27 41 35 40 2 211
49 1 7 7 4 2 7 1 43 38 29 29 35 2 368 1 9 8 7 6 5 0 31 19 31 27 25 1 503
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 4 582 7 10 9 5 14 40 29 27 26 27 10 260 14 17 17 16 5 14 14 28 48 33 34 38 10 148
2 2 92 1 2 6 2 2 39 30 21 42 43 2 398 13 14 8 1 2 4 2 37 13 30 20 20 17 317
3 1 62 13 6 7 11 6 38 30 28 28 35 4 217 9 27 16 12 16 10 12 27 28 32 49 48 11 299
4 0 11 0 1 2 0 1 1 3 1 6 10 0 94 1 1 0 0 0 0 0 12 7 12 17 11 2 66
4 4 189 12 13 8 9 5 35 37 45 87 73 6 443 13 18 15 14 12 4 6 46 48 42 43 44 7 395
5 0 8 0 1 0 1 1 3 5 0 5 5 0 79 0 0 0 0 0 1 1 2 6 0 1 5 1 65
5 10 133 5 23 15 13 11 38 33 26 53 72 3 290 12 12 7 15 10 4 10 62 46 34 33 67 9 233
6 7 284 9 14 12 29 31 105 76 129 97 87 4 729 6 10 7 7 14 32 7 56 47 62 55 67 12 613
7 4 393 15 17 13 10 18 63 96 117 99 74 2 456 2 16 11 10 16 5 4 77 88 81 69 46 3 394
8 1 231 12 15 17 8 38 74 50 61 50 42 0 192 0 9 4 9 9 22 0 80 81 44 52 50 0 222
9 6 230 31 27 11 14 30 72 106 31 54 99 8 361 11 13 10 5 15 16 3 32 15 21 12 19 4 315
10 6 43 10 7 7 8 8 14 17 13 16 8 3 150 1 7 8 9 8 9 4 25 20 7 14 15 4 138
11 0 258 15 29 28 16 22 81 111 117 83 70 2 558 7 27 18 17 5 15 5 88 48 54 84 79 12 332
12 6 86 7 4 6 4 11 32 18 23 24 18 3 199 4 5 11 9 5 18 8 35 20 26 25 18 2 189
13 0 4 0 2 0 0 0 43 34 28 44 45 0 241 0 7 3 0 5 3 0 13 12 9 18 9 0 41
14 0 146 9 4 7 5 6 42 33 28 27 22 0 205 1 25 40 24 33 29 0 183
17 2 33 7 3 2 1 7 11 7 9 2 10 0 255 1 1 1 6 1 5 1 10 14 9 10 7 1 121
17 3 112 9 6 11 11 11 22 27 15 18 15 1 226 2 7 1 8 5 6 0 15 8 14 11 14 7 180
18 1 164 8 8 16 9 12 58 53 44 45 34 4 516 3 19 16 10 7 7 2 44 48 41 43 35 11 435
19 0 223 58 58 41 46 34 68 73 47 42 47 0 564 1 15 12 13 13 8 0 24 25 18 27 21 9 228
20 37 212 38 41 44 42 44 68 70 63 57 58 41 411 28 33 32 34 28 35 17 29 23 30 25 25 17 285
21 4 281 21 24 22 33 23 100 96 84 87 77 17 890 12 38 13 25 21 37 28 84 56 55 69 73 26 353
22 14 111 16 20 18 12 16 39 48 44 56 63 18 598 3 11 9 10 10 10 5 22 26 18 24 21 11 214
23 5 154 11 26 17 19 19 43 43 39 37 32 3 210 1 18 12 16 21 13 3 46 37 22 29 28 2 114
24 0 7 1 3 3 2 2 29 6 6 17 7 0 217 0 1 2 0 1 2 3 20 11 9 21 5 10 232
24 1 13 3 4 4 1 1 15 10 10 9 6 0 206 0 7 4 2 1 2 7 11 14 8 12 7 11 155
25 11 414 19 12 31 24 17 163 116 109 112 94 11 812 7 21 17 9 12 14 19 57 94 99 75 62 15 657
26 0 4 1 1 2 0 1 41 45 46 21 42 0 273 1 1 1 0 1 1 1 29 29 36 57 47 0 186
27 1 194 11 19 16 7 16 88 85 77 66 78 0 711 4 20 30 9 21 15 2 56 28 43 51 48 4 568
28 0 258 27 32 27 22 20 65 85 53 50 70 2 854 0 30 31 22 14 10 2 54 91 24 38 72 0 303
28 0 5 0 2 2 1 3 2 3 1 1 1 1 42 0 2 1 1 1 1 0 2 0 0 2 1 0 9
29 2 15 2 4 2 1 3 16 9 9 13 15 4 140 3 0 1 0 1 1 2 11 11 9 7 15 2 90
29 19 154 36 21 25 38 20 87 76 60 58 56 7 491 4 2 4 3 4 2 7 15 17 10 12 8 7 164
30 4 286 10 22 20 21 14 77 69 88 89 78 8 611 1 30 28 34 31 21 8 58 59 56 48 63 8 336
31 0 2 0 0 0 0 0 18 21 28 18 44 0 840 0 0 0 0 0 0 0 6 8 4 11 10 1 329
32 0 8 1 3 0 1 2 3 4 5 1 1 1 572 3 363
33 4 70 7 10 7 12 13 49 40 36 35 29 4 705 12 12 14 15 18 7 13 50 42 27 42 39 7 394
34 5 117 5 3 13 1 0 5 11 20 14 11 4 225 5 8 5 1 2 2 8 16 15 12 14 11 7 219
34 0 37 8 8 2 5 5 20 18 22 25 18 0 399 2 4 10 7 9 8 8 34 23 24 20 24 23 310
35 4 39 8 11 5 6 0 51 47 44 33 24 1 370 3 3 4 5 0 6 0 17 18 19 14 23 2 289
36 30 366 39 40 28 44 35 117 125 125 86 138 29 814 22 24 24 20 21 17 26 83 63 85 69 60 52 471
37 6 101 15 4 7 11 5 21 33 25 30 18 9 246 4 6 11 8 4 4 8 22 15 15 23 12 9 190
39 0 88 6 4 6 3 1 65 65 35 32 43 0 483 0 0 2 4 4 5 1 58 35 28 45 21 0 237
41 2 80 21 7 13 15 3 42 39 46 33 53 7 694 17 19 16 8 18 20 10 27 17 20 21 15 15 292
42 3 140 37 40 19 11 13 106 105 108 121 92 2 708 1 4 4 4 3 0 3 15 16 16 30 9 5 108
43 3 103 9 15 10 22 19 49 46 35 42 36 0 205 1 16 12 6 4 29 0 23 49 26 17 17 5 163
44 0 17 1 0 1 1 0 56 58 58 50 55 0 386 0 0 1 2 1 1 0 42 50 50 44 37 0 218
46 3 43 5 10 3 10 7 54 51 42 39 36 6 457 1 7 9 7 5 7 4 31 30 29 21 31 4 423
47 0 8 1 1 1 2 3 13 12 13 14 13 0 60 0 0 0 0 1 0 0 4 4 1 3 5 0 45
48 0 32 4 6 4 5 1 21 21 16 17 15 0 152 0 3 4 3 1 5 0 13 15 15 15 12 1 82
49 0 36 3 3 1 2 0 25 15 34 27 29 0 396 0 0 0 0 0 1 0 5 5 0 2 6 0 276
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 35 37 31 47 35 17 11 44 42 41 46 35 12 284 10 31 35 30 27 31 15 53 42 50 33 39 14 283
2 0 7 4 3 1 3 0 34 20 21 18 13 2 287 1 10 4 7 2 10 2 36 38 13 19 49 0 387
3 20 25 24 25 18 23 3 45 16 40 29 12 11 295 14 10 18 20 24 29 10 30 24 35 21 27 20 233
4 0 3 1 0 1 0 1 10 11 5 17 10 1 86 0 2 3 0 0 1 0 12 12 9 10 10 0 136
4 2 13 18 14 11 8 12 53 51 37 36 44 8 334 22 30 14 23 26 27 22 47 63 58 78 56 8 475
5 0 1 1 0 1 0 1 4 3 1 8 3 2 17 1 3 2 0 2 0 0 11 9 9 5 9 0 128
5 9 9 16 10 10 9 13 65 55 36 48 62 23 429 14 28 36 22 25 19 30 62 48 78 75 83 9 396
6 3 12 7 6 17 10 6 67 69 65 71 65 6 341 10 30 26 24 20 11 9 48 64 59 55 65 3 525
7 4 30 25 23 12 14 3 83 64 79 61 61 4 418 1 9 22 20 19 25 4 66 70 64 71 70 3 429
8 0 3 14 0 9 38 1 52 53 61 52 54 2 204 7 40 22 6 22 44 1 67 56 51 57 48 0 204
9 10 6 14 13 25 16 8 19 26 23 30 18 9 177 15 16 21 13 13 23 1 39 35 22 34 26 10 227
10 5 7 11 8 7 8 8 27 14 19 15 12 6 148 8 17 13 1 1 5 3 26 35 8 24 24 6 144
11 4 13 13 15 15 6 2 84 73 82 43 55 6 459 3 25 19 21 9 44 4 69 101 84 88 93 2 379
12 1 8 13 6 9 5 12 41 25 19 20 24 13 139 4 9 4 1 7 5 6 23 17 24 24 15 6 201
13 0 0 0 0 0 0 0 11 44 31 20 19 0 193
14 1 17 8 11 6 11 3 37 30 42 27 30 0 81 1 6 5 3 14 7 2 39 24 23 28 21 1 65
17 3 5 7 4 1 3 0 21 20 24 14 9 24 292 3 3 4 0 5 3 0 23 19 11 10 11 4 204
17 3 4 5 4 3 7 0 17 18 9 11 8 7 179 3 2 3 11 3 9 0 27 15 20 30 14 0 130
18 5 23 13 13 12 10 4 42 41 38 34 36 7 292 5 13 16 12 10 13 7 49 47 27 35 29 8 382
19 3 7 16 13 3 20 0 11 22 22 18 32 0 201 0 14 11 8 13 16 0 22 37 72 17 60 7 384
20 13 34 27 29 31 25 31 31 28 34 29 34 36 293 10 25 23 24 24 22 10 25 23 24 24 22 33 312
21 10 9 34 16 22 29 22 71 66 50 75 44 32 390 5 8 2 8 20 17 4 61 53 66 74 55 16 528
22 4 11 6 4 14 11 2 30 21 28 19 22 5 207 2 12 10 8 7 6 0 21 17 18 22 25 2 343
23 1 15 6 15 11 11 2 39 34 39 28 20 7 213 0 9 16 14 17 14 3 48 37 31 37 34 5 161
24 1 2 5 0 5 1 3 21 7 17 12 12 2 136 0 0 0 0 1 0 1 9 20 9 12 6 1 161
24 3 2 5 3 0 3 8 20 6 15 14 17 10 142 3 5 3 3 2 4 3 17 13 13 11 5 3 164
25 12 20 7 35 37 25 1 109 88 17 129 85 15 674 9 20 14 14 14 13 10 118 96 110 88 116 17 809
26 2 36 36 76 52 43 5 353 8 2 5 7 5 11 2 73 75 57 85 71 1 290
27 2 20 35 29 19 15 16 87 102 112 107 79 6 452 4 22 24 21 39 20 8 78 73 77 83 88 11 712
28 1 15 15 8 23 11 0 61 65 58 36 68 0 449 0 28 11 12 10 13 0 61 79 60 64 89 0 615
28 1 0 1 1 2 2 1 1 0 1 4 1 0 11 0 3 1 2 0 4 0 0 2 2 3 3 0 24
29 3 4 0 5 3 0 5 6 8 17 11 10 0 92 1 2 4 0 1 2 4 8 10 9 14 5 1 100
29 8 9 10 4 10 6 9 24 21 22 14 16 7 219 4 15 12 7 7 13 3 23 36 42 29 30 4 204
30 8 10 13 20 4 14 14 65 73 41 50 43 1 206 10 17 18 26 12 12 15 31 25 28 25 32 11 308
31 0 0 0 0 0 0 0 16 5 16 14 24 0 368 0 0 0 0 0 0 1 44 43 40 44 64 0 639
32 2 329 3 393
33 11 17 20 14 21 17 9 35 29 31 31 39 16 435 16 20 14 12 18 17 5 48 25 73 51 35 4 478
34 6 2 7 2 3 6 7 21 10 18 13 17 2 214 0 9 14 3 15 6 4 18 20 19 15 16 3 314
34 2 15 9 10 9 10 20 47 32 34 27 33 0 318 5 16 12 13 16 13 24 38 29 33 34 31 1 351
35 2 0 2 3 7 5 5 33 14 14 12 15 3 298 1 7 0 13 3 0 1 27 24 13 19 25 3 296
36 17 79 64 54 62 69 18 493 11 27 10 14 14 20 23 58 67 50 54 50 22 631
37 3 10 1 11 5 1 6 13 11 21 15 17 2 216 3 7 2 0 8 6 6 7 4 18 10 12 2 124
39 0 2 8 3 1 7 0 52 45 36 25 27 0 195 0 6 3 4 1 5 0 51 48 32 53 42 0 315
41 4 6 8 3 4 21 3 27 37 33 26 43 15 453 10 15 16 10 20 17 10 46 44 46 42 23 1 441
42 2 10 7 0 5 3 4 45 19 10 10 11 2 478 2 16 4 8 9 11 2 35 59 81 59 46 6 556
43 0 6 16 18 24 13 0 23 21 37 16 21 3 211 2 3 16 3 1 6 2 23 20 24 16 17 6 149
44 0 1 1 1 1 3 0 53 56 54 43 50 1 334 0 1 1 2 2 2 0 39 61 51 45 44 0 344
46 3 8 5 10 5 10 4 46 40 35 34 29 4 437 8 6 10 5 8 6 6 54 41 45 33 20 4 362
47 0 0 0 1 0 0 0 3 2 0 2 2 0 64 0 0 0 0 0 3 0 8 4 4 1 6 0 104
48 3 6 4 9 7 1 3 12 31 24 20 21 0 168 2 8 11 7 7 4 5 23 26 15 33 14 1 247
49 0 1 0 1 1 1 0 8 11 5 6 6 0 190 0 3 1 1 0 2 1 13 11 15 16 3 0 250
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Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol.
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 4 22 11 13 10 21 5 28 23 17 17 30 8 169 2 8 12 8 7 16 2 19 24 23 25 24 6 137
2 0 9 4 5 5 7 3 24 22 7 17 14 7 349 3 8 9 7 2 7 2 14 23 21 13 17 9 149
3 8 18 27 23 27 15 6 24 36 24 26 31 12 322 1 5 6 4 5 9 0 15 14 14 22 12 6 229
4 0 1 0 1 0 0 1 11 7 7 9 14 1 197 1 0 0 0 0 0 1 13 11 8 15 12 1 53
4 5 14 10 10 10 8 8 62 66 40 51 67 12 579 20 17 16 27 9 14 33 76 46 68 85 68 11 367
5 0 0 1 0 2 2 0 3 7 4 3 6 6 50 1 1 0 1 0 1 2 1 2 4 4 3 0 75
5 6 18 11 15 18 23 14 60 96 70 57 66 39 455 6 27 22 27 25 38 30 59 90 54 86 92 10 361
6 16 23 49 46 12 8 3 59 58 58 76 62 4 607 7 36 16 16 8 15 11 61 72 62 75 90 6 588
7 3 29 30 31 20 15 3 76 54 79 62 89 4 451 2 25 26 24 20 17 5 75 65 67 100 80 2 439
8 1 13 10 9 3 12 0 76 52 60 47 61 0 214
9 3 15 29 24 21 18 15 57 38 22 27 24 9 268 6 24 23 30 12 31 8 39 39 23 10 19 10 264
10 4 7 9 2 9 8 8 49 13 19 18 12 4 118 0 4 2 4 2 2 2 19 5 17 21 18 2 62
11 5 24 10 56 41 12 1 89 72 58 50 59 7 681 14 20 27 15 24 20 6 107 91 83 78 118 8 881
12 8 8 6 2 10 5 10 41 30 23 24 19 7 172 3 7 6 8 7 6 1 49 16 18 28 21 7 224
13
14 2 15 12 2 10 5 4 35 32 24 29 22 1 107 0 10 1 2 5 7 3 47 29 32 20 32 0 170
17 1 5 3 0 2 3 1 24 15 13 11 16 0 161 0 17 1 7 2 0 4 16 26 11 22 38 1 266
17 0 7 4 3 6 6 0 26 15 13 11 13 0 164 0 14 5 7 7 4 1 33 38 19 25 24 1 244
18 11 23 33 19 16 14 3 51 49 46 50 45 10 575 7 22 22 20 19 8 4 63 35 42 49 73 10 630
19 1 9 9 11 8 8 0 40 30 34 47 42 1 338 0 25 8 26 0 12 0 36 11 31 31 46 0 400
20 21 24 18 29 27 25 16 30 14 26 14 15 34 329 7 10 11 10 19 13 8 13 6 7 12 12 20 156
21 2 21 15 26 20 13 17 77 61 58 63 63 10 887 4 11 5 7 22 10 4 100 73 67 73 72 4 673
22 1 7 4 8 4 5 1 42 21 33 25 36 12 479 0 6 5 3 2 5 2 48 48 59 41 57 9 585
23 1 17 12 19 14 16 5 29 37 33 25 32 2 160 5 9 17 11 17 9 7 39 34 19 42 27 7 196
24 0 2 0 2 3 1 1 9 9 15 10 7 0 220 1 0 1 0 0 0 0 6 24 9 18 3 1 211
24 0 4 7 2 1 2 5 18 13 17 13 13 1 193 3 6 4 3 1 0 10 17 19 19 23 14 2 165
25 18 38 21 17 34 18 13 79 87 106 100 92 26 790 11 43 51 23 50 40 19 71 71 125 82 120 31 742
26 15 13 7 6 3 7 8 77 71 54 56 64 5 451 2 3 1 0 3 0 0 57 41 81 69 56 5 301
27 2 26 18 24 33 8 1 85 78 102 132 133 6 770 16 63 24 13 28 43 2 93 130 109 89 103 6 1058
28 4 17 30 9 26 14 0 59 55 65 85 57 1 527 0 37 64 72 43 64 0 448
28 0 0 2 3 1 2 1 3 1 0 1 1 1 84 0 0 0 0 0 5 0 3 7 6 4 3 0 93
29 1 1 1 1 0 1 0 6 10 8 11 7 1 68 3 5 2 4 2 2 3 20 11 14 12 16 0 129
29 2 2 7 4 10 7 6 61 40 43 64 53 7 308 10 14 15 16 8 17 8 67 49 39 46 62 7 340
30 4 13 17 12 7 14 3 26 9 11 22 15 2 362 0 9 10 16 22 9 3 29 16 25 16 17 3 175
31 0 4 5 5 5 4 1 46 54 36 32 36 0 954
32 3 499 3 385
33 12 11 10 14 13 18 9 34 36 29 24 39 1 508 17 15 28 24 17 33 16 49 60 54 41 58 5 521
34 2 5 4 16 3 4 3 20 10 20 15 8 2 245 13 4 26 3 27 10 5 24 20 25 22 22 2 305
34 1 12 14 10 5 2 10 48 33 38 42 25 1 283 16 9 15 18 15 12 21 44 39 49 39 36 0 303
35 0 7 2 3 6 8 0 6 6 4 6 11 0 295 2 3 0 1 5 3 1 26 15 15 14 27 1 194
36 6 14 17 13 9 7 11 95 57 76 54 53 15 569 8 3 10 16 8 20 13 51 47 50 35 55 19 589
37 1 0 3 0 1 2 3 1 3 8 6 4 4 74 4 4 4 8 9 10 6 20 18 12 18 20 8 277
39 0 6 4 12 5 6 0 43 46 64 47 42 0 340 0 18 6 2 11 9 2 65 66 66 62 74 0 510
41 4 13 11 15 15 9 10 50 36 41 33 45 5 570 2 8 1 11 4 15 8 32 31 34 33 51 8 578
42 9 7 13 8 2 6 10 60 58 63 60 63 7 674 4 18 11 2 8 3 8 74 67 58 58 58 12 617
43 0 49 19 11 20 20 2 46 40 43 28 38 8 223 1 26 12 22 33 16 4 39 28 34 31 30 3 235
44 3 3 2 12 2 5 2 49 51 53 49 51 0 304 2 5 7 6 2 2 7 83 76 72 74 68 8 457
46 6 5 11 11 9 8 5 53 56 46 43 34 5 545 3 4 4 4 9 13 6 42 46 43 51 43 6 459
47 0 0 1 0 0 0 0 2 2 6 4 5 0 94 0 0 0 0 2 2 0 8 8 6 5 11 0 54
48 2 20 6 5 2 0 2 29 11 46 33 33 4 169 3 12 8 4 3 11 1 27 21 34 20 30 1 166
49 0 0 2 1 2 3 0 26 20 15 8 4 0 351 0 1 0 1 0 0 0 10 11 9 4 16 0 266
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Table D.6. Spike counts after burst or tonic SCS on day 7 following painful nerve 
root compression with spinal superfusion of bicuculline (Chapter 7).  
 
Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
7 0 88 3 15 14 2 6 33 35 40 19 40 0 135 0 3 2 9 0 2 0 44 51 49 26 41 0 72
9 18 173 59 55 64 84 70 226 213 206 146 203 73 1200 0 31 30 48 12 32 0 184 179 82 23 76 7 204
11 0 96 5 3 8 1 2 39 42 42 26 34 1 142 0 14 9 13 12 10 0 30 25 28 24 29 0 207
12 14 226 54 78 68 64 73 157 149 162 178 174 7 860 45 111 103 37 54 53 11 92 69 49 114 70 80 675
13 4 190 18 10 16 16 33 63 32 47 34 43 0 569 2 19 21 5 6 13 0 54 43 46 27 19 66 767
14 19 301 33 22 33 33 22 138 53 69 111 84 23 519 9 23 32 25 12 15 24 44 61 41 43 31 14 372
15 34 916 146 156 139 92 121 297 294 292 249 241 8 1848 8 49 57 42 36 36 4 158 140 96 100 95 9 495
16 9 317 18 11 24 27 13 105 40 108 77 75 2 485 5 4 12 6 12 7 10 43 22 38 103 79 8 477
17 0 282 19 21 96 65 68 120 96 94 78 79 1 728 0 52 3 11 14 49 2 27 55 47 35 47 1 404
18 5 150 8 14 5 9 12 69 57 58 49 70 15 506 4 32 14 10 18 17 4 64 47 33 26 22 10 335
7 8 326 25 44 21 33 15 59 78 103 88 100 3 130 3 9 5 2 6 4 0 12 27 11 10 12 0 19
8 0 28 9 15 7 3 39 30 14 27 47 81 6 261 0 6 1 2 5 1 0 25 25 18 13 21 0 96
11 0 119 8 15 14 6 9 39 37 52 46 36 0 153 0 10 13 18 9 23 2 35 33 24 31 32 0 247
12 0 5 0 0 0 0 0 0 0 0 0 0 0 139 0 6 0 0 0 1 0 2 1 1 4 5 0 111
12 10 231 11 25 25 14 19 26 44 20 39 29 1 283 7 17 15 17 17 18 0 44 28 15 11 24 1 144
13 3 185 24 19 14 19 15 96 115 101 70 113 0 641 0 16 44 11 2 12 0 73 82 153 111 124 5 579
16 10 394 41 39 45 40 48 37 88 69 46 51 9 589 1 7 12 11 22 12 8 41 49 54 45 47 16 341
17 0 509 26 21 44 57 70 147 134 90 95 110 2 828 3 63 13 18 19 25 1 54 33 69 33 47 0 616
18 4 303 39 15 17 31 11 74 88 81 91 66 9 571 10 6 20 4 14 14 5 58 36 30 36 36 5 248
19 0 18 1 2 0 3 4 10 5 66 61 17 0 756 1 12 0 11 3 18 0 14 17 14 17 4 0 553
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
7 2 21 6 22 14 14 10 20 50 72 68 41 5 144 7 19 34 10 16 10 0 31 10 25 51 27 0 100
9 0 1 1 3 1 1 0 169 113 282 210 102 0 729 0 1 0 0 1 2 0 159 125 100 102 52 0 680
11 3 16 16 10 9 6 0 32 26 28 33 28 2 183 0 9 10 3 7 7 0 46 36 13 20 30 1 155
12 20 49 55 15 71 49 3 78 79 84 76 53 5 357 25 114 122 79 83 55 35 113 97 108 104 80 8 909
13 9 26 26 30 62 40 1 44 77 36 51 13 0 35 28 32 20 12 1 45 43 44 44 68
14 6 14 11 11 20 15 13 26 15 42 37 30 26 342 2 13 5 7 14 7 6 18 16 14 13 13 0 236
15 4 29 28 28 21 25 8 85 113 79 73 98 19 1214 15 86 47 42 41 49 0 90 78 73 57 22 3 1659
16 3 17 19 15 9 6 6 61 48 28 45 38 15 493 4 13 20 62 18 38 7 97 141 126 135 136 8 793
17 1 5 13 0 2 21 1 86 74 60 54 86 3 433 3 60 34 10 8 12 3 26 74 86 99 79 3 456
18 5 14 14 24 22 11 8 75 51 69 65 55 8 290 6 27 32 24 13 35 14 77 76 63 86 55 5 466
7 0 4 1 8 1 4 0 24 18 21 31 11 0 38 1 12 4 28 12 7 0 40 39 51 44 59 2 186
8 0 5 1 3 1 1 8 39 33 47 21 40 8 272 0 14 18 5 7 0 2 49 20 24 21 30 0 190
11 0 14 8 8 21 14 4 25 30 33 19 45 0 238 1 6 11 14 13 11 0 27 21 33 43 38 5 204
12 0 4 0 2 0 5 1 1 6 11 0 5 1 169 10 34 23 32 37 28 29 43 36 37 28 46 11 218
12 1 22 14 28 4 16 20 45 36 45 68 44 0 270 8 1 4 4 12 0 4 12 7 5 11 1 0 97
13 7 15 18 28 18 18 3 90 82 57 57 50 8 406 0 15 14 18 6 19 0 93 58 103 101 107 2 470
16 9 27 46 18 12 39 24 47 52 57 115 36 28 523 6 10 8 12 13 3 5 38 48 64 49 79 3 379
17 1 12 16 3 17 10 0 40 87 60 65 41 2 437 1 26 26 9 6 61 3 111 92 101 83 56 2 672
18 3 10 8 9 12 28 4 38 72 64 21 33 3 189 5 21 34 8 30 12 3 62 45 72 33 60 4 406
19 0 0 7 0 0 1 0 7 16 15 20 17 0 391 0 5 0 0 0 0 0 22 10 3 6 7 0 648
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Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol. 
 
 
 
 
 
 
 
 
  
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
7 0 3 19 8 8 6 0 24 28 15 25 50 0 103 0 11 8 13 4 26 0 38 13 23 35 36 1 216
9
11 0 7 7 15 8 14 0 13 17 19 22 26 6 88 0 12 8 11 9 13 0 45 17 18 26 40 0 101
12 25 90 107 106 94 34 17 103 129 103 107 123 17 583 25 54 78 68 64 73 18 157 149 162 178 174 7 860
13 2 28 17 38 12 20 9 51 52 50 33 58 15 18 23 22 23 18 2 85 114 73 91 69 3 496
14 3 10 9 6 7 6 8 46 39 31 51 63 8 120 0 17 8 14 2 0 2 190
15 12 1772
16 4 48 18 54 32 26 7 102 103 92 89 87 6 531 6 8 8 13 42 21 4 80 97 73 45 59 9 450
17 3 35 68 17 11 66 4 70 106 91 85 129 4 713 5 17 46 50 23 52 3 137 76 87 101 104 7 726
18 7 30 24 16 14 35 5 91 98 30 66 106 11 386 5 39 15 17 31 11 2 74 88 81 91 66 9 571
7 2 13 11 7 1 8 0 25 24 20 14 11 0 54 0 5 9 8 3 4 0 14 6 13 6 14 0 37
8 0 5 8 1 1 1 0 36 43 29 29 21 11 173 4 14 17 6 3 3 5 19 22 9 4 8 1 206
11 0 9 18 8 11 6 1 65 44 41 34 8 0 349 0 21 8 13 13 4 0 59 46 39 31 35 1 217
12 22 18 22 25 23 36 9 37 20 29 29 40 7 168 7 20 50 32 29 27 13 46 45 23 37 32 0 248
12 4 14 15 10 17 17 1 42 29 29 51 29 0 135 5 11 12 20 10 13 12 49 29 38 13 47 9 192
13 3 20 15 24 14 10 0 98 58 63 71 95 6 650 0 24 19 14 19 15 0 96 80 54 44 78 0 641
16 6 14 24 53 26 53 12 67 60 54 39 75 6 237 6 24 10 3 10 2 7 67 81 82 61 74 2 331
17 0 46 67 34 3 93 2 101 114 118 98 102 1 668 0 19 21 96 65 68 5 120 96 94 78 79 1 728
18 0 19 17 9 20 21 2 62 39 37 44 39 2 296 0 24 28 17 11 5 2 86 117 71 86 86 3 467
19 0 1 10 3 0 4 0 11 19 8 5 1 0 749 0 11 6 8 2 11 0 22 13 14 27 24 0 914
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Table D.7. Spike counts after burst or tonic SCS on day 7 following painful nerve 
root compression with spinal superfusion of CGP35348 (Chapter 7).  
 
Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 9 120 21 25 16 24 26 50 51 47 85 81 20 517 0 7 10 2 9 4 3 10 25 17 13 14 5 213
2 17 117 20 26 21 20 21 31 33 40 59 62 17 705 9 9 14 18 23 9 10 34 29 19 28 39 13 208
4 11 72 15 18 14 13 18 35 35 35 66 39 11 671 23 21 22 27 24 22 16 57 37 48 28 28 15 344
5 15 224 26 37 24 33 32 96 85 93 95 124 16 851 12 20 17 21 9 14 4 88 58 76 69 95 8 772
6 13 172 24 26 35 36 17 100 59 67 74 78 14 763 11 20 22 24 25 28 25 29 39 38 42 41 20 488
20 12 206 18 19 21 16 25 43 49 33 27 34 18 500 12 21 19 15 23 15 13 31 42 46 31 33 21 475
21 10 652 93 112 130 116 99 196 137 143 123 146 23 616 6 105 93 61 85 157 6 84 100 87 110 106 6 314
22 2 460 49 52 72 56 79 124 122 108 113 104 1 745 8 27 20 26 35 38 8 66 50 53 42 24 2 158
23 23 154 24 34 17 20 13 42 49 43 56 45 16 366 3 9 5 3 6 8 0 12 11 14 9 12 1 94
24 0 161 8 13 10 10 16 27 18 19 13 11 0 159 0 7 7 5 4 4 0 20 8 18 22 19 0 150
25 0 38 3 0 3 3 0 15 20 11 22 12 0 507 0 18 3 14 5 6 0 20 8 8 21 20 0 324
26 8 349 45 60 49 42 54 94 71 87 96 93 8 716 11 46 65 57 49 45 10 90 80 59 72 74 7 433
27 4 50 6 3 5 5 9 46 32 30 29 30 3 134 1 3 2 6 2 2 1 43 32 26 25 17 4 98
28 1 16 7 3 3 6 3 44 55 32 47 42 0 500 2 3 3 2 2 1 0 14 23 20 23 17 11 281
29 12 306 47 39 26 28 17 94 116 75 98 105 17 1094 11 12 21 12 13 13 16 43 53 39 48 51 9 423
30 5 251 18 13 11 16 30 52 51 58 51 51 6 340 3 17 16 12 14 18 4 49 49 38 35 49 4 279
32 8 70 12 8 7 8 9 27 18 22 19 26 2 291 9 8 14 7 11 7 4 13 17 16 13 16 0 124
34 2 601 12 8 14 12 15 87 81 79 65 71 3 556 0 7 3 7 5 6 1 34 46 54 44 38 0 205
36 1 62 4 3 1 4 1 60 62 45 34 45 2 507 1 4 4 2 3 3 0 40 41 28 24 20 3 320
37 0 16 3 5 3 3 2 58 82 61 41 47 0 340 0 19 8 6 0 1 0 49 48 24 26 22 1 260
38 2 76 8 5 9 6 6 33 36 32 31 17 2 111 4 15 5 4 8 6 2 33 12 6 12 29 2 75
39 0 62 30 28 27 28 26 81 71 71 70 65 6 832 2 92 22 32 19 29 1 48 75 71 33 46 22 555
40 0 8 0 0 0 0 0 10 7 12 9 14 0 299 0 1 0 1 0 0 0 6 7 15 7 5 0 118
41 0 0 0 0 0 0 0 25 24 19 14 20 0 355 0 0 1 0 0 1 0 13 16 7 9 10 0 333
44 8 241 34 17 28 28 44 86 76 80 63 77 9 540 3 15 4 5 11 5 5 27 25 19 17 16 17 187
46 1 97 11 12 5 7 14 35 44 44 31 35 0 351 0 7 5 3 3 4 2 22 26 35 23 17 0 155
47 0 71 1 4 3 6 1 29 31 18 24 23 0 425 0 1 2 1 0 0 0 13 7 9 8 10 0 235
48 0 19 2 5 3 3 2 36 17 29 42 35 2 365 0 1 2 0 2 2 0 10 7 9 6 10 1 120
49 10 457 63 68 58 50 72 138 107 128 98 106 16 530 7 22 15 32 15 12 3 62 75 68 137 53 8 373
26g Pinch
0min post-SCS
Rat #
N
eu
ro
n
M
od
e
1.4g vF 26g vF
pre-SCS baseline
Brush Pinch 1.4g
249
252
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ur
st
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266
267
268
269
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 1 13 18 8 8 14 1 28 27 29 36 31 2 611 3 20 7 9 8 5 3 15 17 10 11 14 0 188
2 8 18 24 11 16 21 8 33 28 28 33 36 13 227 16 27 22 11 27 20 17 61 31 33 20 36 28 620
4 23 34 18 26 21 21 17 32 37 30 53 41 10 457 29 36 28 34 30 26 26 48 46 51 58 57 9 531
5 10 20 34 33 28 21 20 77 65 74 74 93 18 788 22 19 38 48 24 33 26 97 107 81 109 92 34 883
6 7 15 2 11 19 10 9 38 41 32 40 47 15 630 17 17 23 27 23 23 22 60 45 49 40 37 23 617
20 17 23 16 22 17 17 6 45 19 31 23 48 13 434 19 25 45 25 18 15 14 30 36 47 36 53 8 395
21 0 95 82 73 56 57 3 173 146 107 105 59 4 344 2 78 57 65 77 84 0 91 82 42 45 90 1 336
22 7 10 28 10 25 20 1 33 20 33 18 20 5 56 5 41 45 41 35 27 3 37 41 22 28 20 0 109
23 0 7 4 5 5 3 26 37 26 26 27 27 0 127 7 15 16 11 11 11 3 28 19 17 30 27 1 264
24 0 8 7 6 4 3 0 14 25 19 16 11 0 85 0 2 11 6 9 10 0 18 24 27 26 18 1 118
25 1 14 8 5 6 3 0 10 25 18 12 12 0 375 0 3 2 3 1 3 0 38 46 36 27 23 0 399
26 11 49 46 46 49 56 8 76 69 87 85 71 5 393 9 41 45 39 28 51 8 91 59 68 68 54 11 469
27 1 1 6 10 7 9 0 29 37 26 25 24 2 105 5 5 2 10 6 6 5 36 34 37 31 27 3 193
28 2 7 1 3 4 3 1 10 22 24 21 14 0 260 1 7 5 3 3 4 0 30 29 25 33 28 1 374
29 8 11 15 10 16 14 9 31 39 46 53 33 11 328 16 28 19 8 15 18 9 45 41 38 27 47 13 480
30 2 5 11 14 6 12 1 35 48 37 42 40 7 237 5 14 23 14 15 17 5 53 55 37 63 47 5 314
32 4 9 8 5 9 7 0 10 15 12 16 10 0 124 11 17 11 9 10 10 3 17 18 18 24 35 1 222
34 2 3 8 9 5 4 2 45 40 41 40 48 1 223 1 6 6 5 8 3 3 49 52 58 27 35 1 345
36 0 4 2 5 3 5 2 27 48 28 32 49 0 360 3 6 9 11 7 5 3 67 51 53 43 69 1 420
37 2 17 6 10 8 2 1 67 33 30 24 5 0 302 2 13 1 2 1 2 0 49 26 48 35 36 0 341
38 3 11 6 10 13 10 4 13 21 19 11 28 3 72 0 4 1 12 9 11 4 23 25 24 19 24 4 61
39 0 7 26 13 22 21 5 34 31 32 28 35 0 208 7 19 40 15 23 24 3 98 84 70 81 77 4 692
40 0 3 3 2 0 1 0 4 14 5 12 5 0 142 0 1 0 0 0 0 0 11 7 5 7 11 0 152
41 0 3 3 1 0 0 0 30 14 18 21 15 0 350 0 0 0 1 0 1 0 24 27 17 14 28 0 402
44 5 37 19 23 27 29 3 49 60 54 58 57 7 285 4 23 27 32 31 30 2 35 26 37 42 57 11 355
46 0 6 5 2 3 3 2 32 12 26 14 28 0 249 0 4 1 4 2 3 2 38 32 30 32 38 0 272
47 1 1 1 0 2 1 0 17 12 8 12 12 0 257 0 1 2 3 2 1 0 25 23 21 26 24 0 335
48 0 2 1 2 0 2 0 20 18 23 19 9 1 189 0 2 4 3 1 3 0 26 17 42 18 22 0 286
49 3 13 70 55 22 34 0 79 48 72 66 147 7 229 9 25 36 84 94 91 7 161 71 53 107 133 7 618
B
ur
st
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252
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266
267
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1.4g 26g Pinch 1.4g 26g Pinch
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 0 5 2 12 8 13 2 19 19 23 20 23 1 90 31 67 47 51 45 38 22 79 70 75 97 78 14 653
2 25 27 19 22 21 15 13 44 38 53 32 29 10 456 25 34 30 37 30 38 35 58 57 65 52 41 20 697
4 26 31 32 21 32 21 22 36 36 32 43 56 7 480 37 43 33 29 32 39 25 65 73 62 69 58 13 514
5 19 49 42 36 27 48 19 84 81 68 88 87 11 1120 15 46 39 24 24 28 17 111 136 107 101 108 34 1099
6 24 33 37 24 43 85 28 44 45 50 47 50 20 712 19 22 31 21 22 34 25 58 72 67 65 66 20 708
20 16 26 29 10 18 17 6 31 39 46 43 46 6 360 11 13 19 5 5 11 3 22 29 32 32 24 5 404
21 3 125 139 144 148 44 0 156 112 122 89 87 0 281 7 79 99 69 100 56 1 183 131 133 110 74 1 506
22 7 42 30 42 49 44 2 26 28 35 33 34 1 125 4 25 45 48 21 41 0 45 21 28 32 27 2 152
23 7 16 13 7 9 10 2 29 27 25 24 20 0 273 8 16 13 15 21 12 2 32 27 20 21 26 0 345
24 0 10 3 7 4 5 0 29 16 13 24 7 0 168 3 7 9 6 2 4 0 20 17 13 21 15 3 152
25 0 11 9 1 1 1 0 25 43 52 45 59 0 444 0 9 8 1 3 4 0 19 21 22 17 29 0 363
26 12 58 59 56 51 51 7 117 119 133 64 83 4 598 10 75 33 66 42 45 13 106 96 72 142 138 8 504
27 4 10 6 12 7 5 4 42 26 30 27 29 2 220 3 6 9 6 8 11 11 38 34 41 42 29 4 210
28 4 14 12 8 3 6 0 45 52 52 46 46 1 507 0 5 8 5 2 6 0 62 58 47 57 66 4 512
29 7 23 13 20 23 12 10 46 55 58 47 51 8 513 19 23 23 13 18 19 12 70 63 57 40 40 13 504
30 6 17 14 14 24 27 1 46 52 59 34 54 7 434 7 14 34 22 20 28 6 61 80 92 75 64 6 403
32 13 19 15 14 16 11 5 29 35 25 31 29 0 214 22 23 21 20 22 22 10 25 32 33 38 30 0 306
34 3 6 5 7 6 7 1 50 43 38 30 33 1 301 0 9 8 4 5 4 0 54 61 54 62 50 0 461
36 1 6 5 7 4 7 3 69 66 36 45 59 3 342 2 8 7 6 5 5 4 57 35 36 41 37 2 381
37 1 6 0 3 0 0 0 39 20 37 20 39 0 313
38 4 11 9 5 8 5 1 28 16 20 27 31 4 99 4 8 4 5 6 14 3 32 20 22 27 32 4 122
39 6 53 16 21 59 27 1 105 92 69 72 80 8 763 5 30 28 27 28 26 1 81 71 71 70 65 6 832
40 0 4 2 5 0 0 0 16 10 10 11 8 0 162 0 4 2 11 2 1 0 8 6 6 7 7 0 180
41 0 3 0 1 0 0 0 42 14 18 18 15 0 275 1 5 5 3 1 1 0 36 38 31 31 28 0 363
44 7 25 30 29 18 23 2 60 49 44 59 50 9 451 5 27 16 19 23 13 7 36 26 30 29 44 4 298
46 0 5 3 5 8 6 0 45 49 39 39 40 0 235 3 7 6 7 8 7 0 78 48 43 51 49 1 308
47 0 8 3 1 2 2 0 33 21 29 40 34 0 442 0 1 1 1 2 3 0 31 27 34 33 25 0 380
48 0 3 1 0 0 4 0 19 35 40 34 36 0 311 3 3 3 2 0 4 1 28 26 23 23 27 0 364
49 9 59 75 23 99 72 5 138 142 127 123 122 8 519 10 61 63 68 50 72 12 138 107 128 98 106 16 530
N
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n
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 16 183 34 39 29 24 25 48 51 37 52 43 15 329 14 26 28 22 27 28 11 66 68 59 49 61 6 462
2 15 121 18 21 14 16 18 43 43 27 21 30 18 273 8 9 6 18 11 10 10 41 25 33 27 30 2 306
3 0 102 5 11 8 10 7 27 25 27 16 38 2 564 2 8 13 14 9 9 0 42 32 34 43 22 0 662
4 37 186 43 33 29 32 39 65 73 62 69 58 13 514 16 24 12 4 9 11 7 37 40 52 35 53 1 320
5 9 191 28 33 14 28 20 56 74 52 61 64 4 733 2 15 20 13 12 10 1 67 93 35 90 66 6 829
6 9 204 18 28 31 28 36 45 43 40 34 25 9 408 45 49 41 39 49 32 31 59 48 49 52 51 48 713
20 0 93 1 7 20 3 9 15 11 9 15 24 2 374 0 3 7 3 1 5 0 14 9 10 6 8 0 188
21 2 689 145 142 120 118 172 110 86 123 88 136 5 456 14 138 140 133 105 109 18 169 96 95 106 76 10 450
22 4 388 68 65 65 64 74 81 99 66 72 62 3 726
23 7 125 16 13 15 21 12 37 32 25 26 31 0 345 4 13 8 13 13 8 2 28 23 14 20 20 0 296
24 0 222 3 4 3 1 4 33 35 15 23 14 0 153 0 4 4 0 0 2 0 14 5 3 8 4 0 203
25 0 11 1 1 1 1 1 23 27 16 23 27 0 388 6 23 19 12 14 6 2 17 38 20 16 29 0 381
26 2 416 11 20 22 34 36 105 123 112 90 143 4 580 3 18 55 10 32 46 3 109 101 100 96 105 5 530
27 2 88 8 18 6 6 3 37 30 34 26 31 5 173 0 11 6 7 7 9 4 30 24 17 24 13 5 162
28 1 107 4 2 2 2 7 40 44 49 26 37 0 452 19 24 19 19 20 16 14 56 56 65 59 57 2 592
29 13 119 23 23 13 18 19 70 63 57 40 40 13 504 0 1 3 1 3 2 0 8 16 15 13 20 0 207
30 12 224 16 19 21 32 16 47 76 56 45 56 6 291 9 15 20 12 20 19 4 59 39 37 35 37 6 282
32 0 28 4 6 4 3 2 12 15 20 20 13 0 288 4 23 10 11 9 8 3 22 12 13 19 21 0 180
33 8 177 47 45 23 43 16 74 72 83 63 64 6 527 3 7 14 10 14 9 2 49 33 22 35 36 0 281
34 1 380 6 7 8 9 24 43 44 64 51 48 0 503 0 7 8 7 3 8 0 41 45 39 38 34 0 421
36 0 13 0 1 0 0 0 11 6 25 14 15 0 249 3 4 4 2 3 6 2 31 16 33 24 54 0 356
38 11 176 16 24 14 14 11 59 53 60 61 64 5 39 5 10 3 14 8 11 3 42 40 22 15 39 5 46
39 4 329 29 27 27 31 26 79 73 67 65 65 1 824 2 24 14 8 20 32 0 104 77 72 69 117 2 821
40 0 6 0 2 0 0 0 45 48 39 50 30 0 324 3 5 1 1 5 0 1 32 36 29 22 28 0 219
41 1 9 5 3 3 1 1 36 38 31 31 28 0 363 0 4 3 2 1 0 0 29 14 18 27 26 0 422
45 3 162 20 21 19 27 14 52 50 53 52 43 3 722 1 9 4 12 4 11 1 58 45 53 39 54 8 604
46 0 70 3 3 3 2 3 18 24 19 22 22 0 189 0 7 6 3 6 4 1 33 34 24 21 31 1 270
47 0 55 1 1 1 2 3 31 27 34 33 25 0 380 0 1 1 0 2 1 0 26 23 29 24 37 0 316
48 0 44 4 5 1 8 4 31 27 31 28 28 0 406 1 5 0 2 2 1 0 32 28 37 43 21 1 362
49 10 475 61 63 68 51 74 147 117 133 106 129 16 557 16 52 29 43 48 64 8 154 148 128 94 142 8 521
M
od
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Brush Pinch Pinch1.4g vF 26g vF 1.4g 26g
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 17 28 30 35 25 19 12 33 43 65 58 47 13 444 18 26 31 22 36 21 12 54 43 47 27 45 12 429
2 0 12 5 8 10 20 5 23 43 40 36 34 12 290 6 14 21 12 9 13 3 27 36 31 30 22 6 330
3 9 18 14 15 17 5 1 24 18 29 20 28 14 676
4 15 24 21 15 12 16 7 28 27 19 37 60 1 501 23 22 22 19 13 11 9 43 66 33 44 70 1 418
5 18 22 17 12 29 6 6 79 114 97 69 73 8 993 1 16 9 15 14 14 5 75 120 112 111 102 11 942
6 25 38 39 31 32 36 30 33 54 38 53 54 32 597 13 23 18 24 24 28 20 50 47 43 36 36 22 468
20 13 34 29 17 19 25 10 59 64 44 35 45 3 285 12 46 35 35 18 17 16 50 44 41 49 53 21 459
21 7 65 40 40 53 22 6 87 104 67 55 93 7 367 17 127 154 88 116 107 8 101 116 125 128 67 1 299
22 5 73 53 42 39 44 2 77 115 99 102 89 3 694 14 78 65 95 75 84 4 105 136 97 110 101 1 664
23 11 20 14 14 12 11 6 28 23 23 25 33 1 334 14 30 23 23 24 28 13 430
24 0 12 10 10 7 7 0 15 33 29 10 17 0 214 0 9 12 8 7 6 0 33 31 21 23 9 0 264
25 0 10 2 2 1 1 0 15 27 11 16 34 0 416 0 3 3 2 5 3 0 15 37 12 25 31 0 352
26 4 55 50 62 23 40 3 108 79 82 140 115 0 567 3 39 33 44 54 77 1 93 98 100 79 78 1 407
27 3 4 3 6 6 4 4 44 15 32 29 25 2 169 8 7 6 18 14 9 6 41 32 21 28 26 8 238
28 6 10 12 8 8 5 1 47 41 41 35 52 1 649 3 9 9 7 5 9 1 33 27 63 64 63 0 571
29 2 10 7 4 8 6 2 25 26 25 27 36 0 195 2 7 3 9 12 5 1 32 39 29 40 48 4 360
30 6 22 20 15 20 17 5 61 35 40 48 51 3 325 13 20 29 25 24 27 7 62 47 57 42 60 9 356
32 8 10 10 10 10 9 0 22 20 20 17 24 0 162 3 16 10 11 9 13 1 17 22 28 20 33 0 199
33 1 6 4 12 16 18 2 46 40 39 36 40 2 339 0 12 23 12 19 9 0 58 58 68 55 52 3 425
34 1 7 3 3 3 5 0 57 41 44 40 39 1 455 2 3 3 5 5 6 1 54 57 57 43 46 0 336
36 3 9 2 1 2 2 4 31 23 23 12 38 1 480 1 4 5 1 2 9 0 50 36 30 24 19 0 386
38 6 6 11 20 12 8 0 19 26 26 19 15 3 89 3 17 10 7 8 9 0 32 15 19 21 17 0 147
39 1 36 11 21 15 25 1 78 90 101 106 95 2 848 4 54 20 24 18 38 7 96 96 115 118 103 10 1015
40 2 2 7 3 2 4 0 23 25 35 32 35 2 315 0 9 3 4 1 4 0 21 29 29 31 43 0 342
41 0 6 4 1 3 5 1 27 30 29 30 44 0 329 7 26 7 4 5 3 2 36 25 24 34 63 0 407
45
46 0 0 2 4 3 6 3 41 40 18 38 33 3 381 3 7 3 4 6 4 0 39 34 28 25 60 1 315
47 0 0 2 4 2 2 0 19 18 14 30 19 0 306 0 1 2 2 2 2 0 29 18 23 16 22 0 412
48 0 1 3 3 1 1 0 14 39 11 25 19 0 391 4 6 6 13 16 18 9 48 45 27 25 19 1 421
49 10 60 66 68 68 63 8 161 135 92 150 129 3 361 1 63 70 80 68 82 3 143 172 136 139 126 3 551
N
eu
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Pinch1.4g 26g Pinch 1.4g 26g
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Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol. 
  
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 22 43 46 36 36 29 17 47 37 25 29 31 13 345 20 36 41 22 17 33 20 75 36 30 34 37 18 327
2 17 24 23 21 22 15 15 53 28 23 37 39 6 441 16 39 33 20 30 27 18 42 44 28 34 56 10 415
3
4 19 30 19 15 18 13 9 55 45 34 41 35 3 529 24 26 23 22 20 18 13 88 73 60 75 65 3 458
5 21 37 23 32 31 44 11 101 120 72 80 77 15 1197 22 41 58 27 46 43 21 114 84 118 96 84 15 935
6 28 38 34 35 46 35 36 75 71 60 57 57 16 743 25 32 32 31 29 25 26 58 50 54 47 55 19 625
20 28 47 44 23 39 22 15 82 70 63 44 64 10 468 11 18 19 21 16 25 17 43 49 33 27 34 18 500
21 8 134 120 69 80 93 4 156 96 94 96 71 1 422 7 126 68 59 62 67 2 92 59 59 62 70 3 364
22 9 60 31 65 33 38 4 91 49 90 89 52 4 809 13 49 52 72 56 79 9 124 122 108 113 104 1 745
23 12 19 24 19 19 15 7 40 20 23 25 20 8 459 13 22 15 21 11 22 6 40 20 26 29 29 0 417
24 0 9 11 11 3 6 0 24 22 12 19 25 0 252 0 20 15 15 5 4 0 24 27 19 8 17 0 193
25 0 6 13 6 4 10 0 19 40 10 23 21 0 423 0 10 12 8 5 7 1 24 19 26 33 42 0 401
26 0 27 69 35 55 44 2 89 70 76 100 125 1 570 8 63 39 49 52 52 4 83 63 97 79 104 5 513
27 4 17 15 8 4 13 4 44 26 24 25 23 6 220 4 7 10 9 8 10 5 38 29 21 11 23 7 256
28 3 3 2 6 1 4 0 44 40 42 28 37 0 445 1 7 3 3 6 3 1 44 55 32 47 42 0 500
29 5 6 11 9 8 15 1 30 50 39 38 49 3 190 5 6 5 4 5 6 0 33 34 29 22 39 1 339
30 12 20 29 21 15 27 0 63 39 54 41 73 9 381 16 30 26 34 26 25 8 47 54 62 42 51 4 348
32 5 18 17 16 10 14 3 48 42 39 48 32 1 231 17 28 22 25 23 18 9 36 31 46 43 49 0 279
33 4 12 11 11 9 13 3 48 46 51 51 40 5 361 0 4 11 4 5 12 2 48 59 57 33 50 2 305
34 0 5 11 10 16 2 1 52 63 45 50 45 0 483 1 5 7 12 27 8 1 68 50 56 35 31 3 676
36 0 6 9 8 6 10 0 40 36 42 46 49 0 458 1 12 14 8 11 8 2 85 68 38 54 57 2 536
38 3 8 11 11 11 13 4 25 18 19 10 21 2 98 2 8 5 9 6 6 2 33 36 32 31 17 2 111
39 2 76 54 29 21 23 8 115 105 89 111 133 6 849 7 24 43 17 45 26 6 106 102 102 97 85 13 831
40 1 8 6 1 5 3 1 34 23 38 29 29 0 298 0 1 2 0 0 0 0 13 15 11 8 21 1 339
41 0 14 5 4 0 1 0 39 42 27 37 50 0 432 9 20 17 11 12 16 0 68 55 41 41 44 3 450
45
46 2 11 10 6 7 9 0 65 58 49 61 49 2 351 2 9 10 11 7 13 7 37 49 50 37 28 0 313
47 0 1 1 2 1 0 0 44 46 36 31 34 0 335 1 2 2 0 4 0 0 38 29 12 22 45 0 382
48 0 0 6 3 1 3 0 25 37 42 44 57 3 399 0 2 5 2 2 3 0 36 17 29 42 35 2 365
49 16 90 25 86 82 67 12 190 160 171 131 153 16 541 14 72 72 47 89 82 11 140 90 82 113 77 15 691
Pinch 1.4g 26g Pinch
N
eu
ro
n
10min post-SCS 15min post-SCS
1.4g 26g
To
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252
M
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e
Rat #
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 282 
Table D.8. Spike counts after burst or tonic SCS on day 7 following painful facet 
joint injury (Chapter 7). 
 
Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 8 158 9 15 15 16 14 54 39 35 44 37 6 908 8 21 17 20 11 28 12 52 43 41 52 34 20 719
2 0 10 1 1 0 2 1 31 16 16 20 17 0 162 0 1 0 0 0 0 0 10 6 4 2 5 0 52
3 0 81 55 37 25 50 21 58 66 75 65 96 0 414 1 8 9 16 6 4 0 46 55 53 57 41 0 305
7 6 268 40 32 26 35 39 78 50 68 70 44 13 340 5 14 11 9 11 8 6 71 47 59 46 42 5 158
8 0 0 0 0 0 0 0 2 5 1 3 4 0 200 0 0 0 0 0 0 0 6 10 5 6 6 0 81
9 0 44 5 4 3 4 2 32 33 36 31 35 0 293 0 0 0 0 0 1 0 8 0 2 7 3 0 89
10 1 136 22 12 16 14 16 58 56 62 73 80 6 1297 9 19 19 19 19 25 5 105 101 81 85 88 10 684
11 0 22 11 11 22 5 8 43 34 22 18 24 0 254 0 12 14 14 6 2 2 55 39 44 27 37 0 169
12 7 74 42 32 19 24 20 63 42 53 49 48 8 356 6 17 16 5 9 28 8 53 43 20 34 13 7 131
13 17 95 33 15 25 20 16 95 93 45 69 74 0 773 0 9 3 0 2 0 9 46 47 40 37 25 0 458
14 10 225 30 29 20 17 24 59 56 55 55 95 12 839 7 18 17 13 24 20 13 51 39 46 39 44 8 666
15 4 255 37 52 35 38 25 70 51 45 45 45 7 551 7 28 23 27 22 34 8 79 65 57 59 49 15 524
16 14 138 16 7 17 13 19 57 51 69 58 54 14 764 10 13 9 9 9 4 6 16 11 28 11 20 7 419
17 3 155 19 16 11 26 12 49 45 50 36 27 5 475 4 9 21 7 2 5 2 34 39 38 39 33 3 291
18 0 42 13 2 11 2 4 24 20 18 18 19 0 341 0 0 0 0 1 0 0 10 8 10 9 11 0 218
19 0 283 17 7 7 9 5 93 87 76 64 52 0 686 1 33 21 22 25 10 5 95 56 53 51 46 0 449
21 0 8 0 0 0 0 0 29 34 34 38 46 0 302 0 0 0 0 0 0 0 50 37 38 47 55 0 372
22 0 154 18 16 12 17 17 56 54 53 60 43 2 226 0 16 8 11 14 16 0 71 57 34 44 38 4 220
23 0 69 1 1 2 1 1 16 32 33 38 21 0 893 2 6 2 1 2 1 0 12 21 15 12 13 1 279
23 1 113 7 6 11 8 9 50 59 47 57 48 1 382 1 13 3 2 7 6 2 40 40 37 41 50 3 173
24 0 171 50 31 20 35 15 85 81 86 69 94 0 551 1 21 16 6 14 6 0 29 43 42 42 31 3 318
25 23 124 33 26 34 29 31 42 45 38 41 39 11 500 0 0 0 0 1 2 4 16 12 12 5 10 4 303
26 0 149 7 12 7 7 6 49 42 35 38 36 0 350 1 5 7 8 7 4 0 25 15 22 11 23 0 159
27 1 148 22 23 18 8 13 40 37 54 33 44 0 477 1 8 10 4 7 10 0 30 23 33 30 31 0 215
28 0 91 5 4 1 4 5 59 50 56 37 43 3 658 27 38 24 30 35 42 12 54 52 48 50 49 0 430
30 0 50 8 4 8 2 9 33 28 36 28 31 0 153 0 2 15 4 15 11 0 22 15 29 21 22 0 106
31 0 159 79 52 51 37 50 101 81 74 71 73 5 540 2 20 10 9 17 17 1 34 24 14 9 31 0 121
32 3 67 2 2 4 5 1 27 18 22 14 24 4 147 0 3 4 0 4 0 1 17 15 19 11 11 1 33
33 2 430 22 14 11 13 20 74 64 93 77 71 1 812 4 50 22 9 44 15 1 90 74 59 47 58 1 629
34 1 133 17 14 12 8 10 60 54 69 100 84 0 666 0 18 10 17 11 10 4 56 42 29 42 31 0 202
36 1 205 12 28 37 27 17 85 106 93 123 102 27 680 26 43 26 28 37 31 10 99 108 125 94 78 42 674
38 4 387 7 11 14 13 12 46 63 76 55 81 2 480 4 16 14 11 10 14 3 76 47 64 60 67 4 228
40 0 316 38 33 25 22 27 112 71 126 93 86 0 264 0 23 32 26 14 19 0 107 87 74 70 74 1 140
41 0 121 11 6 3 3 1 26 21 14 17 20 0 142 0 2 1 2 1 3 0 13 28 19 15 18 0 91
222 42 0 268 1 4 8 40 38 46 25 31 19 50 0 110 0 5 23 6 19 20 0 47 28 23 16 14 0 49
0min post-SCS
1.4g vF 26g vF
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PinchPinchRat #
N
e
u
ro
n pre-SCS baseline
Brush
B
u
rs
t
1.4g 26g
220
221
213
214
217
218
219
 283 
 
Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 13 23 14 29 14 21 8 57 45 51 36 37 29 514 14 22 19 25 32 21 15 65 43 53 61 64 13 725
2 0 0 0 0 0 0 0 19 12 15 11 5 0 50 0 0 0 0 0 0 0 9 12 5 6 13 0 94
3 1 7 4 15 10 7 0 40 31 26 27 19 2 286 1 3 6 20 4 19 0 34 87 57 38 40 0 330
7 13 21 17 19 15 15 15 44 43 41 56 44 2 245 2 14 13 18 8 16 2 53 46 61 31 27 10 232
8 0 0 0 0 0 0 0 5 2 1 0 1 0 68 0 0 0 0 0 0 0 9 6 4 7 4 0 97
9 0 0 0 0 0 0 0 10 9 5 2 3 0 105 0 0 0 0 0 0 0 7 7 3 4 5 0 184
10 10 27 21 22 21 24 3 105 77 85 81 96 9 662 5 22 18 26 26 21 6 172 151 129 132 114 4 803
11 13 41 35 15 13 25 12 57 51 30 37 56 24 310 1 17 11 16 12 15 1 39 33 27 21 36 3 271
12 5 22 15 10 19 8 1 44 33 33 32 30 8 185 8 22 16 13 22 11 13 35 36 23 32 28 11 242
13 1 16 6 5 4 3 0 52 56 33 30 50 0 442 3 13 15 17 12 11 0 96 67 56 47 62 0 696
14 10 25 27 17 22 15 8 47 81 40 32 39 12 669 14 16 15 24 16 24 13 51 60 73 58 44 10 646
15 0 31 34 30 30 27 5 49 37 46 66 59 6 591 11 25 26 16 18 21 5 54 55 34 39 40 3 337
16 0 1 0 2 2 0 0 6 17 10 22 14 2 444 0 0 0 0 2 1 0 10 17 20 18 21 0 466
17 5 7 25 5 6 14 7 44 22 36 26 27 3 247 14 26 27 13 18 18 7 68 43 29 44 20 8 348
18 0 0 0 0 1 1 0 14 15 16 14 18 0 283 0 0 0 0 0 0 0 15 15 17 17 19 0 267
19 0 38 40 21 22 26 0 96 82 58 62 54 0 522 25 73 59 29 53 52 21 125 106 85 75 79 0 667
21 0 0 0 0 0 0 0 76 42 46 31 19 0 459 0 0 0 0 0 0 0 29 16 87 58 65 0 320
22 1 21 18 25 14 17 0 45 51 64 64 58 2 224 0 12 10 11 23 20 7 69 52 46 25 49 2 265
23 0 1 1 2 1 3 0 22 29 16 14 20 0 347 1 4 1 0 0 0 1 22 23 14 23 26 0 507
23 0 6 7 10 8 13 0 49 41 41 29 35 0 194 1 6 5 6 3 3 1 52 49 47 43 46 0 284
24 0 17 8 4 11 24 3 55 48 56 51 64 0 355 3 28 32 13 23 23 5 65 64 64 47 62 3 326
25 0 1 3 2 2 5 3 22 23 20 23 23 3 180 0 0 0 2 1 3 0 19 20 20 25 20 6 313
26 0 7 1 6 7 5 0 25 30 24 36 28 0 193 0 9 6 2 6 7 0 22 39 32 44 31 0 366
27 2 10 13 4 9 15 2 27 23 39 23 23 1 241 1 1 3 2 3 4 0 9 5 7 8 9 1 267
28 6 15 15 20 27 34 2 37 41 44 39 42 23 465 0 5 4 10 9 11 6 52 53 49 53 58 12 514
30 0 1 3 4 4 3 0 11 21 36 46 32 0 104 0 1 5 3 1 6 0 46 32 36 30 30 0 93
31 4 12 10 15 18 13 2 18 22 25 23 28 2 170 6 18 15 24 20 23 6 34 28 26 24 24 4 182
32 0 7 0 1 3 6 0 23 16 19 13 7 1 90 1 1 4 0 5 2 1 30 10 22 10 12 1 134
33 0 61 26 29 17 8 0 106 81 70 33 31 2 642 3 67 24 17 30 22 2 101 99 62 63 60 1 757
34 4 19 17 9 16 13 6 40 47 30 37 36 9 247 3 14 7 11 18 9 5 46 68 86 83 57 0 530
36 17 20 30 18 6 11 3 85 53 81 76 80 0 942 35 41 42 40 49 17 27 101 90 98 36 74 0 665
38 3 13 7 10 12 9 5 83 79 81 53 67 6 309 3 15 10 11 7 12 3 82 79 70 78 91 4 496
40 0 29 22 26 23 19 1 129 83 92 76 89 1 219 5 33 21 29 27 22 1 103 87 90 81 78 1 202
41 0 2 4 0 1 1 0 23 22 13 18 17 0 170 0 1 1 0 0 0 0 26 24 15 17 15 0 203
222 42 0 6 7 7 8 4 0 34 21 19 20 13 0 112 0 8 11 1 4 9 1 29 14 12 13 14 1 108
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 18 21 25 28 26 29 22 67 63 55 72 54 14 674 7 22 35 23 16 21 30 75 58 60 78 56 20 896
2
3 4 9 22 36 8 32 5 25 61 36 52 45 2 322 4 44 11 12 22 8 7 40 64 96 65 82 0 322
7 8 24 21 33 22 19 4 40 46 41 72 55 9 317 7 11 15 23 20 12 4 36 45 59 39 44 8 325
8 0 0 0 0 0 0 0 4 4 2 6 5 0 115 0 0 0 0 0 1 0 11 5 3 4 3 0 106
9 0 0 0 0 0 0 0 22 16 7 10 9 0 200 0 1 1 0 0 0 0 34 34 30 23 29 0 214
10 4 24 19 16 24 20 9 132 129 111 98 96 6 1188 1 32 24 16 21 22 6 179 135 132 125 116 10 1062
11 3 12 10 10 7 4 1 38 25 23 28 20 3 157 0 11 7 11 9 18 7 45 44 42 23 33 16 283
12 5 27 18 28 11 5 1 52 37 29 32 48 0 357 5 24 26 12 22 24 1 57 53 44 45 38 5 311
13 7 21 11 21 13 15 18 56 54 84 28 84 0 669 10 19 15 18 17 18 10 75 62 46 59 65 0 669
14 14 23 20 17 22 28 15 58 68 80 76 63 13 783 17 27 17 30 22 21 11 63 61 68 46 61 24 919
15 4 36 32 39 33 39 4 47 49 36 48 54 5 418 1 19 28 18 11 12 2 41 45 47 65 65 0 313
16 0 0 0 0 1 1 0 30 25 24 21 32 0 557 1 2 1 0 1 1 0 25 22 9 29 17 0 583
17 2 8 11 26 16 24 15 46 43 26 41 46 5 415 9 17 15 18 18 15 7 60 47 47 35 39 6 438
18 0 0 0 0 0 0 0 9 12 16 17 18 0 231 0 0 0 0 0 0 0 16 15 17 12 14 0 301
19 4 21 30 17 21 19 2 97 94 81 58 53 0 613 27 111 53 67 37 38 7 77 62 47 70 71 6 643
21 0 0 0 0 0 0 0 53 54 53 50 73 0 556 0 0 0 0 0 0 0 81 41 89 65 70 0 368
22 0 15 21 25 29 10 7 76 65 62 52 48 4 279 2 22 12 11 18 21 2 45 71 62 60 47 2 320
23 0 1 1 0 1 3 3 26 18 32 22 29 1 650 1 6 6 1 3 2 0 24 30 34 31 25 0 593
23 1 5 4 7 5 7 3 60 37 47 49 38 2 365 0 7 10 3 6 1 1 50 53 48 39 41 1 393
24 6 17 10 9 19 8 1 34 50 42 55 51 6 427 4 13 11 12 13 14 2 35 34 23 23 33 6 379
25 0 0 0 0 0 0 0 20 26 26 29 36 4 420 0 0 0 0 0 0 1 19 27 16 17 22 2 442
26 0 5 4 1 7 4 0 54 44 55 31 46 0 317 0 0 0 0 4 3 0 23 69 53 51 55 0 346
27 1 2 8 6 4 5 3 23 31 27 27 29 12 366 1 4 2 2 6 5 0 14 22 15 19 13 2 192
28 0 3 5 4 7 8 3 45 56 47 47 48 9 571 2 11 18 20 14 19 6 43 47 47 40 60 17 589
30 0 13 5 12 6 14 0 40 32 36 39 32 0 148 0 3 6 4 3 4 0 19 21 21 33 26 0 164
31 2 19 38 23 20 16 1 32 40 41 31 20 4 259 1 42 5 24 17 21 8 61 44 36 38 42 6 442
32 2 1 4 4 5 2 3 24 27 13 17 19 2 114 1 0 3 4 1 5 1 30 20 16 16 19 9 144
33 6 31 48 46 31 28 2 84 92 77 54 44 0 638 3 18 40 28 27 15 0 104 80 87 70 69 7 536
34 2 13 16 16 11 18 5 46 85 105 96 106 7 586 2 11 16 9 8 12 0 61 76 87 74 82 3 646
36 26 21 50 27 32 35 24 91 117 109 78 93 5 830 54 48 53 35 59 34 1 66 113 80 69 94 10 746
38 0 14 11 7 6 19 2 108 93 90 97 96 1 460 2 12 19 3 8 19 5 92 87 65 74 79 1 654
40 0 25 28 20 18 27 0 140 77 78 65 102 0 308 0 39 30 18 30 17 0 94 71 69 81 68 0 350
41 0 1 2 0 1 1 0 23 23 20 15 22 0 139 0 6 4 1 2 2 0 29 19 20 14 24 0 159
222 42 0 15 6 4 0 5 0 27 20 11 15 21 0 92 0 8 7 3 9 39 1 15 18 17 20 46 3 162
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 6 115 28 11 17 22 11 92 78 52 57 70 2 1034 2 7 2 8 7 5 7 41 49 23 17 35 4 441
3 7 44 11 12 22 8 40 64 96 65 82 0 322 3 23 34 3 6 4 2 22 28 39 42 20 0 167
5 0 0 0 0 0 0 0 22 14 9 8 25 0 157 0 0 0 0 0 0 0 20 8 18 2 3 0 73
6 0 227 19 22 20 14 18 38 46 65 62 53 0 234 2 30 45 43 27 31 4 39 72 39 61 54 3 216
7 9 165 18 23 17 20 23 33 43 52 35 50 6 146 0 3 5 2 6 5 1 13 9 7 9 3 2 46
8 0 1 0 0 0 0 0 13 12 11 14 14 0 172 0 0 0 0 0 0 1 1 3 4 3 6 0 45
9 0 0 0 0 0 0 0 34 34 30 23 29 0 271 0 0 0 0 0 0 0 19 10 9 9 5 0 180
10 5 179 6 8 10 11 7 33 47 35 56 32 6 318 9 17 15 22 7 18 10 39 30 42 41 38 4 254
11 0 19 3 3 2 2 1 47 38 37 37 32 0 209 0 1 7 3 7 1 0 38 27 19 18 34 0 57
12 4 99 36 34 20 20 23 45 43 40 30 37 1 398 4 19 15 12 14 13 2 57 42 34 38 31 2 309
13 0 13 1 0 0 1 1 46 60 42 48 60 0 846 1 5 2 2 4 1 2 46 36 25 29 35 0 458
14 12 190 30 35 26 19 22 56 85 102 86 74 16 832 15 14 17 22 18 24 14 75 56 98 85 86 24 644
15 7 384 54 49 47 47 47 94 116 101 108 118 19 1104 11 56 64 63 42 54 21 98 115 69 92 78 22 595
16 2 104 5 6 4 2 3 65 65 68 56 54 4 949 2 3 2 0 4 4 1 38 35 30 36 29 2 613
17 4 367 28 39 20 17 35 72 55 46 54 33 7 372 4 20 7 19 10 8 1 46 38 38 32 41 2 307
19 9 335 41 35 41 32 33 89 64 79 60 71 4 764 1 31 17 19 15 15 0 50 33 36 40 40 0 425
20 2 96 37 37 29 24 38 63 75 55 73 55 0 210 0 22 14 31 14 16 0 57 55 67 54 53 0 60
21 0 31 41 30 37 12 44 98 95 91 69 130 0 450 0 0 0 9 1 0 0 61 57 49 63 26 0 552
22 1 269 17 17 32 36 16 56 57 61 59 45 0 296 2 19 15 39 21 16 4 52 58 40 42 45 2 173
23 0 57 0 3 2 1 1 29 39 30 28 29 1 692 0 4 2 1 1 0 0 12 11 10 16 7 0 334
23 0 121 5 3 9 6 9 56 56 55 46 45 0 420 0 10 8 5 1 5 0 39 48 44 26 30 0 240
24 6 149 29 26 36 28 22 51 36 42 48 43 12 307 3 7 7 5 11 8 3 10 19 23 22 27 7 261
25 9 106 9 10 5 14 15 60 40 31 44 45 5 374 1 5 5 3 11 19 12 32 36 38 38 28 23 431
26 0 71 3 2 5 1 3 50 44 51 29 36 0 278 0 6 8 6 5 4 0 43 52 33 25 30 2 180
27 0 170 6 10 9 8 11 36 27 35 58 58 1 459 2 6 11 8 14 11 3 47 49 50 49 61 0 222
28 2 76 10 7 6 12 14 56 55 56 49 60 2 671 0 11 8 19 20 28 14 42 46 39 41 41 2 448
29 0 43 4 3 4 2 2 10 7 12 9 9 0 408 1 1 3 0 3 2 0 12 7 7 6 6 0 372
30 0 102 3 4 3 4 1 27 27 24 23 22 0 146 3 5 4 6 5 6 0 35 13 26 30 19 0 76
31 4 190 29 13 30 19 23 48 36 42 44 54 3 330 0 22 23 18 25 14 5 42 40 35 29 39 2 269
32 0 34 3 2 2 3 4 26 16 19 19 16 0 85 0 1 4 2 7 3 0 16 15 5 5 15 0 23
33 2 454 54 25 20 18 25 92 85 89 58 64 1 684 8 40 19 24 14 11 0 79 78 51 41 60 4 641
34 0 119 11 10 7 24 3 42 46 38 16 28 0 338 0 18 20 13 6 14 0 28 22 17 19 12 0 115
36 0 221 10 15 9 11 5 60 52 56 61 71 1 776 4 30 25 12 9 16 3 45 69 63 57 52 0 352
37 0 9 0 0 1 0 2 64 76 56 60 51 0 672 0 0 0 0 0 0 0 47 45 46 57 46 0 604
38 3 250 10 6 5 9 14 81 77 91 107 100 3 932 2 15 19 12 16 13 2 95 76 52 85 67 6 401
40 0 185 10 11 15 14 17 64 68 48 62 62 0 228 1 25 8 12 13 15 1 69 27 49 50 62 0 156
41 0 99 0 0 0 1 1 23 13 17 13 17 0 190 0 0 0 0 1 0 0 17 20 19 9 23 0 98
222 42 0 325 4 6 5 4 4 34 31 22 27 25 0 232 1 16 4 1 3 4 0 28 18 14 8 11 0 62
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Note – Table is continued on the next page. 
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 4 11 11 11 5 5 3 37 40 30 38 36 7 543 3 11 14 10 13 10 6 65 78 53 53 45 8 698
3 0 4 3 4 2 2 1 23 21 19 24 22 0 99 4 8 2 11 5 11 0 22 21 34 23 19 0 122
5 0 0 0 0 0 0 0 19 17 11 10 12 0 95 0 0 0 0 0 0 0 10 6 13 5 16 0 195
6 5 34 27 27 27 46 3 44 56 63 40 46 4 273 9 31 17 16 19 33 7 68 76 49 31 66 11 157
7 0 7 7 6 6 5 1 10 8 12 11 11 4 59 1 2 6 5 4 1 2 24 31 11 19 14 3 78
8 0 0 0 0 0 0 0 2 6 7 4 5 0 44 0 0 0 0 0 0 0 2 9 2 5 1 0 130
9 0 0 1 0 0 0 0 22 20 15 14 11 0 135 0 1 0 0 1 0 0 18 12 9 6 11 0 199
10 1 14 15 17 18 14 6 29 43 33 36 35 6 266 5 21 15 13 12 9 5 38 36 33 29 30 20 361
11 0 12 8 16 8 7 0 33 43 34 29 25 0 70 0 12 13 7 7 17 0 51 39 29 33 26 0 170
12 3 26 18 12 12 30 5 62 56 54 40 36 7 269 2 5 19 17 14 19 5 42 31 44 36 33 3 246
13 0 2 2 1 2 1 2 45 34 50 50 18 0 404 0 6 6 2 3 6 0 46 36 46 58 63 0 655
14 11 26 32 21 23 16 14 100 64 92 72 78 14 852 22 34 26 32 27 27 20 74 91 85 79 78 28 991
15 24 60 63 42 39 43 14 96 74 69 64 68 20 550 5 52 33 41 54 48 13 80 70 78 64 68 11 673
16 3 1 0 2 4 0 0 29 39 45 32 23 3 604 1 0 1 0 2 1 1 39 44 45 45 42 1 645
17 5 9 11 7 10 10 2 43 39 27 12 13 8 302 6 15 29 44 17 15 1 66 40 38 35 26 1 340
19 0 21 42 27 24 20 1 86 79 63 49 50 1 416 0 457
20 0 36 38 38 29 39 0 48 56 59 62 59 0 67 1 43 53 46 30 38 0 67 65 74 75 71 1 193
21 0 0 2 7 9 4 0 89 58 8 62 89 0 557 0 38 35 37 2 6 0 69 19 23 51 42 0 490
22 0 12 16 8 12 18 0 65 68 53 74 44 6 257 1 7 7 20 15 11 1 52 66 53 48 48 1 220
23 1 1 1 2 0 1 0 18 16 13 20 12 1 405 0 3 2 0 1 0 0 17 23 6 29 16 0 559
23 1 5 4 5 3 4 3 51 39 29 24 36 1 227 1 4 9 4 5 8 1 43 39 32 39 48 0 304
24 4 6 11 10 9 2 1 31 27 16 32 16 3 222 3 9 6 4 4 10 5 28 32 23 33 40 1 252
25 3 12 8 14 27 14 5 25 28 38 26 27 21 328 1 1 1 1 1 3 8 32 24 24 27 27 3 381
26 1 12 2 14 1 9 0 55 50 43 37 52 0 290 1 16 8 6 19 4 1 54 52 46 41 38 1 383
27 0 12 5 6 15 7 4 37 41 36 31 37 0 401 11 21 15 8 9 10 2 39 42 40 38 50 3 511
28 0 9 29 34 39 28 4 46 37 37 52 43 26 452 3 8 8 16 22 25 18 48 38 45 45 43 33 617
29 0 2 5 3 3 3 0 12 6 11 23 15 1 338 1 2 1 2 3 3 0 10 8 31 27 32 1 378
30 0 2 4 5 6 5 0 33 33 35 31 30 1 162 0 6 4 4 4 9 0 39 27 24 33 37 0 203
31 6 34 27 23 25 34 2 65 64 41 45 46 7 355
32 0 4 4 2 4 3 0 11 9 19 12 23 0 43 3 2 4 1 3 2 0 16 18 16 14 11 0 129
33 2 25 33 15 28 15 1 79 97 55 30 39 7 520 2 33 36 37 31 20 8 99 86 81 71 71 5 689
34 0 10 9 13 10 13 0 25 38 22 26 32 0 189 0 11 15 14 12 10 3 35 21 21 24 23 0 308
36 29 53 27 30 32 32 20 58 82 91 40 80 2 553 6 24 17 26 20 4 3 54 55 61 36 52 0 600
37 0 0 0 0 0 0 0 51 53 52 51 41 0 504 0 0 0 0 0 0 0 50 63 42 38 50 0 545
38 3 12 20 35 48 26 2 97 68 78 83 101 37 486 6 6 14 8 22 8 3 76 71 69 88 64 2 574
40 0 24 11 16 17 18 0 97 32 29 41 49 0 176 0 29 17 21 21 25 0 104 67 43 55 70 0 257
41 0 1 0 3 2 1 0 22 18 16 17 19 0 94 1 4 3 1 2 1 0 32 23 19 19 25 0 135
222 42 1 7 4 5 6 2 1 25 15 14 13 8 0 106 0 20 8 12 1 41 0 35 19 14 26 28 0 129
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Note – Missing data points are from neurons that were lost during recording before 
completing the stimulation protocol. 
  
BL 1 2 3 4 5 BL 1 2 3 4 5 BL BL 1 2 3 4 5 BL 1 2 3 4 5 BL
1 10 10 13 20 9 15 6 62 56 52 72 59 12 923 7 11 22 8 20 14 12 72 63 58 51 41 16 761
3 1 6 6 2 3 3 6 14 16 24 33 14 0 150 0 8 10 6 9 4 0 20 10 9 11 10 0 161
5 0 0 0 0 0 0 0 21 14 17 10 18 0 140 0 0 0 0 0 0 0 17 17 9 14 18 0 172
6 1 15 16 26 16 17 6 28 21 29 25 27 14 121 0 17 16 13 22 19 0 28 29 32 41 46 23 205
7 1 4 8 7 6 8 3 20 10 7 3 10 4 89 2 1 4 2 4 0 0 12 13 9 7 7 2 37
8 1 1 0 0 1 1 0 6 10 8 4 5 6 143 0 0 0 0 0 0 0 1 0 1 2 0 0 90
9 0 0 1 0 0 0 0 16 11 12 12 11 0 257 0 1 0 0 0 0 0 24 16 7 13 16 0 255
10 2 14 11 11 8 10 2 27 22 27 24 14 6 258 4 13 9 13 10 11 1 27 28 40 27 39 5 286
11 0 22 31 51 50 27 0 45 59 35 34 39 0 198 0 36 22 21 21 12 0 75 45 35 46 41 0 222
12 2 22 17 22 10 12 2 48 32 16 37 26 4 248 1 5 18 11 8 3 0 35 27 29 24 46 2 328
13 9 17 10 10 18 11 10 67 56 74 86 61 0 729 17 33 15 25 20 16 13 95 93 45 69 74 0 773
14 17 28 45 29 43 30 20 57 64 45 67 74 18 807 25 34 32 30 31 17 9 85 70 89 90 55 9 930
15 6 41 37 43 42 45 5 95 88 69 73 56 17 595 3 28 41 30 33 43 11 67 61 57 52 68 6 515
16 1 3 1 0 0 1 0 41 51 35 51 47 1 607 1 0 0 0 1 0 0 37 20 33 28 27 1 666
17 4 29 15 13 13 20 0 41 38 21 23 32 2 379 22 35 53 21 28 22 4 59 51 118 48 77 0 580
19
20 0 36 40 28 20 26 0 69 61 63 55 53 0 192 0 32 44 42 32 25 1 79 67 62 71 50 3 107
21 0 32 23 7 36 17 0 41 32 44 70 45 0 300 0 31 25 28 4 39 0 52 82 26 83 80 0 461
22 2 16 12 9 22 18 0 61 66 59 49 70 6 313 3 9 11 17 16 25 0 52 62 57 64 56 2 254
23 18 20 18 20 20 9 12 29 21 18 17 24 18 1050 3 1 3 13 5 2 2 19 22 23 21 17 7 965
23 0 7 7 5 12 9 1 46 46 32 40 39 0 490 0 11 7 11 5 6 2 57 66 45 49 44 0 449
24 2 9 13 23 13 21 3 27 42 51 43 46 3 240 4 18 16 16 18 12 2 41 34 35 36 38 3 381
25 0 2 1 2 1 4 4 23 25 21 25 29 7 450 14 18 24 21 19 18 19 33 47 46 47 47 11 484
26 7 8 31 20 5 12 0 58 60 42 53 53 1 446 0 3 4 2 3 2 0 41 53 33 41 42 3 377
27 1 7 10 9 5 11 3 41 52 37 66 43 2 492 7 22 17 11 16 12 1 49 32 31 34 41 4 633
28 2 1 6 3 9 9 6 40 49 45 37 42 23 604 4 5 6 6 5 10 0 35 40 32 37 45 10 402
29 2 8 7 17 7 8 2 24 14 20 22 17 0 188 5 12 22 11 20 19 7 21 35 26 33 19 5 333
30 0 4 6 2 8 2 0 22 26 23 23 37 2 109 0 1 0 0 0 1 0 24 29 20 17 24 1 154
31
32 4 3 2 2 1 1 1 19 30 20 12 10 7 149 2 1 1 5 2 1 0 22 17 13 19 17 2 122
33 0 18 13 26 34 37 5 83 83 61 82 59 8 714 2 63 25 29 41 16 5 67 90 109 75 70 6 781
34 1 12 22 21 18 11 1 55 59 67 63 52 0 601 6 39 17 14 11 12 2 57 39 59 80 92 2 265
36 6 22 33 12 9 13 5 64 55 43 56 51 2 523 31 44 39 50 29 36 27 65 73 66 72 55 0 549
37 0 0 0 0 0 0 0 50 64 55 66 67 0 423 0 0 0 0 0 0 0 18 19 15 37 37 0 340
38 2 12 11 14 12 12 4 57 74 68 55 62 1 432 5 10 9 10 14 5 1 86 61 57 65 67 1 607
40 0 27 22 13 13 9 0 107 42 61 53 61 0 276 0 32 21 26 26 29 0 149 97 112 92 77 0 253
41 0 2 0 0 1 2 0 14 26 23 25 15 0 243 0 3 2 1 1 4 0 26 24 27 22 19 0 163
222 42 1 17 17 1 3 7 3 16 13 10 13 9 1 175 3 6 0 5 10 6 0 45 20 30 22 21 0 118
N
e
u
ro
n 10min post-SCS 15min post-SCS
1.4g 26g Pinch 1.4g 26g Pinch
To
n
ic
213
214
217
218
219
220
221
M
o
d
e
Rat #
 288 
 
APPENDIX E 
 
Customized Matlab Codes 
 
 
This appendix includes the Matlab codes that were used in the studies throughout 
this thesis. A Matlab code was used for densitometric quantification of fluorescent 
immunolabeling in the studies in Chapters 4 and 5 (Section E.1). This code requires that 
all images be located in the same file directory. Prior to running this script, the detection 
threshold (0-255) should be defined separately for both the red and green channels based 
on the threshold to detect positive labeling in tissue from naïve rats. The code detects all 
of the pixels that exceed those defined threshold in the red and green channels, and also 
identifies pixels with colocalized red and green labeling. The code generates an Excel file 
containing the filenames of each image. The output variables can be manually copied and 
pasted from the Matlab Variable Editor into the Excel file to correlate each image 
filename with the fraction of positively-labeled red, green, and colocalized pixels in that 
image. 
Section E.2 details the code used to generate the maximum intensity projections 
(MIP) from each set of three images in confocal image stacks of spinal cord sections 
labeled with synaptic markers. This code was used for the studies in Chapter 5. Image 
stacks should be contained in sequentially named folders (i.e., stack1, stack2, stack3, etc). 
The code loads all images within a stack folder using the naming convention “image#” 
(i.e., image1, image2, image3, etc). If the image stacks or image files are named using a 
different convention, the code should be altered at the indicated lines in Section E.2 in 
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order to recognize the image stack folders and image filenames. The code loads each set 
of three images and separately compares the pixel intensity in the three images at each 
pixel location in each channel. A new image is constructed by taking the highest-intensity 
red and green pixels at each pixel location from the three constituent images, and the 
resulting MIP is saved with a new filename. 
Section E.3 includes the Matlab code used to quantify the percent area of tissue in 
immunolabeled spinal cord sections for studies in Chapter 5. The code allows a user to 
iteratively set a threshold to create a black and white mask that discriminates 
immunolabeled tissue (white) from holes, gaps, and unlabeled regions in the image 
(black). The code then quantifies the fraction of pixels in the image that represents 
immunolabeled tissue, and outputs the result to the Matlab workspace.  
 
E.1 Densitometry Code 
 
clear all; 
close all; 
 
%Identify and load images based on common prefix 
D = dir('*.tif');  
IPfname = 'NDC_TSP4_GFAP_07-9-13'; 
OPfile = strcat(IPfname, '.xls'); 
fid = fopen(OPfile, 'w'); 
  
%Set thresholds for red and green channels 
red_thresh = 115; 
green_thresh = 165; 
% higher value corresponds to more positive pixels 
h1 = waitbar(0,'Please wait...'); 
  
for k=1:length(D); 
    %Read file in 
    file=D(k).name; 
    %Load the image 
    imag_orig = imread(file);  
    imag_red = imag_orig(:,:,1);%grab the green/red labeled image 
    imag_green = imag_orig(:,:,2);%grab the green labeled image   
    %Take the inverse of the image 
    imag_red = uint8(-double(imag_red) + 255); 
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    imag_green = uint8(-double(imag_green) + 255);     
    %Calculate number of pixels 
    [a b]=size(imag_red); 
    tsize=a*b;     
    low=double(min(imag_red(:))); 
    high=double(max(imag_red(:))); 
    whiteSpace = 0.85*high;  
 
 
    %calc percent of positive pixels in tissue for red signal 
    backg=sum(sum(imag_red > whiteSpace)); 
    posp=sum(sum(imag_red < red_thresh)); 
    red_avg(k)=mean(imag_red(imag_red<red_thresh)); 
    percpos(k)=  posp/(tsize-backg); 
     
    %calc percent of positive pixels in tissue for green signal 
    backg_green=sum(sum(imag_green > whiteSpace)); 
    posp_green=sum(sum(imag_green < green_thresh)); 
    percpos_green(k) = posp_green/(tsize-backg_green); 
    green_avg(k)=mean(imag_green(imag_green<green_thresh)); 
     
     
    %map out pos and neg pixels 
    pmap_red=(imag_red < red_thresh); 
    nmap=(imag_red > whiteSpace); 
    pmap_green = (imag_green < green_thresh); 
     
    %make positive pixels  green, and background pixels blue 
    imag1(:,:,1) = zeros(a,b); 
    imag1(:,:,2) = pmap_red; 
    imag1(:,:,3) = zeros(a,b); 
    imag2(:,:,1) = zeros(a,b); 
    imag2(:,:,2) = pmap_green; 
    imag2(:,:,3) = zeros(a,b); 
     
     
    %Create a new image for the co-localization 
    [R, C] = find(pmap_red == 0);% 
    imag_co = imag2; 
    for ind = 1:length(R) 
        imag_co(R(ind),C(ind),2) = 0; 
    end 
     
    %calculate the number of green positive pixels relative to total 
    %number of pixels that express red(gfap/map2, etc.) 
    tot_green(k) = length(find(pmap_green == 1)); 
    tot_co(k) = length(find(imag_co(:,:,2) == 1)); 
    col_per_red(k) = tot_co(k)/posp; %amount col per red area 
    perc_co(k) = tot_co(k)/(tsize-backg_green); 
     
    %Print name of image in Excel file 
    fprintf(fid, '%s \n', D(k).name); 
     
    %Image the red and green channels with positive pixels 
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    imag_red_channel = imag_orig; 
    imag_red_channel(:,:,2:3)=0; 
    imag_green_channel = imag_orig; 
    imag_green_channel(:,:,[1,3])=0; 
    figure; image(imag_red_channel) 
    figure; image(imag1) 
    figure; image(imag_green_channel) 
    figure; image(imag2) 
 
     
    %saveas(h, ['colocalize-' D(k).name], 'jpg') 
    waitbar(k/length(D)) 
    clear imag imag1 imag2 R C    
end 
 
%Format output to copy and paste into Excel file 
out1=percpos_green';  %overall fraction green pixels 
out2=percpos';   %overall fraction red pixels 
out3=perc_co';   %overall fraction colocalized pixels 
out4=col_per_red';   %colocalized pixels as fraction of red-positive 
close(h1) 
status = fclose(fid); 
 
 
E.2 Create Maximum Intensity Projections from Confocal Image Stacks 
 
for k=1:INSERT NUMBER OF STACKS 
     
    %name of folder containing image stack MODIFY STACK NAMES HERE: 
    foldername=['stack', num2str(k)];  
 
%set working file directory to the location of the image stack     
cd(['E:\Nate\Imaging and Staining\synapse counting\BPD4 synapses\', 
foldername])     
  
%specify image naming convention (* = wildcard character so that the 
directory function (dir) will locate all filenames containing “image” 
followed by any other character or number) MODIFY IMAGE NAMES HERE: 
di = dir('image*.tif'); 
 
%load all images from image stack (comment out lines if stack is fewer 
than 12 images)  
A = imread(di(1).name); 
B = imread(di(2).name); 
C = imread(di(3).name); 
D = imread(di(4).name); 
E = imread(di(5).name); 
F = imread(di(6).name); 
G = imread(di(7).name); 
H = imread(di(8).name); 
I = imread(di(9).name); 
J = imread(di(10).name); 
K = imread(di(11).name); 
L = imread(di(12).name); 
 292 
 
MIParray1 = zeros(size(A)); 
MIParray2 = zeros(size(A)); 
MIParray3 = zeros(size(A)); 
MIParray4 = zeros(size(A)); 
 
%select the pixel at each coordinate location with the highest 
intensity from among the 3 constituent images 
for i=1:3 
    for j=1:size(A,1) 
        for k=1:size(A,2) 
            MIParray1(j,k,i) = max([A(j,k,i) B(j,k,i) C(j,k,i)]); 
            MIParray2(j,k,i) = max([D(j,k,i) E(j,k,i) F(j,k,i)]); 
            MIParray3(j,k,i) = max([G(j,k,i) H(j,k,i) I(j,k,i)]); 
            MIParray4(j,k,i) = max([J(j,k,i) K(j,k,i) L(j,k,i)]); 
        end 
    end 
end 
  
MIPimg1 = uint8(MIParray1); 
MIPimg2 = uint8(MIParray2); 
MIPimg3 = uint8(MIParray3); 
MIPimg4 = uint8(MIParray4); 
imwrite(MIPimg1,'MIP_um1.tif','tif','compression','none') 
imwrite(MIPimg2,'MIP_um2.tif','tif','compression','none') 
imwrite(MIPimg3,'MIP_um3.tif','tif','compression','none') 
imwrite(MIPimg4,'MIP_um4.tif','tif','compression','none') 
  
clearvars -except k 
close all 
end 
 
E.3 Quantify the Percentage of Tissue Area in Immunolabeled Sections 
 
%specify the filenames of each maximum intensity projection for which 
the tissue area will be quantified  
names=['MIP_um1.tif'; 'MIP_um2.tif'; 'MIP_um3.tif']; 
file = names(k,:);     
t=imread(file); 
 
%Load image and follow command line prompts to interactively choose 
threshold for detection of tissue area 
if k==1 
    trig=0; 
    while trig==0; 
        close all 
        bwthresh=input('select b/w threshold (start at 0.06): '); 
        tt=im2bw(t,bwthresh); %adjust BW threshold based on image 
brightness to get good mask 
        figure; 
        subplot(1,2,1),imshow(t) 
        subplot(1,2,2),imshow(tt) 
        trig=input('0 to reset baseline, 1 to move on: '); 
    end 
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else 
    tt=im2bw(t,bwthresh); 
%     figure; 
%     subplot(1,2,1),imshow(t) 
%     subplot(1,2,2),imshow(tt) 
end 
  
%% Find regions with area and all pixels in each region 
S=regionprops(tt,'Area','PixelList'); 
c=struct2cell(S); 
A=(cell2mat(c(1,:)))'; 
  
%Find regions with pixel count under threshold and fill in as 
background 
thresh1=100; 
fill1=tt; 
for i=1:numel(A) 
    if A(i)<thresh1 
        pix=c{2,i}; 
         
        for j=1:size(pix,1) 
            fill1(pix(j,2),pix(j,1))=0; 
        end 
    end 
end 
  
%Invert image and repeat filling process for tissue areas 
ttt=imcomplement(fill1); 
S2=regionprops(ttt,'Area','PixelList'); 
c2=struct2cell(S2); 
A2=(cell2mat(c2(1,:)))'; 
  
thresh2=100; 
fill2=ttt; 
for i=1:numel(A2) 
    if A2(i)<thresh2 
        pix=c2{2,i}; 
         
        for j=1:size(pix,1) 
            fill2(pix(j,2),pix(j,1))=0; 
        end 
    end 
end 
 
tissArea(k)=bwarea(imcomplement(fill2))/numel(fill2); 
  
figure; 
subplot(2,2,1),imshow(t) 
subplot(2,2,2),imshow(tt) 
subplot(2,2,3),imshow(imcomplement(fill2)) 
%Read out threshold value and tissue area percentage 
bwthresh  
tissArea   
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APPENDIX F 
 
Protein Quantification in the DRG and Spinal 
Cord using Western Blot 
 
 
This appendix itemizes the quantification of proteins from the dorsal root ganglia 
(DRG) and spinal cord tissue for the studies using Western blot in Chapters 4 and 5. 
Table F.1 details the quantification of proteins in the spinal cord tissue from the rats that 
underwent sham or painful facet joint injury followed by intra-articular injections of 
bupivacaine (BP) or a saline vehicle (VEH) in the studies presented in Chapter 4. 
Injections were administered immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at day 
4 (inj-BPd4, inj-VEHd4, sham-VEHd4) after injury. Quantified proteins included 
glutamatergic signaling proteins (ERK, pERK, NR1, pNR1, mGluR5, GLAST, GLT1) 
and glial fibrillary acidic protein (GFAP) as an indicator of astrocyte activation. The 
levels of each protein in each rat were normalized to β-tubulin to control for the amount 
of protein loaded for each sample, and then normalized to the average of the sham group 
for each treatment time point. 
Quantification of β-tubulin, TSP4, and TSP4 normalized to the average of the 
sham group in the DRG and spinal cord at days 1 and 7 after sham or painful facet joint 
injury are summarized in Table F.2 (for studies in Chapter 5). Similarly, Table F.3 
includes the quantification of β-tubulin TSP4 in the spinal cord at day 7 after painful 
facet joint injury with daily administration of TSP4 antisense or mismatch 
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oligonucleotides, for studies that are also included in Chapter 5. Table F.3 also includes 
TSP4 normalized to the average of the group receiving mismatch oligonucleotides. 
 
Table F.1. Western blot quantification of glutamatergic signaling proteins and 
GFAP on day 7 for bupivacaine treatment study, normalized to sham for each 
treatment time point (Chapter 4). 
 Rat # ERK pERK NR1 pNR1 mGluR5 GLAST GLT1 GFAP 
inj-BP0h 
41 1.20 0.80 0.61 0.33 0.92 1.11 0.75 1.23 
42 0.54 1.52 0.87 0.36 1.52 1.27 0.84 2.36 
43 0.80 0.89 0.68 1.43 1.41 1.00 1.02 1.17 
46 0.79 0.84 1.14 n/a 0.71 0.21 0.84 2.12 
49 1.29 n/a 1.63 0.17 0.67 0.60 n/a 2.65 
51 0.77 0.63 0.76 0.13 1.26 0.63 0.73 1.92 
inj-VEH0h 
45 0.83 0.72 0.65 8.11 1.58 1.88 0.67 1.85 
48 0.77 1.58 0.87 1.32 1.15 1.60 0.78 1.75 
50 0.63 3.44 1.10 n/a 1.15 0.93 n/a 2.62 
52 0.75 1.95 1.25 2.99 1.66 1.44 0.66 2.27 
53 1.04 2.02 1.33 7.63 1.86 1.62 0.76 2.06 
54 0.90 1.76 1.29 5.62 2.14 1.64 0.46 2.16 
72 0.90 1.51 1.33 1.01 1.90 1.30 0.38 1.40 
sham-VEH0h 
78 0.88 0.71 1.33 0.05 0.98 1.20 n/a 1.14 
79 n/a 1.23 0.95 0.07 0.83 0.79 n/a 0.77 
80 0.96 0.53 1.10 0.30 0.90 0.97 0.90 0.79 
81 0.67 0.61 1.25 0.17 1.29 0.88 1.32 0.90 
133 1.10 1.16 0.53 2.05 n/a n/a 0.94 1.05 
134 1.39 1.75 0.84 3.36 n/a 1.16 0.84 1.35 
inj-BPd4 
53a 0.95 1.19 1.74 1.35 1.38 2.18 0.36 1.33 
56 0.87 n/a 0.58 1.21 1.41 2.07 0.35 1.03 
63 1.06 2.24 1.17 1.59 1.90 3.02 0.66 1.95 
64 1.05 1.32 0.58 1.22 1.71 1.90 0.35 1.03 
70 1.27 1.49 0.85 1.92 1.68 1.96 0.52 1.09 
inj-VEHd4 
52a 1.12 1.05 0.88 1.43 1.28 2.74 0.57 1.06 
54a 0.80 1.63 0.90 0.68 1.59 2.02 0.24 1.04 
65 1.20 1.52 2.06 1.45 1.53 3.75 0.19 1.39 
66 1.31 1.73 0.62 2.46 2.45 3.30 0.25 2.05 
67 1.34 1.36 1.99 n/a 2.48 3.19 0.54 1.17 
69 1.09 2.83 1.15 1.51 1.74 3.98 0.25 2.06 
71 n/a 1.17 n/a 1.75 n/a 2.46 n/a 1.27 
sham-VEHd4 
132 0.85 0.99 1.86 0.96 0.70 0.62 0.53 0.86 
135 1.08 1.79 0.79 1.55 0.98 1.18 0.95 1.01 
136 1.25 0.52 0.76 1.21 1.28 1.12 0.93 1.19 
137 0.99 0.73 0.60 1.01 1.04 1.34 1.03 1.28 
138 0.93 0.92 0.38 0.84 0.92 0.84 1.16 0.81 
139 0.98 1.26 0.75 0.75 1.01 1.01 1.20 0.96 
140 0.92 0.80 1.86 0.68 1.07 0.90 1.19 0.89 
n/a = data not collected due to inconsistent protein transfer pattern 
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Table F.2. Western blot quantification of DRG and spinal TSP4 on day 7 after sham 
or painful facet joint injury (Chapter 5). 
  Group Rat # β-tubulin TSP4 
TSP4 Normalized to 
Average of Sham for Each 
Time Point 
DRG D1 
Injury 273 38.44 0.29 0.45 
Injury 278 46.17 0.18 0.23 
Injury 279 38.51 0.33 0.52 
Injury 280 41.97 0.63 0.90 
Injury 287 35.67 0.23 0.39 
Injury 292 38.44 0.40 0.63 
Injury 296 41.89 0.58 0.83 
Sham 274 29.85 0.50 1.01 
Sham 275 33.73 0.80 1.43 
Sham 281 37.21 0.35 0.57 
Sham 293 28.91 0.57 1.19 
Sham 300 33.64 0.45 0.81 
DRG D7 
Injury 249 54.63 1.53 0.42 
Injury 254 37.32 0.64 0.25 
Injury 255 44.32 0.79 0.26 
Injury 264 53.57 1.43 0.40 
Injury 265 40.29 2.27 0.84 
Injury 266 41.19 2.35 0.85 
Injury 268 49.95 1.83 0.54 
Injury 271 44.70 0.39 0.13 
Sham 253 36.27 4.07 1.67 
Sham 256 39.55 3.91 1.47 
Sham 257 36.58 1.53 0.62 
Sham 262 36.58 3.36 1.36 
Sham 263 26.97 1.17 0.64 
Sham 267 28.73 0.46 0.24 
Spinal 
Cord D1 
Injury 273 29.60 21.60 0.99 
Injury 278 29.00 27.30 1.28 
Injury 279 28.60 26.40 1.26 
Injury 280 29.70 26.90 1.23 
Injury 287 29.70 24.60 1.13 
Injury 292 30.70 27.70 1.23 
Injury 296 31.00 29.20 1.28 
Injury 299 26.90 25.10 1.27 
Sham 272 25.50 22.80 1.22 
Sham 274 22.00 18.30 1.13 
Sham 275 27.80 18.20 0.89 
Sham 281 27.50 15.40 0.76 
Sham 293 29.20 17.50 0.82 
Sham 300 32.60 28.20 1.18 
Note – Table is continued on the next page. 
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  Group Rat # β-tubulin TSP4 
TSP4 Normalized to 
Average of Sham for Each 
Time Point 
Spinal 
Cord D7 
Injury 248 17.92 1.97 1.54 
Injury 254 18.65 1.48 1.11 
Injury 255 21.54 1.53 1.00 
Injury 264 20.26 0.31 1.34 
Injury 265 18.76 0.38 1.78 
Injury 268 22.70 0.34 1.31 
Injury 271 19.25 0.36 1.64 
Sham 252 17.93 1.31 1.02 
Sham 253 15.06 1.41 1.31 
Sham 256 17.76 1.20 0.95 
Sham 257 19.95 1.29 0.91 
Sham 262 7.11 0.04 0.49 
Sham 263 15.28 0.21 1.20 
Sham 267 20.21 0.20 0.87 
Sham 270 16.21 0.23 1.24 
 
 
Table F.3. Western blot quantification of spinal TSP4 on day 7 after painful facet 
injury with administration of antisense or mismatch oligonucleotides (Chapter 5). 
 
Rat # β-tubulin TSP4 
TSP4 Normalized to 
Average of Mismatch 
Injury + TSP4 
Antisense 
Oligonucleotides 
229 18.21 0.35 0.60 
231 20.43 0.58 0.88 
236 18.94 0.34 0.56 
237 25.54 0.68 0.83 
241 23.91 0.35 0.46 
Injury + TSP4 
Mismatch 
Oligonucleotides 
232 21.92 0.37 0.53 
233 17.79 0.74 1.30 
234 20.15 0.79 1.22 
238 25.24 0.87 1.07 
239 24.15 0.82 1.06 
240 26.70 0.71 0.83 
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APPENDIX G 
 
Quantification of Immunolabeled Proteins in the 
Spinal Cord  
 
 
This appendix summarizes the quantification of immunolabeled proteins in the 
spinal cord in the studies presented in Chapters 4 and 5. Immunolabeling was quantified 
by densitometry using a custom Matlab code (see Section E.1 of Appendix E), and data 
in each table are presented as the fraction of positively-labeled pixels in each image. In 
each table, images are identified by the group, rat number, and image number that 
includes the side of the spinal cord (L or R for the left or right side) and the tissue section 
number (consecutive sections were numbered 1-6 on each slide). Table G.1 details the 
quantification of phosphorylated NMDA receptor subunit NR1 (pNR1), metabotropic 
glutamate receptor mGluR5, and glial fibrillary acidic protein (GFAP). Proteins were 
quantified in the superficial dorsal horn at day 7 after sham or painful facet joint injury 
followed by intra-articular bupivacaine (BP) or saline vehicle (VEH) injections either 
immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at day 4 (inj-BPd4, inj-VEHd4, 
sham-VEHd4) after injury, in the studies presented in Chapter 4. Figure G.1 presents 
representative images of spinal dorsal horns labeled for mGluR5 and GFAP, and Figure 
G.2 presents representative images of spinal dorsal horns labeled for pNR1 and GFAP 
from each rat in each group. 
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Tables G.2 and G.3 summarize the quantification of thrombospondin-4 (TSP4), 
GFAP, and colocalized TSP4 and GFAP (Coloc) in the superficial dorsal horn (DH), 
dorsal columns, and deep dorsal horn in the studies presented in Chapter 5. Table G.2 
presents the quantification of TSP4 and GFAP at day 7 after sham or painful facet joint 
injury. Figure G.3 presents representative images of TSP4- and GFAP-labeled superficial 
dorsal horns, deep dorsal horns, and dorsal columns of spinal cords from each rat at day 7 
after sham or painful facet joint injury. Table G.3 lists the quantification of TSP4 and 
GFAP at day 7 after sham or painful facet joint injury followed by BP or VEH injections 
immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at day 4 (inj-BPd4, inj-VEHd4, 
sham-VEHd4) after injury. Figures G.4-G.6 present representative TSP4- and GFAP-
labeled images of the superficial dorsal horn (G.4), deep dorsal horn (G.5), and dorsal 
columns (G.6) of spinal cords from each rat in each group. 
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Table G.1. Densitometric quantification of pNR1, mGluR5, and GFAP at day 7 for 
bupivacaine treatment study (Chapter 4).  
 
Note – Table is continued on the next page. Missing values are due to tissue sections that 
were torn or folded, preventing quantification of immunolabeling in the dorsal horn. 
Rat # Image pNR1 mGluR5 GFAP Rat # Image pNR1 mGluR5 GFAP
L1 0.18 0.22 0.22 L1 0.14 0.26 0.07
L2 0.22 0.29 0.29 L2 0.31
L3 0.15 0.37 0.37 L3 0.23 0.29 0.07
L4 0.13 0.37 0.37 L4 0.19 0.24 0.04
L5 0.18 0.28 0.28 L5 0.29 0.34 0.06
L6 0.15 0.21 0.21 L6 0.26 0.31 0.10
R1 0.14 0.29 0.29 R1 0.21 0.29 0.12
R2 0.08 0.31 0.31 R2 0.26 0.29 0.09
R3 0.20 0.30 0.30 R3 0.25 0.33 0.13
R4 0.12 0.23 0.23 R4 0.28 0.30 0.12
R5 0.18 0.31 0.31 R5 0.26 0.35 0.13
R6 0.20 0.26 0.26 R6 0.26 0.36 0.12
L1 0.20 0.27 0.27 L1 0.13 0.36 0.08
L2 0.29 0.42 0.42 L2 0.14 0.26 0.03
L3 0.23 0.27 0.27 L3 0.26 0.19 0.04
L4 0.34 0.32 0.32 L4 0.26 0.07
L5 0.35 0.34 0.34 L5 0.24 0.11
L6 0.18 0.35 0.35 L6 0.27 0.21 0.07
R1 0.08 0.24 0.24 R1 0.21 0.15 0.02
R2 0.22 0.17 0.17 R2 0.13 0.31 0.05
R3 0.23 0.15 0.15 R3 0.24 0.21 0.08
R4 0.40 0.18 0.18 R4
R5 0.33 0.22 0.22 R5 0.17 0.09
R6 0.28 0.21 0.21 R6 0.16 0.05
L1 0.22 0.21 0.21 L1 0.21 0.26 0.12
L2 0.19 0.20 0.20 L2 0.21 0.32 0.17
L3 0.25 0.33 0.33 L3 0.19 0.31 0.13
L4 0.33 0.30 0.30 L4 0.21 0.31 0.16
L5 0.16 0.40 0.40 L5 0.14 0.35 0.13
L6 0.26 0.34 0.34 L6 0.21 0.38 0.14
R1 0.20 0.30 0.30 R1 0.13 0.20 0.10
R2 0.28 0.30 0.30 R2 0.25 0.31 0.19
R3 0.33 0.30 0.30 R3 0.20 0.25 0.11
R4 0.12 0.31 0.31 R4 0.12 0.27 0.16
R5 0.22 R5 0.23 0.37 0.15
R6 0.34 0.23 0.23 R6 0.19 0.27 0.14
148
147
injBP-0h sham-VEH0h
159
160
161149
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Note – Table is continued on the next page. Missing values are due to tissue sections that 
were torn or folded, preventing quantification of immunolabeling in the dorsal horn. 
 
Rat # Image pNR1 mGluR5 GFAP Rat # Image pNR1 mGluR5 GFAP
L1 0.27 0.29 0.29 L1 0.15 0.23 0.09
L2 0.28 0.40 0.40 L2 0.23 0.27 0.10
L3 0.18 0.33 0.33 L3 0.23 0.43 0.09
L4 0.26 L4 0.19 0.30 0.08
L5 0.21 0.29 0.29 L5 0.33 0.14
L6 0.27 0.36 0.36 L6 0.38 0.45
R1 0.25 0.35 0.35 R1 0.23 0.37 0.11
R2 0.29 0.39 0.39 R2 0.22 0.30 0.12
R3 0.26 0.48 0.48 R3 0.26 0.37 0.13
R4 0.35 0.20 0.20 R4 0.28 0.14
R5 0.23 0.34 0.34 R5 0.28 0.35 0.15
R6 0.21 0.35 0.35 R6 0.26 0.25 0.14
L1 0.19 0.20 0.20 L1 0.29 0.30 0.13
L2 0.15 0.38 0.38 L2 0.27 0.36 0.11
L3 0.23 0.18 0.18 L3 0.24 0.40 0.14
L4 0.07 0.22 0.22 L4 0.24 0.50
L5 0.11 0.28 0.28 L5 0.37 0.43 0.14
L6 0.18 0.30 0.30 L6 0.29 0.43 0.17
R1 0.25 0.21 0.21 R1 0.34 0.35 0.13
R2 0.22 0.35 0.35 R2 0.30 0.43 0.07
R3 0.27 0.34 0.34 R3 0.30 0.42 0.14
R4 0.25 0.31 0.31 R4 0.38 0.42 0.07
R5 0.01 0.31 0.31 R5 0.32 0.41 0.11
R6 0.29 0.20 0.20 R6 0.33 0.35 0.15
L1 0.11 0.30 0.30 L1 0.24 0.35 0.12
L2 0.16 0.39 0.39 L2 0.22 0.32 0.11
L3 0.16 0.23 0.23 L3 0.38 0.18
L4 0.22 0.22 L4
L5 0.14 0.34 0.34 L5 0.31 0.35 0.12
L6 0.20 0.39 0.39 L6 0.26 0.40 0.14
R1 0.22 0.17 0.17 R1 0.30 0.25 0.08
R2 0.20 0.39 0.39 R2 0.20 0.34 0.08
R3 0.19 0.27 0.27 R3 0.31 0.13
R4 0.11 0.19 0.19 R4 0.43
R5 0.18 0.37 0.37 R5 0.32 0.38 0.14
R6 0.36 0.41 0.41 R6 0.20 0.32 0.12
injBP-0h (continued)
152
163
164
150 162
151
sham-VEH0h (continued)
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Note – Table is continued on the next page. Missing values are due to tissue sections that 
were torn or folded, preventing quantification of immunolabeling in the dorsal horn. 
 
Rat # Image pNR1 mGluR5 GFAP Rat # Image pNR1 mGluR5 GFAP
L1 0.22 0.25 0.12 L1 0.26 0.16 0.08
L2 0.17 0.35 0.18 L2 0.20 0.34
L3 0.21 0.41 0.16 L3 0.24 0.31
L4 0.30 0.33 0.12 L4 0.30 0.30 0.07
L5 0.29 0.44 0.14 L5 0.30 0.30 0.05
L6 0.20 0.40 0.13 L6 0.35 0.30 0.05
R1 0.29 0.28 0.09 R1 0.23 0.09
R2 0.18 0.39 0.15 R2 0.22 0.29
R3 0.16 0.39 0.19 R3 0.23 0.23
R4 0.32 0.08 R4 0.17 0.21 0.10
R5 0.26 0.37 0.16 R5 0.28 0.37 0.04
R6 0.23 0.36 0.12 R6 0.21 0.28 0.05
L1 0.33 0.44 0.13 L1 0.12 0.31 0.06
L2 0.27 0.52 0.14 L2 0.27 0.42 0.09
L3 0.27 0.43 0.14 L3 0.18 0.35 0.10
L4 0.26 0.33 0.12 L4 0.25
L5 0.33 0.47 0.15 L5 0.26 0.37 0.09
L6 0.27 0.42 0.20 L6 0.25 0.32
R1 0.23 0.41 0.13 R1 0.17
R2 0.37 0.42 0.16 R2 0.38 0.23 0.07
R3 0.35 0.41 0.13 R3 0.21 0.16 0.07
R4 0.31 0.34 0.18 R4 0.24
R5 0.41 0.11 R5 0.20 0.30 0.06
R6 0.27 0.45 0.16 R6 0.14 0.32 0.07
L1 0.38 0.36 0.08 L1 0.36 0.27 0.08
L2 0.39 0.36 0.09 L2 0.28 0.26 0.16
L3 0.38 0.35 0.05 L3 0.28 0.32 0.12
L4 0.45 0.48 0.13 L4 0.29 0.21 0.11
L5 0.27 0.44 0.12 L5 0.19 0.35 0.12
L6 0.33 0.27 0.09 L6 0.23 0.34 0.11
R1 0.23 0.44 0.16 R1 0.16 0.26 0.13
R2 0.25 0.41 0.14 R2 0.34 0.43 0.15
R3 0.32 0.40 0.10 R3 0.34 0.29 0.16
R4 0.35 0.47 0.30 R4 0.27 0.33 0.18
R5 0.25 0.43 0.14 R5 0.34 0.43 0.16
R6 0.36 0.29 0.17 R6 0.23 0.40 0.12
155173
154
153
inj-VEH0h inj-BPd4
171
172
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Note – Table is continued on the next page. Missing values are due to tissue sections that 
were torn or folded, preventing quantification of immunolabeling in the dorsal horn. 
 
Rat # Image pNR1 mGluR5 GFAP Rat # Image pNR1 mGluR5 GFAP
L1 0.29 0.14 L1 0.29 0.35 0.16
L2 0.27 0.36 0.18 L2 0.27 0.40 0.12
L3 0.30 0.20 L3 0.34 0.35 0.18
L4 0.29 0.20 L4 0.33 0.18 0.10
L5 0.33 0.16 L5 0.28
L6 0.21 0.32 0.19 L6 0.33 0.19
R1 0.42 0.10 R1 0.37 0.29 0.08
R2 0.21 0.40 0.09 R2 0.15 0.39 0.10
R3 0.20 0.39 0.12 R3 0.24 0.40 0.15
R4 0.34 0.13 R4 0.31 0.36
R5 0.24 0.33 0.13 R5 0.34 0.24 0.15
R6 0.28 0.37 0.12 R6 0.40 0.12
L1 0.37 0.12 L1 0.20 0.27 0.08
L2 0.37 L2 0.30 0.33 0.08
L3 0.34 L3 0.19 0.28
L4 0.38 0.21 0.08 L4 0.26 0.31 0.14
L5 0.27 0.42 0.09 L5 0.33 0.37 0.12
L6 0.37 L6 0.27 0.34 0.15
R1 0.13 0.05 R1 0.31 0.10
R2 0.26 0.36 R2 0.18 0.32 0.14
R3 0.28 0.11 R3 0.21
R4 0.29 0.28 0.05 R4 0.29 0.27 0.09
R5 0.29 0.46 0.18 R5 0.33 0.35 0.12
R6 0.24 0.33 0.11 R6 0.30 0.32 0.13
L1 0.16 0.35 0.09 L1 0.34 0.30 0.08
L2 0.22 0.46 0.08 L2 0.30 0.33 0.10
L3 0.19 0.32 0.12 L3 0.24 0.28 0.08
L4 0.25 0.30 0.06 L4 0.32 0.41 0.13
L5 0.44 0.07 L5 0.30 0.35 0.15
L6 0.25 0.47 0.08 L6 0.26 0.40 0.17
R1 0.29 0.25 0.08 R1 0.30 0.23 0.12
R2 0.29 0.35 0.07 R2 0.34 0.30 0.17
R3 0.21 0.28 0.10 R3 0.24 0.33 0.16
R4 0.20 0.28 0.05 R4 0.31 0.32 0.17
R5 0.42 0.07 R5 0.44 0.33 0.13
R6 0.23 0.36 0.10 R6 0.35 0.35 0.12
176 158
156174
inj-VEH0h (continued) inj-BPd4 (continued)
157175
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Note – Table is continued on the next page. Missing values are due to tissue sections that 
were torn or folded, preventing quantification of immunolabeling in the dorsal horn. 
 
Rat # Image pNR1 mGluR5 GFAP Rat # Image pNR1 mGluR5 GFAP
L1 0.13 0.40 L1 0.15 0.33 0.07
L2 0.14 0.30 0.09 L2 0.39 0.36 0.06
L3 0.35 0.25 0.09 L3 0.37 0.34 0.11
L4 0.08 0.33 0.07 L4 0.29 0.31 0.12
L5 0.15 0.29 0.11 L5 0.30 0.37 0.07
L6 0.34 0.36 0.14 L6 0.22 0.41 0.13
R1 0.19 0.27 0.11 R1 0.42 0.06
R2 0.27 0.28 0.06 R2 0.30 0.39 0.12
R3 0.29 0.26 0.06 R3 0.24 0.37 0.14
R4 0.15 0.29 0.08 R4 0.20 0.36 0.11
R5 0.19 0.23 0.03 R5 0.27 0.38 0.15
R6 0.31 0.33 0.09 R6 0.18 0.37 0.08
L1 0.21 0.16 0.11 L1 0.38 0.09
L2 0.27 0.30 0.19 L2 0.23 0.40 0.08
L3 0.22 0.35 0.11 L3 0.24 0.38 0.10
L4 0.23 0.28 0.12 L4 0.24 0.28
L5 0.20 0.32 0.09 L5 0.14 0.30 0.12
L6 0.24 0.31 0.12 L6 0.41 0.08
R1 0.24 0.34 0.10 R1 0.15 0.32 0.13
R2 0.16 0.36 0.20 R2 0.25 0.37 0.13
R3 0.26 0.17 R3 0.23 0.32 0.09
R4 0.28 0.10 R4 0.20 0.29 0.20
R5 0.38 0.12 R5 0.18 0.27 0.08
R6 0.35 0.13 R6 0.28 0.32 0.13
L1 0.28 L1 0.41 0.30 0.08
L2 0.27 L2 0.35 0.35 0.14
L3 0.23 0.19 0.05 L3 0.31 0.27 0.13
L4 0.10 0.32 0.09 L4 0.28 0.33 0.12
L5 0.11 0.31 0.07 L5 0.32 0.40 0.12
L6 0.09 0.19 0.02 L6 0.30 0.35 0.15
R1 0.23 0.12 R1 0.29 0.38 0.14
R2 0.26 0.20 0.06 R2 0.32 0.39 0.08
R3 0.25 0.27 0.04 R3 0.32 0.32 0.13
R4 0.14 0.29 0.08 R4 0.28 0.36 0.08
R5 0.22 0.29 0.05 R5 0.37 0.42 0.13
R6 0.23 0.28 0.06 R6 0.39 0.35 0.12
inj-VEHd4
165
sham-VEHd4
177
166 178
167 179
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Note – Missing values are due to tissue sections that were torn or folded, preventing 
quantification of immunolabeling in the dorsal horn. 
 
 
  
Rat # Image pNR1 mGluR5 GFAP Rat # Image pNR1 mGluR5 GFAP
L1 0.23 0.19 0.05 L1 0.35 0.36 0.14
L2 0.17 0.24 0.05 L2 0.29 0.36 0.10
L3 0.12 0.39 0.08 L3 0.31 0.42 0.10
L4 0.15 0.21 0.05 L4 0.31 0.07
L5 0.31 0.18 0.01 L5 0.28 0.05
L6 0.21 0.39 0.06 L6 0.35 0.11
R1 0.26 0.22 0.05 R1 0.29 0.42 0.09
R2 0.29 0.17 0.12 R2 0.31 0.38 0.13
R3 0.26 0.33 0.12 R3 0.33 0.38 0.19
R4 0.10 0.28 0.06 R4 0.32 0.12
R5 0.23 0.44 0.10 R5 0.38 0.14
R6 0.13 0.23 0.03 R6 0.42 0.42 0.16
L1 0.21 0.27 0.11 L1 0.34 0.14
L2 0.11 0.24 0.11 L2 0.34 0.27 0.10
L3 0.16 0.29 0.09 L3 0.30 0.37 0.17
L4 0.23 0.31 0.14 L4 0.31 0.29 0.12
L5 0.16 0.37 0.07 L5 0.32 0.34 0.15
L6 0.16 0.37 0.07 L6 0.34 0.28 0.13
R1 0.25 0.07 R1 0.33 0.14
R2 0.24 0.12 R2 0.27 0.28 0.19
R3 0.19 0.13 R3 0.43 0.37 0.15
R4 0.16 0.09 R4 0.23 0.34 0.14
R5 0.22 0.12 R5 0.33 0.33 0.13
R6 0.24 0.16 R6 0.30 0.42 0.19
L1 0.23 0.25
L2 0.15 0.26 0.10
L3 0.14 0.19 0.09
L4 0.24 0.33 0.18
L5 0.23 0.27
L6 0.25 0.15
R1 0.25 0.33 0.11
R2 0.29 0.16 0.12
R3 0.17 0.17 0.12
R4 0.21 0.38 0.13
R5 0.16 0.32 0.09
R6 0.31
170
169
sham-VEHd4 (continued)
182
180168
inj-VEHd4 (continued)
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Figure G.1. Immunolabeling of mGluR5 (green) and GFAP (red) in the spinal dorsal 
horn at day 7 for the bupivacaine treatment study. Proteins were evaluated after sham or 
painful facet joint injury followed by intra-articular bupivacaine (BP) or saline vehicle 
(VEH) injections either immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at day 4 
(inj-BPd4, inj-VEHd4, sham-VEHd4). Representative images are indicated by the rat 
number, and an image number that includes the right (R) or left (L) side of the spinal cord 
and the section of tissue (consecutive sections were labeled 1-6 for each rat). 
Inj-BP0h
147 (L2)        148 (L1) 149 (R6) 150 (L1) 151 (L3) 152 (L3)
Inj-BPd4
153 (L4)        154 (L2) 155 (R2) 156 (L3) 157 (L5) 158 (R6)
Sham-VEH0h
159 (R4)        160 (R1) 161 (R3) 162 (R4) 163 (R5) 164 (R3)
Sham-VEHd4
165  (R5)       166 (R2) 167 (L6) 168 (L5) 169 (L4) 170 (L3)
Inj-VEH0h
171  (L3)       172 (L2) 173 (L5) 174 (R6) 175 (R6) 176 (R6)
Inj-VEHd4
177 (L6)        178 (L3) 179 (L5) 180 (L4) 182 (L3)
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Figure G.2. Immunolabeling of pNR1 (green) and GFAP (red) in the spinal dorsal horn 
at day 7 for the bupivacaine treatment study. Proteins were evaluated after sham or 
painful facet joint injury followed by intra-articular bupivacaine (BP) or saline vehicle 
(VEH) injections either immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at day 4 
(inj-BPd4, inj-VEHd4, sham-VEHd4). Representative images are indicated by the rat 
number, and an image number that includes the right (R) or left (L) side of the spinal cord 
and the section of tissue (consecutive sections were labeled 1-6 for each rat). 
Inj-BP0h
147 (L4)        148 (R1) 149 (R4) 150 (R1) 151 (R5) 152 (R2)
Inj-BPd4
153 (R5)        154 (R2) 155 (L1) 156 (R5) 157 (L6) 158 (L5)
Sham-VEH0h
159  (L1)        160 (R3) 161 (R1) 162 (R4) 163 (R4) 164 (L1)
Sham-VEHd4
165  (R1)      166 (L3) 167 (L4) 168 (L2) 169 (L6) 170 (R4)
Inj-VEH0h
171 (R6)        172 (L3) 173 (L4) 174 (R6) 175 (R5) 176 (L3)
Inj-VEHd4
177 (L5)        178 (R6) 179 (L6) 180 (L3) 182 (R2)
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Table G.2. Densitometric quantification of TSP4 and GFAP at day 7 after sham or 
painful facet joint injury (Chapter 5).  
  
Note – Table is continued on the next page. 
Rat # Image TSP4 GFAP Coloc. Rat # Image TSP4 GFAP Coloc.
L1 0.085 0.109 0.027 L2 0.077 0.032 0.017
R1 0.020 0.069 0.003 L4 0.059 0.062 0.006
L2 0.166 0.109 0.029 R4 0.043 0.029 0.002
R2 0.104 0.080 0.012 L5 0.137 0.055 0.006
L3 0.048 0.092 0.012 R5 0.046 0.115 0.006
R3 0.032 0.058 0.002 L6 0.059 0.045 0.003
L4 0.020 0.028 0.001 R6 0.090 0.081 0.010
R4 0.013 0.075 0.003 L1 0.161 0.140 0.055
L5 0.370 0.124 0.078 R1 0.098 0.076 0.005
R5 0.039 0.156 0.016 L2 0.143 0.135 0.037
R6 0.096 0.051 0.010 R2 0.109 0.137 0.021
L1 0.024 0.071 0.006 L3 0.168 0.171 0.046
R1 0.026 0.077 0.006 R3 0.201 0.147 0.030
L2 0.752 0.217 0.161 L4 0.111 0.114 0.019
R2 0.444 0.132 0.085 R4 0.118 0.151 0.031
L3 0.142 0.138 0.033 L1 0.047 0.021 0.001
R3 0.487 0.143 0.081 R1 0.072 0.035 0.002
R1 0.020 0.028 0.002 L2 0.068 0.030 0.003
L2 0.086 0.050 0.010 L3 0.059 0.020 0.001
R2 0.131 0.085 0.029 R3 0.088 0.031 0.003
R3 0.069 0.039 0.009 R4 0.048 0.043 0.001
R4 0.034 0.036 0.003 L5 0.098 0.075 0.008
L5 0.321 0.068 0.033 R5 0.089 0.061 0.007
R5 0.179 0.065 0.019 L1 0.142 0.078 0.018
L6 0.286 0.042 0.019 R1 0.236 0.132 0.056
L2 0.279 0.150 0.066 L2 0.255 0.142 0.082
L3 0.016 0.132 0.003 R2 0.063 0.043 0.004
L4 0.008 0.053 0.001 L4 0.042 0.089 0.009
R4 0.004 0.062 0.001 R4 0.039 0.101 0.010
L5 0.256 0.123 0.042 L5 0.120 0.102 0.022
R5 0.061 0.030 0.002 R5 0.165 0.107 0.027
L3 0.182 0.061 0.018 L6 0.145 0.067 0.010
R3 0.399 0.199 0.128 R6 0.111 0.059 0.006
L4 0.022 0.135 0.010 L2 0.300 0.116 0.050
R4 0.128 0.109 0.023 R2 0.128 0.066 0.014
L5 0.131 0.109 0.024 L3 0.138 0.124 0.041
R5 0.034 0.082 0.007 L5 0.132 0.131 0.033
L1 0.016 0.043 0.001 R6 0.022 0.046 0.001
R1 0.003 0.048 0.001 L1 0.032 0.077 0.002
L2 0.194 0.148 0.049 R1 0.049 0.096 0.007
R2 0.229 0.156 0.060 L2 0.097 0.116 0.011
L3 0.056 0.077 0.010 R2 0.069 0.154 0.014
R3 0.044 0.053 0.008 L3 0.106 0.126 0.014
L5 0.303 0.112 0.054 R3 0.083 0.098 0.009
R5 0.029 0.045 0.005 L5 0.110 0.166 0.035
L6 0.029 0.029 0.001
Superficial DH
59
54
53
54
47
48
49
Dorsal Columns
59
Injury
Injury
53
49
48
47
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Note – Table is continued on the next page. 
 
Rat # Image TSP4 GFAP Coloc. Rat # Image TSP4 GFAP Coloc.
L2 0.012 0.030 0.001 L1 0.039 0.049 0.003
R2 0.061 0.017 0.003 L2 0.107 0.077 0.023
L4 0.014 0.035 0.000 R2 0.035 0.076 0.003
R4 0.017 0.020 0.000 R3 0.057 0.029 0.002
L5 0.169 0.054 0.008 L4 0.056 0.018 0.002
R5 0.292 0.065 0.023 R4 0.044 0.039 0.000
L6 0.064 0.053 0.006 R5 0.121 0.066 0.008
R6 0.009 0.033 0.000 L6 0.081 0.082 0.010
L1 0.045 0.138 0.015 R6 0.019 0.052 0.001
L2 0.221 0.106 0.043 L1 0.048 0.089 0.008
R2 0.035 0.086 0.013 R1 0.066 0.112 0.016
R3 0.020 0.095 0.005 L3 0.094 0.087 0.014
L4 0.043 0.131 0.016 R3 0.091 0.081 0.011
R4 0.052 0.070 0.010 L4 0.051 0.086 0.006
L5 0.197 0.077 0.018 R4 0.049 0.060 0.008
R5 0.196 0.081 0.030 L5 0.086 0.118 0.017
L6 0.185 0.070 0.015 L1 0.043 0.132 0.010
L1 0.085 0.140 0.026 R1 0.101 0.091 0.010
R1 0.102 0.075 0.013 L2 0.130 0.106 0.013
L2 0.115 0.116 0.021 R2 0.116 0.090 0.010
R2 0.170 0.110 0.029 L3 0.049 0.086 0.008
L3 0.069 0.091 0.013 R3 0.059 0.161 0.020
L4 0.100 0.126 0.027 L4 0.050 0.105 0.010
R4 0.059 0.072 0.011 R4 0.060 0.092 0.010
L5 0.057 0.075 0.011 R6 0.194 0.074 0.012
L6 0.158 0.078 0.021 R2 0.055 0.057 0.004
L2 0.117 0.060 0.014 R3 0.077 0.089 0.014
R2 0.113 0.097 0.028 L4 0.029 0.037 0.001
L3 0.111 0.037 0.006 L5 0.085 0.077 0.014
R3 0.071 0.132 0.017 L6 0.065 0.069 0.007
L4 0.012 0.029 0.001 R6 0.024 0.052 0.005
R4 0.030 0.038 0.002
L5 0.088 0.077 0.015
R5 0.114 0.040 0.008
L6 0.018 0.036 0.001
R6 0.066 0.034 0.003
60
50
55
56
60
Superficial DH (continued) Dorsal Columns (continued)
Sham
Sham
50
55
56
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Rat # Image TSP4 GFAP Coloc. Rat # Image TSP4 GFAP Coloc.
R1 0.003 0.053 0.000 L1 0.003 0.033 0.000
R2 0.029 0.060 0.005 R1 0.005 0.039 0.000
L3 0.024 0.080 0.002 R2 0.010 0.039 0.001
R3 0.017 0.037 0.000 L3 0.005 0.049 0.001
L4 0.013 0.035 0.003 L4 0.012 0.013 0.000
R4 0.048 0.027 0.004 R4 0.005 0.031 0.000
L5 0.043 0.060 0.006 L5 0.006 0.031 0.000
R5 0.048 0.075 0.013 R5 0.005 0.034 0.001
L6 0.041 0.048 0.003 L6 0.015 0.028 0.001
R6 0.018 0.042 0.001 R1 0.010 0.023 0.000
L1 0.021 0.019 0.000 L2 0.028 0.037 0.003
R1 0.025 0.013 0.000 L3 0.057 0.008 0.001
L2 0.023 0.039 0.001 R3 0.011 0.002 0.000
R2 0.009 0.046 0.001 L4 0.029 0.013 0.000
L3 0.067 0.041 0.003 R4 0.023 0.010 0.000
R3 0.014 0.045 0.001 L5 0.077 0.037 0.005
R4 0.083 0.017 0.001 R5 0.045 0.037 0.002
R1 0.027 0.003 0.000 L6 0.005 0.013 0.000
R2 0.026 0.028 0.001 R6 0.005 0.025 0.000
L3 0.037 0.008 0.000 L2 0.016 0.017 0.000
R3 0.020 0.012 0.000 R2 0.035 0.052 0.003
L4 0.057 0.030 0.002 L3 0.010 0.075 0.001
R4 0.018 0.020 0.000 R3 0.020 0.021 0.000
L5 0.035 0.015 0.001 L4 0.004 0.018 0.000
R5 0.072 0.077 0.010 R4 0.004 0.021 0.000
R6 0.044 0.013 0.000 L5 0.013 0.007 0.001
L1 0.028 0.011 0.000 R5 0.034 0.044 0.003
R1 0.023 0.018 0.000 L6 0.016 0.024 0.000
L2 0.014 0.047 0.000 R6 0.026 0.036 0.001
R2 0.061 0.010 0.001 L1 0.028 0.041 0.001
L4 0.007 0.019 0.000 R1 0.026 0.054 0.002
R4 0.002 0.023 0.000 L2 0.065 0.038 0.005
R5 0.024 0.032 0.001 L4 0.017 0.026 0.000
L6 0.013 0.012 0.000 R4 0.007 0.018 0.000
R6 0.018 0.015 0.000 L5 0.014 0.005 0.000
L2 0.040 0.009 0.000 R5 0.069 0.022 0.005
R2 0.057 0.008 0.000 L6 0.003 0.009 0.000
L3 0.086 0.011 0.002 R1 0.013 0.016 0.001
R3 0.050 0.013 0.001 L2 0.022 0.053 0.001
L4 0.004 0.054 0.003 R2 0.063 0.049 0.011
R4 0.002 0.017 0.000 L3 0.020 0.035 0.001
R5 0.006 0.018 0.000 R3 0.017 0.086 0.003
L6 0.053 0.024 0.003 R4 0.033 0.007 0.000
R6 0.029 0.017 0.000 L5 0.029 0.026 0.002
R5 0.049 0.028 0.004
L6 0.014 0.025 0.001
R6 0.032 0.020 0.002
47
48
49
53
54
Injury
60
Deep DH (continued)
56
55
50
59
Deep DH
Injury
Sham
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Figure G.3. Immunolabeling of TSP4 (green) and GFAP (red) in the spinal cord at day 7 
after sham or painful facet joint injury. TSP4 and GFAP labeling were evaluated in the 
superficial dorsal horn, deep dorsal horn, and dorsal columns of the spinal cord. 
Representative images are indicated by the rat number, and an image number that 
includes the right (R) or left (L) side of the spinal cord and the section of tissue 
(consecutive sections were labeled 1-6 for each rat). 
  
47  (L1)       48 (L3) 49 (R5) 53 (R5) 54 (L5) 59 (R2)
50  (R2)       55 (R4) 56 (R4) 60 (L4)
Injury
Sham
Superficial Dorsal Horn
Deep Dorsal Horn
Dorsal Columns
47 (R5)        48 (L3) 49 (L5) 53 (R5) 54 (R3) 59 (L5)
47  (R3)      48 (R2) 49 (L5) 53 (L2) 54 (R3) 59 (R2)
Superficial Dorsal Horn
Deep Dorsal Horn
Dorsal Columns
50 (R6)        55 (R4) 56 (L3) 60 (L6)
50 (R6)       55 (L6) 56 (L1) 60 (L6)
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Table G.3. Densitometric quantification of TSP4 and GFAP at day 7 for 
bupivacaine treatment study (Chapter 5). 
 
Note – Table is continued on the next page. 
Rat # Section TSP4 GFAP Coloc. Rat # Section TSP4 GFAP Coloc.
L2 0.143 0.061 0.027 L2 0.223 0.121 0.024
R2 0.199 0.094 0.041 R2 0.265 0.201 0.050
L3 0.061 0.047 0.007 L3 0.125 0.088 0.003
R3 0.123 0.047 0.015 R3 0.171 0.108 0.008
L4 0.027 0.018 0.002 L5 0.189 0.158 0.022
R4 0.011 0.022 0.000 R5 0.229 0.143 0.028
L5 0.169 0.061 0.026 L6 0.287 0.132 0.017
R5 0.277 0.088 0.043 L2 0.152 0.096 0.003
L6 0.253 0.165 0.081 R2 0.176 0.137 0.006
R6 0.092 0.040 0.007 L3 0.280 0.077 0.004
L2 0.254 0.133 0.064 L4 0.110 0.065 0.003
R2 0.138 0.088 0.020 L5 0.344 0.190 0.041
L4 0.098 0.052 0.014 R5 0.299 0.248 0.077
L5 0.297 0.089 0.038 L6 0.178 0.066 0.004
R5 0.153 0.071 0.016 L1 0.059 0.078 0.002
L6 0.060 0.075 0.007 R1 0.023 0.217 0.009
R6 0.218 0.032 0.007 L2 0.130 0.223 0.026
L1 0.009 0.012 0.000 R2 0.087 0.196 0.013
R1 0.039 0.167 0.016 L3 0.085 0.192 0.010
L2 0.098 0.154 0.035 R3 0.140 0.204 0.031
R2 0.046 0.086 0.010 L4 0.092 0.173 0.014
L3 0.047 0.128 0.015 L5 0.117 0.270 0.039
R3 0.096 0.138 0.036 R5 0.259 0.318 0.089
L4 0.054 0.064 0.008 L6 0.119 0.210 0.021
R4 0.049 0.052 0.004 R6 0.178 0.229 0.038
L5 0.270 0.160 0.079 R4 0.075 0.109 0.006
R5 0.228 0.110 0.043 L1 0.268 0.083 0.003
L6 0.061 0.109 0.014 R1 0.108 0.246 0.007
R6 0.091 0.090 0.015 L2 0.092 0.209 0.023
L1 0.100 0.031 0.003 R2 0.171 0.283 0.049
L2 0.230 0.178 0.083 L3 0.079 0.204 0.013
R2 0.354 0.206 0.114 R3 0.162 0.257 0.036
L3 0.098 0.125 0.032 L5 0.286 0.230 0.039
L4 0.201 0.110 0.023 R5 0.280 0.249 0.034
L5 0.205 0.094 0.025 L6 0.241 0.171 0.013
R5 0.214 0.124 0.035 L1 0.015 0.242 0.005
L6 0.091 0.035 0.004 L2 0.112 0.334 0.046
R6 0.004 0.055 0.001 R2 0.123 0.366 0.047
L1 0.012 0.143 0.004 L3 0.081 0.331 0.036
L2 0.098 0.177 0.039 R3 0.148 0.354 0.065
R2 0.042 0.210 0.022 R4 0.072 0.148 0.008
L3 0.020 0.125 0.006 R5 0.098 0.244 0.040
L4 0.006 0.104 0.001 R6 0.124 0.171 0.025
R4 0.038 0.042 0.004 L1 0.070 0.196 0.006
L5 0.092 0.168 0.039 R2 0.137 0.269 0.023
R5 0.104 0.214 0.053 R5 0.015 0.278 0.001
L6 0.036 0.042 0.004 L1 0.004 0.055 0.000
R6 0.114 0.091 0.020 R1 0.005 0.052 0.000
L1 0.012 0.086 0.002 L2 0.029 0.180 0.005
L2 0.017 0.132 0.003 R2 0.024 0.144 0.003
R2 0.003 0.074 0.000 L3 0.018 0.168 0.002
R5 0.001 0.084 0.000 R3 0.021 0.162 0.002
L1 0.003 0.018 0.000 L4 0.012 0.102 0.001
R1 0.003 0.014 0.000 L5 0.015 0.151 0.001
L2 0.010 0.082 0.003 R5 0.020 0.137 0.002
R2 0.050 0.094 0.015 L6 0.039 0.131 0.001
L3 0.038 0.116 0.020 R6 0.014 0.113 0.000
R3 0.006 0.063 0.002 L2 0.015 0.212 0.004
L4 0.019 0.038 0.002 R2 0.019 0.247 0.005
R4 0.004 0.011 0.000 L3 0.023 0.176 0.002
L5 0.026 0.106 0.007 R3 0.029 0.214 0.005
R5 0.009 0.094 0.002 L4 0.005 0.092 0.000
L6 0.004 0.073 0.001 R4 0.012 0.109 0.001
R6 0.001 0.065 0.000 L5 0.023 0.215 0.003
175
174
173
sham-
VEH0h
sham-
VEH0h
160
171
172
176
159
Superficial DH
159
172
inj-
VEH0h
inj-
VEH0h
171
173
174
175
176
Dorsal Columns
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Note – Table is continued on the next page. 
 
Rat # Section TSP4 GFAP Coloc. Rat # Section TSP4 GFAP Coloc.
L2 0.013 0.072 0.004 160 L6 0.077 0.056 0.003
R2 0.011 0.061 0.003 L1 0.094 0.109 0.005
R3 0.001 0.064 0.000 R1 0.087 0.091 0.004
R4 0.000 0.030 0.000 L2 0.054 0.159 0.007
L5 0.008 0.066 0.001 R2 0.047 0.158 0.007
R5 0.006 0.089 0.001 R3 0.076 0.127 0.006
L6 0.002 0.052 0.000 L4 0.028 0.117 0.003
R1 0.009 0.009 0.000 R4 0.034 0.133 0.003
L2 0.036 0.043 0.007 L5 0.071 0.182 0.017
R2 0.010 0.026 0.001 R5 0.063 0.241 0.019
L3 0.058 0.051 0.009 R6 0.115 0.182 0.010
R3 0.011 0.031 0.001 R2 0.026 0.246 0.008
L4 0.024 0.040 0.003 L3 0.047 0.149 0.004
R4 0.019 0.031 0.001 R3 0.042 0.155 0.002
L5 0.062 0.097 0.017 R4 0.055 0.154 0.004
R5 0.037 0.097 0.011 L5 0.026 0.172 0.002
L6 0.051 0.055 0.010 R5 0.032 0.191 0.005
R6 0.053 0.036 0.006 L6 0.064 0.198 0.006
R1 0.037 0.034 0.002 R6 0.042 0.218 0.004
L3 0.022 0.070 0.007 L1 0.100 0.079 0.002
R3 0.034 0.119 0.008 R1 0.020 0.009 0.000
R4 0.002 0.056 0.000 L2 0.335 0.295 0.076
L5 0.051 0.087 0.013 R2 0.237 0.352 0.077
R5 0.026 0.086 0.007 L3 0.202 0.310 0.045
L6 0.011 0.102 0.003 R3 0.228 0.259 0.030
R6 0.010 0.104 0.002 L5 0.117 0.188 0.003
L1 0.032 0.007 0.001 R5 0.166 0.097 0.007
R1 0.026 0.003 0.000 L6 0.222 0.220 0.027
L3 0.112 0.085 0.020 R6 0.191 0.271 0.027
R3 0.042 0.125 0.012 L4 0.056 0.189 0.006
L5 0.112 0.011 0.003 L4 0.151 0.015 0.001
R5 0.104 0.011 0.002 R4 0.206 0.014 0.001
L6 0.108 0.116 0.025 L5 0.069 0.106 0.005
R6 0.054 0.136 0.017 R6 0.152 0.155 0.033
L4 0.009 0.015 0.000 L1 0.046 0.076 0.003
R4 0.002 0.033 0.000 R1 0.062 0.063 0.001
L5 0.420 0.116 0.077 R2 0.164 0.126 0.010
R5 0.097 0.089 0.018 L1 0.074 0.047 0.001
R6 0.078 0.026 0.006 R1 0.048 0.062 0.001
L1 0.031 0.040 0.003 L2 0.031 0.091 0.001
R1 0.015 0.039 0.003 R2 0.076 0.110 0.004
L2 0.054 0.094 0.015 L3 0.154 0.103 0.005
R2 0.084 0.076 0.016 R3 0.179 0.102 0.008
L3 0.113 0.022 0.005 L4 0.122 0.090 0.004
L4 0.042 0.057 0.009 R4 0.044 0.074 0.003
R4 0.025 0.034 0.003 L5 0.206 0.081 0.013
L5 0.173 0.020 0.008 R5 0.117 0.062 0.007
R5 0.109 0.027 0.009 R6 0.096 0.075 0.004
L6 0.079 0.019 0.005 L1 0.060 0.071 0.002
R6 0.030 0.023 0.001 R1 0.077 0.117 0.003
L1 0.004 0.011 0.000 L2 0.157 0.115 0.011
R1 0.019 0.033 0.002 R2 0.088 0.075 0.003
L2 0.066 0.050 0.008 L3 0.116 0.188 0.014
R2 0.085 0.023 0.005 R3 0.059 0.153 0.007
L3 0.071 0.037 0.009 L4 0.032 0.165 0.005
R3 0.026 0.037 0.003 R4 0.044 0.143 0.004
L4 0.010 0.043 0.001 L5 0.026 0.115 0.003
R4 0.023 0.028 0.002 R5 0.021 0.146 0.002
L5 0.103 0.097 0.023 R6 0.088 0.206 0.016
R5 0.088 0.085 0.018 L1 0.074 0.108 0.002
L6 0.123 0.103 0.032 R1 0.029 0.094 0.000
R6 0.125 0.063 0.022 L2 0.065 0.170 0.009
sham-
VEH0h
sham-
VEH0h
inj-
BP0h
inj-
BP0h
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Note – Table is continued on the next page. 
 
Rat # Section TSP4 GFAP Coloc. Rat # Section TSP4 GFAP Coloc.
R1 0.053 0.032 0.002 R2 0.054 0.113 0.003
L2 0.088 0.110 0.023 R3 0.139 0.149 0.014
R2 0.084 0.034 0.005 R4 0.050 0.087 0.001
L3 0.066 0.099 0.017 L5 0.062 0.164 0.012
R3 0.094 0.062 0.012 R5 0.015 0.113 0.002
L5 0.375 0.153 0.099 L6 0.168 0.038 0.002
R5 0.039 0.035 0.003 R6 0.183 0.027 0.002
L6 0.022 0.025 0.003 L3 0.108 0.174 0.014
R6 0.042 0.009 0.001 R1 0.010 0.115 0.001
L1 0.004 0.046 0.000 L2 0.021 0.240 0.006
R1 0.004 0.042 0.000 R2 0.007 0.246 0.002
L2 0.006 0.102 0.001 L3 0.006 0.211 0.001
R2 0.003 0.146 0.002 R3 0.009 0.193 0.002
L3 0.001 0.070 0.000 L4 0.005 0.134 0.000
R3 0.000 0.116 0.000 R4 0.003 0.105 0.000
L4 0.001 0.034 0.000 L5 0.029 0.090 0.001
R4 0.000 0.050 0.000 R5 0.024 0.039 0.000
L5 0.010 0.028 0.000 R6 0.009 0.109 0.001
R5 0.007 0.039 0.001 L1 0.051 0.080 0.001
L6 0.002 0.014 0.000 R1 0.043 0.086 0.000
R6 0.000 0.125 0.000 L2 0.060 0.113 0.008
L1 0.004 0.017 0.000 L3 0.066 0.125 0.005
R1 0.003 0.023 0.000 R3 0.144 0.197 0.035
L2 0.024 0.052 0.004 L5 0.030 0.102 0.001
R2 0.047 0.045 0.003 R5 0.022 0.075 0.001
L3 0.093 0.069 0.014 L6 0.005 0.079 0.000
R3 0.048 0.082 0.007 R6 0.060 0.096 0.002
L5 0.012 0.013 0.000 L1 0.004 0.135 0.000
L6 0.013 0.018 0.001 R1 0.005 0.131 0.001
R6 0.022 0.037 0.002 L2 0.020 0.128 0.002
R1 0.001 0.041 0.000 R2 0.022 0.209 0.004
L2 0.017 0.130 0.008 L3 0.010 0.214 0.001
R2 0.021 0.147 0.011 R3 0.019 0.202 0.002
L3 0.001 0.095 0.000 L4 0.009 0.178 0.001
R3 0.003 0.089 0.000 R4 0.007 0.083 0.001
L4 0.001 0.057 0.000 L6 0.076 0.203 0.016
R4 0.001 0.065 0.000 R6 0.063 0.175 0.013
L6 0.083 0.132 0.031 L1 0.068 0.085 0.012
R6 0.044 0.123 0.015 R1 0.056 0.048 0.006
L1 0.061 0.125 0.020 L2 0.041 0.103 0.009
R1 0.084 0.125 0.027 R2 0.063 0.106 0.013
L2 0.141 0.167 0.053 L3 0.057 0.113 0.011
R2 0.061 0.193 0.032 R3 0.056 0.095 0.011
L3 0.145 0.181 0.051 L4 0.026 0.093 0.006
R3 0.019 0.178 0.011 R4 0.013 0.035 0.001
L4 0.032 0.108 0.011 L5 0.090 0.174 0.036
R4 0.021 0.133 0.009 L6 0.040 0.097 0.009
L5 0.130 0.208 0.062 R6 0.030 0.102 0.007
R5 0.054 0.201 0.027 L1 0.017 0.070 0.002
L6 0.070 0.173 0.025 R1 0.008 0.063 0.001
R6 0.008 0.132 0.003 L2 0.048 0.141 0.018
L1 0.001 0.053 0.000 R2 0.088 0.105 0.021
R1 0.001 0.050 0.000 L3 0.042 0.113 0.010
L2 0.095 0.158 0.040 R3 0.035 0.080 0.007
R2 0.089 0.148 0.039 L5 0.097 0.127 0.029
L3 0.031 0.088 0.008 L6 0.028 0.066 0.005
R3 0.011 0.086 0.003 R6 0.048 0.093 0.011
L4 0.005 0.052 0.001 L1 0.066 0.079 0.017
R4 0.001 0.033 0.000 L2 0.031 0.153 0.015
L5 0.019 0.131 0.007 R2 0.066 0.159 0.028
R5 0.014 0.123 0.006 L3 0.030 0.096 0.007
L6 0.007 0.063 0.002 R3 0.028 0.117 0.007
R6 0.009 0.067 0.002 R4 0.193 0.081 0.036
inj-
VEHd4
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Note – Table is continued on the next page. 
Rat # Section TSP4 GFAP Coloc. Rat # Section TSP4 GFAP Coloc.
L1 0.009 0.032 0.001 L5 0.069 0.068 0.015
R1 0.069 0.060 0.012 R5 0.068 0.095 0.016
L2 0.068 0.214 0.038 R6 0.044 0.076 0.007
R2 0.019 0.147 0.010 L1 0.017 0.032 0.001
L3 0.020 0.063 0.006 R1 0.012 0.030 0.000
L4 0.031 0.097 0.008 L3 0.019 0.041 0.001
L5 0.057 0.186 0.021 R3 0.026 0.049 0.002
R5 0.032 0.112 0.010 L4 0.029 0.040 0.003
L6 0.064 0.191 0.023 R4 0.030 0.042 0.003
R6 0.016 0.070 0.003 L5 0.126 0.076 0.017
L1 0.021 0.042 0.004 L6 0.064 0.044 0.003
R1 0.005 0.048 0.001 R6 0.047 0.051 0.003
L3 0.006 0.041 0.001 L2 0.028 0.051 0.003
R3 0.010 0.120 0.003 R2 0.024 0.044 0.002
L4 0.034 0.066 0.009 L3 0.097 0.075 0.012
R4 0.010 0.070 0.003 R3 0.074 0.081 0.011
L5 0.068 0.129 0.026 L4 0.062 0.065 0.005
R5 0.016 0.114 0.005 R4 0.076 0.073 0.007
L6 0.007 0.049 0.001 R5 0.009 0.049 0.001
R6 0.013 0.099 0.004 L6 0.023 0.059 0.002
L1 0.011 0.043 0.002 L1 0.025 0.034 0.002
R1 0.009 0.034 0.002 R1 0.014 0.020 0.001
L2 0.027 0.065 0.007 L2 0.015 0.046 0.001
R2 0.013 0.053 0.003 L3 0.009 0.047 0.000
L3 0.045 0.102 0.013 R3 0.013 0.038 0.001
R3 0.065 0.097 0.018 L4 0.028 0.050 0.003
L4 0.058 0.089 0.017 R4 0.017 0.043 0.002
R4 0.028 0.084 0.008 L5 0.018 0.045 0.002
L5 0.013 0.074 0.003 L6 0.056 0.042 0.001
R5 0.008 0.070 0.002 R6 0.030 0.035 0.000
L6 0.048 0.080 0.011 L1 0.051 0.059 0.006
L1 0.014 0.036 0.002 R1 0.009 0.036 0.001
R1 0.006 0.021 0.000 L2 0.025 0.061 0.002
L2 0.015 0.040 0.004 R2 0.020 0.042 0.001
R2 0.011 0.035 0.001 L3 0.019 0.033 0.001
L3 0.004 0.037 0.000 R3 0.023 0.040 0.001
R3 0.028 0.049 0.004 L4 0.000 0.010 0.000
L4 0.032 0.045 0.004 L5 0.000 0.013 0.000
L5 0.032 0.042 0.006 L6 0.001 0.021 0.000
R5 0.020 0.079 0.006 R6 0.000 0.016 0.000
L6 0.016 0.027 0.001 R2 0.009 0.002 0.000
R6 0.005 0.038 0.000 L3 0.006 0.004 0.000
L1 0.019 0.076 0.006 R3 0.005 0.008 0.000
L2 0.017 0.076 0.006 L4 0.006 0.005 0.000
R2 0.017 0.061 0.002 R4 0.007 0.002 0.000
L3 0.003 0.051 0.001 L5 0.005 0.004 0.000
R3 0.004 0.050 0.001 R5 0.004 0.004 0.000
L4 0.000 0.009 0.000 L6 0.005 0.007 0.000
R4 0.000 0.001 0.000 R6 0.004 0.007 0.000
L1 0.000 0.000 0.000 L1 0.010 0.024 0.000
R1 0.001 0.000 0.000 R1 0.007 0.009 0.000
L2 0.008 0.002 0.000 L2 0.023 0.043 0.002
R2 0.003 0.001 0.000 R2 0.014 0.023 0.001
L3 0.004 0.008 0.000 L3 0.020 0.059 0.001
R3 0.002 0.008 0.000 R3 0.006 0.032 0.000
L4 0.002 0.001 0.000 L4 0.008 0.011 0.000
L5 0.001 0.004 0.000 R4 0.001 0.023 0.000
R5 0.001 0.014 0.000 L5 0.043 0.045 0.004
L6 0.002 0.008 0.000 R5 0.017 0.037 0.002
R6 0.001 0.009 0.000 L6 0.027 0.074 0.002
L1 0.000 0.010 0.000 R6 0.018 0.071 0.001
R1 0.001 0.002 0.000 L1 0.002 0.004 0.000
L2 0.001 0.040 0.000 R1 0.005 0.005 0.000
R2 0.002 0.023 0.000 L2 0.015 0.016 0.000
L3 0.005 0.064 0.003 R2 0.011 0.011 0.000
R3 0.001 0.032 0.000 L3 0.022 0.020 0.000
L5 0.011 0.034 0.001 R3 0.014 0.017 0.000
R5 0.001 0.037 0.000 L4 0.029 0.019 0.001
inj-
VEHd4
inj-
VEHd4
179
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Note – Table is continued on the next page. 
Rat # Section TSP4 GFAP Coloc. Rat # Section TSP4 GFAP Coloc.
L1 0.001 0.015 0.000 R4 0.019 0.014 0.000
L2 0.015 0.035 0.003 L5 0.028 0.018 0.001
R2 0.009 0.008 0.000 R5 0.042 0.034 0.002
L3 0.008 0.038 0.001 L6 0.026 0.036 0.001
R3 0.003 0.011 0.000 R6 0.018 0.051 0.001
L4 0.030 0.053 0.008 L2 0.046 0.045 0.003
R4 0.012 0.008 0.000 R2 0.045 0.050 0.003
L5 0.064 0.067 0.017 L3 0.050 0.016 0.000
R5 0.030 0.011 0.001 L4 0.067 0.022 0.002
L6 0.035 0.061 0.007 R4 0.042 0.028 0.001
R6 0.006 0.033 0.000 L5 0.019 0.010 0.000
L2 0.076 0.046 0.006 L2 0.008 0.043 0.001
R2 0.054 0.063 0.012 L3 0.053 0.115 0.016
L3 0.107 0.064 0.018 R3 0.059 0.157 0.018
L4 0.009 0.028 0.001 L4 0.009 0.053 0.001
R4 0.006 0.016 0.000 L5 0.005 0.046 0.001
L5 0.046 0.021 0.001 R5 0.113 0.235 0.063
L2 0.023 0.169 0.014 L6 0.014 0.070 0.004
R2 0.003 0.024 0.001 R6 0.039 0.099 0.015
L3 0.012 0.039 0.004 L1 0.030 0.071 0.003
R3 0.005 0.036 0.001 R1 0.036 0.060 0.004
L4 0.006 0.016 0.002 L2 0.033 0.061 0.005
L5 0.011 0.099 0.006 R2 0.054 0.109 0.011
R5 0.006 0.099 0.002 L4 0.026 0.050 0.002
L6 0.021 0.071 0.010 L5 0.017 0.094 0.003
R6 0.010 0.099 0.003 R5 0.027 0.073 0.005
L1 0.013 0.062 0.003 L6 0.106 0.126 0.020
R1 0.020 0.030 0.002 L2 0.005 0.028 0.001
L2 0.049 0.107 0.022 R2 0.005 0.019 0.000
R2 0.013 0.068 0.004 L3 0.005 0.029 0.000
R3 0.295 0.245 0.169 R3 0.003 0.031 0.000
L4 0.004 0.015 0.000 L5 0.017 0.061 0.001
L5 0.017 0.077 0.008 R5 0.005 0.033 0.000
R5 0.004 0.072 0.001 L2 0.005 0.020 0.000
L6 0.007 0.016 0.000 R2 0.058 0.083 0.014
R6 0.021 0.052 0.010 R3 0.015 0.044 0.002
L2 0.013 0.078 0.004 R5 0.015 0.029 0.001
R2 0.001 0.029 0.000 L6 0.012 0.027 0.000
L3 0.007 0.059 0.002 R6 0.023 0.022 0.001
R3 0.001 0.030 0.000 L2 0.012 0.038 0.001
L4 0.001 0.020 0.000 L3 0.013 0.029 0.001
L5 0.002 0.037 0.000 L5 0.023 0.054 0.002
R5 0.005 0.015 0.000 R5 0.019 0.053 0.002
R2 0.001 0.049 0.000 R6 0.017 0.042 0.002
L3 0.001 0.040 0.000 R1 0.018 0.037 0.001
R3 0.001 0.039 0.000 L2 0.060 0.089 0.012
L4 0.012 0.051 0.003 R2 0.055 0.067 0.010
R4 0.001 0.041 0.000 L3 0.020 0.039 0.002
L5 0.031 0.104 0.010 R3 0.024 0.064 0.003
R6 0.003 0.029 0.000 L4 0.034 0.031 0.001
L2 0.033 0.212 0.024 L5 0.038 0.063 0.003
R2 0.016 0.147 0.009 R5 0.028 0.052 0.002
L3 0.017 0.210 0.013 L6 0.025 0.045 0.003
R3 0.007 0.128 0.004 R6 0.024 0.053 0.003
R5 0.019 0.127 0.006
L6 0.020 0.083 0.004
R6 0.021 0.114 0.007
L1 0.008 0.066 0.005
R1 0.003 0.066 0.001
L2 0.031 0.184 0.017
R2 0.108 0.193 0.064
L3 0.002 0.126 0.001
R3 0.002 0.128 0.001
L5 0.057 0.102 0.033
R5 0.063 0.102 0.024
L6 0.036 0.110 0.012
R6 0.029 0.071 0.006
sham-
VEHd4
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Note – Table is continued on the next page. 
 
Rat # Section TSP4 GFAP Coloc. Rat # Section TSP4 GFAP Coloc.
L2 0.140 0.086 0.009 L1 0.024 0.077 0.001
L3 0.069 0.050 0.003 L2 0.096 0.028 0.001
L4 0.094 0.085 0.005 L3 0.049 0.074 0.005
L5 0.103 0.112 0.006 L4 0.023 0.094 0.002
L6 0.099 0.072 0.003 L5 0.083 0.098 0.015
L2 0.110 0.039 0.008 L6 0.061 0.089 0.007
L4 0.175 0.118 0.003 L1 0.032 0.097 0.002
L5 0.062 0.017 0.002 L2 0.048 0.142 0.008
L1 0.012 0.089 0.001 L3 0.082 0.090 0.005
L2 0.023 0.138 0.002 L4 0.017 0.027 0.000
L3 0.026 0.129 0.002 L5 0.062 0.084 0.009
L4 0.018 0.124 0.001 L6 0.005 0.058 0.000
L5 0.054 0.134 0.005 L1 0.019 0.045 0.001
L6 0.041 0.152 0.004 L2 0.002 0.125 0.001
L1 0.040 0.032 0.001 L3 0.002 0.112 0.000
L3 0.019 0.141 0.002 L5 0.015 0.046 0.000
L4 0.123 0.120 0.005 L1 0.021 0.060 0.000
L1 0.007 0.179 0.000 R1 0.039 0.083 0.001
L2 0.015 0.197 0.002 R2 0.017 0.078 0.001
L3 0.006 0.147 0.000 R2 0.039 0.047 0.001
L4 0.059 0.085 0.001 L3 0.045 0.023 0.001
L5 0.004 0.180 0.000 R3 0.045 0.048 0.001
L6 0.146 0.049 0.001 R5 0.019 0.007 0.000
176 L5 0.021 0.122 0.000 L6 0.003 0.038 0.000
L2 0.012 0.101 0.001 R6 0.008 0.054 0.000
L3 0.010 0.073 0.001 L2 0.005 0.113 0.000
L4 0.014 0.088 0.001 L3 0.002 0.097 0.000
L5 0.012 0.094 0.002 L4 0.002 0.094 0.000
L6 0.010 0.093 0.001 L5 0.013 0.130 0.002
L2 0.011 0.095 0.001 L6 0.018 0.118 0.003
L3 0.006 0.095 0.000 L1 0.025 0.034 0.003
L5 0.008 0.091 0.000 L2 0.044 0.039 0.005
L6 0.008 0.076 0.000 L4 0.009 0.037 0.001
L1 0.012 0.061 0.000 L5 0.009 0.036 0.001
R1 0.023 0.047 0.000 L1 0.005 0.045 0.001
L2 0.016 0.078 0.001 L2 0.023 0.047 0.003
L3 0.020 0.090 0.001 L3 0.004 0.033 0.001
L5 0.041 0.088 0.008 L4 0.009 0.037 0.001
L6 0.037 0.089 0.004 L5 0.001 0.032 0.000
L1 0.064 0.057 0.000 L6 0.013 0.037 0.001
L2 0.030 0.167 0.005 L1 0.044 0.045 0.008
L3 0.030 0.121 0.002 L2 0.001 0.034 0.000
L4 0.012 0.133 0.001 L6 0.036 0.043 0.004
L5 0.011 0.106 0.000 L1 0.021 0.025 0.001
L6 0.014 0.113 0.001 L3 0.006 0.038 0.001
L2 0.025 0.134 0.001 L4 0.043 0.026 0.004
L3 0.086 0.089 0.003 L5 0.035 0.065 0.006
L4 0.017 0.116 0.001 L6 0.010 0.050 0.003
L5 0.078 0.004 0.000 L1 0.018 0.036 0.002
L6 0.020 0.114 0.001 L2 0.012 0.024 0.001
L5 0.075 0.047 0.002 L3 0.028 0.026 0.002
L6 0.070 0.031 0.001 L4 0.035 0.025 0.002
L1 0.025 0.038 0.001 L5 0.018 0.060 0.003
R1 0.013 0.039 0.000 L6 0.022 0.028 0.001
L2 0.054 0.039 0.002 L2 0.013 0.016 0.000
R2 0.075 0.027 0.001 L3 0.011 0.013 0.000
R3 0.114 0.058 0.003 L4 0.009 0.008 0.000
L4 0.006 0.031 0.000 L5 0.019 0.018 0.001
R4 0.011 0.028 0.000 L6 0.011 0.019 0.000
L5 0.081 0.005 0.000 L1 0.005 0.037 0.001
R5 0.077 0.006 0.001 L2 0.010 0.038 0.001
L6 0.030 0.006 0.000 L3 0.009 0.027 0.001
R6 0.070 0.025 0.000 L6 0.001 0.020 0.000
151
152
inj-
BP0h
inj-
VEHd4
sham-
VEHd4
164
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149
150
Deep DH (continued)
148
inj-
BP0h
165
166
177
178
180
182
Deep DH
inj-
VEH0h
sham-
VEH0h
175
159
160
161
147
162
163
 318 
 
 
  
Rat # Section TSP4 GFAP Coloc.
L3 0.006 0.002 0.000
L4 0.003 0.003 0.000
L5 0.006 0.004 0.000
L6 0.004 0.005 0.000
L1 0.002 0.004 0.000
L2 0.004 0.006 0.000
L3 0.003 0.027 0.000
L5 0.008 0.016 0.000
L1 0.003 0.001 0.000
L2 0.012 0.005 0.000
L3 0.003 0.006 0.000
L4 0.013 0.004 0.000
L5 0.021 0.008 0.000
L2 0.057 0.044 0.004
L4 0.006 0.021 0.000
L2 0.008 0.006 0.000
L5 0.004 0.006 0.000
L1 0.017 0.008 0.000
L2 0.021 0.018 0.002
L4 0.002 0.004 0.000
L5 0.004 0.010 0.000
L6 0.020 0.007 0.000
L3 0.002 0.021 0.000
L4 0.001 0.016 0.000
L1 0.004 0.005 0.000
L2 0.004 0.008 0.000
L3 0.003 0.011 0.000
L4 0.011 0.034 0.001
L6 0.011 0.017 0.001
L2 0.048 0.065 0.013
L3 0.016 0.032 0.004
L5 0.028 0.064 0.006
L1 0.009 0.023 0.001
L2 0.029 0.037 0.003
L3 0.006 0.027 0.001
L4 0.012 0.012 0.001
L5 0.019 0.019 0.001
L6 0.016 0.027 0.002
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Figure G.4. Immunolabeling of TSP4 (green) and GFAP (red) in the superficial dorsal 
horn at day 7 for the bupivacaine treatment study. TSP4 and GFAP labeling were 
evaluated after sham or painful facet joint injury followed by intra-articular bupivacaine 
(BP) or saline vehicle (VEH) injections either immediately (inj-BP0h, inj-VEH0h, sham-
VEH0h) or at day 4 (inj-BPd4, inj-VEHd4, sham-VEHd4). Representative images are 
indicated by the rat number, and an image number that includes the right (R) or left (L) 
side of the spinal cord and the section of tissue (consecutive sections were labeled 1-6 for 
each rat). 
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 320 
 
 
Figure G.5. Immunolabeling of TSP4 (green) and GFAP (red) in the deep dorsal horn at 
day 7 for the bupivacaine treatment study. TSP4 and GFAP labeling were evaluated after 
sham or painful facet joint injury followed by intra-articular bupivacaine (BP) or saline 
vehicle (VEH) injections either immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at 
day 4 (inj-BPd4, inj-VEHd4, sham-VEHd4). Representative images are indicated by the 
rat number and section of tissue (consecutive sections were labeled 1-6 for each rat). 
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Figure G.6. Immunolabeling of TSP4 (green) and GFAP (red) in the dorsal columns at 
day 7 for the bupivacaine treatment study. TSP4 and GFAP labeling were evaluated after 
sham or painful facet joint injury followed by intra-articular bupivacaine (BP) or saline 
vehicle (VEH) injections either immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at 
day 4 (inj-BPd4, inj-VEHd4, sham-VEHd4). Representative images are indicated by the 
rat number, and an image number that includes the right (R) or left (L) side of the spinal 
cord and the section of tissue (consecutive sections were labeled 1-6 for each rat). 
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APPENDIX H 
 
Protocol for Counting Excitatory Synaptic Puncta 
 
 
This appendix details the protocol used for counting excitatory synapses from 
confocal microscopy images of immunolabeled spinal cord sections. The protocol, 
detailed in Section H.1, is based on previously published methods (Ippolito and Eroglu, 
2010). Spinal cord sections were labeled for synapsin, a presynaptic structural protein, 
and homer, a postsynaptic protein found in excitatory synapses. Detailed methods for 
immunolabeling and confocal imaging of synaptic proteins are presented in Section 5.3.5 
of Chapter 5. Confocal image stacks were acquired with up to 12 images at increments of 
0.33µm in the z-axis. Each sequence of three images (i.e., images 1-3, images 4-6, etc.) 
was combined to create a maximum intensity projection (MIP) corresponding to 1µm of 
tissue depth using a custom MATLAB code (see Section E.2 of Appendix E). 
 
H.1. Protocol for Counting Synaptic Puncta 
1. Open an MIP in ImageJ (NIH; Bethesda, MD) with the Puncta Analyzer plug-in 
installed. The Puncta Analyzer plug-in requires ImageJ version 1.29 or older. 
2. Select a region of interest or select the entire image and initialize the Punta Analyzer 
plug-in. 
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3. In the opening dialogue box, select the boxes for the red and green channels, and 
select the boxes to subtract background in the red and green channels (Fig. H.1). 
 
4. For the first (red) channel, subtract background by selecting a rolling ball radius of 50 
and deselecting the check box marked “White Background” (Fig. H.2). 
 
5. Move the slider bar to set the threshold for positive labeling in the red channel. The 
threshold should be set such that puncta in the spinal cord are discriminated from 
background labeling. The grayscale image with an overlayed depiction of positively-
 
 
Fig. H.2. Background subtraction dialogue box. Select a rolling ball radius of 50 for 
background subtraction. The grayscale images have a black background, so deselect 
the check box for white background. 
 
 
 
Fig. H.1. Puncta Analyzer initialization dialogue box. The red and green channels are 
selected for synapsin- (red) and homer-labeled (green) images, and background 
subtraction is selected for each channel. 
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labeled pixels can be compared with the original two-color image to determine if the 
selected threshold value discriminates positively-labeled puncta (Fig. H.3). 
 
6. Once a threshold value is selected, the next dialogue box determines the sensitivity of 
the detection algorithm to the size of positively-labeled puncta. Choose a minimum 
size of 4 pixels to discount all puncta with clusters of 3 or fewer pixels (Fig. H.4). 
7. Repeat steps 4-6 for the green channel. 
8. The generated results file reports the number of red, green, and colocalized puncta. 
Save the results as a .TXT file and save the new .TIFF image showing the locations of 
detected puncta overlaid on the original image. Record the red threshold, green 
threshold, and number of colocalized puncta in a separate Microsoft Excel table. 
 
 
Fig. H.3. Detection threshold for synaptic puncta. Choose a detection threshold that 
discriminates positively-labeled puncta (shown in red on the grayscale image to the 
left) from the background of the image. Use the original image (right) to confirm 
detection of positively-labeled puncta. 
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9. Determine the area of the tissue as a percentage of the total image area, excluding any 
holes or gaps in the tissue. A custom MATLAB code was written to find the area of 
the tissue parenchyma (see Section E.3 of Appendix E). For each image, choose a 
detection threshold that best discriminates the labeled tissue from holes or gaps in the 
tissue section (Fig. H.5). Record the chosen threshold value and the percentage of the 
image area identified as tissue. 
10. Divide the number of colocalized synaptic puncta by the tissue area percentage to 
calculate the synapse number normalized to the tissue area, or the synapse density. 
 
 
Fig. H.4. Puncta size dialogue box. Set the “Minimum Size” to 4 pixels to detect only 
those puncta comprised of 4 or more positively-labeled pixels clustered together. 
Check the box marked “Display Results” to output the number of puncta for the red 
and green channels and the number of colocalized puncta. 
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Fig. H.5. Detection of tissue area. A black and white mask is applied to the original 
image (a) by converting each pixel to black or white depending on its fluorescence 
intensity. (b) The black/white intensity threshold can be iteratively determined to 
discriminate tissue (white) from holes and gaps in the tissue (black). The threshold 
was set to 0.065 for this representative image. (c) After smoothing the black and white 
mask, the black areas correspond to the unlabeled regions in the original image. 
 
a) b)
c)
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APPENDIX I 
 
Quantification of Synaptic Puncta in the Spinal 
Dorsal Horn 
 
 
This appendix summarizes the quantification of excitatory synapses in the spinal 
dorsal horn. The protocol for synapse counting is presented in detail in Section H.1 of 
Appendix H. The tables in this appendix include the number of synapses identified in 
each image of the spinal dorsal horn, along with the group, rat number, and tissue section 
number (consecutive sections were numbered 1-6 on each slide). The percentage of tissue 
parenchyma in each image was measured using a custom MATLAB code (see Section 
E.3 of Appendix E) and used to calculate the normalized number of synapses per area. 
The fraction of the image detected as tissue area (Area), the threshold used for detection 
of tissue area (Area Coefficient), and the normalized synapse number (Normalized 
Synapses) are presented for each image in all tables. Tables I.2-I.4 also include the red 
and green channel thresholds (Red Threshold and Green Threshold) used for detecting 
synaptic puncta. 
 Table I.1 details the synapse counts from the superficial and deep dorsal horn at day 7 
after sham or painful facet joint injury in the studies presented in Chapter 5. Table I.2 
presents synapse counts in the superficial dorsal horn at day 7 after painful facet joint 
injury for rats that received TSP4 antisense or mismatch oligonucleotides, and Table I.3 
presents synapse counts in the superficial dorsal horn at day 7 after painful facet joint 
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injury for rats that received and gabapentin (Inj-GBP) or vehicle treatment (Inj-VEH); 
both tables correspond to studies presented in Chapter 5. Lastly, Table I.4 lists synapse 
counts in the superficial dorsal horn at day 7 after sham or painful facet joint injury in 
rats that received intra-articular bupivacaine (BP) or saline vehicle (VEH) either 
immediately (inj-BP0h, inj-VEH0h, sham-VEH0h) or at day 4 (inj-BPd4, inj-VEHd4, 
sham-VEHd4) after injury, in studies presented in Chapter 5.  
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Table I.1. Quantification of synapses at day 7 after sham or painful facet joint 
injury (Chapter 5). 
Rat # Slice Side Stack Synapses Area
Area 
Coefficient
Normalized 
Synapses
4 L 41 314 0.800 0.065 392.35
5 L 43 176 0.717 0.065 245.36
1 R 81 521 0.727 0.07 717.04
2 R 83 175 0.689 0.07 253.84
2 R 37 91 0.669 0.055 136.00
2 R 79 323 0.598 0.075 539.95
3 R 77a 207 0.834 0.075 248.08
7 L 21 203 0.607 0.06 334.60
8 L 23 346 0.787 0.075 439.70
2 R 61a 190 0.652 0.065 291.50
4 L 25 456 0.801 0.07 569.43
5 L 27 197 0.591 0.065 333.39
5 R 65 422 0.483 0.075 873.89
6 L 67 127 0.739 0.075 171.76
9 R 85 242 0.617 0.07 392.28
7 R 45a 93 0.762 0.07 122.06
4 L 5 202 0.740 0.05 272.97
5 L 7 189 0.440 0.055 429.74
10 R 49 178 0.743 0.065 239.47
11 L 51 67 0.561 0.07 119.34
6 R 87 170 0.655 0.075 259.54
8 L 29 119 0.534 0.06 222.93
9 L 31 45 0.675 0.055 66.66
1 L 69 161 0.802 0.065 200.65
2 R 71 171 0.860 0.07 198.93
7 L 17 128 0.645 0.05 198.36
8 L 19 339 0.814 0.06 416.56
2 L 53 246 0.693 0.07 355.18
9 L 55 150 0.881 0.06 170.36
4 L 13 114 0.526 0.06 216.73
7 R 57 122 0.711 0.065 171.49
8 R 59 136 0.721 0.07 188.63
4 L 33 107 0.594 0.06 180.26
5 L 35 152 0.804 0.06 189.01
11 L 73 128 0.741 0.06 172.72
6 R 75 258 0.776 0.065 332.69
4 L 42 141 0.641 0.06 220.07
5 L 44 42 0.624 0.05 67.34
1 R 82 81 0.815 0.075 99.36
2 R 84 427 0.795 0.07 537.38
2 R 38 56 0.774 0.05 72.36
4 L 40 100 0.688 0.06 145.29
3 R 78 279 0.810 0.07 344.66
2 R 80 57 0.729 0.055 78.19
7 L 22 189 0.718 0.055 263.34
8 L 24 26 0.641 0.07 40.56
2 R 62a 134 0.518 0.075 258.54
Group
49
49
56
55
50
60
53
54
52
48
48
47
47
Superficial 
Dorsal Horn
Injury
Sham
Deep Dorsal 
Horn
Injury
 
Note – Table is continued on the next page. 
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Rat # Slice Side Stack Synapses Area
Area 
Coefficient
Normalized 
Synapses
4 L 26 12 0.586 0.06 20.50
5 L 28 204 0.596 0.065 342.05
5 R 66 405 0.680 0.07 595.41
6 L 68 107 0.674 0.06 158.75
1 L 2 119 0.681 0.05 174.74
2 L 3 53 0.647 0.05 81.98
9 R 86 166 0.640 0.07 259.29
7 R 46a 49 0.734 0.06 66.74
4 L 6 280 0.819 0.05 341.88
5 L 8 107 0.792 0.05 135.14
10 R 50 155 0.584 0.065 265.41
6 L 88 152 0.690 0.06 220.23
8 L 30 37 0.819 0.05 45.17
9 L 32 89 0.731 0.05 121.72
1 L 70 242 0.726 0.06 333.47
2 R 72 295 0.890 0.07 331.65
7 L 18 284 0.714 0.07 397.76
8 L 20 169 0.784 0.06 215.53
2 L 54 282 0.766 0.07 368.24
9 L 56 177 0.754 0.06 234.81
5 L 16 50 0.817 0.06 61.19
7 R 58 214 0.664 0.065 322.29
8 R 60 508 0.731 0.075 694.75
4 L 34 175 0.610 0.06 286.70
5 L 36 30 0.506 0.05 59.32
11 L 74 44 0.653 0.06 67.36
6 R 76 141 0.853 0.065 165.34
Group
52
56
55
50
Sham
Injury
Deep Dorsal 
Horn 
(continued)
60
53
54
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Table I.2. Quantification of synapses at day 7 after painful facet injury and prior 
treatment with TSP4 antisense or mismatch oligonucleotides (Chapter 5). 
 
Note – Table is continued on the next page. 
Group Rat # Slice Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 1 542 85 105 0.888 0.07 610.43
2 2 330 90 100 0.880 0.06 375.17
3 3 516 95 95 0.912 0.07 566.04
4 4 418 95 110 0.809 0.06 516.75
5 5 531 95 105 0.929 0.06 571.34
6 6 259 105 80 0.930 0.06 278.43
1 7 194 68 80 0.888 0.045 218.44
2 8 264 100 110 0.978 0.065 269.94
3 9 304 70 80 0.839 0.055 362.29
4 10 186 60 60 0.892 0.047 208.64
5 11 240 80 75 0.661 0.05 363.03
6 12 275 75 75 0.871 0.045 315.91
1 39 161 50 65 0.680 0.025 236.83
2 40 223 48 60 0.713 0.03 312.81
3 41 171 45 53 0.718 0.018 238.33
4 42 497 75 85 0.725 0.037 685.42
5 43 367 75 90 0.776 0.03 472.94
6 44 319 90 90 0.825 0.05 386.48
1 45 295 75 85 0.743 0.027 397.04
2 46 241 80 85 0.713 0.022 337.87
3 47 251 70 75 0.764 0.04 328.71
4 48 397 82 90 0.753 0.035 527.15
5 49 315 68 83 0.722 0.025 436.17
6 50 207 50 75 0.769 0.025 269.15
1 69 702 95 100 0.828 0.05 847.83
2 70 347 90 90 0.869 0.06 399.13
3 71 147 70 62 0.883 0.04 166.57
4 73 550 70 73 0.850 0.04 647.36
5 74 331 80 75 0.936 0.05 353.78
1 75 767 125 130 0.954 0.06 804.40
2 76 816 125 130 0.901 0.06 905.56
3 77 124 77 73 0.871 0.025 142.45
4 78 468 115 115 0.892 0.05 524.49
5 79 594 130 115 0.837 0.045 709.68
6 80 276 60 60 0.926 0.027 298.22
1 27 330 85 85 0.644 0.04 512.42
2 28 570 95 95 0.796 0.055 716.44
3 29 225 70 60 0.781 0.035 288.17
4 30 534 95 85 0.691 0.035 772.68
5 31 392 80 77 0.756 0.035 518.31
6 32 259 60 50 0.760 0.035 340.70
Antisense 
Oligonucleotide 
Treatment
253
254
255
256
259
260
257
Mismatch 
Oligonucleotide 
Treatment
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Group Rat # Slice Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 33 479 100 105 0.740 0.055 647.30
2 34 442 77 85 0.797 0.045 554.58
3 35 232 80 75 0.823 0.032 281.93
4 36 538 75 95 0.822 0.03 654.26
5 37 533 75 90 0.775 0.03 687.56
6 38 253 50 80 0.760 0.03 332.72
1 13 499 60 70 0.930 0.06 536.33
2 14 749 105 110 0.861 0.065 870.12
3 15 549 100 105 0.952 0.065 576.98
4 16 446 55 65 0.909 0.055 490.54
5 17 1091 100 120 0.973 0.06 1121.62
6 18 519 100 115 0.909 0.075 570.83
1 19 299 70 55 0.903 0.055 331.08
2 20 737 105 95 0.972 0.065 758.54
3 21 404 75 80 0.940 0.06 429.79
4 22 328 50 50 0.750 0.045 437.51
5 23 548 105 95 0.934 0.07 586.66
6 24 340 67 70 0.840 0.05 404.76
1 57 484 82 97 0.676 0.065 715.98
2 58 646 82 102 0.692 0.06 933.26
3 59 310 75 87 0.737 0.055 420.85
4 60 375 73 82 0.561 0.05 668.33
5 61 691 80 90 0.876 0.06 789.08
6 62 254 80 80 0.792 0.055 320.87
1 63 949 115 100 0.911 0.065 1041.48
2 64 450 95 90 0.902 0.05 498.78
3 65 248 73 77 0.832 0.045 297.97
4 66 923 135 130 0.843 0.07 1094.51
5 67 966 135 130 0.966 0.07 1000.52
6 68 442 90 85 0.825 0.05 535.76
Mismatch 
Oligonucleotide 
Treatment 
(continued)
261
262
258
263
264
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Table I.3. Quantification of synapses at day 7 for gabapentin treatment study 
(Chapter 5). 
 
 
 
  
Group Rat # Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 187 115 160 0.508 0.07 367.97
2 153 100 160 0.661 0.07 231.47
6 141 75 145 0.584 0.055 241.31
4 243 95 185 0.566 0.07 429.10
5 220 95 165 0.730 0.06 301.58
7 132 90 150 0.825 0.055 160.06
8 132 95 155 0.733 0.06 180.20
41 46 70 110 0.405 0.055 113.47
42 124 90 115 0.602 0.06 205.91
46 152 90 120 0.746 0.05 203.70
47 247 95 130 0.646 0.06 382.23
43 111 90 120 0.672 0.06 165.23
44 75 85 110 0.625 0.055 119.94
45 159 100 135 0.781 0.06 203.48
48 107 85 145 0.726 0.065 147.40
33 57 90 125 0.550 0.065 103.64
34 96 90 125 0.480 0.06 200.00
36 64 90 125 0.369 0.06 173.44
35 144 95 155 0.762 0.07 188.90
37 179 85 130 0.649 0.06 275.98
38 154 85 125 0.466 0.065 330.19
26 124 80 115 0.496 0.07 250.20
29 61 85 130 0.434 0.065 140.49
30 122 90 135 0.543 0.078 224.84
27 179 90 120 0.497 0.06 360.09
28 339 90 145 0.643 0.07 526.89
31 229 90 135 0.614 0.065 373.15
17 124 82 150 0.437 0.065 283.95
18 252 90 135 0.566 0.06 444.92
19 154 80 135 0.311 0.075 494.70
22 243 95 140 0.428 0.075 568.29
20 303 100 130 0.460 0.07 659.27
21 109 90 140 0.421 0.07 259.09
23 235 95 185 0.402 0.11 585.16
24 239 90 125 0.562 0.065 424.96
9 94 75 125 0.341 0.075 275.42
10 123 85 125 0.539 0.07 228.12
13 389 105 120 0.562 0.07 691.92
14 152 85 130 0.549 0.07 276.87
11 198 85 120 0.510 0.07 388.39
12 73 80 135 0.540 0.065 135.14
15 217 85 155 0.584 0.08 371.32
16 336 90 145 0.596 0.07 564.14
337
338
302
304
Inj-GBP
Inj-VEH
301
303
307
308
305
306
339
341
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Table I.4. Quantification of synapses at day 7 for bupivacaine treatment study 
(Chapter 5). 
 
Note – Table is continued on the next page. 
Group Rat # Slice Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 25 351 75 103 0.582 0.07 602.99
2 26 330 90 90 0.839 0.07 393.56
4 27 538 105 100 0.754 0.07 713.15
5 28 802 115 110 0.896 0.075 895.29
1 29 1258 115 95 0.916 0.07 1372.76
4 30 572 100 105 0.969 0.075 590.48
1 1 329 80 70 0.724 0.075 454.23
2 2 260 75 60 0.840 0.065 309.45
3 3 277 73 67 0.930 0.075 297.98
4 16 535 100 90 0.955 0.07 560.39
5 17 604 110 85 0.973 0.07 620.76
6 18 390 95 78 0.942 0.07 414.19
1 19 713 115 90 0.799 0.07 892.81
2 20 569 115 95 0.932 0.07 610.52
3 21 350 90 80 0.925 0.075 378.21
4 22 449 105 85 0.939 0.075 478.27
5 23 724 115 90 0.956 0.07 757.01
6 24 453 90 78 0.921 0.065 491.70
1 4 240 73 70 0.847 0.06 283.29
2 5 216 82 75 0.937 0.07 230.57
3 6 275 73 75 0.977 0.06 281.62
4 7 624 115 90 0.902 0.065 692.10
5 8 630 110 90 0.967 0.07 651.70
6 9 685 95 90 0.899 0.07 762.30
1 10 1016 110 95 0.941 0.07 1080.05
2 11 945 115 100 0.972 0.07 972.62
3 12 486 100 97 0.917 0.065 529.93
4 13 547 90 60 0.854 0.06 640.29
5 14 726 110 75 0.901 0.06 805.68
6 15 710 100 87 0.857 0.06 828.37
1 31 162 70 75 0.473 0.07 342.78
2 32 170 55 60 0.587 0.07 289.81
3 33 208 65 70 0.674 0.065 308.61
4 34 282 90 95 0.845 0.065 333.57
5 35 212 77 75 0.713 0.065 297.42
6 36 131 70 65 0.681 0.05 192.51
1 43 327 75 80 0.766 0.055 426.84
2 44 407 68 70 0.771 0.06 528.02
3 45 122 70 60 0.789 0.05 154.61
4 46 426 90 87 0.731 0.06 583.08
5 47 303 73 70 0.790 0.05 383.69
6 48 223 70 60 0.749 0.05 297.77
1 49 376 100 85 0.906 0.06 415.10
2 50 185 75 65 0.809 0.055 228.71
3 51 253 80 55 0.860 0.055 294.05
4 52 860 120 100 0.854 0.07 1006.67
5 53 150 80 65 0.887 0.055 169.15
6 54 426 120 110 0.891 0.07 477.95
173
inj-VEH0h
149
148
147
171
172
inj-BP0h
174
173
176
175
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Note – Table is continued on the next page. 
Group Rat # Slice Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 55 300 90 82 0.811 0.055 370.00
2 56 335 80 70 0.856 0.05 391.45
3 57 171 75 85 0.852 0.06 200.63
4 58 338 115 100 0.889 0.06 380.29
5 59 167 85 75 0.895 0.06 186.53
6 60 384 115 100 0.847 0.06 453.26
1 37 310 65 63 0.890 0.06 348.43
2 38 312 64 70 0.809 0.065 385.52
3 39 224 70 72 0.821 0.065 272.77
4 40 250 100 80 0.819 0.06 305.40
5 41 188 45 50 0.778 0.04 241.55
6 42 78 58 50 0.720 0.035 108.36
1 61 645 125 105 0.951 0.07 678.09
2 62 336 115 105 0.925 0.07 363.24
3 63 309 85 80 0.890 0.06 347.11
4 64 225 90 75 0.910 0.06 247.28
5 65 193 72 78 0.920 0.07 209.85
6 66 255 87 65 0.845 0.06 301.81
1 67 431 105 93 0.890 0.07 484.54
2 68 77 75 70 0.811 0.055 94.96
3 69 69 75 70 0.846 0.06 81.57
4 70 650 105 115 0.923 0.075 704.61
5 71 166 110 90 0.898 0.07 184.96
6 72 282 85 70 0.917 0.065 307.63
1 73 381 105 115 0.841 0.06 452.92
2 74 261 105 90 0.840 0.06 310.79
3 75 176 68 65 0.906 0.05 194.26
4 76 383 90 85 0.838 0.06 457.10
5 77 65 72 68 0.839 0.07 77.44
1 80 79 80 75 0.949 0.07 83.28
2 81 145 73 70 0.829 0.055 174.85
3 82 57 67 60 0.839 0.04 67.91
4 83 396 100 95 0.836 0.06 473.97
5 84 305 105 90 0.815 0.06 374.19
6 85 187 65 70 0.652 0.06 286.72
1 86 514 115 105 0.912 0.07 563.84
2 87 733 115 120 0.980 0.075 747.65
3 88 374 100 95 0.926 0.06 403.89
4 89 488 90 88 0.934 0.075 522.26
5 90 294 105 100 0.938 0.075 313.40
1 91 180 95 85 0.934 0.07 192.82
2 92 139 82 85 0.678 0.06 205.17
3 93 189 85 85 0.781 0.06 241.94
4 94 187 90 92 0.720 0.06 259.90
5 95 320 125 100 0.752 0.06 425.59
6 96 191 90 85 0.696 0.055 274.35
1 97 210 90 100 0.876 0.06 239.86
2 98 293 100 103 0.858 0.06 341.41
3 99 253 75 75 0.857 0.06 295.08
4 100 351 75 80 0.823 0.07 426.44
5 101 607 105 90 0.893 0.07 679.50
6 102 287 85 70 0.973 0.07 294.87
sham-VEH0h
164
163
162
161
160
159
152
150
151
inj-BP0h 
(continued)
 336 
 
Note – Table is continued on the next page. 
Group Rat # Slice Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 1 328 64 65 0.853 0.075 384.75
2 2 438 85 80 0.948 0.075 461.98
3 3 263 85 70 0.882 0.07 298.32
4 4 278 85 75 0.937 0.075 296.79
5 5 474 95 80 0.931 0.075 509.24
6 6 554 100 75 0.919 0.065 603.16
1 7 720 100 85 0.955 0.07 754.24
2 8 593 90 85 0.954 0.075 621.59
3 9 595 100 80 0.937 0.06 634.87
4 10 904 100 85 0.966 0.07 935.82
5 11 429 80 72 0.961 0.075 446.64
6 12 338 85 70 0.872 0.07 387.79
1 13 200 75 62 0.837 0.075 239.06
2 14 150 80 60 0.630 0.07 238.28
3 15 503 100 75 0.867 0.07 580.36
4 16 363 80 65 0.887 0.075 409.15
5 17 263 75 60 0.881 0.075 298.46
6 18 700 90 80 0.731 0.075 958.25
1 19 503 100 85 0.851 0.075 591.14
2 20 324 85 73 0.854 0.075 379.39
3 21 613 100 90 0.892 0.075 687.61
4 22 401 85 67 0.852 0.075 470.88
5 23 266 75 50 0.847 0.05 313.94
6 24 446 100 85 0.887 0.065 502.99
1 25 557 100 80 0.967 0.09 576.19
2 26 689 105 85 0.868 0.075 793.96
3 27 334 85 70 0.888 0.08 376.30
4 28 709 115 95 0.797 0.075 889.59
5 29 691 100 85 0.856 0.075 806.96
6 30 216 80 60 0.671 0.068 321.81
1 31 167 85 70 0.832 0.075 200.70
2 32 252 60 50 0.672 0.06 374.89
3 33 564 95 80 0.857 0.075 657.96
4 42 623 105 95 0.908 0.09 686.43
5 43 576 115 100 0.741 0.075 777.22
1 36 859 125 110 0.838 0.075 1025.06
2 37 670 125 120 0.890 0.08 753.23
3 38 439 85 75 0.701 0.075 626.25
4 39 688 105 115 0.893 0.08 770.78
5 40 685 105 105 0.793 0.08 863.37
6 41 210 105 85 0.760 0.075 276.28
1 44 283 70 70 0.853 0.09 331.69
2 45 361 75 65 0.849 0.08 425.11
3 46 311 75 62 0.906 0.08 343.27
4 47 113 90 75 0.970 0.085 116.46
5 48 481 105 85 0.961 0.08 500.57
6 49 227 95 75 0.948 0.08 239.43
1 50 701 95 85 0.770 0.08 910.63
2 51 611 105 90 0.862 0.08 708.90
3 52 262 85 70 0.815 0.07 321.43
4 53 580 115 90 0.655 0.075 886.04
5 54 561 115 105 0.880 0.075 637.64
6 55 264 105 90 0.834 0.06 316.43
153
inj-BPd4
inj-VEHd4
177
178
179
180
182
156
155
154
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Group Rat # Slice Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Area 
Coefficient
Normalized 
Synapses
1 56 406 85 85 0.696 0.075 583.17
2 57 490 105 90 0.888 0.075 551.62
3 58 434 85 75 0.932 0.07 465.57
4 59 515 100 90 0.801 0.065 643.27
5 60 863 115 105 0.929 0.075 928.76
6 61 465 105 85 0.857 0.08 542.59
1 62 502 112 100 0.669 0.075 749.93
2 63 760 90 82 0.904 0.075 840.71
3 64 307 83 75 0.855 0.07 358.98
4 65 529 115 108 0.865 0.08 611.35
5 66 712 115 100 0.802 0.075 887.56
6 67 580 105 100 0.946 0.08 612.85
1 68 263 80 75 0.759 0.035 346.33
2 69 129 80 65 0.519 0.045 248.60
3 70 199 85 75 0.632 0.045 314.67
4 71 382 120 115 0.655 0.075 583.12
5 72 702 110 90 0.767 0.045 915.13
6 73 304 92 80 0.747 0.03 406.74
1 74 525 125 110 0.813 0.06 645.44
2 75 791 125 125 0.729 0.055 1085.79
3 76 268 115 100 0.794 0.045 337.45
4 77 277 105 105 0.799 0.04 346.77
5 78 467 105 90 0.761 0.035 613.42
6 79 359 105 90 0.746 0.03 481.30
1 80 103 100 67 0.615 0.03 167.40
2 81 177 100 85 0.789 0.04 224.25
3 82 100 95 70 0.782 0.04 127.94
4 83 409 120 100 0.785 0.045 521.35
5 84 308 115 110 0.781 0.04 394.21
6 85 123 90 80 0.714 0.035 172.32
1 86 195 125 115 0.643 0.04 303.45
2 87 357 125 110 0.748 0.04 477.40
3 88 236 90 80 0.810 0.035 291.43
5 89 333 90 115 0.679 0.035 490.57
6 90 184 100 85 0.727 0.03 253.16
1 91 46 75 70 0.707 0.03 65.11
2 92 220 90 85 0.932 0.07 235.95
4 93 235 95 75 0.884 0.04 265.96
5 94 231 100 85 0.824 0.045 280.34
6 95 131 90 72 0.753 0.04 173.97
1 96 337 98 87 0.522 0.065 646.09
2 97 302 130 115 0.700 0.035 431.68
3 98 168 95 62 0.514 0.05 327.17
4 99 410 135 115 0.715 0.04 573.19
5 100 272 90 85 0.743 0.04 366.03
6 101 91 90 75 0.702 0.04 129.61
inj-BPd4 
(continued)
158
157
sham-VEHd4
170
169
168
167
166
165
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APPENDIX J 
 
Mechanical Hyperalgesia after Nerve Root 
Compression  
 
 
This appendix summarizes the temporal mechanical hyperalgesia responses in the 
forepaws for each rat that underwent a painful C7 dorsal nerve root compression in the 
studies of spinal cord stimulation in Chapters 6 and 7. Mechanical hyperalgesia is 
reported as the paw withdrawal threshold (PWT) for the ipsilateral and contralateral 
forepaws of each rat on each testing day, including the average baseline response (BL). 
Paw withdrawal thresholds for each forepaw were averaged based on three separate 
rounds of testing on each day. Table J.1 details the PWTs for all the rats included in 
studies using burst or tonic spinal cord stimulation; painful nerve root compression was 
applied seven days before spinal cord stimulation and hyperalgesia was assessed at 
baseline and on days 1, 3, 5, and 7 after nerve root compression. 
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Table J.1. Paw withdrawal thresholds after painful nerve root compression for 
spinal cord stimulation at day 7 (Chapters 6 and 7).   
 
 
Ipsilateral Forepaw Contralateral Forepaw 
 
Rat # BL D1 D3 D5 D7 BL D1 D3 D5 D7 
Painful 
Nerve Root 
Compression 
J69 6.67 3.33 4.00 4.00 4.67 11.67 11.00 10.00 17.00 12.67 
J71 15.00 2.13 1.13 4.00 5.33 6.67 11.00 15.00 13.33 9.33 
J73 15.67 4.00 4.47 6.67 5.33 14.00 11.67 16.33 18.67 12.67 
J88 8.33 0.87 2.67 2.67 3.53 8.50 7.33 8.67 8.33 9.33 
J89 3.67 0.60 1.80 0.87 1.53 4.00 3.13 6.67 6.00 2.00 
J90 11.00 2.47 5.33 7.33 6.67 14.83 14.67 13.33 11.00 18.67 
J91 11.33 11.67 3.33 1.80 2.27 16.17 26.00 26.00 8.00 7.33 
J92 4.00 0.60 0.60 1.40 1.33 4.00 8.00 1.80 1.80 3.13 
207 8.67 4.67 3.33 2.67 4.00 9.50 8.00 7.33 7.33 7.33 
208 12.17 4.67 6.67 4.00 4.00 14.17 15.00 10.00 8.00 8.00 
209 13.50 6.00 8.00 10.00 8.67 19.67 13.33 11.67 18.67 18.67 
210 19.67 4.00 4.00 4.00 5.33 20.50 15.00 10.00 10.00 11.00 
211 13.33 5.33 4.67 4.00 4.00 12.17 18.67 11.00 13.33 11.67 
212 16.00 6.00 6.00 5.33 5.33 20.33 26.00 26.00 15.00 18.67 
215 17.83 8.00 6.00 4.67 3.33 14.17 17.00 13.33 11.00 11.67 
216 20.50 6.67 4.67 6.67 5.33 19.67 22.33 13.33 15.00 11.67 
249 8.67 2.47 1.60 1.80 3.33 12.67 15.00 8.33 6.67 8.00 
250 18.67 8.00 10.33 5.33 4.00 18.67 11.67 14.67 18.67 15.00 
251 12.67 2.47 1.33 2.47 2.20 13.33 15.00 6.00 9.67 9.67 
252 11.00 0.60 1.33 1.33 3.33 11.00 9.67 7.33 10.33 11.00 
265 22.33 2.67 4.00 4.00 7.00 24.17 22.33 22.33 18.67 22.33 
266 18.50 4.00 4.00 4.00 4.00 16.00 11.67 8.67 13.33 18.67 
267 10.33 0.60 2.67 2.67 3.33 9.17 9.33 12.67 8.67 13.33 
268 14.50 1.80 2.67 2.67 1.80 12.17 18.67 15.00 11.00 18.67 
269 22.33 2.67 4.67 1.80 4.00 16.83 12.67 15.00 15.00 15.00 
Note - Rats #J69-J92 were labeled according to Jenell Smith’s rat numbering scheme. 
Rats #207-269 were labeled according to the numbering scheme used in the remainder of 
this thesis. Rats #J69-J92 were used in the studies presented in Chapter 6, and rats #207-
269 were used in the studies presented in Chapter 7. 
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APPENDIX K 
 
Joint Distraction Mechanics, Hyperalgesia, and 
Synapse Density in the Dorsal Horn at Day 14 
after Painful Facet Joint Injury  
 
 
 This appendix summarizes the data presented in Chapter 8, including the 
quantification of mechanical hyperalgesia and excitatory and inhibitory synapses in the 
spinal cord on day 14 after either a sham surgery or painful facet joint injury. Table K.1 
summarizes the force, displacement, and strain data measured across the C6/C7 facet 
joint for each rat that underwent joint distraction. Table K.2 lists the paw withdrawal 
thresholds for each rat at baseline (BL) and on days 1, 3, 5, 7, 10, and 14 after the sham 
or painful facet joint injury procedures.  
Table K.3 presents the quantification of excitatory synapses in the superficial 
dorsal horn at day 14 in those same groups. Excitatory synapses were quantified by 
immunolabeling the colocalization of the pre-synaptic marker, synapsin (red), and the 
post-synaptic marker, homer (green), as described in detail in Section 5.3.5 of Chapter 5 
and in Section H.1 of Appendix H. In two separate rounds of quantification, the number 
of synapses was identified in each image, and the percentage of tissue parenchyma was 
measured using a custom MATLAB code (see Section E.3 of Appendix E) (Crosby et al., 
2014c). The percentage of the image detected as tissue area (Area) was then used to 
calculate the number of synapses normalized to the tissue area for each image (synapse 
density). The synapse densities in the injury group were normalized to the average of the 
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synapse densities in the sham group for each round. The normalized synapse densities 
from the two rounds of quantification were averaged to yield a single synapse density for 
each tissue section. Table K.3 presents the synapse number and percentage of area for 
each image of the spinal dorsal horn for each rat, along with the group, rat number, and 
tissue section number. The table also lists the normalized synapse densities from each 
round of labeling, and the average of the two rounds for each tissue section. 
Table K.4 summarizes the quantification of inhibitory synapses in the superficial 
dorsal horn at day 14 after sham or painful facet joint injury. Inhibitory synapses were 
quantified by immunolabeling gephyrin (red), a post-synaptic protein in inhibitory 
synapses, and bassoon (green), a pre-synaptic structural protein, using the same protocol 
described in Section H.1 of Appendix H for excitatory synapses. The number of synapses 
identified in each image of the spinal dorsal horn is presented for each rat, along with the 
group, rat number, tissue section number (consecutive sections were numbered 1-6 on 
each slide), and the side of the spinal cord (left, L, or right, R). The table also includes the 
red and green channel thresholds (Red Threshold and Green Threshold) used for 
detecting synaptic puncta. The percentage of tissue parenchyma in each image was 
measured using a custom MATLAB code (see Section E.3 of Appendix E) (Crosby et al., 
2014c). The percentage of the image detected as tissue area (Area) was then used to 
calculate the number of synapses normalized to the tissue area (Normalized Synapses) for 
each image. 
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Table K.1. Facet joint distraction mechanics for rats that were tested for 
hyperalgesia through day 14 after painful facet joint injury (Chapter 8). 
 
 
Table K.2. Paw withdrawal thresholds through day 14 after sham or painful facet 
joint injury (Chapter 8). 
 
Group Rat # Load (N)
Vertebral 
Distraction 
(mm)
Average 
Capsule 
Distraction 
(mm)
Maximum 
MPS (%)
Average 
MPS (%)
Maximum              
x-strain 
(%)
Average                    
x-strain 
(%)
Maximum                 
y-strain 
(%)
Average                   
y-strain 
(%)
100 3.35 0.72 0.44 23.6 21.9 19.0 15.8 7.0 2.5
101 3.16 0.83 0.37 25.3 23.4 21.3 17.0 1.3 -1.9
102 3.33 0.69 0.31 22.3 19.0 17.9 13.8 11.9 6.3
103 4.04 0.64 0.33 23.2 18.0 15.5 12.3 7.9 -0.7
104 2.92 0.68 0.33 34.3 24.2 24.6 15.5 7.1 2.3
105 3.06 0.60 0.54 56.6 39.7 41.1 31.1 -0.5 -7.2
Injury
Group Rat # BL D1 D3 D5 D7 D10 D14
100 7.60 3.67 5.00 6.00 6.00 8.33 7.67
101 11.80 6.33 4.00 2.00 2.33 1.70 2.00
102 18.30 4.00 6.33 4.00 3.33 3.67 3.67
103 12.80 6.67 4.67 6.33 3.33 4.67 4.67
104 10.60 6.00 5.33 6.33 7.67 6.00 6.67
105 12.00 6.67 5.33 3.67 4.33 3.47 3.33
106 10.10 9.00 8.33 9.83 9.67 8.00 10.17
107 10.90 8.33 16.17 15.17 10.33 10.67 10.50
108 7.60 10.17 9.33 7.00 7.33 12.50 14.00
109 18.90 13.33 9.17 11.33 9.67 8.67 10.83
110 10.50 10.75 10.50 9.00 11.33 10.50 11.33
Injury
Sham
 343 
Table K.3. Quantification of excitatory synapses in the superficial dorsal horn at 
day 14 after sham or painful facet joint injury (Chapter 8). 
 
Note – Table is continued on the next page. Missing values are from sections that were 
torn, folded over, or came off the slide during immunolabeling. These data were collected 
and analyzed by Ben Bulka. 
Average
Group Rat # Slice Synapses Area (%)
Synapse Density 
Normalized to 
Sham Avg
Synapses Area (%)
Synapse Density 
Normalized to 
Sham Avg
Synapse Density 
Normalized to 
Sham Avg
1 254 0.7865 3.067 --- --- --- 3.067
2 113 0.8078 1.330 547 0.8608 3.898 2.614
3 --- --- --- 188 0.7598 1.518 1.518
4 81 0.7719 0.997 70 0.9351 0.459 0.728
5 --- --- --- 173 0.85 1.249 1.249
5 65 0.6447 0.959 302 0.8323 2.226 1.593
6 57 0.6261 0.864 --- --- --- 0.864
1 80 0.7294 1.045 --- --- --- 1.045
2 70 0.8412 0.788 397 0.9182 2.653 1.720
2 --- --- --- 236 0.9106 1.590 1.590
3 101 0.62 1.548 148 0.8476 1.071 1.310
3 --- --- --- 100 0.9091 0.675 0.675
4 65 0.655 0.940 57 0.7704 0.454 0.697
5 --- --- --- 427 0.8792 2.980 2.980
6 --- --- --- 219 0.8127 1.653 1.653
1 40 0.495 0.769 --- --- --- 0.769
2 84 0.6328 1.263 90 0.6292 0.878 1.070
3 1 0.4491 0.019 170 0.6533 1.596 0.808
4 256 0.5859 4.150 172 0.8148 1.295 2.723
5 22 0.6774 0.304 224 0.8292 1.657 0.981
6 37 0.5658 0.617 570 0.8488 4.120 2.369
1 3 0.4492 0.066 54 0.8232 0.402 0.234
2 32 0.7445 0.408 79 0.9047 0.536 0.472
3 91 0.7701 1.121 74 0.8875 0.512 0.816
5 5 0.6985 0.066 153 0.801 1.172 0.619
5 --- --- --- 62 0.7707 0.494 0.494
6 248 0.8058 2.925 58 0.8468 0.420 1.673
1 222 0.5198 4.056 --- --- --- 4.056
2 36 0.6666 0.513 --- --- --- 0.513
3 120 0.6632 1.718 --- --- --- 1.718
4 134 0.6306 2.018 --- --- --- 2.018
5 29 0.7282 0.378 --- --- --- 0.378
6 144 0.52512 2.604 --- --- --- 2.604
1 76 0.7011 1.026 103 0.79 0.800 0.913
2 50 0.416 1.140 141 0.7995 1.082 1.111
3 69 0.59 1.111 60 0.3832 0.961 1.036
4 30 0.59 0.484 163 0.6585 1.519 1.001
5 --- --- --- 107 0.9534 0.689 0.689
6 146 0.4968 2.792 29 0.4482 0.397 1.594
Round 2Round 1
Injury
100
101
102
103
104
105
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Note –Missing values are from sections that were torn, folded over, or came off the slide 
during immunolabeling. These data were collected and analyzed by Ben Bulka. 
 
  
Average
Group Rat # Slice Synapses Area (%)
Synapse Density 
Normalized to 
Sham Avg
Synapses Area (%)
Synapse Density 
Normalized to 
Sham Avg
Synapse Density 
Normalized to 
Sham Avg
1 8 0.6942 0.114 248 0.9125 1.667 0.891
2 5 0.5791 0.085 239 0.8593 1.706 0.896
3 140 0.7085 1.880 127 0.9 0.866 1.373
4 74 0.5239 1.339 201 0.8957 1.377 1.358
5 --- --- --- 180 0.9189 1.202 1.202
6 --- --- --- 49 0.745 0.404 0.404
1 101 0.6926 1.415 34 0.8854 0.236 0.825
2 --- --- --- 119 0.8984 0.813 0.813
3 --- --- --- 63 0.7605 0.508 0.508
4 143 0.6958 1.956 86 0.9419 0.560 1.258
5 --- --- --- 72 0.939 0.470 0.470
6 154 0.7513 1.947 158 0.882 1.099 1.523
1 163 0.9764 1.586 9 0.4627 0.119 0.853
2 --- --- --- 54 0.8335 0.397 0.397
2 112 0.9611 1.111 24 0.5816 0.253 0.682
4 123 0.8039 1.453 --- --- --- 1.453
6 73 0.9665 0.722 --- --- --- 0.722
1 24 0.6896 0.332 243 0.8645 1.724 1.028
2 114 0.8203 1.320 371 0.8904 2.556 1.938
3 49 0.603 0.769 332 0.9369 2.174 1.472
4 83 0.676 1.168 176 0.8675 1.245 1.206
5 66 0.8496 0.741 122 0.8806 0.850 0.795
6 10 0.9326 0.104 112 0.9169 0.749 0.427
1 --- --- --- 119 0.8667 0.842 0.842
2 --- --- --- 184 0.7673 1.471 1.471
3 --- --- --- 106 0.8971 0.725 0.725
4 --- --- --- 88 0.8071 0.669 0.669
5 --- --- --- 212 0.9279 1.402 1.402
6 --- --- --- 122 0.8929 0.838 0.838
Round 1 Round 2
Sham
106
107
108
109
110
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Table K.4. Quantification of inhibitory synapses in the superficial dorsal horn at 
day 14 after sham or painful facet joint injury (Chapter 8). 
 
Note – These data were collected and analyzed by Ben Bulka. 
 
Group Rat # Slice Side Stack Synapses
Red 
Threshold
Green 
Threshold
Area
Normalized 
Synapses
1 L 7 169 110 115 0.963 175
2 L 8 485 115 120 0.708 686
3 L 9 1570 130 115 0.963 1630
4 L 10 1133 115 120 0.455 2488
5 L 11 117 115 100 0.681 172
1 L 1 1376 110 100 0.968 1421
2 L 2 726 120 110 0.965 752
3 L 3 1503 120 90 0.992 1516
4 L 4 657 110 110 0.985 667
5 L 5 514 120 120 0.979 525
6 L 6 801 120 115 0.976 820
1 L 18 1722 145 110 0.925 1861
2 L 19 1122 110 115 0.953 1177
3 L 20 684 125 90 0.827 827
4 L 21 1253 135 100 0.936 1338
5 L 22 1443 130 90 0.947 1524
6 L 23 359 130 110 0.658 546
1 L 12 267 140 120 0.895 298
2 L 13 1294 125 110 0.959 1349
3 L 14 944 130 85 0.948 996
4 L 15 582 120 85 0.961 606
5 L 16 504 120 90 0.800 630
6 L 17 1403 135 90 0.941 1490
1 L 24 845 145 115 0.913 926
2 L 25 901 130 115 0.800 1127
3 L 26 970 130 100 0.834 1163
4 L 27 737 135 95 0.844 873
5 L 28 251 130 105 0.901 278
6 L 29 1040 120 100 0.834 1247
1 L 34 2239 130 110 0.991 2259
2 L 35 2590 125 110 0.995 2604
3 L 36 2176 125 105 0.981 2219
4 L 37 2556 150 120 0.996 2566
5 L 38 2384 135 95 0.994 2400
6 L 39 2108 130 110 0.990 2130
2 L 30 1290 140 115 0.982 1313
3 L 31 1524 140 130 0.985 1547
5 L 32 3259 125 100 0.990 3293
6 L 33 1660 130 115 0.966 1718
1 L 45 359 125 105 0.990 363
2 L 46 973 125 90 0.989 984
3 L 47 826 125 100 0.990 835
4 L 48 1519 135 125 0.996 1526
5 L 49 2181 130 120 0.993 2196
6 L 50 987 120 120 0.996 991
1 L 40 1030 135 130 0.453 2274
2 L 41 1983 135 125 0.975 2033
3 L 42 1552 140 120 0.996 1559
5 L 43 531 125 105 0.246 2159
1 L 51 2199 125 125 0.982 2239
2 L 52 2057 135 110 0.960 2142
3 L 53 1965 130 120 0.986 1993
4 L 54 2107 135 125 0.928 2270
5 L 55 2309 140 120 0.982 2352
6 L 56 2250 130 115 0.998 2256
Injury
100
101
102
104
105
Sham
110
109
108
107
106
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